




Analysis Type:	PANTHER Overrepresentation Test (Released 20221013)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.6799722 Released 2022-07-01
Analyzed List:	L2-3 IT All DE Genes.txt (Mus musculus)
Reference List:	L2-3 IT All Expressed Genes.txt (Mus musculus)	There are duplicate IDs in the file. The unique set of IDs will be used.
Test Type:	FISHER
Correction:	FDR
GO biological process complete	L2-3 IT All Expressed Genes.txt - REFLIST (9465)	L2-3 IT All DE Genes.txt (249)	L2-3 IT All DE Genes.txt (expected)	L2-3 IT All DE Genes.txt (over/under)	L2-3 IT All DE Genes.txt (fold Enrichment)	L2-3 IT All DE Genes.txt (raw P-value)	L2-3 IT All DE Genes.txt (FDR)
facial nucleus development (GO:0021754)	1	1	.03	+	38.01	5.06E-02	1.00E00
hypoglossal nucleus development (GO:0021743)	1	1	.03	+	38.01	5.06E-02	1.00E00
abducens nucleus development (GO:0021742)	1	1	.03	+	38.01	5.06E-02	1.00E00
basophil chemotaxis (GO:0002575)	1	1	.03	+	38.01	5.06E-02	1.00E00
cerebellar cortex structural organization (GO:0021698)	1	1	.03	+	38.01	5.06E-02	1.00E00
cyclooxygenase pathway (GO:0019371)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	1	1	.03	+	38.01	5.06E-02	1.00E00
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	1	1	.03	+	38.01	5.06E-02	1.00E00
olfactory nerve structural organization (GO:0021629)	1	1	.03	+	38.01	5.06E-02	1.00E00
olfactory nerve morphogenesis (GO:0021627)	1	1	.03	+	38.01	5.06E-02	1.00E00
protein localization to pericentric heterochromatin (GO:1902682)	1	1	.03	+	38.01	5.06E-02	1.00E00
cellular response to fluoride (GO:1902618)	1	1	.03	+	38.01	5.06E-02	1.00E00
response to fluoride (GO:1902617)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of vasculogenesis (GO:2001213)	1	1	.03	+	38.01	5.06E-02	1.00E00
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of T cell mediated cytotoxicity (GO:0001915)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	1	1	.03	+	38.01	5.06E-02	1.00E00
trophectodermal cellular morphogenesis (GO:0001831)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of miRNA catabolic process (GO:2000626)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	1	1	.03	+	38.01	5.06E-02	1.00E00
extraction of mislocalized protein from mitochondrial outer membrane (GO:0140570)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of CD24 production (GO:2000560)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of CD24 production (GO:2000559)	1	1	.03	+	38.01	5.06E-02	1.00E00
glutamate biosynthetic process (GO:0006537)	2	2	.05	+	38.01	3.80E-03	5.93E-01
cell proliferation in midbrain (GO:0033278)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	1	1	.03	+	38.01	5.06E-02	1.00E00
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of monocyte extravasation (GO:2000439)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of monocyte extravasation (GO:2000438)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of monocyte extravasation (GO:2000437)	2	2	.05	+	38.01	3.80E-03	5.86E-01
cellular response to non-ionic osmotic stress (GO:0071471)	1	1	.03	+	38.01	5.06E-02	1.00E00
basal protein localization (GO:0045175)	1	1	.03	+	38.01	5.06E-02	1.00E00
trehalose metabolic process (GO:0005991)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of protein activation cascade (GO:2000257)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of platelet-derived growth factor production (GO:0090362)	1	1	.03	+	38.01	5.06E-02	1.00E00
thermosensory behavior (GO:0040040)	1	1	.03	+	38.01	5.06E-02	1.00E00
AMPA selective glutamate receptor signaling pathway (GO:0098990)	1	1	.03	+	38.01	5.06E-02	1.00E00
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	1	1	.03	+	38.01	5.06E-02	1.00E00
protein-containing complex assembly involved in synapse maturation (GO:0090126)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	1	1	.03	+	38.01	5.06E-02	1.00E00
cellular response to glyceraldehyde (GO:1905631)	1	1	.03	+	38.01	5.06E-02	1.00E00
response to glyceraldehyde (GO:1905630)	1	1	.03	+	38.01	5.06E-02	1.00E00
monocyte aggregation (GO:0070487)	1	1	.03	+	38.01	5.06E-02	1.00E00
trehalose metabolism in response to stress (GO:0070413)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of ERBB3 signaling pathway (GO:1905580)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of ERBB3 signaling pathway (GO:1905578)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of ephrin receptor signaling pathway (GO:1901189)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of Golgi lumen acidification (GO:1905528)	1	1	.03	+	38.01	5.06E-02	1.00E00
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	1	1	.03	+	38.01	5.06E-02	1.00E00
cell adhesion involved in sprouting angiogenesis (GO:0120078)	1	1	.03	+	38.01	5.06E-02	1.00E00
angiogenic sprout fusion (GO:0120077)	1	1	.03	+	38.01	5.06E-02	1.00E00
polynucleotide 5' dephosphorylation (GO:0098507)	1	1	.03	+	38.01	5.06E-02	1.00E00
pseudopodium retraction (GO:0031270)	1	1	.03	+	38.01	5.06E-02	1.00E00
ATP export (GO:1904669)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of MDA-5 signaling pathway (GO:1900245)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of free ubiquitin chain polymerization (GO:1904544)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of free ubiquitin chain polymerization (GO:1904542)	1	1	.03	+	38.01	5.06E-02	1.00E00
L-ascorbic acid transmembrane transport (GO:0015882)	1	1	.03	+	38.01	5.06E-02	1.00E00
cytosol to endoplasmic reticulum transport (GO:0046967)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of GTP binding (GO:1904426)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of receptor clustering (GO:1903910)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	1	.03	+	38.01	5.06E-02	1.00E00
cellular stress response to acid chemical (GO:0097533)	1	1	.03	+	38.01	5.06E-02	1.00E00
stress response to acid chemical (GO:0097532)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of Wnt protein secretion (GO:0061358)	1	1	.03	+	38.01	5.06E-02	1.00E00
sperm entry (GO:0035037)	1	1	.03	+	38.01	5.06E-02	1.00E00
establishment of glial blood-brain barrier (GO:0060857)	1	1	.03	+	38.01	5.06E-02	1.00E00
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	1	.03	+	38.01	5.06E-02	1.00E00
endothelial cell fate specification (GO:0060847)	1	1	.03	+	38.01	5.06E-02	1.00E00
blood vessel endothelial cell fate commitment (GO:0060846)	1	1	.03	+	38.01	5.06E-02	1.00E00
arterial endothelial cell fate commitment (GO:0060844)	1	1	.03	+	38.01	5.06E-02	1.00E00
arterial endothelial cell differentiation (GO:0060842)	1	1	.03	+	38.01	5.06E-02	1.00E00
opsonization (GO:0008228)	1	1	.03	+	38.01	5.06E-02	1.00E00
positive regulation of protein kinase D signaling (GO:1903572)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of protein kinase D signaling (GO:1903570)	1	1	.03	+	38.01	5.06E-02	1.00E00
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	1	1	.03	+	38.01	5.06E-02	1.00E00
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	1	.03	+	38.01	5.06E-02	1.00E00
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	1	1	.03	+	38.01	5.06E-02	1.00E00
blood vessel endothelial cell fate specification (GO:0097101)	1	1	.03	+	38.01	5.06E-02	1.00E00
establishment of blood-nerve barrier (GO:0008065)	1	1	.03	+	38.01	5.06E-02	1.00E00
lymphocyte migration into lymph node (GO:0097022)	1	1	.03	+	38.01	5.06E-02	1.00E00
response to non-ionic osmotic stress (GO:0010335)	1	1	.03	+	38.01	5.06E-02	1.00E00
blood vessel lumenization (GO:0072554)	1	1	.03	+	38.01	5.06E-02	1.00E00
coronary vein morphogenesis (GO:0003169)	1	1	.03	+	38.01	5.06E-02	1.00E00
glutamine catabolic process (GO:0006543)	3	2	.08	+	25.34	6.22E-03	6.46E-01
cellular response to interleukin-12 (GO:0071349)	3	2	.08	+	25.34	6.22E-03	6.41E-01
positive regulation of type B pancreatic cell proliferation (GO:1904692)	3	2	.08	+	25.34	6.22E-03	6.36E-01
activation of meiosis involved in egg activation (GO:0060466)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of lens fiber cell differentiation (GO:1902747)	4	2	.11	+	19.01	9.17E-03	7.57E-01
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	4	2	.11	+	19.01	9.17E-03	7.52E-01
wax metabolic process (GO:0010166)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of establishment of endothelial barrier (GO:1903141)	2	1	.05	+	19.01	7.50E-02	1.00E00
pyrimidine nucleotide transport (GO:0006864)	2	1	.05	+	19.01	7.50E-02	1.00E00
central nervous system vasculogenesis (GO:0022009)	2	1	.05	+	19.01	7.50E-02	1.00E00
wax biosynthetic process (GO:0010025)	2	1	.05	+	19.01	7.50E-02	1.00E00
medulla oblongata development (GO:0021550)	2	1	.05	+	19.01	7.50E-02	1.00E00
blood vessel maturation (GO:0001955)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of transcription of Notch receptor target (GO:0007221)	4	2	.11	+	19.01	9.17E-03	7.48E-01
endoplasmic reticulum tubular network formation (GO:0071787)	4	2	.11	+	19.01	9.17E-03	7.43E-01
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of cardiac muscle myoblast proliferation (GO:0110022)	2	1	.05	+	19.01	7.50E-02	1.00E00
signal complex assembly (GO:0007172)	2	1	.05	+	19.01	7.50E-02	1.00E00
inner ear receptor cell fate commitment (GO:0060120)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of transforming growth factor beta2 production (GO:0032915)	2	1	.05	+	19.01	7.50E-02	1.00E00
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	2	1	.05	+	19.01	7.50E-02	1.00E00
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	2	1	.05	+	19.01	7.50E-02	1.00E00
putrescine biosynthetic process from ornithine (GO:0033387)	2	1	.05	+	19.01	7.50E-02	1.00E00
S-adenosylmethionine cycle (GO:0033353)	2	1	.05	+	19.01	7.50E-02	1.00E00
extraction of mislocalized protein from membrane (GO:0140568)	2	1	.05	+	19.01	7.50E-02	1.00E00
VEGF-activated neuropilin signaling pathway (GO:0038190)	2	1	.05	+	19.01	7.50E-02	1.00E00
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of polyamine transmembrane transport (GO:1902269)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	2	1	.05	+	19.01	7.50E-02	1.00E00
disaccharide metabolic process (GO:0005984)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of acrosome reaction (GO:2000344)	2	1	.05	+	19.01	7.50E-02	1.00E00
cellular response to interleukin-15 (GO:0071350)	2	1	.05	+	19.01	7.50E-02	1.00E00
activation of meiosis (GO:0090427)	2	1	.05	+	19.01	7.50E-02	1.00E00
retrograde axonal protein transport (GO:0099642)	2	1	.05	+	19.01	7.50E-02	1.00E00
polyamine transmembrane transport (GO:1902047)	2	1	.05	+	19.01	7.50E-02	1.00E00
bone regeneration (GO:1990523)	2	1	.05	+	19.01	7.50E-02	1.00E00
pyrimidine nucleotide import into mitochondrion (GO:1990519)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of endothelial cell development (GO:1901551)	2	1	.05	+	19.01	7.50E-02	1.00E00
dense core granule maturation (GO:1990502)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of mRNA modification (GO:0090367)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of mRNA modification (GO:0090365)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of platelet-derived growth factor production (GO:0090361)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	2	1	.05	+	19.01	7.50E-02	1.00E00
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	6	3	.16	+	19.01	1.25E-03	4.04E-01
ossification involved in bone remodeling (GO:0043932)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of glucocorticoid metabolic process (GO:0031944)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of somatostatin secretion (GO:0090274)	2	1	.05	+	19.01	7.50E-02	1.00E00
response to interleukin-12 (GO:0070671)	4	2	.11	+	19.01	9.17E-03	7.39E-01
protein localization to nuclear pore (GO:0090204)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of male gonad development (GO:2000020)	2	1	.05	+	19.01	7.50E-02	1.00E00
prostaglandin secretion (GO:0032310)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of prostaglandin secretion (GO:0032307)	2	1	.05	+	19.01	7.50E-02	1.00E00
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	2	1	.05	+	19.01	7.50E-02	1.00E00
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	2	1	.05	+	19.01	7.50E-02	1.00E00
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	2	1	.05	+	19.01	7.50E-02	1.00E00
epidermal cell fate specification (GO:0009957)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	4	2	.11	+	19.01	9.17E-03	7.34E-01
auditory receptor cell fate commitment (GO:0009912)	2	1	.05	+	19.01	7.50E-02	1.00E00
cell-cell adhesion involved in synapse maturation (GO:0090125)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	2	1	.05	+	19.01	7.50E-02	1.00E00
notochord morphogenesis (GO:0048570)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of response to nutrient levels (GO:0032109)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of response to extracellular stimulus (GO:0032106)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of appetite (GO:0032100)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of ephrin receptor signaling pathway (GO:1901187)	2	1	.05	+	19.01	7.50E-02	1.00E00
ncRNA polyadenylation (GO:0043629)	2	1	.05	+	19.01	7.50E-02	1.00E00
cortical microtubule organization (GO:0043622)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of Golgi lumen acidification (GO:1905526)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of response to food (GO:0032097)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	2	1	.05	+	19.01	7.50E-02	1.00E00
calcium ion import into sarcoplasmic reticulum (GO:1990036)	2	1	.05	+	19.01	7.50E-02	1.00E00
dorsal aorta morphogenesis (GO:0035912)	2	1	.05	+	19.01	7.50E-02	1.00E00
dorsal aorta development (GO:0035907)	2	1	.05	+	19.01	7.50E-02	1.00E00
detection of virus (GO:0009597)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of epithelial tube formation (GO:1905278)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of epithelial tube formation (GO:1905276)	2	1	.05	+	19.01	7.50E-02	1.00E00
interleukin-15-mediated signaling pathway (GO:0035723)	2	1	.05	+	19.01	7.50E-02	1.00E00
interleukin-12-mediated signaling pathway (GO:0035722)	2	1	.05	+	19.01	7.50E-02	1.00E00
clathrin-coated pit assembly (GO:1905224)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	2	1	.05	+	19.01	7.50E-02	1.00E00
pseudopodium organization (GO:0031268)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of vascular associated smooth muscle contraction (GO:1904694)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of melanin biosynthetic process (GO:0048022)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of RIG-I signaling pathway (GO:1900246)	4	2	.11	+	19.01	9.17E-03	7.30E-01
dendrite regeneration (GO:0031104)	2	1	.05	+	19.01	7.50E-02	1.00E00
membrane bending (GO:0097753)	2	1	.05	+	19.01	7.50E-02	1.00E00
polyamine transport (GO:0015846)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	4	2	.11	+	19.01	9.17E-03	7.25E-01
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	4	2	.11	+	19.01	9.17E-03	7.21E-01
positive regulation of neuromuscular synaptic transmission (GO:1900075)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of neuromuscular synaptic transmission (GO:1900073)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of secretory granule organization (GO:1904411)	2	1	.05	+	19.01	7.50E-02	1.00E00
O-glycan processing, core 1 (GO:0016267)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of secretory granule organization (GO:1904409)	2	1	.05	+	19.01	7.50E-02	1.00E00
myo-inositol transport (GO:0015798)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of neuromuscular junction development (GO:1904397)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of synaptic vesicle priming (GO:0010808)	2	1	.05	+	19.01	7.50E-02	1.00E00
sno(s)RNA catabolic process (GO:0016077)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of potassium ion export across plasma membrane (GO:1903764)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	2	1	.05	+	19.01	7.50E-02	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	4	2	.11	+	19.01	9.17E-03	7.17E-01
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	2	1	.05	+	19.01	7.50E-02	1.00E00
cardiac vascular smooth muscle cell development (GO:0060948)	2	1	.05	+	19.01	7.50E-02	1.00E00
cellular response to vasopressin (GO:1904117)	2	1	.05	+	19.01	7.50E-02	1.00E00
response to vasopressin (GO:1904116)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of cell adhesion involved in heart morphogenesis (GO:0061344)	2	1	.05	+	19.01	7.50E-02	1.00E00
endothelial cell fate commitment (GO:0060839)	2	1	.05	+	19.01	7.50E-02	1.00E00
blood vessel endothelial cell differentiation (GO:0060837)	2	1	.05	+	19.01	7.50E-02	1.00E00
growth plate cartilage chondrocyte proliferation (GO:0003419)	2	1	.05	+	19.01	7.50E-02	1.00E00
cellular response to anisomycin (GO:0072740)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	2	1	.05	+	19.01	7.50E-02	1.00E00
fasciculation of motor neuron axon (GO:0097156)	2	1	.05	+	19.01	7.50E-02	1.00E00
epithelial fluid transport (GO:0042045)	2	1	.05	+	19.01	7.50E-02	1.00E00
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	2	1	.05	+	19.01	7.50E-02	1.00E00
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	4	2	.11	+	19.01	9.17E-03	7.13E-01
guanylate kinase-associated protein clustering (GO:0097117)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	1	.05	+	19.01	7.50E-02	1.00E00
epithelial cell differentiation involved in salivary gland development (GO:0060690)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	2	1	.05	+	19.01	7.50E-02	1.00E00
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	2	1	.05	+	19.01	7.50E-02	1.00E00
negative regulation of adherens junction organization (GO:1903392)	2	1	.05	+	19.01	7.50E-02	1.00E00
vascular wound healing (GO:0061042)	2	1	.05	+	19.01	7.50E-02	1.00E00
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	2	1	.05	+	19.01	7.50E-02	1.00E00
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	2	1	.05	+	19.01	7.50E-02	1.00E00
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	2	1	.05	+	19.01	7.50E-02	1.00E00
mammary placode formation (GO:0060596)	2	1	.05	+	19.01	7.50E-02	1.00E00
cellular chloride ion homeostasis (GO:0030644)	7	3	.18	+	16.29	1.75E-03	4.74E-01
cellular monovalent inorganic anion homeostasis (GO:0030320)	7	3	.18	+	16.29	1.75E-03	4.64E-01
regulation of lens fiber cell differentiation (GO:1902746)	5	2	.13	+	15.20	1.26E-02	8.43E-01
leukocyte migration involved in inflammatory response (GO:0002523)	5	2	.13	+	15.20	1.26E-02	8.39E-01
histone H3-K27 demethylation (GO:0071557)	5	2	.13	+	15.20	1.26E-02	8.35E-01
establishment of centrosome localization (GO:0051660)	5	2	.13	+	15.20	1.26E-02	8.30E-01
autophagosome membrane docking (GO:0016240)	5	2	.13	+	15.20	1.26E-02	8.26E-01
sympathetic ganglion development (GO:0061549)	5	2	.13	+	15.20	1.26E-02	8.22E-01
amino acid homeostasis (GO:0080144)	5	2	.13	+	15.20	1.26E-02	8.18E-01
cellular anion homeostasis (GO:0030002)	8	3	.21	+	14.25	2.36E-03	4.82E-01
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	3	1	.08	+	12.67	9.87E-02	1.00E00
ammonium transmembrane transport (GO:0072488)	3	1	.08	+	12.67	9.87E-02	1.00E00
club cell differentiation (GO:0060486)	3	1	.08	+	12.67	9.87E-02	1.00E00
acrosomal vesicle exocytosis (GO:0060478)	3	1	.08	+	12.67	9.87E-02	1.00E00
lung vasculature development (GO:0060426)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of axon guidance (GO:1902669)	3	1	.08	+	12.67	9.87E-02	1.00E00
cardiac epithelial to mesenchymal transition (GO:0060317)	6	2	.16	+	12.67	1.65E-02	9.09E-01
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	3	1	.08	+	12.67	9.87E-02	1.00E00
xenobiotic transmembrane transport (GO:0006855)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of gamma-delta T cell differentiation (GO:0045586)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	6	2	.16	+	12.67	1.65E-02	9.05E-01
negative regulation of osteoclast development (GO:2001205)	3	1	.08	+	12.67	9.87E-02	1.00E00
olfactory nerve development (GO:0021553)	3	1	.08	+	12.67	9.87E-02	1.00E00
protein localization to P-body (GO:0110012)	3	1	.08	+	12.67	9.87E-02	1.00E00
NK T cell differentiation (GO:0001865)	3	1	.08	+	12.67	9.87E-02	1.00E00
nephric duct morphogenesis (GO:0072178)	3	1	.08	+	12.67	9.87E-02	1.00E00
epithelial cell fate commitment (GO:0072148)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	3	1	.08	+	12.67	9.87E-02	1.00E00
viral protein processing (GO:0019082)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of acrosome reaction (GO:0060046)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of cellular pH reduction (GO:0032849)	3	1	.08	+	12.67	9.87E-02	1.00E00
ornithine metabolic process (GO:0006591)	3	1	.08	+	12.67	9.87E-02	1.00E00
ERBB4-ERBB4 signaling pathway (GO:0038138)	3	1	.08	+	12.67	9.87E-02	1.00E00
ERBB4 signaling pathway (GO:0038130)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	3	1	.08	+	12.67	9.87E-02	1.00E00
T-tubule organization (GO:0033292)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of glucokinase activity (GO:0033133)	3	1	.08	+	12.67	9.87E-02	1.00E00
cellular response to ether (GO:0071362)	6	2	.16	+	12.67	1.65E-02	9.01E-01
calcium ion export (GO:1901660)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of T cell differentiation in thymus (GO:0033089)	3	1	.08	+	12.67	9.87E-02	1.00E00
glutamate homeostasis (GO:0090461)	3	1	.08	+	12.67	9.87E-02	1.00E00
acinar cell differentiation (GO:0090425)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of gonad development (GO:1905941)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of serotonin uptake (GO:0051612)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of serotonin uptake (GO:0051611)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of branching morphogenesis of a nerve (GO:2000173)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	3	1	.08	+	12.67	9.87E-02	1.00E00
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of sodium:proton antiporter activity (GO:0032417)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of sodium:proton antiporter activity (GO:0032415)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of neurotransmitter uptake (GO:0051581)	3	1	.08	+	12.67	9.87E-02	1.00E00
histone H2B acetylation (GO:0043969)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of lymphangiogenesis (GO:1901492)	3	1	.08	+	12.67	9.87E-02	1.00E00
nuclear matrix anchoring at nuclear membrane (GO:0090292)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of fibroblast growth factor production (GO:0090271)	3	1	.08	+	12.67	9.87E-02	1.00E00
response to interleukin-15 (GO:0070672)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of icosanoid secretion (GO:0032304)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of pancreatic juice secretion (GO:0090188)	3	1	.08	+	12.67	9.87E-02	1.00E00
lactone metabolic process (GO:1901334)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of blood-brain barrier permeability (GO:1905604)	3	1	.08	+	12.67	9.87E-02	1.00E00
leukocyte aggregation (GO:0070486)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of steroid hormone biosynthetic process (GO:0090032)	3	1	.08	+	12.67	9.87E-02	1.00E00
serotonergic neuron axon guidance (GO:0036515)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	3	1	.08	+	12.67	9.87E-02	1.00E00
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	3	1	.08	+	12.67	9.87E-02	1.00E00
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	3	1	.08	+	12.67	9.87E-02	1.00E00
messenger ribonucleoprotein complex assembly (GO:1990120)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of fever generation (GO:0031622)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of fever generation (GO:0031620)	3	1	.08	+	12.67	9.87E-02	1.00E00
ventral trunk neural crest cell migration (GO:0036486)	3	1	.08	+	12.67	9.87E-02	1.00E00
trunk neural crest cell migration (GO:0036484)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	3	1	.08	+	12.67	9.87E-02	1.00E00
nuclear matrix organization (GO:0043578)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	3	1	.08	+	12.67	9.87E-02	1.00E00
response to nematode (GO:0009624)	3	1	.08	+	12.67	9.87E-02	1.00E00
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	3	1	.08	+	12.67	9.87E-02	1.00E00
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	3	1	.08	+	12.67	9.87E-02	1.00E00
putrescine biosynthetic process (GO:0009446)	3	1	.08	+	12.67	9.87E-02	1.00E00
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	3	1	.08	+	12.67	9.87E-02	1.00E00
phosphatidylserine acyl-chain remodeling (GO:0036150)	3	1	.08	+	12.67	9.87E-02	1.00E00
histone H3-K9 trimethylation (GO:0036124)	3	1	.08	+	12.67	9.87E-02	1.00E00
cellular response to ionomycin (GO:1904637)	3	1	.08	+	12.67	9.87E-02	1.00E00
response to ionomycin (GO:1904636)	3	1	.08	+	12.67	9.87E-02	1.00E00
histone H4-K20 demethylation (GO:0035574)	3	1	.08	+	12.67	9.87E-02	1.00E00
phosphatidylinositol catabolic process (GO:0031161)	3	1	.08	+	12.67	9.87E-02	1.00E00
aminophospholipid transport (GO:0015917)	3	1	.08	+	12.67	9.87E-02	1.00E00
meiotic chromosome movement towards spindle pole (GO:0016344)	3	1	.08	+	12.67	9.87E-02	1.00E00
secretory granule maturation (GO:0061792)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of Notch signaling pathway involved in heart induction (GO:0035480)	3	1	.08	+	12.67	9.87E-02	1.00E00
cell migration involved in vasculogenesis (GO:0035441)	3	1	.08	+	12.67	9.87E-02	1.00E00
serine phosphorylation of STAT protein (GO:0042501)	3	1	.08	+	12.67	9.87E-02	1.00E00
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	3	1	.08	+	12.67	9.87E-02	1.00E00
prostaglandin transport (GO:0015732)	3	1	.08	+	12.67	9.87E-02	1.00E00
membrane repolarization during action potential (GO:0086011)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	6	2	.16	+	12.67	1.65E-02	8.98E-01
negative regulation of sequestering of triglyceride (GO:0010891)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of ATF6-mediated unfolded protein response (GO:1903891)	3	1	.08	+	12.67	9.87E-02	1.00E00
trigeminal ganglion development (GO:0061551)	3	1	.08	+	12.67	9.87E-02	1.00E00
trunk segmentation (GO:0035290)	3	1	.08	+	12.67	9.87E-02	1.00E00
basal dendrite arborization (GO:0150020)	3	1	.08	+	12.67	9.87E-02	1.00E00
sympathetic neuron projection guidance (GO:0097491)	3	1	.08	+	12.67	9.87E-02	1.00E00
sympathetic neuron projection extension (GO:0097490)	3	1	.08	+	12.67	9.87E-02	1.00E00
basal dendrite morphogenesis (GO:0150019)	3	1	.08	+	12.67	9.87E-02	1.00E00
basal dendrite development (GO:0150018)	3	1	.08	+	12.67	9.87E-02	1.00E00
snRNA catabolic process (GO:0016076)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of p38MAPK cascade (GO:1903753)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of MDA-5 signaling pathway (GO:0039533)	3	1	.08	+	12.67	9.87E-02	1.00E00
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of gamma-delta T cell activation (GO:0046643)	3	1	.08	+	12.67	9.87E-02	1.00E00
establishment of Sertoli cell barrier (GO:0097368)	3	1	.08	+	12.67	9.87E-02	1.00E00
protein localization to heterochromatin (GO:0097355)	3	1	.08	+	12.67	9.87E-02	1.00E00
L-ascorbic acid metabolic process (GO:0019852)	3	1	.08	+	12.67	9.87E-02	1.00E00
establishment of blood-brain barrier (GO:0060856)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	3	1	.08	+	12.67	9.87E-02	1.00E00
cellular response to rapamycin (GO:0072752)	3	1	.08	+	12.67	9.87E-02	1.00E00
brainstem development (GO:0003360)	3	1	.08	+	12.67	9.87E-02	1.00E00
response to anisomycin (GO:0072739)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of mast cell chemotaxis (GO:0060754)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of mast cell chemotaxis (GO:0060753)	3	1	.08	+	12.67	9.87E-02	1.00E00
fasciculation of sensory neuron axon (GO:0097155)	3	1	.08	+	12.67	9.87E-02	1.00E00
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	6	2	.16	+	12.67	1.65E-02	8.94E-01
mesodermal cell migration (GO:0008078)	3	1	.08	+	12.67	9.87E-02	1.00E00
lymphocyte migration into lymphoid organs (GO:0097021)	3	1	.08	+	12.67	9.87E-02	1.00E00
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	3	1	.08	+	12.67	9.87E-02	1.00E00
facioacoustic ganglion development (GO:1903375)	3	1	.08	+	12.67	9.87E-02	1.00E00
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	3	1	.08	+	12.67	9.87E-02	1.00E00
hypothalamus cell migration (GO:0021855)	3	1	.08	+	12.67	9.87E-02	1.00E00
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	3	1	.08	+	12.67	9.87E-02	1.00E00
endothelial cell apoptotic process (GO:0072577)	3	1	.08	+	12.67	9.87E-02	1.00E00
liver morphogenesis (GO:0072576)	3	1	.08	+	12.67	9.87E-02	1.00E00
positive regulation of hexokinase activity (GO:1903301)	3	1	.08	+	12.67	9.87E-02	1.00E00
endocardium morphogenesis (GO:0003160)	3	1	.08	+	12.67	9.87E-02	1.00E00
monovalent inorganic anion homeostasis (GO:0055083)	10	3	.26	+	11.40	3.93E-03	5.94E-01
chloride ion homeostasis (GO:0055064)	10	3	.26	+	11.40	3.93E-03	5.87E-01
regulation of potassium ion import (GO:1903286)	7	2	.18	+	10.86	2.09E-02	9.89E-01
regulation of vascular associated smooth muscle contraction (GO:0003056)	7	2	.18	+	10.86	2.09E-02	9.86E-01
regulation of heterotypic cell-cell adhesion (GO:0034114)	7	2	.18	+	10.86	2.09E-02	9.82E-01
cranial nerve structural organization (GO:0021604)	7	2	.18	+	10.86	2.09E-02	9.79E-01
lymphangiogenesis (GO:0001946)	7	2	.18	+	10.86	2.09E-02	9.75E-01
activation of adenylate cyclase activity (GO:0007190)	7	2	.18	+	10.86	2.09E-02	9.72E-01
chemical homeostasis within a tissue (GO:0048875)	7	2	.18	+	10.86	2.09E-02	9.69E-01
regulation of branching morphogenesis of a nerve (GO:2000172)	7	2	.18	+	10.86	2.09E-02	9.65E-01
dicarboxylic acid biosynthetic process (GO:0043650)	7	2	.18	+	10.86	2.09E-02	9.62E-01
endothelial cell chemotaxis (GO:0035767)	7	2	.18	+	10.86	2.09E-02	9.59E-01
positive regulation of aspartic-type peptidase activity (GO:1905247)	7	2	.18	+	10.86	2.09E-02	9.55E-01
ubiquitin recycling (GO:0010992)	7	2	.18	+	10.86	2.09E-02	9.52E-01
glutamine family amino acid biosynthetic process (GO:0009084)	7	2	.18	+	10.86	2.09E-02	9.49E-01
negative regulation of mitochondrial fusion (GO:0010637)	7	2	.18	+	10.86	2.09E-02	9.46E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	8	2	.21	+	9.50	2.57E-02	1.00E00
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	4	1	.11	+	9.50	1.22E-01	1.00E00
bud elongation involved in lung branching (GO:0060449)	4	1	.11	+	9.50	1.22E-01	1.00E00
lung growth (GO:0060437)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	4	1	.11	+	9.50	1.22E-01	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of cell adhesion mediated by integrin (GO:0033629)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	4	1	.11	+	9.50	1.22E-01	1.00E00
trigeminal nerve structural organization (GO:0021637)	4	1	.11	+	9.50	1.22E-01	1.00E00
trigeminal nerve morphogenesis (GO:0021636)	4	1	.11	+	9.50	1.22E-01	1.00E00
bone trabecula formation (GO:0060346)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of grooming behavior (GO:2000821)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of synaptic vesicle clustering (GO:2000809)	8	2	.21	+	9.50	2.57E-02	1.00E00
primitive erythrocyte differentiation (GO:0060319)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of vasculogenesis (GO:2001212)	4	1	.11	+	9.50	1.22E-01	1.00E00
trigeminal nerve development (GO:0021559)	4	1	.11	+	9.50	1.22E-01	1.00E00
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	8	2	.21	+	9.50	2.57E-02	1.00E00
detection of cell density (GO:0060245)	4	1	.11	+	9.50	1.22E-01	1.00E00
response to ether (GO:0045472)	8	2	.21	+	9.50	2.57E-02	1.00E00
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	4	1	.11	+	9.50	1.22E-01	1.00E00
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	4	1	.11	+	9.50	1.22E-01	1.00E00
nephric duct development (GO:0072176)	4	1	.11	+	9.50	1.22E-01	1.00E00
trophectodermal cell differentiation (GO:0001829)	8	2	.21	+	9.50	2.57E-02	1.00E00
regulation of miRNA catabolic process (GO:2000625)	4	1	.11	+	9.50	1.22E-01	1.00E00
sphingomyelin biosynthetic process (GO:0006686)	8	2	.21	+	9.50	2.57E-02	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	8	2	.21	+	9.50	2.57E-02	1.00E00
neuropilin signaling pathway (GO:0038189)	4	1	.11	+	9.50	1.22E-01	1.00E00
hard palate development (GO:0060022)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of synapse assembly (GO:0051964)	4	1	.11	+	9.50	1.22E-01	1.00E00
endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	1	.11	+	9.50	1.22E-01	1.00E00
neurotransmitter receptor metabolic process (GO:0045213)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of polyamine transmembrane transport (GO:1902267)	4	1	.11	+	9.50	1.22E-01	1.00E00
N-terminal protein myristoylation (GO:0006499)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	4	1	.11	+	9.50	1.22E-01	1.00E00
G protein-coupled opioid receptor signaling pathway (GO:0038003)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of histone ubiquitination (GO:0033183)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	8	2	.21	+	9.50	2.57E-02	1.00E00
lipid export from cell (GO:0140353)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of hepatocyte proliferation (GO:2000347)	8	2	.21	+	9.50	2.57E-02	1.00E00
regulation of terminal button organization (GO:2000331)	4	1	.11	+	9.50	1.22E-01	1.00E00
protein myristoylation (GO:0018377)	4	1	.11	+	9.50	1.22E-01	1.00E00
interleukin-4 production (GO:0032633)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of translation at postsynapse (GO:0140245)	4	1	.11	+	9.50	1.22E-01	1.00E00
cellular response to iron ion (GO:0071281)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of lymphangiogenesis (GO:1901490)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of somatostatin secretion (GO:0090273)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of fibroblast growth factor production (GO:0090270)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of retinal ganglion cell axon guidance (GO:0090259)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of male gonad development (GO:2000018)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of protein localization to cell surface (GO:2000009)	8	2	.21	+	9.50	2.57E-02	1.00E00
inhibitory chemical synaptic transmission (GO:0098977)	4	1	.11	+	9.50	1.22E-01	1.00E00
response to rapamycin (GO:1901355)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	8	2	.21	+	9.50	2.57E-02	1.00E00
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of pancreatic juice secretion (GO:0090186)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	4	1	.11	+	9.50	1.22E-01	1.00E00
synapse pruning (GO:0098883)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of artery morphogenesis (GO:1905653)	4	1	.11	+	9.50	1.22E-01	1.00E00
chromosome movement towards spindle pole (GO:0051305)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of protein kinase C signaling (GO:0090037)	4	1	.11	+	9.50	1.22E-01	1.00E00
anatomical structure arrangement (GO:0048532)	12	3	.32	+	9.50	6.03E-03	6.41E-01
dopaminergic neuron axon guidance (GO:0036514)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of protein localization to endoplasmic reticulum (GO:1905550)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of mitotic cell cycle, embryonic (GO:0009794)	4	1	.11	+	9.50	1.22E-01	1.00E00
planar cell polarity pathway involved in axon guidance (GO:1904938)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of macrophage proliferation (GO:0120041)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of macrophage proliferation (GO:0120040)	4	1	.11	+	9.50	1.22E-01	1.00E00
lymph vessel morphogenesis (GO:0036303)	8	2	.21	+	9.50	2.57E-02	1.00E00
atrioventricular canal development (GO:0036302)	4	1	.11	+	9.50	1.22E-01	1.00E00
notochord development (GO:0030903)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of prostaglandin biosynthetic process (GO:0031394)	4	1	.11	+	9.50	1.22E-01	1.00E00
putrescine metabolic process (GO:0009445)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of metalloendopeptidase activity (GO:1904684)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of metallopeptidase activity (GO:1905049)	4	1	.11	+	9.50	1.22E-01	1.00E00
long-chain fatty acid import into peroxisome (GO:0015910)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of TORC2 signaling (GO:1904515)	4	1	.11	+	9.50	1.22E-01	1.00E00
anion homeostasis (GO:0055081)	16	4	.42	+	9.50	1.48E-03	4.36E-01
motor learning (GO:0061743)	4	1	.11	+	9.50	1.22E-01	1.00E00
post-embryonic camera-type eye development (GO:0031077)	4	1	.11	+	9.50	1.22E-01	1.00E00
R-loop disassembly (GO:0062176)	4	1	.11	+	9.50	1.22E-01	1.00E00
free ubiquitin chain polymerization (GO:0010994)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of protein kinase C activity (GO:1900020)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of protein kinase C activity (GO:1900019)	4	1	.11	+	9.50	1.22E-01	1.00E00
spontaneous neurotransmitter secretion (GO:0061669)	8	2	.21	+	9.50	2.57E-02	1.00E00
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of hippo signaling (GO:0035332)	4	1	.11	+	9.50	1.22E-01	1.00E00
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	4	1	.11	+	9.50	1.22E-01	1.00E00
peristalsis (GO:0030432)	4	1	.11	+	9.50	1.22E-01	1.00E00
cranial ganglion development (GO:0061550)	4	1	.11	+	9.50	1.22E-01	1.00E00
peptidyl-arginine omega-N-methylation (GO:0035247)	4	1	.11	+	9.50	1.22E-01	1.00E00
motor neuron migration (GO:0097475)	8	2	.21	+	9.50	2.57E-02	1.00E00
positive regulation of protein kinase A signaling (GO:0010739)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	8	2	.21	+	9.50	2.57E-02	1.00E00
regulation of Wnt protein secretion (GO:0061356)	4	1	.11	+	9.50	1.22E-01	1.00E00
nuclear speck organization (GO:0035063)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	4	1	.11	+	9.50	1.22E-01	1.00E00
transition between fast and slow fiber (GO:0014883)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of inhibitory postsynaptic potential (GO:0097151)	8	2	.21	+	9.50	2.57E-02	1.00E00
gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of striated muscle contraction (GO:0045989)	4	1	.11	+	9.50	1.22E-01	1.00E00
postsynaptic membrane assembly (GO:0097104)	8	2	.21	+	9.50	2.57E-02	1.00E00
cell differentiation involved in salivary gland development (GO:0060689)	4	1	.11	+	9.50	1.22E-01	1.00E00
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	4	1	.11	+	9.50	1.22E-01	1.00E00
vascular associated smooth muscle cell development (GO:0097084)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of phospholipid translocation (GO:0061092)	4	1	.11	+	9.50	1.22E-01	1.00E00
negative regulation of T cell mediated immunity (GO:0002710)	4	1	.11	+	9.50	1.22E-01	1.00E00
regulation of adherens junction organization (GO:1903391)	4	1	.11	+	9.50	1.22E-01	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	4	1	.11	+	9.50	1.22E-01	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	4	1	.11	+	9.50	1.22E-01	1.00E00
interneuron migration from the subpallium to the cortex (GO:0021830)	4	1	.11	+	9.50	1.22E-01	1.00E00
mammary gland formation (GO:0060592)	4	1	.11	+	9.50	1.22E-01	1.00E00
pyrimidine-containing compound transmembrane transport (GO:0072531)	4	1	.11	+	9.50	1.22E-01	1.00E00
secondary heart field specification (GO:0003139)	4	1	.11	+	9.50	1.22E-01	1.00E00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	13	3	.34	+	8.77	7.28E-03	6.81E-01
positive regulation of amyloid-beta formation (GO:1902004)	13	3	.34	+	8.77	7.28E-03	6.76E-01
positive regulation of fatty acid biosynthetic process (GO:0045723)	9	2	.24	+	8.45	3.09E-02	1.00E00
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	9	2	.24	+	8.45	3.09E-02	1.00E00
commissural neuron axon guidance (GO:0071679)	9	2	.24	+	8.45	3.09E-02	1.00E00
negative regulation of synapse organization (GO:1905809)	9	2	.24	+	8.45	3.09E-02	1.00E00
positive regulation of synapse maturation (GO:0090129)	9	2	.24	+	8.45	3.09E-02	1.00E00
modulation of inhibitory postsynaptic potential (GO:0098828)	9	2	.24	+	8.45	3.09E-02	1.00E00
regulation of trophoblast cell migration (GO:1901163)	9	2	.24	+	8.45	3.09E-02	1.00E00
sympathetic nervous system development (GO:0048485)	9	2	.24	+	8.45	3.09E-02	1.00E00
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	9	2	.24	+	8.45	3.09E-02	1.00E00
ceramide transport (GO:0035627)	9	2	.24	+	8.45	3.09E-02	1.00E00
negative regulation of long-term synaptic potentiation (GO:1900272)	9	2	.24	+	8.45	3.09E-02	1.00E00
ganglion development (GO:0061548)	9	2	.24	+	8.45	3.09E-02	1.00E00
regulation of RIG-I signaling pathway (GO:0039535)	9	2	.24	+	8.45	3.09E-02	1.00E00
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	9	2	.24	+	8.45	3.09E-02	1.00E00
positive regulation of ERBB signaling pathway (GO:1901186)	14	3	.37	+	8.15	8.67E-03	7.43E-01
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	15	3	.39	+	7.60	1.02E-02	7.67E-01
potassium ion homeostasis (GO:0055075)	15	3	.39	+	7.60	1.02E-02	7.62E-01
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	15	3	.39	+	7.60	1.02E-02	7.58E-01
positive regulation of acute inflammatory response (GO:0002675)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	5	1	.13	+	7.60	1.44E-01	1.00E00
branchiomotor neuron axon guidance (GO:0021785)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of oxidative stress-induced neuron death (GO:1903223)	5	1	.13	+	7.60	1.44E-01	1.00E00
hypotonic response (GO:0006971)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of endothelial cell differentiation (GO:0045602)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of dopamine secretion (GO:0033603)	5	1	.13	+	7.60	1.44E-01	1.00E00
egg activation (GO:0007343)	5	1	.13	+	7.60	1.44E-01	1.00E00
facial nerve structural organization (GO:0021612)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of synaptic vesicle clustering (GO:2000807)	10	2	.26	+	7.60	3.65E-02	1.00E00
mRNA alternative polyadenylation (GO:0110104)	5	1	.13	+	7.60	1.44E-01	1.00E00
inflammatory response to antigenic stimulus (GO:0002437)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of osteoclast development (GO:2001204)	5	1	.13	+	7.60	1.44E-01	1.00E00
lymph vessel development (GO:0001945)	10	2	.26	+	7.60	3.65E-02	1.00E00
T cell mediated cytotoxicity (GO:0001913)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of mesenchymal cell proliferation (GO:0072201)	5	1	.13	+	7.60	1.44E-01	1.00E00
T cell cytokine production (GO:0002369)	5	1	.13	+	7.60	1.44E-01	1.00E00
histamine secretion (GO:0001821)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of transforming growth factor beta2 production (GO:0032909)	5	1	.13	+	7.60	1.44E-01	1.00E00
immunological synapse formation (GO:0001771)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation by host of viral genome replication (GO:0044828)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of cellular pH reduction (GO:0032847)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of receptor internalization (GO:0002092)	20	4	.53	+	7.60	2.99E-03	5.59E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301)	5	1	.13	+	7.60	1.44E-01	1.00E00
protein geranylgeranylation (GO:0018344)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of myoblast proliferation (GO:2000288)	5	1	.13	+	7.60	1.44E-01	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of calcium ion import across plasma membrane (GO:1905949)	5	1	.13	+	7.60	1.44E-01	1.00E00
fatty acid derivative biosynthetic process (GO:1901570)	10	2	.26	+	7.60	3.65E-02	1.00E00
venous blood vessel morphogenesis (GO:0048845)	5	1	.13	+	7.60	1.44E-01	1.00E00
trans-synaptic signaling by endocannabinoid (GO:0099542)	5	1	.13	+	7.60	1.44E-01	1.00E00
trans-synaptic signaling by lipid (GO:0099541)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of histone H3-K9 methylation (GO:0051574)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of glucocorticoid biosynthetic process (GO:0031946)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of filopodium assembly (GO:0051490)	5	1	.13	+	7.60	1.44E-01	1.00E00
CUT metabolic process (GO:0071043)	5	1	.13	+	7.60	1.44E-01	1.00E00
CUT catabolic process (GO:0071034)	5	1	.13	+	7.60	1.44E-01	1.00E00
cellular sphingolipid homeostasis (GO:0090156)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of neuron projection regeneration (GO:0070572)	10	2	.26	+	7.60	3.65E-02	1.00E00
positive regulation of axon regeneration (GO:0048680)	10	2	.26	+	7.60	3.65E-02	1.00E00
regulation of artery morphogenesis (GO:1905651)	5	1	.13	+	7.60	1.44E-01	1.00E00
spontaneous synaptic transmission (GO:0098814)	10	2	.26	+	7.60	3.65E-02	1.00E00
negative regulation of protein kinase C signaling (GO:0090038)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of timing of cell differentiation (GO:0048505)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of heat generation (GO:0031652)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of trophoblast cell migration (GO:1901165)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	5	1	.13	+	7.60	1.44E-01	1.00E00
calcium ion export across plasma membrane (GO:1990034)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of aspartic-type peptidase activity (GO:1905245)	10	2	.26	+	7.60	3.65E-02	1.00E00
long-chain fatty acid biosynthetic process (GO:0042759)	5	1	.13	+	7.60	1.44E-01	1.00E00
surfactant homeostasis (GO:0043129)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of receptor binding (GO:1900121)	5	1	.13	+	7.60	1.44E-01	1.00E00
fatty-acyl-CoA biosynthetic process (GO:0046949)	5	1	.13	+	7.60	1.44E-01	1.00E00
protein folding in endoplasmic reticulum (GO:0034975)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of TORC2 signaling (GO:1903939)	5	1	.13	+	7.60	1.44E-01	1.00E00
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	10	2	.26	+	7.60	3.65E-02	1.00E00
bundle of His cell to Purkinje myocyte communication (GO:0086069)	5	1	.13	+	7.60	1.44E-01	1.00E00
cell junction disassembly (GO:0150146)	5	1	.13	+	7.60	1.44E-01	1.00E00
membrane repolarization (GO:0086009)	10	2	.26	+	7.60	3.65E-02	1.00E00
regulation of neuromuscular junction development (GO:1904396)	5	1	.13	+	7.60	1.44E-01	1.00E00
melanin biosynthetic process (GO:0042438)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	10	2	.26	+	7.60	3.65E-02	1.00E00
positive regulation of T cell chemotaxis (GO:0010820)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of T cell chemotaxis (GO:0010819)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of dendrite extension (GO:1903861)	25	5	.66	+	7.60	8.96E-04	3.84E-01
peptidyl-arginine N-methylation (GO:0035246)	5	1	.13	+	7.60	1.44E-01	1.00E00
interleukin-17-mediated signaling pathway (GO:0097400)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of nitric oxide mediated signal transduction (GO:0010749)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	10	2	.26	+	7.60	3.65E-02	1.00E00
coronary artery morphogenesis (GO:0060982)	5	1	.13	+	7.60	1.44E-01	1.00E00
cardiac vascular smooth muscle cell differentiation (GO:0060947)	5	1	.13	+	7.60	1.44E-01	1.00E00
macrophage differentiation (GO:0030225)	10	2	.26	+	7.60	3.65E-02	1.00E00
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	5	1	.13	+	7.60	1.44E-01	1.00E00
sperm DNA condensation (GO:0035093)	5	1	.13	+	7.60	1.44E-01	1.00E00
positive regulation of Rac protein signal transduction (GO:0035022)	5	1	.13	+	7.60	1.44E-01	1.00E00
apical constriction (GO:0003383)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	5	1	.13	+	7.60	1.44E-01	1.00E00
phasic smooth muscle contraction (GO:0014821)	5	1	.13	+	7.60	1.44E-01	1.00E00
NMDA glutamate receptor clustering (GO:0097114)	5	1	.13	+	7.60	1.44E-01	1.00E00
gamma-aminobutyric acid receptor clustering (GO:0097112)	5	1	.13	+	7.60	1.44E-01	1.00E00
protein maturation by protein folding (GO:0022417)	5	1	.13	+	7.60	1.44E-01	1.00E00
mechanosensory behavior (GO:0007638)	10	2	.26	+	7.60	3.65E-02	1.00E00
positive regulation of protein localization to early endosome (GO:1902966)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of protein localization to early endosome (GO:1902965)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of phospholipid translocation (GO:0061091)	5	1	.13	+	7.60	1.44E-01	1.00E00
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	5	1	.13	+	7.60	1.44E-01	1.00E00
substrate-independent telencephalic tangential migration (GO:0021826)	5	1	.13	+	7.60	1.44E-01	1.00E00
heart field specification (GO:0003128)	5	1	.13	+	7.60	1.44E-01	1.00E00
negative regulation of cellular extravasation (GO:0002692)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of synaptic vesicle transport (GO:1902803)	5	1	.13	+	7.60	1.44E-01	1.00E00
regulation of dendrite extension (GO:1903859)	26	5	.68	+	7.31	1.05E-03	3.76E-01
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	21	4	.55	+	7.24	3.49E-03	5.72E-01
negative regulation of epithelial to mesenchymal transition (GO:0010719)	21	4	.55	+	7.24	3.49E-03	5.65E-01
ligand-gated ion channel signaling pathway (GO:1990806)	16	3	.42	+	7.13	1.19E-02	8.24E-01
ionotropic glutamate receptor signaling pathway (GO:0035235)	16	3	.42	+	7.13	1.19E-02	8.19E-01
regulation of acute inflammatory response (GO:0002673)	11	2	.29	+	6.91	4.24E-02	1.00E00
regulation of establishment of endothelial barrier (GO:1903140)	11	2	.29	+	6.91	4.24E-02	1.00E00
blastoderm segmentation (GO:0007350)	11	2	.29	+	6.91	4.24E-02	1.00E00
positive regulation of transforming growth factor beta production (GO:0071636)	11	2	.29	+	6.91	4.24E-02	1.00E00
cell migration involved in sprouting angiogenesis (GO:0002042)	11	2	.29	+	6.91	4.24E-02	1.00E00
regulation of hepatocyte proliferation (GO:2000345)	11	2	.29	+	6.91	4.24E-02	1.00E00
protein localization to nuclear envelope (GO:0090435)	11	2	.29	+	6.91	4.24E-02	1.00E00
regulation of endothelial cell development (GO:1901550)	11	2	.29	+	6.91	4.24E-02	1.00E00
dendrite arborization (GO:0140059)	11	2	.29	+	6.91	4.24E-02	1.00E00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	11	2	.29	+	6.91	4.24E-02	1.00E00
brown fat cell differentiation (GO:0050873)	11	2	.29	+	6.91	4.24E-02	1.00E00
membrane raft organization (GO:0031579)	11	2	.29	+	6.91	4.24E-02	1.00E00
regulation of synaptic vesicle priming (GO:0010807)	11	2	.29	+	6.91	4.24E-02	1.00E00
synaptic vesicle docking (GO:0016081)	11	2	.29	+	6.91	4.24E-02	1.00E00
decidualization (GO:0046697)	11	2	.29	+	6.91	4.24E-02	1.00E00
negative regulation of smooth muscle contraction (GO:0045986)	11	2	.29	+	6.91	4.24E-02	1.00E00
regulation of amyloid-beta formation (GO:1902003)	28	5	.74	+	6.79	1.40E-03	4.33E-01
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	17	3	.45	+	6.71	1.37E-02	8.49E-01
regulation of cardiac muscle cell action potential (GO:0098901)	17	3	.45	+	6.71	1.37E-02	8.45E-01
negative regulation of epithelial cell differentiation (GO:0030857)	17	3	.45	+	6.71	1.37E-02	8.41E-01
positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	17	3	.45	+	6.71	1.37E-02	8.38E-01
centrosome localization (GO:0051642)	23	4	.61	+	6.61	4.65E-03	6.12E-01
positive regulation of bone mineralization (GO:0030501)	23	4	.61	+	6.61	4.65E-03	6.06E-01
negative regulation of acute inflammatory response (GO:0002674)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of bone resorption (GO:0045779)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of hexokinase activity (GO:1903299)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of potassium ion import across plasma membrane (GO:1903288)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	6	1	.16	+	6.34	1.66E-01	1.00E00
foregut morphogenesis (GO:0007440)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of neuroblast proliferation (GO:0007406)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of digestive system process (GO:0060457)	6	1	.16	+	6.34	1.66E-01	1.00E00
facial nerve morphogenesis (GO:0021610)	6	1	.16	+	6.34	1.66E-01	1.00E00
cranial nerve morphogenesis (GO:0021602)	12	2	.32	+	6.34	4.86E-02	1.00E00
axonogenesis involved in innervation (GO:0060385)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of biomineralization (GO:0110151)	24	4	.63	+	6.34	5.32E-03	6.36E-01
positive regulation of regulatory T cell differentiation (GO:0045591)	6	1	.16	+	6.34	1.66E-01	1.00E00
facial nerve development (GO:0021561)	6	1	.16	+	6.34	1.66E-01	1.00E00
inositol trisphosphate metabolic process (GO:0032957)	6	1	.16	+	6.34	1.66E-01	1.00E00
glomerulus morphogenesis (GO:0072102)	6	1	.16	+	6.34	1.66E-01	1.00E00
embryonic process involved in female pregnancy (GO:0060136)	6	1	.16	+	6.34	1.66E-01	1.00E00
sphingomyelin metabolic process (GO:0006684)	12	2	.32	+	6.34	4.86E-02	1.00E00
membrane hyperpolarization (GO:0060081)	6	1	.16	+	6.34	1.66E-01	1.00E00
estrous cycle (GO:0044849)	6	1	.16	+	6.34	1.66E-01	1.00E00
angiogenesis involved in wound healing (GO:0060055)	6	1	.16	+	6.34	1.66E-01	1.00E00
glutamine metabolic process (GO:0006541)	12	2	.32	+	6.34	4.86E-02	1.00E00
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	6	1	.16	+	6.34	1.66E-01	1.00E00
N-terminal protein lipidation (GO:0006498)	6	1	.16	+	6.34	1.66E-01	1.00E00
clustering of voltage-gated potassium channels (GO:0045163)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of histone deacetylase activity (GO:1901727)	6	1	.16	+	6.34	1.66E-01	1.00E00
establishment of endothelial intestinal barrier (GO:0090557)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of glucokinase activity (GO:0033131)	6	1	.16	+	6.34	1.66E-01	1.00E00
luteinization (GO:0001553)	6	1	.16	+	6.34	1.66E-01	1.00E00
7-methylguanosine mRNA capping (GO:0006370)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of gonad development (GO:1905939)	6	1	.16	+	6.34	1.66E-01	1.00E00
histamine transport (GO:0051608)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of DNA demethylation (GO:1901537)	6	1	.16	+	6.34	1.66E-01	1.00E00
ether biosynthetic process (GO:1901503)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of axon extension involved in axon guidance (GO:0048842)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	18	3	.47	+	6.34	1.57E-02	8.90E-01
embryonic cleavage (GO:0040016)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of cAMP-mediated signaling (GO:0043950)	12	2	.32	+	6.34	4.86E-02	1.00E00
locomotion involved in locomotory behavior (GO:0031987)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of glucocorticoid metabolic process (GO:0031943)	6	1	.16	+	6.34	1.66E-01	1.00E00
cell-cell adhesion mediated by cadherin (GO:0044331)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of hormone biosynthetic process (GO:0032353)	6	1	.16	+	6.34	1.66E-01	1.00E00
icosanoid secretion (GO:0032309)	6	1	.16	+	6.34	1.66E-01	1.00E00
excitatory chemical synaptic transmission (GO:0098976)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of kidney development (GO:0090183)	6	1	.16	+	6.34	1.66E-01	1.00E00
embryonic foregut morphogenesis (GO:0048617)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of cellular response to osmotic stress (GO:0106049)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of heat generation (GO:0031650)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	6	1	.16	+	6.34	1.66E-01	1.00E00
paraxial mesoderm morphogenesis (GO:0048340)	6	1	.16	+	6.34	1.66E-01	1.00E00
mRNA 5'-splice site recognition (GO:0000395)	6	1	.16	+	6.34	1.66E-01	1.00E00
learned vocalization behavior or vocal learning (GO:0098598)	6	1	.16	+	6.34	1.66E-01	1.00E00
imitative learning (GO:0098596)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of biomineral tissue development (GO:0070169)	24	4	.63	+	6.34	5.32E-03	6.31E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of cell killing (GO:0031342)	6	1	.16	+	6.34	1.66E-01	1.00E00
behavioral response to ethanol (GO:0048149)	6	1	.16	+	6.34	1.66E-01	1.00E00
maintenance of blood-brain barrier (GO:0035633)	12	2	.32	+	6.34	4.86E-02	1.00E00
post-translational protein targeting to membrane, translocation (GO:0031204)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of metalloendopeptidase activity (GO:1904683)	6	1	.16	+	6.34	1.66E-01	1.00E00
very long-chain fatty acid catabolic process (GO:0042760)	6	1	.16	+	6.34	1.66E-01	1.00E00
microtubule organizing center localization (GO:0061842)	24	4	.63	+	6.34	5.32E-03	6.25E-01
negative regulation of execution phase of apoptosis (GO:1900118)	6	1	.16	+	6.34	1.66E-01	1.00E00
ATP transport (GO:0015867)	6	1	.16	+	6.34	1.66E-01	1.00E00
myeloid dendritic cell differentiation (GO:0043011)	6	1	.16	+	6.34	1.66E-01	1.00E00
O-glycan processing (GO:0016266)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of protein K63-linked ubiquitination (GO:1900045)	6	1	.16	+	6.34	1.66E-01	1.00E00
ether lipid biosynthetic process (GO:0008611)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of protein targeting to mitochondrion (GO:1903955)	6	1	.16	+	6.34	1.66E-01	1.00E00
glutamine family amino acid catabolic process (GO:0009065)	12	2	.32	+	6.34	4.86E-02	1.00E00
negative regulation of bone remodeling (GO:0046851)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of cardiac muscle cell contraction (GO:0086004)	24	4	.63	+	6.34	5.32E-03	6.20E-01
regulation of sequestering of triglyceride (GO:0010889)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of centrosome duplication (GO:0010825)	6	1	.16	+	6.34	1.66E-01	1.00E00
histone H4-K20 trimethylation (GO:0034773)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of type B pancreatic cell proliferation (GO:0061469)	12	2	.32	+	6.34	4.86E-02	1.00E00
bone trabecula morphogenesis (GO:0061430)	6	1	.16	+	6.34	1.66E-01	1.00E00
cAMP-mediated signaling (GO:0019933)	18	3	.47	+	6.34	1.57E-02	8.86E-01
vocal learning (GO:0042297)	6	1	.16	+	6.34	1.66E-01	1.00E00
cellular lipid biosynthetic process (GO:0097384)	6	1	.16	+	6.34	1.66E-01	1.00E00
regulation of mitochondrial fusion (GO:0010635)	12	2	.32	+	6.34	4.86E-02	1.00E00
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	6	1	.16	+	6.34	1.66E-01	1.00E00
growth plate cartilage chondrocyte differentiation (GO:0003418)	6	1	.16	+	6.34	1.66E-01	1.00E00
glycerol ether biosynthetic process (GO:0046504)	6	1	.16	+	6.34	1.66E-01	1.00E00
prostate gland growth (GO:0060736)	6	1	.16	+	6.34	1.66E-01	1.00E00
amelogenesis (GO:0097186)	6	1	.16	+	6.34	1.66E-01	1.00E00
cell migration involved in gastrulation (GO:0042074)	6	1	.16	+	6.34	1.66E-01	1.00E00
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	6	1	.16	+	6.34	1.66E-01	1.00E00
postsynaptic density protein 95 clustering (GO:0097119)	6	1	.16	+	6.34	1.66E-01	1.00E00
hypothalamus cell differentiation (GO:0021979)	6	1	.16	+	6.34	1.66E-01	1.00E00
endocardial cushion formation (GO:0003272)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	18	3	.47	+	6.34	1.57E-02	8.82E-01
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of meiotic nuclear division (GO:0045836)	6	1	.16	+	6.34	1.66E-01	1.00E00
pulmonary valve development (GO:0003177)	6	1	.16	+	6.34	1.66E-01	1.00E00
positive regulation of sodium ion transmembrane transport (GO:1902307)	19	3	.50	+	6.00	1.79E-02	9.39E-01
positive regulation of protein autophosphorylation (GO:0031954)	19	3	.50	+	6.00	1.79E-02	9.35E-01
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	19	3	.50	+	6.00	1.79E-02	9.32E-01
blastocyst formation (GO:0001825)	32	5	.84	+	5.94	2.37E-03	4.77E-01
regulation of peptidyl-threonine phosphorylation (GO:0010799)	32	5	.84	+	5.94	2.37E-03	4.70E-01
regulation of actin filament-based movement (GO:1903115)	26	4	.68	+	5.85	6.84E-03	6.58E-01
bicellular tight junction assembly (GO:0070830)	13	2	.34	+	5.85	5.52E-02	1.00E00
regulation of protein kinase C signaling (GO:0090036)	13	2	.34	+	5.85	5.52E-02	1.00E00
positive regulation of macrophage migration (GO:1905523)	13	2	.34	+	5.85	5.52E-02	1.00E00
postsynapse assembly (GO:0099068)	13	2	.34	+	5.85	5.52E-02	1.00E00
stress fiber assembly (GO:0043149)	13	2	.34	+	5.85	5.52E-02	1.00E00
androgen receptor signaling pathway (GO:0030521)	13	2	.34	+	5.85	5.52E-02	1.00E00
cellular response to forskolin (GO:1904322)	13	2	.34	+	5.85	5.52E-02	1.00E00
response to forskolin (GO:1904321)	13	2	.34	+	5.85	5.52E-02	1.00E00
contractile actin filament bundle assembly (GO:0030038)	13	2	.34	+	5.85	5.52E-02	1.00E00
short-term memory (GO:0007614)	13	2	.34	+	5.85	5.52E-02	1.00E00
axonal fasciculation (GO:0007413)	20	3	.53	+	5.70	2.02E-02	9.86E-01
neuron projection fasciculation (GO:0106030)	20	3	.53	+	5.70	2.02E-02	9.82E-01
myotube cell development (GO:0014904)	20	3	.53	+	5.70	2.02E-02	9.79E-01
glutamate receptor signaling pathway (GO:0007215)	34	5	.89	+	5.59	3.00E-03	5.54E-01
regulation of amyloid precursor protein catabolic process (GO:1902991)	34	5	.89	+	5.59	3.00E-03	5.47E-01
thalamus development (GO:0021794)	7	1	.18	+	5.43	1.88E-01	1.00E00
preganglionic parasympathetic fiber development (GO:0021783)	7	1	.18	+	5.43	1.88E-01	1.00E00
salivary gland morphogenesis (GO:0007435)	14	2	.37	+	5.43	6.20E-02	1.00E00
cerebellar granule cell differentiation (GO:0021707)	7	1	.18	+	5.43	1.88E-01	1.00E00
skeletal muscle contraction (GO:0003009)	7	1	.18	+	5.43	1.88E-01	1.00E00
cerebellar granular layer formation (GO:0021684)	7	1	.18	+	5.43	1.88E-01	1.00E00
tripartite regional subdivision (GO:0007351)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of neuron migration (GO:2001223)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of cytoplasmic translation (GO:2000766)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of glial cell proliferation (GO:0060253)	14	2	.37	+	5.43	6.20E-02	1.00E00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	7	1	.18	+	5.43	1.88E-01	1.00E00
primitive hemopoiesis (GO:0060215)	7	1	.18	+	5.43	1.88E-01	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	14	2	.37	+	5.43	6.20E-02	1.00E00
positive regulation of growth hormone secretion (GO:0060124)	7	1	.18	+	5.43	1.88E-01	1.00E00
angiotensin-activated signaling pathway (GO:0038166)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation by host of viral genome replication (GO:0044829)	7	1	.18	+	5.43	1.88E-01	1.00E00
melanin metabolic process (GO:0006582)	7	1	.18	+	5.43	1.88E-01	1.00E00
glutamate metabolic process (GO:0006536)	14	2	.37	+	5.43	6.20E-02	1.00E00
negative regulation by host of viral process (GO:0044793)	7	1	.18	+	5.43	1.88E-01	1.00E00
p38MAPK cascade (GO:0038066)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of lymphocyte chemotaxis (GO:1901623)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of myoblast proliferation (GO:2000291)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of translation at synapse (GO:0140243)	7	1	.18	+	5.43	1.88E-01	1.00E00
tRNA surveillance (GO:0106354)	7	1	.18	+	5.43	1.88E-01	1.00E00
anterograde axonal protein transport (GO:0099641)	7	1	.18	+	5.43	1.88E-01	1.00E00
protein O-linked glycosylation via serine (GO:0018242)	7	1	.18	+	5.43	1.88E-01	1.00E00
fatty acid transmembrane transport (GO:1902001)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of DNA demethylation (GO:1901535)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of mitophagy (GO:1901526)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of fatty acid transport (GO:2000192)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of lymphocyte chemotaxis (GO:0140131)	7	1	.18	+	5.43	1.88E-01	1.00E00
hair follicle maturation (GO:0048820)	14	2	.37	+	5.43	6.20E-02	1.00E00
regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of development, heterochronic (GO:0040034)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of neurotransmitter transport (GO:0051589)	14	2	.37	+	5.43	6.20E-02	1.00E00
sebaceous gland development (GO:0048733)	7	1	.18	+	5.43	1.88E-01	1.00E00
fibroblast apoptotic process (GO:0044346)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of hormone metabolic process (GO:0032351)	7	1	.18	+	5.43	1.88E-01	1.00E00
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	7	1	.18	+	5.43	1.88E-01	1.00E00
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	7	1	.18	+	5.43	1.88E-01	1.00E00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	7	1	.18	+	5.43	1.88E-01	1.00E00
nuclear ncRNA surveillance (GO:0071029)	7	1	.18	+	5.43	1.88E-01	1.00E00
nuclear mRNA surveillance (GO:0071028)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of neuron projection regeneration (GO:0070571)	14	2	.37	+	5.43	6.20E-02	1.00E00
regulation of synapse maturation (GO:0090128)	14	2	.37	+	5.43	6.20E-02	1.00E00
histone H3-K36 demethylation (GO:0070544)	7	1	.18	+	5.43	1.88E-01	1.00E00
histone H2A K63-linked deubiquitination (GO:0070537)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of blood-brain barrier permeability (GO:1905603)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of myelination (GO:0031643)	7	1	.18	+	5.43	1.88E-01	1.00E00
parasympathetic nervous system development (GO:0048486)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of synaptic membrane adhesion (GO:0099179)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of fatty acid beta-oxidation (GO:0032000)	7	1	.18	+	5.43	1.88E-01	1.00E00
sarcoplasmic reticulum calcium ion transport (GO:0070296)	7	1	.18	+	5.43	1.88E-01	1.00E00
protein localization to presynapse (GO:1905383)	7	1	.18	+	5.43	1.88E-01	1.00E00
detection of biotic stimulus (GO:0009595)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of receptor-mediated endocytosis (GO:0048260)	35	5	.92	+	5.43	3.36E-03	5.65E-01
excitatory synapse assembly (GO:1904861)	14	2	.37	+	5.43	6.20E-02	1.00E00
regulation of prostaglandin biosynthetic process (GO:0031392)	7	1	.18	+	5.43	1.88E-01	1.00E00
7-methylguanosine RNA capping (GO:0009452)	7	1	.18	+	5.43	1.88E-01	1.00E00
anagen (GO:0042640)	7	1	.18	+	5.43	1.88E-01	1.00E00
vitamin transmembrane transport (GO:0035461)	7	1	.18	+	5.43	1.88E-01	1.00E00
cellular response to interferon-beta (GO:0035458)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of low-density lipoprotein particle clearance (GO:0010988)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of cardiac muscle cell membrane potential (GO:0086036)	7	1	.18	+	5.43	1.88E-01	1.00E00
anterior/posterior axis specification, embryo (GO:0008595)	7	1	.18	+	5.43	1.88E-01	1.00E00
amyloid-beta clearance by transcytosis (GO:0150093)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of fibroblast migration (GO:0010764)	7	1	.18	+	5.43	1.88E-01	1.00E00
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	7	1	.18	+	5.43	1.88E-01	1.00E00
cellular response to interleukin-17 (GO:0097398)	7	1	.18	+	5.43	1.88E-01	1.00E00
signal transduction involved in regulation of gene expression (GO:0023019)	7	1	.18	+	5.43	1.88E-01	1.00E00
T-helper 1 type immune response (GO:0042088)	7	1	.18	+	5.43	1.88E-01	1.00E00
fluid transport (GO:0042044)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of skeletal muscle contraction (GO:0014819)	7	1	.18	+	5.43	1.88E-01	1.00E00
postsynaptic density assembly (GO:0097107)	7	1	.18	+	5.43	1.88E-01	1.00E00
presynaptic membrane assembly (GO:0097105)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of vasoconstriction (GO:0045906)	7	1	.18	+	5.43	1.88E-01	1.00E00
ventricular trabecula myocardium morphogenesis (GO:0003222)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of dendritic spine morphogenesis (GO:0061002)	7	1	.18	+	5.43	1.88E-01	1.00E00
aortic valve development (GO:0003176)	7	1	.18	+	5.43	1.88E-01	1.00E00
regulation of fertilization (GO:0080154)	7	1	.18	+	5.43	1.88E-01	1.00E00
intestinal epithelial cell development (GO:0060576)	7	1	.18	+	5.43	1.88E-01	1.00E00
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	43	6	1.13	+	5.30	1.48E-03	4.28E-01
regulation of neuron projection regeneration (GO:0070570)	29	4	.76	+	5.24	9.62E-03	7.34E-01
stress granule assembly (GO:0034063)	22	3	.58	+	5.18	2.52E-02	1.00E00
positive regulation of adenylate cyclase activity (GO:0045762)	15	2	.39	+	5.07	6.91E-02	1.00E00
positive regulation of glial cell proliferation (GO:0060252)	15	2	.39	+	5.07	6.91E-02	1.00E00
regulation of glial cell proliferation (GO:0060251)	30	4	.79	+	5.07	1.07E-02	7.72E-01
positive regulation of miRNA-mediated gene silencing (GO:2000637)	15	2	.39	+	5.07	6.91E-02	1.00E00
phosphatidylserine metabolic process (GO:0006658)	15	2	.39	+	5.07	6.91E-02	1.00E00
vocalization behavior (GO:0071625)	15	2	.39	+	5.07	6.91E-02	1.00E00
positive regulation of neuroblast proliferation (GO:0002052)	15	2	.39	+	5.07	6.91E-02	1.00E00
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	15	2	.39	+	5.07	6.91E-02	1.00E00
protein localization to postsynaptic specialization membrane (GO:0099633)	15	2	.39	+	5.07	6.91E-02	1.00E00
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	15	2	.39	+	5.07	6.91E-02	1.00E00
neuron projection arborization (GO:0140058)	15	2	.39	+	5.07	6.91E-02	1.00E00
intracellular cholesterol transport (GO:0032367)	15	2	.39	+	5.07	6.91E-02	1.00E00
autonomic nervous system development (GO:0048483)	15	2	.39	+	5.07	6.91E-02	1.00E00
negative regulation of defense response to virus (GO:0050687)	15	2	.39	+	5.07	6.91E-02	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	15	2	.39	+	5.07	6.91E-02	1.00E00
non-canonical Wnt signaling pathway (GO:0035567)	15	2	.39	+	5.07	6.91E-02	1.00E00
response to auditory stimulus (GO:0010996)	15	2	.39	+	5.07	6.91E-02	1.00E00
fatty-acyl-CoA metabolic process (GO:0035337)	15	2	.39	+	5.07	6.91E-02	1.00E00
negative regulation of sodium ion transport (GO:0010766)	15	2	.39	+	5.07	6.91E-02	1.00E00
establishment of endothelial barrier (GO:0061028)	15	2	.39	+	5.07	6.91E-02	1.00E00
regulation of neuroblast proliferation (GO:1902692)	23	3	.61	+	4.96	2.80E-02	1.00E00
endothelial cell development (GO:0001885)	23	3	.61	+	4.96	2.80E-02	1.00E00
intracellular pH reduction (GO:0051452)	23	3	.61	+	4.96	2.80E-02	1.00E00
negative regulation of protein localization to membrane (GO:1905476)	23	3	.61	+	4.96	2.80E-02	1.00E00
salivary gland development (GO:0007431)	16	2	.42	+	4.75	7.65E-02	1.00E00
embryonic body morphogenesis (GO:0010172)	8	1	.21	+	4.75	2.08E-01	1.00E00
cerebellar granular layer morphogenesis (GO:0021683)	8	1	.21	+	4.75	2.08E-01	1.00E00
arachidonic acid metabolic process (GO:0019369)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of cell adhesion mediated by integrin (GO:0033628)	16	2	.42	+	4.75	7.65E-02	1.00E00
acrosome reaction (GO:0007340)	8	1	.21	+	4.75	2.08E-01	1.00E00
nucleotide transport (GO:0006862)	16	2	.42	+	4.75	7.65E-02	1.00E00
specification of animal organ identity (GO:0010092)	8	1	.21	+	4.75	2.08E-01	1.00E00
T cell mediated immunity (GO:0002456)	16	2	.42	+	4.75	7.65E-02	1.00E00
transferrin transport (GO:0033572)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of protein localization to plasma membrane (GO:1903077)	16	2	.42	+	4.75	7.65E-02	1.00E00
icosanoid transport (GO:0071715)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of phospholipid transport (GO:2001140)	8	1	.21	+	4.75	2.08E-01	1.00E00
maternal placenta development (GO:0001893)	16	2	.42	+	4.75	7.65E-02	1.00E00
neuron cell-cell adhesion (GO:0007158)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of transcription regulatory region DNA binding (GO:2000678)	8	1	.21	+	4.75	2.08E-01	1.00E00
mesenchyme morphogenesis (GO:0072132)	16	2	.42	+	4.75	7.65E-02	1.00E00
positive regulation of post-transcriptional gene silencing (GO:0060148)	16	2	.42	+	4.75	7.65E-02	1.00E00
negative regulation of activin receptor signaling pathway (GO:0032926)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of amyloid-beta formation (GO:1902430)	16	2	.42	+	4.75	7.65E-02	1.00E00
hair cycle phase (GO:0044851)	8	1	.21	+	4.75	2.08E-01	1.00E00
nerve growth factor signaling pathway (GO:0038180)	8	1	.21	+	4.75	2.08E-01	1.00E00
polyamine biosynthetic process (GO:0006596)	8	1	.21	+	4.75	2.08E-01	1.00E00
cellular response to dexamethasone stimulus (GO:0071549)	8	1	.21	+	4.75	2.08E-01	1.00E00
meiotic cytokinesis (GO:0033206)	8	1	.21	+	4.75	2.08E-01	1.00E00
neuron projection extension involved in neuron projection guidance (GO:1902284)	8	1	.21	+	4.75	2.08E-01	1.00E00
protein demethylation (GO:0006482)	24	3	.63	+	4.75	3.09E-02	1.00E00
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	8	1	.21	+	4.75	2.08E-01	1.00E00
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	24	3	.63	+	4.75	3.09E-02	1.00E00
antiviral innate immune response (GO:0140374)	8	1	.21	+	4.75	2.08E-01	1.00E00
3'-UTR-mediated mRNA stabilization (GO:0070935)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	8	1	.21	+	4.75	2.08E-01	1.00E00
axo-dendritic protein transport (GO:0099640)	8	1	.21	+	4.75	2.08E-01	1.00E00
protein O-linked glycosylation via threonine (GO:0018243)	8	1	.21	+	4.75	2.08E-01	1.00E00
axon extension involved in axon guidance (GO:0048846)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of neural precursor cell proliferation (GO:2000179)	32	4	.84	+	4.75	1.30E-02	8.29E-01
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	8	1	.21	+	4.75	2.08E-01	1.00E00
Rap protein signal transduction (GO:0032486)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	8	1	.21	+	4.75	2.08E-01	1.00E00
cAMP biosynthetic process (GO:0006171)	8	1	.21	+	4.75	2.08E-01	1.00E00
histone H3-K9 methylation (GO:0051567)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of lipid kinase activity (GO:0090219)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of prostaglandin secretion (GO:0032306)	8	1	.21	+	4.75	2.08E-01	1.00E00
induction of positive chemotaxis (GO:0050930)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of calcium ion import across plasma membrane (GO:1905665)	8	1	.21	+	4.75	2.08E-01	1.00E00
nuclear pore complex assembly (GO:0051292)	8	1	.21	+	4.75	2.08E-01	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	8	1	.21	+	4.75	2.08E-01	1.00E00
mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	8	1	.21	+	4.75	2.08E-01	1.00E00
sodium ion export across plasma membrane (GO:0036376)	8	1	.21	+	4.75	2.08E-01	1.00E00
observational learning (GO:0098597)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of secondary metabolic process (GO:0043455)	8	1	.21	+	4.75	2.08E-01	1.00E00
semi-lunar valve development (GO:1905314)	8	1	.21	+	4.75	2.08E-01	1.00E00
lipoprotein transport (GO:0042953)	8	1	.21	+	4.75	2.08E-01	1.00E00
mRNA stabilization (GO:0048255)	32	4	.84	+	4.75	1.30E-02	8.25E-01
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of secondary metabolite biosynthetic process (GO:1900376)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of post-transcriptional gene silencing by RNA (GO:1900370)	16	2	.42	+	4.75	7.65E-02	1.00E00
phosphatidylcholine acyl-chain remodeling (GO:0036151)	8	1	.21	+	4.75	2.08E-01	1.00E00
auditory behavior (GO:0031223)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of melanin biosynthetic process (GO:0048021)	8	1	.21	+	4.75	2.08E-01	1.00E00
relaxation of cardiac muscle (GO:0055119)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of metallopeptidase activity (GO:1905048)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of response to osmotic stress (GO:0047484)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of macrophage activation (GO:0043031)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of bone remodeling (GO:0046850)	24	3	.63	+	4.75	3.09E-02	1.00E00
tRNA catabolic process (GO:0016078)	8	1	.21	+	4.75	2.08E-01	1.00E00
coronary vasculature morphogenesis (GO:0060977)	16	2	.42	+	4.75	7.65E-02	1.00E00
heart formation (GO:0060914)	8	1	.21	+	4.75	2.08E-01	1.00E00
positive regulation of macrophage cytokine production (GO:0060907)	8	1	.21	+	4.75	2.08E-01	1.00E00
venous blood vessel development (GO:0060841)	8	1	.21	+	4.75	2.08E-01	1.00E00
growth plate cartilage development (GO:0003417)	8	1	.21	+	4.75	2.08E-01	1.00E00
S-adenosylmethionine metabolic process (GO:0046500)	8	1	.21	+	4.75	2.08E-01	1.00E00
protein dealkylation (GO:0008214)	24	3	.63	+	4.75	3.09E-02	1.00E00
cardiac muscle hypertrophy in response to stress (GO:0014898)	8	1	.21	+	4.75	2.08E-01	1.00E00
cardiac muscle adaptation (GO:0014887)	8	1	.21	+	4.75	2.08E-01	1.00E00
endothelial tube morphogenesis (GO:0061154)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of muscle contraction (GO:0045932)	16	2	.42	+	4.75	7.65E-02	1.00E00
muscle hypertrophy in response to stress (GO:0003299)	8	1	.21	+	4.75	2.08E-01	1.00E00
cardiac left ventricle morphogenesis (GO:0003214)	8	1	.21	+	4.75	2.08E-01	1.00E00
presynaptic membrane organization (GO:0097090)	8	1	.21	+	4.75	2.08E-01	1.00E00
branch elongation of an epithelium (GO:0060602)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of protein polyubiquitination (GO:1902915)	8	1	.21	+	4.75	2.08E-01	1.00E00
regulation of skeletal muscle adaptation (GO:0014733)	8	1	.21	+	4.75	2.08E-01	1.00E00
negative regulation of heart contraction (GO:0045822)	16	2	.42	+	4.75	7.65E-02	1.00E00
morphogenesis of an endothelium (GO:0003159)	8	1	.21	+	4.75	2.08E-01	1.00E00
endocardium development (GO:0003157)	8	1	.21	+	4.75	2.08E-01	1.00E00
RNA stabilization (GO:0043489)	41	5	1.08	+	4.64	6.18E-03	6.47E-01
positive regulation of ossification (GO:0045778)	33	4	.87	+	4.61	1.43E-02	8.50E-01
endothelial cell differentiation (GO:0045446)	33	4	.87	+	4.61	1.43E-02	8.47E-01
positive regulation of nuclear division (GO:0051785)	25	3	.66	+	4.56	3.40E-02	1.00E00
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	25	3	.66	+	4.56	3.40E-02	1.00E00
negative regulation of GTPase activity (GO:0034260)	25	3	.66	+	4.56	3.40E-02	1.00E00
phospholipid transport (GO:0015914)	42	5	1.10	+	4.53	6.78E-03	6.58E-01
negative regulation of osteoclast differentiation (GO:0045671)	17	2	.45	+	4.47	8.41E-02	1.00E00
regulation of endothelial cell differentiation (GO:0045601)	17	2	.45	+	4.47	8.41E-02	1.00E00
regulation of type I interferon-mediated signaling pathway (GO:0060338)	17	2	.45	+	4.47	8.41E-02	1.00E00
activation of innate immune response (GO:0002218)	17	2	.45	+	4.47	8.41E-02	1.00E00
regulation of the force of heart contraction (GO:0002026)	17	2	.45	+	4.47	8.41E-02	1.00E00
vasculogenesis (GO:0001570)	34	4	.89	+	4.47	1.57E-02	8.96E-01
negative regulation of cytosolic calcium ion concentration (GO:0051481)	17	2	.45	+	4.47	8.41E-02	1.00E00
tight junction assembly (GO:0120192)	17	2	.45	+	4.47	8.41E-02	1.00E00
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	17	2	.45	+	4.47	8.41E-02	1.00E00
regulation of receptor clustering (GO:1903909)	17	2	.45	+	4.47	8.41E-02	1.00E00
negative regulation of protein localization to cell periphery (GO:1904376)	17	2	.45	+	4.47	8.41E-02	1.00E00
positive regulation of sodium ion transport (GO:0010765)	34	4	.89	+	4.47	1.57E-02	8.92E-01
negative regulation of blood circulation (GO:1903523)	17	2	.45	+	4.47	8.41E-02	1.00E00
positive regulation of muscle contraction (GO:0045933)	17	2	.45	+	4.47	8.41E-02	1.00E00
vasodilation (GO:0042311)	26	3	.68	+	4.39	3.72E-02	1.00E00
regulation of morphogenesis of a branching structure (GO:0060688)	26	3	.68	+	4.39	3.72E-02	1.00E00
regulation of presynapse organization (GO:0099174)	35	4	.92	+	4.34	1.72E-02	9.19E-01
regulation of bone mineralization (GO:0030500)	35	4	.92	+	4.34	1.72E-02	9.16E-01
regulation of cardiac muscle contraction (GO:0055117)	44	5	1.16	+	4.32	8.09E-03	7.02E-01
organophosphate ester transport (GO:0015748)	62	7	1.63	+	4.29	1.86E-03	4.67E-01
phenol-containing compound biosynthetic process (GO:0046189)	9	1	.24	+	4.22	2.29E-01	1.00E00
branching involved in salivary gland morphogenesis (GO:0060445)	9	1	.24	+	4.22	2.29E-01	1.00E00
apoptotic process involved in development (GO:1902742)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of axon guidance (GO:1902667)	9	1	.24	+	4.22	2.29E-01	1.00E00
response to iron ion (GO:0010039)	9	1	.24	+	4.22	2.29E-01	1.00E00
histone H2B ubiquitination (GO:0033523)	9	1	.24	+	4.22	2.29E-01	1.00E00
diencephalon development (GO:0021536)	27	3	.71	+	4.22	4.06E-02	1.00E00
endothelial cell proliferation (GO:0001935)	18	2	.47	+	4.22	9.19E-02	1.00E00
regulation of T cell mediated cytotoxicity (GO:0001914)	9	1	.24	+	4.22	2.29E-01	1.00E00
myeloid progenitor cell differentiation (GO:0002318)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of phospholipid transport (GO:2001138)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	9	1	.24	+	4.22	2.29E-01	1.00E00
ectodermal placode morphogenesis (GO:0071697)	9	1	.24	+	4.22	2.29E-01	1.00E00
phosphatidylethanolamine biosynthetic process (GO:0006646)	9	1	.24	+	4.22	2.29E-01	1.00E00
myeloid dendritic cell activation (GO:0001773)	9	1	.24	+	4.22	2.29E-01	1.00E00
lipoprotein localization (GO:0044872)	9	1	.24	+	4.22	2.29E-01	1.00E00
neurofilament cytoskeleton organization (GO:0060052)	9	1	.24	+	4.22	2.29E-01	1.00E00
ERBB signaling pathway (GO:0038127)	27	3	.71	+	4.22	4.06E-02	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	18	2	.47	+	4.22	9.19E-02	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	27	3	.71	+	4.22	4.06E-02	1.00E00
regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	9	1	.24	+	4.22	2.29E-01	1.00E00
protein localization to chromosome, centromeric region (GO:0071459)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of histone deacetylase activity (GO:1901725)	9	1	.24	+	4.22	2.29E-01	1.00E00
chromatin organization (GO:0006336)	9	1	.24	+	4.22	2.29E-01	1.00E00
nucleotide transmembrane transport (GO:1901679)	9	1	.24	+	4.22	2.29E-01	1.00E00
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of nitric oxide biosynthetic process (GO:0045019)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	9	1	.24	+	4.22	2.29E-01	1.00E00
neuron projection maintenance (GO:1990535)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of brown fat cell differentiation (GO:0090336)	9	1	.24	+	4.22	2.29E-01	1.00E00
skeletal muscle fiber development (GO:0048741)	18	2	.47	+	4.22	9.19E-02	1.00E00
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	9	1	.24	+	4.22	2.29E-01	1.00E00
intracellular sterol transport (GO:0032366)	18	2	.47	+	4.22	9.19E-02	1.00E00
regulation of axon regeneration (GO:0048679)	27	3	.71	+	4.22	4.06E-02	1.00E00
epithelial cell-cell adhesion (GO:0090136)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of synaptic transmission, dopaminergic (GO:0032225)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of protein localization to endosome (GO:1905668)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of deacetylase activity (GO:0090045)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of steroid hormone biosynthetic process (GO:0090030)	9	1	.24	+	4.22	2.29E-01	1.00E00
post-embryonic animal organ development (GO:0048569)	9	1	.24	+	4.22	2.29E-01	1.00E00
progesterone receptor signaling pathway (GO:0050847)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	9	1	.24	+	4.22	2.29E-01	1.00E00
polyadenylation-dependent RNA catabolic process (GO:0043633)	9	1	.24	+	4.22	2.29E-01	1.00E00
RNA polyadenylation (GO:0043631)	27	3	.71	+	4.22	4.06E-02	1.00E00
regulation of myelination (GO:0031641)	27	3	.71	+	4.22	4.06E-02	1.00E00
regulation of appetite (GO:0032098)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of synaptic vesicle cycle (GO:0098693)	9	1	.24	+	4.22	2.29E-01	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	18	2	.47	+	4.22	9.19E-02	1.00E00
negative regulation of smooth muscle cell differentiation (GO:0051151)	9	1	.24	+	4.22	2.29E-01	1.00E00
blood vessel endothelial cell migration (GO:0043534)	18	2	.47	+	4.22	9.19E-02	1.00E00
post-anal tail morphogenesis (GO:0036342)	9	1	.24	+	4.22	2.29E-01	1.00E00
cellular response to potassium ion (GO:0035865)	9	1	.24	+	4.22	2.29E-01	1.00E00
response to potassium ion (GO:0035864)	9	1	.24	+	4.22	2.29E-01	1.00E00
stem cell division (GO:0017145)	18	2	.47	+	4.22	9.19E-02	1.00E00
RNA capping (GO:0036260)	9	1	.24	+	4.22	2.29E-01	1.00E00
maternal behavior (GO:0042711)	9	1	.24	+	4.22	2.29E-01	1.00E00
ovulation (GO:0030728)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	9	1	.24	+	4.22	2.29E-01	1.00E00
response to interferon-beta (GO:0035456)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of nitric oxide metabolic process (GO:1904406)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of receptor clustering (GO:1903911)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of lipid storage (GO:0010888)	9	1	.24	+	4.22	2.29E-01	1.00E00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	18	2	.47	+	4.22	9.19E-02	1.00E00
histone H4-K20 methylation (GO:0034770)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of fatty acid biosynthetic process (GO:0042304)	18	2	.47	+	4.22	9.19E-02	1.00E00
positive regulation of macrophage chemotaxis (GO:0010759)	9	1	.24	+	4.22	2.29E-01	1.00E00
monocyte differentiation (GO:0030224)	9	1	.24	+	4.22	2.29E-01	1.00E00
positive regulation of sprouting angiogenesis (GO:1903672)	9	1	.24	+	4.22	2.29E-01	1.00E00
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	9	1	.24	+	4.22	2.29E-01	1.00E00
ectodermal placode formation (GO:0060788)	9	1	.24	+	4.22	2.29E-01	1.00E00
negative regulation of androgen receptor signaling pathway (GO:0060766)	9	1	.24	+	4.22	2.29E-01	1.00E00
ether lipid metabolic process (GO:0046485)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of inflammatory response to antigenic stimulus (GO:0002861)	9	1	.24	+	4.22	2.29E-01	1.00E00
cellular potassium ion homeostasis (GO:0030007)	9	1	.24	+	4.22	2.29E-01	1.00E00
pituitary gland development (GO:0021983)	9	1	.24	+	4.22	2.29E-01	1.00E00
endocardial cushion morphogenesis (GO:0003203)	9	1	.24	+	4.22	2.29E-01	1.00E00
synaptic vesicle clustering (GO:0097091)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	9	1	.24	+	4.22	2.29E-01	1.00E00
intestinal epithelial cell differentiation (GO:0060575)	9	1	.24	+	4.22	2.29E-01	1.00E00
regulation of cellular extravasation (GO:0002691)	18	2	.47	+	4.22	9.19E-02	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	36	4	.95	+	4.22	1.87E-02	9.34E-01
ovarian follicle development (GO:0001541)	37	4	.97	+	4.11	2.03E-02	9.81E-01
regulation of smooth muscle contraction (GO:0006940)	28	3	.74	+	4.07	4.41E-02	1.00E00
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	28	3	.74	+	4.07	4.41E-02	1.00E00
intracellular lipid transport (GO:0032365)	28	3	.74	+	4.07	4.41E-02	1.00E00
positive regulation of nervous system process (GO:0031646)	28	3	.74	+	4.07	4.41E-02	1.00E00
adipose tissue development (GO:0060612)	28	3	.74	+	4.07	4.41E-02	1.00E00
positive regulation of leukocyte migration (GO:0002687)	56	6	1.47	+	4.07	4.95E-03	6.20E-01
positive regulation of nitric oxide biosynthetic process (GO:0045429)	19	2	.50	+	4.00	9.99E-02	1.00E00
positive regulation of protein kinase B signaling (GO:0051897)	57	6	1.50	+	4.00	5.35E-03	6.13E-01
regulation of bone resorption (GO:0045124)	19	2	.50	+	4.00	9.99E-02	1.00E00
regulation of interleukin-12 production (GO:0032655)	19	2	.50	+	4.00	9.99E-02	1.00E00
positive regulation of lyase activity (GO:0051349)	19	2	.50	+	4.00	9.99E-02	1.00E00
response to mitochondrial depolarisation (GO:0098780)	19	2	.50	+	4.00	9.99E-02	1.00E00
tight junction organization (GO:0120193)	19	2	.50	+	4.00	9.99E-02	1.00E00
regulation of biomineral tissue development (GO:0070167)	38	4	1.00	+	4.00	2.20E-02	9.65E-01
positive regulation of cyclase activity (GO:0031281)	19	2	.50	+	4.00	9.99E-02	1.00E00
positive regulation of nitric oxide metabolic process (GO:1904407)	19	2	.50	+	4.00	9.99E-02	1.00E00
motor neuron axon guidance (GO:0008045)	19	2	.50	+	4.00	9.99E-02	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	19	2	.50	+	4.00	9.99E-02	1.00E00
receptor clustering (GO:0043113)	48	5	1.26	+	3.96	1.12E-02	7.92E-01
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	29	3	.76	+	3.93	4.78E-02	1.00E00
sprouting angiogenesis (GO:0002040)	29	3	.76	+	3.93	4.78E-02	1.00E00
peptidyl-proline modification (GO:0018208)	29	3	.76	+	3.93	4.78E-02	1.00E00
regulation of protein localization to cell surface (GO:2000008)	29	3	.76	+	3.93	4.78E-02	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	29	3	.76	+	3.93	4.78E-02	1.00E00
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	29	3	.76	+	3.93	4.78E-02	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	58	6	1.53	+	3.93	5.78E-03	6.25E-01
regulation of biomineralization (GO:0110149)	39	4	1.03	+	3.90	2.38E-02	1.00E00
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	69	7	1.82	+	3.86	3.24E-03	5.67E-01
regulation of nitric oxide biosynthetic process (GO:0045428)	30	3	.79	+	3.80	5.16E-02	1.00E00
nucleus localization (GO:0051647)	30	3	.79	+	3.80	5.16E-02	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	30	3	.79	+	3.80	5.16E-02	1.00E00
regulation of striated muscle contraction (GO:0006942)	50	5	1.32	+	3.80	1.30E-02	8.33E-01
positive regulation of toll-like receptor signaling pathway (GO:0034123)	10	1	.26	+	3.80	2.49E-01	1.00E00
heterotypic cell-cell adhesion (GO:0034113)	10	1	.26	+	3.80	2.49E-01	1.00E00
growth hormone receptor signaling pathway (GO:0060396)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	10	1	.26	+	3.80	2.49E-01	1.00E00
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	10	1	.26	+	3.80	2.49E-01	1.00E00
cAMP metabolic process (GO:0046058)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of anoikis (GO:2000811)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of regulatory T cell differentiation (GO:0045589)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of mammary gland epithelial cell proliferation (GO:0033599)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of store-operated calcium entry (GO:2001256)	10	1	.26	+	3.80	2.49E-01	1.00E00
pons development (GO:0021548)	10	1	.26	+	3.80	2.49E-01	1.00E00
retinal rod cell differentiation (GO:0060221)	10	1	.26	+	3.80	2.49E-01	1.00E00
water-soluble vitamin metabolic process (GO:0006767)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of stem cell proliferation (GO:2000647)	10	1	.26	+	3.80	2.49E-01	1.00E00
ectodermal placode development (GO:0071696)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of transforming growth factor beta production (GO:0071634)	20	2	.53	+	3.80	1.08E-01	1.00E00
positive regulation of endothelial cell chemotaxis (GO:2001028)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of cardiac muscle cell proliferation (GO:0060044)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of mRNA catabolic process (GO:1902373)	40	4	1.05	+	3.80	2.57E-02	1.00E00
Sertoli cell development (GO:0060009)	10	1	.26	+	3.80	2.49E-01	1.00E00
response to dexamethasone (GO:0071548)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	10	1	.26	+	3.80	2.49E-01	1.00E00
peptidyl-tyrosine autophosphorylation (GO:0038083)	10	1	.26	+	3.80	2.49E-01	1.00E00
astrocyte development (GO:0014002)	10	1	.26	+	3.80	2.49E-01	1.00E00
calcineurin-NFAT signaling cascade (GO:0033173)	10	1	.26	+	3.80	2.49E-01	1.00E00
histone H3-K9 demethylation (GO:0033169)	10	1	.26	+	3.80	2.49E-01	1.00E00
epiboly involved in wound healing (GO:0090505)	10	1	.26	+	3.80	2.49E-01	1.00E00
prostaglandin biosynthetic process (GO:0001516)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of endothelial cell apoptotic process (GO:2000352)	10	1	.26	+	3.80	2.49E-01	1.00E00
protein prenylation (GO:0018342)	10	1	.26	+	3.80	2.49E-01	1.00E00
type I interferon production (GO:0032606)	10	1	.26	+	3.80	2.49E-01	1.00E00
cellular response to growth hormone stimulus (GO:0071378)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of viral genome replication (GO:0045070)	20	2	.53	+	3.80	1.08E-01	1.00E00
response to progesterone (GO:0032570)	10	1	.26	+	3.80	2.49E-01	1.00E00
potassium ion import across plasma membrane (GO:1990573)	20	2	.53	+	3.80	1.08E-01	1.00E00
regulation of meiotic nuclear division (GO:0040020)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of neurotransmitter uptake (GO:0051580)	10	1	.26	+	3.80	2.49E-01	1.00E00
type B pancreatic cell proliferation (GO:0044342)	10	1	.26	+	3.80	2.49E-01	1.00E00
wound healing, spreading of cells (GO:0044319)	10	1	.26	+	3.80	2.49E-01	1.00E00
histone mRNA catabolic process (GO:0071044)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of meiotic cell cycle (GO:0051446)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of protein localization to endosome (GO:1905666)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of calcium ion import across plasma membrane (GO:1905664)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of response to food (GO:0032095)	10	1	.26	+	3.80	2.49E-01	1.00E00
postsynaptic specialization assembly (GO:0098698)	10	1	.26	+	3.80	2.49E-01	1.00E00
aorta morphogenesis (GO:0035909)	10	1	.26	+	3.80	2.49E-01	1.00E00
vascular associated smooth muscle cell differentiation (GO:0035886)	10	1	.26	+	3.80	2.49E-01	1.00E00
astral microtubule organization (GO:0030953)	10	1	.26	+	3.80	2.49E-01	1.00E00
thyroid gland development (GO:0030878)	10	1	.26	+	3.80	2.49E-01	1.00E00
cellular response to acetylcholine (GO:1905145)	20	2	.53	+	3.80	1.08E-01	1.00E00
response to acetylcholine (GO:1905144)	20	2	.53	+	3.80	1.08E-01	1.00E00
positive regulation of vascular permeability (GO:0043117)	10	1	.26	+	3.80	2.49E-01	1.00E00
calcineurin-mediated signaling (GO:0097720)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of receptor binding (GO:1900120)	10	1	.26	+	3.80	2.49E-01	1.00E00
purine ribonucleotide transport (GO:0015868)	10	1	.26	+	3.80	2.49E-01	1.00E00
phosphate ion transmembrane transport (GO:0035435)	10	1	.26	+	3.80	2.49E-01	1.00E00
regulation of lipoprotein particle clearance (GO:0010984)	10	1	.26	+	3.80	2.49E-01	1.00E00
secondary palate development (GO:0062009)	10	1	.26	+	3.80	2.49E-01	1.00E00
synaptic vesicle priming (GO:0016082)	20	2	.53	+	3.80	1.08E-01	1.00E00
sno(s)RNA metabolic process (GO:0016074)	10	1	.26	+	3.80	2.49E-01	1.00E00
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	10	1	.26	+	3.80	2.49E-01	1.00E00
response to interleukin-17 (GO:0097396)	10	1	.26	+	3.80	2.49E-01	1.00E00
prenylation (GO:0097354)	10	1	.26	+	3.80	2.49E-01	1.00E00
hepatocyte apoptotic process (GO:0097284)	10	1	.26	+	3.80	2.49E-01	1.00E00
parental behavior (GO:0060746)	10	1	.26	+	3.80	2.49E-01	1.00E00
prostanoid biosynthetic process (GO:0046457)	10	1	.26	+	3.80	2.49E-01	1.00E00
striated muscle adaptation (GO:0014888)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of smooth muscle contraction (GO:0045987)	10	1	.26	+	3.80	2.49E-01	1.00E00
corticospinal tract morphogenesis (GO:0021957)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	10	1	.26	+	3.80	2.49E-01	1.00E00
negative regulation of membrane potential (GO:0045837)	10	1	.26	+	3.80	2.49E-01	1.00E00
embryo implantation (GO:0007566)	20	2	.53	+	3.80	1.08E-01	1.00E00
peptidyl-proline hydroxylation (GO:0019511)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of non-motile cilium assembly (GO:1902857)	10	1	.26	+	3.80	2.49E-01	1.00E00
positive regulation of cellular extravasation (GO:0002693)	10	1	.26	+	3.80	2.49E-01	1.00E00
response to osmotic stress (GO:0006970)	41	4	1.08	+	3.71	2.76E-02	1.00E00
regulation of muscle contraction (GO:0006937)	82	8	2.16	+	3.71	2.11E-03	4.75E-01
regulation of sodium ion transmembrane transporter activity (GO:2000649)	41	4	1.08	+	3.71	2.76E-02	1.00E00
regulation of presynapse assembly (GO:1905606)	31	3	.82	+	3.68	5.56E-02	1.00E00
regulation of nitric oxide metabolic process (GO:0080164)	31	3	.82	+	3.68	5.56E-02	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	52	5	1.37	+	3.66	1.51E-02	8.78E-01
negative regulation of RNA catabolic process (GO:1902369)	52	5	1.37	+	3.66	1.51E-02	8.74E-01
epidermal growth factor receptor signaling pathway (GO:0007173)	21	2	.55	+	3.62	1.17E-01	1.00E00
viral gene expression (GO:0019080)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of NMDA receptor activity (GO:2000310)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of axon extension involved in axon guidance (GO:0048841)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of p38MAPK cascade (GO:1900744)	21	2	.55	+	3.62	1.17E-01	1.00E00
protein sumoylation (GO:0016925)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of macrophage migration (GO:1905521)	21	2	.55	+	3.62	1.17E-01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	21	2	.55	+	3.62	1.17E-01	1.00E00
histone lysine demethylation (GO:0070076)	21	2	.55	+	3.62	1.17E-01	1.00E00
histone demethylation (GO:0016577)	21	2	.55	+	3.62	1.17E-01	1.00E00
apical junction assembly (GO:0043297)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of synaptic vesicle endocytosis (GO:1900242)	21	2	.55	+	3.62	1.17E-01	1.00E00
exocrine system development (GO:0035272)	21	2	.55	+	3.62	1.17E-01	1.00E00
regulation of mesenchymal cell proliferation (GO:0010464)	21	2	.55	+	3.62	1.17E-01	1.00E00
positive regulation of fatty acid metabolic process (GO:0045923)	21	2	.55	+	3.62	1.17E-01	1.00E00
neuron recognition (GO:0008038)	42	4	1.10	+	3.62	2.97E-02	1.00E00
endothelium development (GO:0003158)	42	4	1.10	+	3.62	2.97E-02	1.00E00
regulation of synaptic vesicle exocytosis (GO:2000300)	63	6	1.66	+	3.62	8.32E-03	7.18E-01
female gonad development (GO:0008585)	53	5	1.39	+	3.59	1.61E-02	9.02E-01
regulation of protein kinase B signaling (GO:0051896)	85	8	2.24	+	3.58	2.60E-03	4.93E-01
regulation of neural precursor cell proliferation (GO:2000177)	64	6	1.68	+	3.56	8.91E-03	7.54E-01
regulation of protein autophosphorylation (GO:0031952)	32	3	.84	+	3.56	5.97E-02	1.00E00
positive regulation of potassium ion transport (GO:0043268)	32	3	.84	+	3.56	5.97E-02	1.00E00
positive regulation of protein dephosphorylation (GO:0035307)	32	3	.84	+	3.56	5.97E-02	1.00E00
positive regulation of gliogenesis (GO:0014015)	43	4	1.13	+	3.54	3.18E-02	1.00E00
positive regulation of canonical Wnt signaling pathway (GO:0090263)	65	6	1.71	+	3.51	9.53E-03	7.32E-01
epithelium migration (GO:0090132)	55	5	1.45	+	3.46	1.85E-02	9.41E-01
epithelial cell migration (GO:0010631)	55	5	1.45	+	3.46	1.85E-02	9.37E-01
development of primary female sexual characteristics (GO:0046545)	55	5	1.45	+	3.46	1.85E-02	9.34E-01
body morphogenesis (GO:0010171)	33	3	.87	+	3.46	6.39E-02	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	66	6	1.74	+	3.46	1.02E-02	7.69E-01
demethylation (GO:0070988)	33	3	.87	+	3.46	6.39E-02	1.00E00
regulation of DNA-templated transcription in response to stress (GO:0043620)	33	3	.87	+	3.46	6.39E-02	1.00E00
positive regulation of bone resorption (GO:0045780)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of systemic arterial blood pressure (GO:0003084)	11	1	.29	+	3.46	2.68E-01	1.00E00
response to growth hormone (GO:0060416)	11	1	.29	+	3.46	2.68E-01	1.00E00
ether metabolic process (GO:0018904)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of tissue remodeling (GO:0034104)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of catecholamine secretion (GO:0033605)	11	1	.29	+	3.46	2.68E-01	1.00E00
trabecula formation (GO:0060343)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	11	1	.29	+	3.46	2.68E-01	1.00E00
cranial nerve development (GO:0021545)	22	2	.58	+	3.46	1.25E-01	1.00E00
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of stem cell differentiation (GO:2000738)	11	1	.29	+	3.46	2.68E-01	1.00E00
T cell lineage commitment (GO:0002360)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of collagen biosynthetic process (GO:0032967)	11	1	.29	+	3.46	2.68E-01	1.00E00
glycerol ether metabolic process (GO:0006662)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of mononuclear cell migration (GO:0071676)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of mitotic sister chromatid separation (GO:1901970)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of endothelial cell chemotaxis (GO:2001026)	11	1	.29	+	3.46	2.68E-01	1.00E00
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	11	1	.29	+	3.46	2.68E-01	1.00E00
polyamine metabolic process (GO:0006595)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of sodium ion transmembrane transport (GO:1902306)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation by host of viral process (GO:0044794)	11	1	.29	+	3.46	2.68E-01	1.00E00
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of interleukin-12 production (GO:0032735)	11	1	.29	+	3.46	2.68E-01	1.00E00
cellular response to fluid shear stress (GO:0071498)	11	1	.29	+	3.46	2.68E-01	1.00E00
signal peptide processing (GO:0006465)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of protein kinase B signaling (GO:0051898)	22	2	.58	+	3.46	1.25E-01	1.00E00
epithelial cell maturation (GO:0002070)	11	1	.29	+	3.46	2.68E-01	1.00E00
apical protein localization (GO:0045176)	11	1	.29	+	3.46	2.68E-01	1.00E00
neuronal ion channel clustering (GO:0045161)	11	1	.29	+	3.46	2.68E-01	1.00E00
epiboly (GO:0090504)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of interferon-beta production (GO:0032688)	11	1	.29	+	3.46	2.68E-01	1.00E00
cellular response to fatty acid (GO:0071398)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of innate immune response (GO:0045089)	44	4	1.16	+	3.46	3.40E-02	1.00E00
biological process involved in intraspecies interaction between organisms (GO:0051703)	44	4	1.16	+	3.46	3.40E-02	1.00E00
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	11	1	.29	+	3.46	2.68E-01	1.00E00
trans-synaptic signaling by trans-synaptic complex (GO:0099545)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of embryonic development (GO:0040019)	11	1	.29	+	3.46	2.68E-01	1.00E00
IRES-dependent viral translational initiation (GO:0075522)	11	1	.29	+	3.46	2.68E-01	1.00E00
adenine nucleotide transport (GO:0051503)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of synaptic plasticity (GO:0031915)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of calcium ion import (GO:0090279)	11	1	.29	+	3.46	2.68E-01	1.00E00
transepithelial transport (GO:0070633)	11	1	.29	+	3.46	2.68E-01	1.00E00
smooth muscle tissue development (GO:0048745)	11	1	.29	+	3.46	2.68E-01	1.00E00
nuclear RNA surveillance (GO:0071027)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of voltage-gated calcium channel activity (GO:1901386)	11	1	.29	+	3.46	2.68E-01	1.00E00
endoplasmic reticulum membrane organization (GO:0090158)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	11	1	.29	+	3.46	2.68E-01	1.00E00
cellular response to leucine starvation (GO:1990253)	11	1	.29	+	3.46	2.68E-01	1.00E00
interleukin-1-mediated signaling pathway (GO:0070498)	11	1	.29	+	3.46	2.68E-01	1.00E00
white fat cell differentiation (GO:0050872)	11	1	.29	+	3.46	2.68E-01	1.00E00
protein heterotetramerization (GO:0051290)	11	1	.29	+	3.46	2.68E-01	1.00E00
pre-mRNA cleavage required for polyadenylation (GO:0098789)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of respiratory system process (GO:0044065)	11	1	.29	+	3.46	2.68E-01	1.00E00
paraxial mesoderm development (GO:0048339)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	11	1	.29	+	3.46	2.68E-01	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	22	2	.58	+	3.46	1.25E-01	1.00E00
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	11	1	.29	+	3.46	2.68E-01	1.00E00
myelin maintenance (GO:0043217)	11	1	.29	+	3.46	2.68E-01	1.00E00
inositol phosphate-mediated signaling (GO:0048016)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of synaptic vesicle endocytosis (GO:1900244)	11	1	.29	+	3.46	2.68E-01	1.00E00
protein localization to endosome (GO:0036010)	11	1	.29	+	3.46	2.68E-01	1.00E00
purine nucleotide transport (GO:0015865)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of neurotransmitter secretion (GO:0046929)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of GTP binding (GO:1904424)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of protein K63-linked ubiquitination (GO:1900044)	11	1	.29	+	3.46	2.68E-01	1.00E00
histone H3-K9 modification (GO:0061647)	11	1	.29	+	3.46	2.68E-01	1.00E00
cellular response to angiotensin (GO:1904385)	11	1	.29	+	3.46	2.68E-01	1.00E00
negative regulation of steroid biosynthetic process (GO:0010894)	11	1	.29	+	3.46	2.68E-01	1.00E00
viral RNA genome replication (GO:0039694)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of collagen metabolic process (GO:0010714)	11	1	.29	+	3.46	2.68E-01	1.00E00
social behavior (GO:0035176)	44	4	1.16	+	3.46	3.40E-02	1.00E00
mammary gland lobule development (GO:0061377)	11	1	.29	+	3.46	2.68E-01	1.00E00
endochondral bone growth (GO:0003416)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of lamellipodium assembly (GO:0010592)	22	2	.58	+	3.46	1.25E-01	1.00E00
positive regulation of vascular endothelial growth factor production (GO:0010575)	11	1	.29	+	3.46	2.68E-01	1.00E00
positive regulation of autophagy of mitochondrion (GO:1903599)	11	1	.29	+	3.46	2.68E-01	1.00E00
mammary gland alveolus development (GO:0060749)	11	1	.29	+	3.46	2.68E-01	1.00E00
motor neuron apoptotic process (GO:0097049)	11	1	.29	+	3.46	2.68E-01	1.00E00
dendritic cell differentiation (GO:0097028)	11	1	.29	+	3.46	2.68E-01	1.00E00
hypothalamus development (GO:0021854)	11	1	.29	+	3.46	2.68E-01	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	145	13	3.81	+	3.41	2.06E-04	2.48E-01
regulation of sodium ion transport (GO:0002028)	67	6	1.76	+	3.40	1.09E-02	7.76E-01
tissue migration (GO:0090130)	56	5	1.47	+	3.39	1.97E-02	9.67E-01
positive regulation of epithelial cell proliferation (GO:0050679)	90	8	2.37	+	3.38	3.60E-03	5.69E-01
behavioral fear response (GO:0001662)	34	3	.89	+	3.35	6.83E-02	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	34	3	.89	+	3.35	6.83E-02	1.00E00
insulin secretion (GO:0030073)	34	3	.89	+	3.35	6.83E-02	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	23	2	.61	+	3.31	1.34E-01	1.00E00
striated muscle contraction (GO:0006941)	46	4	1.21	+	3.31	3.87E-02	1.00E00
regulation of autophagy of mitochondrion (GO:1903146)	23	2	.61	+	3.31	1.34E-01	1.00E00
regulation of receptor localization to synapse (GO:1902683)	23	2	.61	+	3.31	1.34E-01	1.00E00
blood vessel remodeling (GO:0001974)	23	2	.61	+	3.31	1.34E-01	1.00E00
postsynaptic membrane organization (GO:0001941)	23	2	.61	+	3.31	1.34E-01	1.00E00
phospholipid translocation (GO:0045332)	23	2	.61	+	3.31	1.34E-01	1.00E00
regulation of long-term synaptic potentiation (GO:1900271)	46	4	1.21	+	3.31	3.87E-02	1.00E00
regulation of epithelial to mesenchymal transition (GO:0010717)	46	4	1.21	+	3.31	3.87E-02	1.00E00
trabecula morphogenesis (GO:0061383)	23	2	.61	+	3.31	1.34E-01	1.00E00
negative regulation of mRNA metabolic process (GO:1903312)	69	6	1.82	+	3.31	1.23E-02	8.35E-01
positive regulation of response to external stimulus (GO:0032103)	162	14	4.26	+	3.28	1.68E-04	3.20E-01
female sex differentiation (GO:0046660)	58	5	1.53	+	3.28	2.24E-02	9.78E-01
regulation of peptidyl-serine phosphorylation (GO:0033135)	93	8	2.45	+	3.27	4.33E-03	6.18E-01
positive regulation of response to wounding (GO:1903036)	35	3	.92	+	3.26	7.28E-02	1.00E00
sterol transport (GO:0015918)	35	3	.92	+	3.26	7.28E-02	1.00E00
heart contraction (GO:0060047)	47	4	1.24	+	3.24	4.12E-02	1.00E00
regulation of leukocyte chemotaxis (GO:0002688)	47	4	1.24	+	3.24	4.12E-02	1.00E00
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	12	1	.32	+	3.17	2.87E-01	1.00E00
epithelial tube branching involved in lung morphogenesis (GO:0060441)	12	1	.32	+	3.17	2.87E-01	1.00E00
cerebellar granular layer development (GO:0021681)	12	1	.32	+	3.17	2.87E-01	1.00E00
SMAD protein signal transduction (GO:0060395)	24	2	.63	+	3.17	1.43E-01	1.00E00
head morphogenesis (GO:0060323)	24	2	.63	+	3.17	1.43E-01	1.00E00
phosphate ion transport (GO:0006817)	12	1	.32	+	3.17	2.87E-01	1.00E00
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	12	1	.32	+	3.17	2.87E-01	1.00E00
suckling behavior (GO:0001967)	12	1	.32	+	3.17	2.87E-01	1.00E00
negative regulation of miRNA metabolic process (GO:2000629)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of growth hormone secretion (GO:0060123)	12	1	.32	+	3.17	2.87E-01	1.00E00
prostaglandin metabolic process (GO:0006693)	12	1	.32	+	3.17	2.87E-01	1.00E00
prostanoid metabolic process (GO:0006692)	12	1	.32	+	3.17	2.87E-01	1.00E00
post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	12	1	.32	+	3.17	2.87E-01	1.00E00
behavioral defense response (GO:0002209)	36	3	.95	+	3.17	7.75E-02	1.00E00
Sertoli cell differentiation (GO:0060008)	12	1	.32	+	3.17	2.87E-01	1.00E00
dopaminergic neuron differentiation (GO:0071542)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of excitatory postsynaptic potential (GO:2000463)	36	3	.95	+	3.17	7.75E-02	1.00E00
vascular endothelial growth factor signaling pathway (GO:0038084)	12	1	.32	+	3.17	2.87E-01	1.00E00
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of histone ubiquitination (GO:0033182)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	24	2	.63	+	3.17	1.43E-01	1.00E00
positive regulation of cell division (GO:0051781)	36	3	.95	+	3.17	7.75E-02	1.00E00
transcytosis (GO:0045056)	12	1	.32	+	3.17	2.87E-01	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	24	2	.63	+	3.17	1.43E-01	1.00E00
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	12	1	.32	+	3.17	2.87E-01	1.00E00
peptidyl-arginine methylation (GO:0018216)	12	1	.32	+	3.17	2.87E-01	1.00E00
artery morphogenesis (GO:0048844)	24	2	.63	+	3.17	1.43E-01	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of icosanoid secretion (GO:0032303)	12	1	.32	+	3.17	2.87E-01	1.00E00
RNA surveillance (GO:0071025)	12	1	.32	+	3.17	2.87E-01	1.00E00
dendrite self-avoidance (GO:0070593)	12	1	.32	+	3.17	2.87E-01	1.00E00
negative regulation of axon regeneration (GO:0048681)	12	1	.32	+	3.17	2.87E-01	1.00E00
collateral sprouting (GO:0048668)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of positive chemotaxis (GO:0050927)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of synaptic transmission, GABAergic (GO:0032230)	12	1	.32	+	3.17	2.87E-01	1.00E00
bone growth (GO:0098868)	12	1	.32	+	3.17	2.87E-01	1.00E00
protein transport along microtubule (GO:0098840)	12	1	.32	+	3.17	2.87E-01	1.00E00
mRNA cleavage involved in mRNA processing (GO:0098787)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	96	8	2.53	+	3.17	5.16E-03	6.41E-01
ERK1 and ERK2 cascade (GO:0070371)	24	2	.63	+	3.17	1.43E-01	1.00E00
microtubule-based protein transport (GO:0099118)	12	1	.32	+	3.17	2.87E-01	1.00E00
response to muscle stretch (GO:0035994)	12	1	.32	+	3.17	2.87E-01	1.00E00
peptidyl-threonine dephosphorylation (GO:0035970)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of actin nucleation (GO:0051127)	12	1	.32	+	3.17	2.87E-01	1.00E00
muscle adaptation (GO:0043500)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of morphogenesis of an epithelium (GO:1905332)	12	1	.32	+	3.17	2.87E-01	1.00E00
synaptic vesicle budding (GO:0070142)	12	1	.32	+	3.17	2.87E-01	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive T cell selection (GO:0043368)	12	1	.32	+	3.17	2.87E-01	1.00E00
chemokine-mediated signaling pathway (GO:0070098)	12	1	.32	+	3.17	2.87E-01	1.00E00
histone ubiquitination (GO:0016574)	36	3	.95	+	3.17	7.75E-02	1.00E00
amine biosynthetic process (GO:0009309)	12	1	.32	+	3.17	2.87E-01	1.00E00
peptide catabolic process (GO:0043171)	12	1	.32	+	3.17	2.87E-01	1.00E00
endocrine pancreas development (GO:0031018)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of macrophage cytokine production (GO:0010935)	12	1	.32	+	3.17	2.87E-01	1.00E00
filopodium assembly (GO:0046847)	12	1	.32	+	3.17	2.87E-01	1.00E00
synaptic vesicle maturation (GO:0016188)	12	1	.32	+	3.17	2.87E-01	1.00E00
cellular biogenic amine biosynthetic process (GO:0042401)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of deacetylase activity (GO:0150065)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of macrophage chemotaxis (GO:0010758)	12	1	.32	+	3.17	2.87E-01	1.00E00
melanocyte differentiation (GO:0030318)	12	1	.32	+	3.17	2.87E-01	1.00E00
dendritic spine development (GO:0060996)	36	3	.95	+	3.17	7.75E-02	1.00E00
regulation of miRNA-mediated gene silencing (GO:0060964)	24	2	.63	+	3.17	1.43E-01	1.00E00
tissue regeneration (GO:0042246)	24	2	.63	+	3.17	1.43E-01	1.00E00
axis elongation (GO:0003401)	12	1	.32	+	3.17	2.87E-01	1.00E00
amyloid-beta clearance (GO:0097242)	12	1	.32	+	3.17	2.87E-01	1.00E00
icosanoid biosynthetic process (GO:0046456)	12	1	.32	+	3.17	2.87E-01	1.00E00
protein refolding (GO:0042026)	12	1	.32	+	3.17	2.87E-01	1.00E00
negative regulation of steroid metabolic process (GO:0045939)	12	1	.32	+	3.17	2.87E-01	1.00E00
regulation of dendritic spine maintenance (GO:1902950)	12	1	.32	+	3.17	2.87E-01	1.00E00
positive regulation of protein tyrosine kinase activity (GO:0061098)	24	2	.63	+	3.17	1.43E-01	1.00E00
negative regulation of regulated secretory pathway (GO:1903306)	12	1	.32	+	3.17	2.87E-01	1.00E00
heart valve development (GO:0003170)	24	2	.63	+	3.17	1.43E-01	1.00E00
outflow tract morphogenesis (GO:0003151)	36	3	.95	+	3.17	7.75E-02	1.00E00
cellular response to decreased oxygen levels (GO:0036294)	61	5	1.60	+	3.12	2.67E-02	1.00E00
regulation of ossification (GO:0030278)	61	5	1.60	+	3.12	2.67E-02	1.00E00
regulation of sodium ion transmembrane transport (GO:1902305)	49	4	1.29	+	3.10	4.64E-02	1.00E00
protein K48-linked ubiquitination (GO:0070936)	49	4	1.29	+	3.10	4.64E-02	1.00E00
protein tetramerization (GO:0051262)	49	4	1.29	+	3.10	4.64E-02	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	49	4	1.29	+	3.10	4.64E-02	1.00E00
positive regulation of synaptic transmission (GO:0050806)	123	10	3.24	+	3.09	2.18E-03	4.83E-01
regulation of tissue remodeling (GO:0034103)	37	3	.97	+	3.08	8.22E-02	1.00E00
cardiac muscle contraction (GO:0060048)	37	3	.97	+	3.08	8.22E-02	1.00E00
mRNA 3'-end processing (GO:0031124)	37	3	.97	+	3.08	8.22E-02	1.00E00
fear response (GO:0042596)	37	3	.97	+	3.08	8.22E-02	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	37	3	.97	+	3.08	8.22E-02	1.00E00
somatic stem cell population maintenance (GO:0035019)	37	3	.97	+	3.08	8.22E-02	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	37	3	.97	+	3.08	8.22E-02	1.00E00
lipid translocation (GO:0034204)	25	2	.66	+	3.04	1.51E-01	1.00E00
regulation of protein localization to synapse (GO:1902473)	25	2	.66	+	3.04	1.51E-01	1.00E00
maternal process involved in female pregnancy (GO:0060135)	25	2	.66	+	3.04	1.51E-01	1.00E00
regulation of mononuclear cell migration (GO:0071675)	50	4	1.32	+	3.04	4.91E-02	1.00E00
eye photoreceptor cell differentiation (GO:0001754)	25	2	.66	+	3.04	1.51E-01	1.00E00
mRNA polyadenylation (GO:0006378)	25	2	.66	+	3.04	1.51E-01	1.00E00
negative regulation of lipid localization (GO:1905953)	25	2	.66	+	3.04	1.51E-01	1.00E00
fatty acid derivative metabolic process (GO:1901568)	25	2	.66	+	3.04	1.51E-01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	25	2	.66	+	3.04	1.51E-01	1.00E00
positive regulation of potassium ion transmembrane transport (GO:1901381)	25	2	.66	+	3.04	1.51E-01	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	25	2	.66	+	3.04	1.51E-01	1.00E00
ephrin receptor signaling pathway (GO:0048013)	25	2	.66	+	3.04	1.51E-01	1.00E00
fatty acid transport (GO:0015908)	25	2	.66	+	3.04	1.51E-01	1.00E00
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	25	2	.66	+	3.04	1.51E-01	1.00E00
regulation of leukocyte migration (GO:0002685)	88	7	2.32	+	3.02	1.09E-02	7.75E-01
amide transport (GO:0042886)	63	5	1.66	+	3.02	3.00E-02	1.00E00
peripheral nervous system development (GO:0007422)	38	3	1.00	+	3.00	8.71E-02	1.00E00
membrane assembly (GO:0071709)	38	3	1.00	+	3.00	8.71E-02	1.00E00
endothelial cell migration (GO:0043542)	38	3	1.00	+	3.00	8.71E-02	1.00E00
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	38	3	1.00	+	3.00	8.71E-02	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	51	4	1.34	+	2.98	5.20E-02	1.00E00
regulation of focal adhesion assembly (GO:0051893)	51	4	1.34	+	2.98	5.20E-02	1.00E00
cellular response to ketone (GO:1901655)	51	4	1.34	+	2.98	5.20E-02	1.00E00
regulation of cell-substrate junction assembly (GO:0090109)	51	4	1.34	+	2.98	5.20E-02	1.00E00
regulation of blood vessel endothelial cell migration (GO:0043535)	51	4	1.34	+	2.98	5.20E-02	1.00E00
negative regulation of angiogenesis (GO:0016525)	51	4	1.34	+	2.98	5.20E-02	1.00E00
gland morphogenesis (GO:0022612)	51	4	1.34	+	2.98	5.20E-02	1.00E00
organelle localization by membrane tethering (GO:0140056)	64	5	1.68	+	2.97	3.16E-02	1.00E00
organ growth (GO:0035265)	64	5	1.68	+	2.97	3.16E-02	1.00E00
regulation of protein targeting to mitochondrion (GO:1903214)	13	1	.34	+	2.92	3.05E-01	1.00E00
nuclear pore organization (GO:0006999)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of proton transport (GO:0010155)	13	1	.34	+	2.92	3.05E-01	1.00E00
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	13	1	.34	+	2.92	3.05E-01	1.00E00
cellular sodium ion homeostasis (GO:0006883)	13	1	.34	+	2.92	3.05E-01	1.00E00
sensory perception of pain (GO:0019233)	52	4	1.37	+	2.92	5.49E-02	1.00E00
regulation of vasoconstriction (GO:0019229)	39	3	1.03	+	2.92	9.21E-02	1.00E00
hair follicle development (GO:0001942)	52	4	1.37	+	2.92	5.49E-02	1.00E00
cyclic purine nucleotide metabolic process (GO:0052652)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of post-transcriptional gene silencing (GO:0060147)	26	2	.68	+	2.92	1.61E-01	1.00E00
prepulse inhibition (GO:0060134)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of mononuclear cell migration (GO:0071677)	26	2	.68	+	2.92	1.61E-01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of cardiac muscle cell proliferation (GO:0060043)	26	2	.68	+	2.92	1.61E-01	1.00E00
positive regulation of T cell migration (GO:2000406)	13	1	.34	+	2.92	3.05E-01	1.00E00
response to angiotensin (GO:1990776)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of interleukin-10 production (GO:0032653)	13	1	.34	+	2.92	3.05E-01	1.00E00
mRNA cleavage (GO:0006379)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of gene expression by genomic imprinting (GO:0006349)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of T cell differentiation in thymus (GO:0033081)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of reproductive process (GO:2000243)	39	3	1.03	+	2.92	9.21E-02	1.00E00
regulation of mitophagy (GO:1901524)	13	1	.34	+	2.92	3.05E-01	1.00E00
neural nucleus development (GO:0048857)	13	1	.34	+	2.92	3.05E-01	1.00E00
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	26	2	.68	+	2.92	1.61E-01	1.00E00
regulation of fatty acid beta-oxidation (GO:0031998)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of positive chemotaxis (GO:0050926)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive chemotaxis (GO:0050918)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of calcineurin-mediated signaling (GO:0106058)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of phagocytosis (GO:0050765)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of postsynaptic density assembly (GO:0099151)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of mRNA 3'-end processing (GO:0031440)	26	2	.68	+	2.92	1.61E-01	1.00E00
calcium-ion regulated exocytosis (GO:0017156)	39	3	1.03	+	2.92	9.21E-02	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	26	2	.68	+	2.92	1.61E-01	1.00E00
regulation of post-transcriptional gene silencing by RNA (GO:1900368)	26	2	.68	+	2.92	1.61E-01	1.00E00
positive regulation of long-term synaptic potentiation (GO:1900273)	26	2	.68	+	2.92	1.61E-01	1.00E00
regulation of execution phase of apoptosis (GO:1900117)	13	1	.34	+	2.92	3.05E-01	1.00E00
cyclic nucleotide biosynthetic process (GO:0009190)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of cellular response to hypoxia (GO:1900038)	13	1	.34	+	2.92	3.05E-01	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	26	2	.68	+	2.92	1.61E-01	1.00E00
regulation of neuroinflammatory response (GO:0150077)	13	1	.34	+	2.92	3.05E-01	1.00E00
rRNA catabolic process (GO:0016075)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of protein kinase A signaling (GO:0010738)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of striated muscle cell apoptotic process (GO:0010663)	13	1	.34	+	2.92	3.05E-01	1.00E00
regulation of vascular endothelial growth factor production (GO:0010574)	13	1	.34	+	2.92	3.05E-01	1.00E00
secondary metabolic process (GO:0019748)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of translational initiation (GO:0045947)	13	1	.34	+	2.92	3.05E-01	1.00E00
negative regulation of myeloid leukocyte differentiation (GO:0002762)	26	2	.68	+	2.92	1.61E-01	1.00E00
positive regulation of isotype switching (GO:0045830)	13	1	.34	+	2.92	3.05E-01	1.00E00
positive regulation of endocytosis (GO:0045807)	78	6	2.05	+	2.92	2.06E-02	9.88E-01
regulation of dendritic spine morphogenesis (GO:0061001)	52	4	1.37	+	2.92	5.49E-02	1.00E00
female pregnancy (GO:0007565)	52	4	1.37	+	2.92	5.49E-02	1.00E00
endocardial cushion development (GO:0003197)	13	1	.34	+	2.92	3.05E-01	1.00E00
neurotransmitter-gated ion channel clustering (GO:0072578)	13	1	.34	+	2.92	3.05E-01	1.00E00
blood vessel diameter maintenance (GO:0097746)	79	6	2.08	+	2.89	2.17E-02	9.67E-01
regulation of tube diameter (GO:0035296)	79	6	2.08	+	2.89	2.17E-02	9.64E-01
regulation of tube size (GO:0035150)	79	6	2.08	+	2.89	2.17E-02	9.61E-01
positive regulation of neuron differentiation (GO:0045666)	53	4	1.39	+	2.87	5.79E-02	1.00E00
negative regulation of blood vessel morphogenesis (GO:2000181)	53	4	1.39	+	2.87	5.79E-02	1.00E00
negative regulation of vasculature development (GO:1901343)	53	4	1.39	+	2.87	5.79E-02	1.00E00
skin epidermis development (GO:0098773)	53	4	1.39	+	2.87	5.79E-02	1.00E00
epithelial cell development (GO:0002064)	93	7	2.45	+	2.86	1.42E-02	8.46E-01
negative regulation of neuron differentiation (GO:0045665)	40	3	1.05	+	2.85	9.72E-02	1.00E00
integrin-mediated signaling pathway (GO:0007229)	40	3	1.05	+	2.85	9.72E-02	1.00E00
endocrine system development (GO:0035270)	40	3	1.05	+	2.85	9.72E-02	1.00E00
positive regulation of Wnt signaling pathway (GO:0030177)	80	6	2.10	+	2.85	2.28E-02	9.92E-01
regulation of gliogenesis (GO:0014013)	67	5	1.76	+	2.84	3.71E-02	1.00E00
heart process (GO:0003015)	54	4	1.42	+	2.82	6.10E-02	1.00E00
positive regulation of lamellipodium organization (GO:1902745)	27	2	.71	+	2.82	1.70E-01	1.00E00
positive regulation of glial cell differentiation (GO:0045687)	27	2	.71	+	2.82	1.70E-01	1.00E00
nuclear migration (GO:0007097)	27	2	.71	+	2.82	1.70E-01	1.00E00
somitogenesis (GO:0001756)	27	2	.71	+	2.82	1.70E-01	1.00E00
negative regulation of gliogenesis (GO:0014014)	27	2	.71	+	2.82	1.70E-01	1.00E00
regulation of lyase activity (GO:0051339)	27	2	.71	+	2.82	1.70E-01	1.00E00
'de novo' post-translational protein folding (GO:0051084)	27	2	.71	+	2.82	1.70E-01	1.00E00
regulation of cyclase activity (GO:0031279)	27	2	.71	+	2.82	1.70E-01	1.00E00
cellular amino acid biosynthetic process (GO:0008652)	27	2	.71	+	2.82	1.70E-01	1.00E00
regulation of gene silencing by RNA (GO:0060966)	27	2	.71	+	2.82	1.70E-01	1.00E00
bone mineralization (GO:0030282)	27	2	.71	+	2.82	1.70E-01	1.00E00
hair cycle process (GO:0022405)	54	4	1.42	+	2.82	6.10E-02	1.00E00
molting cycle process (GO:0022404)	54	4	1.42	+	2.82	6.10E-02	1.00E00
histone monoubiquitination (GO:0010390)	27	2	.71	+	2.82	1.70E-01	1.00E00
positive regulation of neurogenesis (GO:0050769)	203	15	5.34	+	2.81	4.81E-04	3.37E-01
skeletal muscle tissue development (GO:0007519)	68	5	1.79	+	2.80	3.90E-02	1.00E00
inorganic anion transmembrane transport (GO:0098661)	41	3	1.08	+	2.78	1.02E-01	1.00E00
defense response to bacterium (GO:0042742)	41	3	1.08	+	2.78	1.02E-01	1.00E00
myotube differentiation (GO:0014902)	41	3	1.08	+	2.78	1.02E-01	1.00E00
negative regulation of response to biotic stimulus (GO:0002832)	41	3	1.08	+	2.78	1.02E-01	1.00E00
regulation of cell morphogenesis (GO:0022604)	233	17	6.13	+	2.77	2.35E-04	2.23E-01
regulation of cell shape (GO:0008360)	96	7	2.53	+	2.77	1.65E-02	9.09E-01
liver development (GO:0001889)	55	4	1.45	+	2.76	6.42E-02	1.00E00
regulation of receptor internalization (GO:0002090)	55	4	1.45	+	2.76	6.42E-02	1.00E00
hair cycle (GO:0042633)	55	4	1.45	+	2.76	6.42E-02	1.00E00
regulation of cell-substrate junction organization (GO:0150116)	55	4	1.45	+	2.76	6.42E-02	1.00E00
molting cycle (GO:0042303)	55	4	1.45	+	2.76	6.42E-02	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	69	5	1.82	+	2.75	4.10E-02	1.00E00
membrane docking (GO:0022406)	69	5	1.82	+	2.75	4.10E-02	1.00E00
cell recognition (GO:0008037)	69	5	1.82	+	2.75	4.10E-02	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	83	6	2.18	+	2.75	2.65E-02	1.00E00
positive regulation of nervous system development (GO:0051962)	249	18	6.55	+	2.75	1.71E-04	2.85E-01
lipid transport (GO:0006869)	139	10	3.66	+	2.73	4.95E-03	6.32E-01
regulation of muscle system process (GO:0090257)	139	10	3.66	+	2.73	4.95E-03	6.26E-01
positive regulation of neutrophil migration (GO:1902624)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	42	3	1.10	+	2.72	1.08E-01	1.00E00
positive regulation of protein localization to plasma membrane (GO:1903078)	42	3	1.10	+	2.72	1.08E-01	1.00E00
neuropeptide signaling pathway (GO:0007218)	28	2	.74	+	2.72	1.79E-01	1.00E00
negative regulation of stem cell differentiation (GO:2000737)	14	1	.37	+	2.72	3.23E-01	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	14	1	.37	+	2.72	3.23E-01	1.00E00
TORC1 signaling (GO:0038202)	14	1	.37	+	2.72	3.23E-01	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of cell cycle checkpoint (GO:1901976)	28	2	.74	+	2.72	1.79E-01	1.00E00
viral translation (GO:0019081)	14	1	.37	+	2.72	3.23E-01	1.00E00
modulation by host of viral genome replication (GO:0044827)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of sensory perception of pain (GO:0051930)	28	2	.74	+	2.72	1.79E-01	1.00E00
'de novo' protein folding (GO:0006458)	28	2	.74	+	2.72	1.79E-01	1.00E00
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	42	3	1.10	+	2.72	1.08E-01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	56	4	1.47	+	2.72	6.74E-02	1.00E00
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of anoikis (GO:2000209)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of brown fat cell differentiation (GO:0090335)	14	1	.37	+	2.72	3.23E-01	1.00E00
synaptic membrane adhesion (GO:0099560)	28	2	.74	+	2.72	1.79E-01	1.00E00
regulation of voltage-gated calcium channel activity (GO:1901385)	28	2	.74	+	2.72	1.79E-01	1.00E00
positive regulation of lipid catabolic process (GO:0050996)	14	1	.37	+	2.72	3.23E-01	1.00E00
COPII-coated vesicle budding (GO:0090114)	28	2	.74	+	2.72	1.79E-01	1.00E00
protein K63-linked deubiquitination (GO:0070536)	28	2	.74	+	2.72	1.79E-01	1.00E00
relaxation of muscle (GO:0090075)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of p38MAPK cascade (GO:1900745)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	42	3	1.10	+	2.72	1.08E-01	1.00E00
regulation of postsynapse organization (GO:0099175)	98	7	2.58	+	2.72	1.81E-02	9.38E-01
lens fiber cell differentiation (GO:0070306)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	14	1	.37	+	2.72	3.23E-01	1.00E00
mitotic G1 DNA damage checkpoint signaling (GO:0031571)	14	1	.37	+	2.72	3.23E-01	1.00E00
COPII vesicle coating (GO:0048208)	14	1	.37	+	2.72	3.23E-01	1.00E00
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	14	1	.37	+	2.72	3.23E-01	1.00E00
behavioral response to cocaine (GO:0048148)	14	1	.37	+	2.72	3.23E-01	1.00E00
cortical cytoskeleton organization (GO:0030865)	42	3	1.10	+	2.72	1.08E-01	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	14	1	.37	+	2.72	3.23E-01	1.00E00
ovulation cycle (GO:0042698)	28	2	.74	+	2.72	1.79E-01	1.00E00
nuclear body organization (GO:0030575)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of protein processing (GO:0010954)	14	1	.37	+	2.72	3.23E-01	1.00E00
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of hippo signaling (GO:0035330)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of dephosphorylation (GO:0035306)	42	3	1.10	+	2.72	1.08E-01	1.00E00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	14	1	.37	+	2.72	3.23E-01	1.00E00
segmentation (GO:0035282)	42	3	1.10	+	2.72	1.08E-01	1.00E00
regulation of vesicle size (GO:0097494)	14	1	.37	+	2.72	3.23E-01	1.00E00
muscle cell cellular homeostasis (GO:0046716)	14	1	.37	+	2.72	3.23E-01	1.00E00
negative regulation of organ growth (GO:0046621)	28	2	.74	+	2.72	1.79E-01	1.00E00
asymmetric cell division (GO:0008356)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of lamellipodium assembly (GO:0010591)	28	2	.74	+	2.72	1.79E-01	1.00E00
regulation of blood circulation (GO:1903522)	126	9	3.31	+	2.72	7.84E-03	6.86E-01
labyrinthine layer blood vessel development (GO:0060716)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of immunoglobulin mediated immune response (GO:0002891)	14	1	.37	+	2.72	3.23E-01	1.00E00
peptide hormone secretion (GO:0030072)	42	3	1.10	+	2.72	1.08E-01	1.00E00
negative regulation of adaptive immune response (GO:0002820)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of translational initiation (GO:0045948)	14	1	.37	+	2.72	3.23E-01	1.00E00
phosphatidylethanolamine metabolic process (GO:0046337)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of fatty acid oxidation (GO:0046321)	14	1	.37	+	2.72	3.23E-01	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	14	1	.37	+	2.72	3.23E-01	1.00E00
positive regulation of B cell mediated immunity (GO:0002714)	14	1	.37	+	2.72	3.23E-01	1.00E00
negative regulation of lymphocyte mediated immunity (GO:0002707)	14	1	.37	+	2.72	3.23E-01	1.00E00
hepaticobiliary system development (GO:0061008)	56	4	1.47	+	2.72	6.74E-02	1.00E00
regulation of non-motile cilium assembly (GO:1902855)	14	1	.37	+	2.72	3.23E-01	1.00E00
regulation of neurotransmitter transport (GO:0051588)	99	7	2.60	+	2.69	1.90E-02	9.43E-01
positive regulation of calcium ion transport (GO:0051928)	71	5	1.87	+	2.68	4.51E-02	1.00E00
response to ketone (GO:1901654)	71	5	1.87	+	2.68	4.51E-02	1.00E00
cellular response to hypoxia (GO:0071456)	57	4	1.50	+	2.67	7.08E-02	1.00E00
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	57	4	1.50	+	2.67	7.08E-02	1.00E00
regulation of intracellular pH (GO:0051453)	43	3	1.13	+	2.65	1.13E-01	1.00E00
regulation of pattern recognition receptor signaling pathway (GO:0062207)	43	3	1.13	+	2.65	1.13E-01	1.00E00
iron ion homeostasis (GO:0055072)	43	3	1.13	+	2.65	1.13E-01	1.00E00
regulation of response to biotic stimulus (GO:0002831)	129	9	3.39	+	2.65	9.00E-03	7.52E-01
peptide secretion (GO:0002790)	43	3	1.13	+	2.65	1.13E-01	1.00E00
cellular response to oxygen levels (GO:0071453)	72	5	1.89	+	2.64	4.73E-02	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	101	7	2.66	+	2.63	2.08E-02	9.93E-01
negative regulation of ion transport (GO:0043271)	101	7	2.66	+	2.63	2.08E-02	9.89E-01
regulation of synapse organization (GO:0050807)	217	15	5.71	+	2.63	9.18E-04	3.70E-01
neuroblast proliferation (GO:0007405)	29	2	.76	+	2.62	1.88E-01	1.00E00
JNK cascade (GO:0007254)	29	2	.76	+	2.62	1.88E-01	1.00E00
protein monoubiquitination (GO:0006513)	58	4	1.53	+	2.62	7.42E-02	1.00E00
regulation of sensory perception (GO:0051931)	29	2	.76	+	2.62	1.88E-01	1.00E00
positive regulation of interleukin-6 production (GO:0032755)	29	2	.76	+	2.62	1.88E-01	1.00E00
export across plasma membrane (GO:0140115)	29	2	.76	+	2.62	1.88E-01	1.00E00
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	29	2	.76	+	2.62	1.88E-01	1.00E00
glutamine family amino acid metabolic process (GO:0009064)	29	2	.76	+	2.62	1.88E-01	1.00E00
regulation of membrane lipid distribution (GO:0097035)	29	2	.76	+	2.62	1.88E-01	1.00E00
neuron migration (GO:0001764)	102	7	2.68	+	2.61	2.18E-02	9.60E-01
negative regulation of cell migration (GO:0030336)	175	12	4.60	+	2.61	3.12E-03	5.61E-01
fat cell differentiation (GO:0045444)	73	5	1.92	+	2.60	4.95E-02	1.00E00
regulation of innate immune response (GO:0045088)	73	5	1.92	+	2.60	4.95E-02	1.00E00
regulation of nervous system development (GO:0051960)	351	24	9.23	+	2.60	3.27E-05	4.35E-01
negative regulation of cell development (GO:0010721)	117	8	3.08	+	2.60	1.50E-02	8.75E-01
peptidyl-tyrosine phosphorylation (GO:0018108)	44	3	1.16	+	2.59	1.19E-01	1.00E00
regulation of action potential (GO:0098900)	44	3	1.16	+	2.59	1.19E-01	1.00E00
membrane biogenesis (GO:0044091)	44	3	1.16	+	2.59	1.19E-01	1.00E00
regulation of protein tyrosine kinase activity (GO:0061097)	44	3	1.16	+	2.59	1.19E-01	1.00E00
regulation of metal ion transport (GO:0010959)	250	17	6.58	+	2.58	5.05E-04	3.35E-01
multi-organism reproductive process (GO:0044703)	59	4	1.55	+	2.58	7.77E-02	1.00E00
organic hydroxy compound transport (GO:0015850)	59	4	1.55	+	2.58	7.77E-02	1.00E00
regulation of synapse structure or activity (GO:0050803)	222	15	5.84	+	2.57	1.14E-03	3.98E-01
regulation of potassium ion transport (GO:0043266)	74	5	1.95	+	2.57	5.18E-02	1.00E00
monovalent inorganic cation homeostasis (GO:0055067)	74	5	1.95	+	2.57	5.18E-02	1.00E00
skeletal muscle organ development (GO:0060538)	74	5	1.95	+	2.57	5.18E-02	1.00E00
regulation of RNA stability (GO:0043487)	119	8	3.13	+	2.56	1.63E-02	9.03E-01
positive regulation of cell development (GO:0010720)	239	16	6.29	+	2.54	8.61E-04	4.09E-01
positive regulation of oxidative stress-induced cell death (GO:1903209)	15	1	.39	+	2.53	3.40E-01	1.00E00
regulation of heart growth (GO:0060420)	45	3	1.18	+	2.53	1.24E-01	1.00E00
response to X-ray (GO:0010165)	15	1	.39	+	2.53	3.40E-01	1.00E00
neuromuscular synaptic transmission (GO:0007274)	15	1	.39	+	2.53	3.40E-01	1.00E00
vitamin metabolic process (GO:0006766)	15	1	.39	+	2.53	3.40E-01	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	15	1	.39	+	2.53	3.40E-01	1.00E00
viral genome replication (GO:0019079)	15	1	.39	+	2.53	3.40E-01	1.00E00
vacuolar acidification (GO:0007035)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of cardiac muscle cell proliferation (GO:0060045)	15	1	.39	+	2.53	3.40E-01	1.00E00
mitotic G1/S transition checkpoint signaling (GO:0044819)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of CREB transcription factor activity (GO:0032793)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of lymphocyte migration (GO:2000403)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of mesenchymal cell proliferation (GO:0002053)	15	1	.39	+	2.53	3.40E-01	1.00E00
oocyte maturation (GO:0001556)	15	1	.39	+	2.53	3.40E-01	1.00E00
cellular response to interleukin-1 (GO:0071347)	30	2	.79	+	2.53	1.98E-01	1.00E00
protein insertion into ER membrane (GO:0045048)	15	1	.39	+	2.53	3.40E-01	1.00E00
alpha-amino acid catabolic process (GO:1901606)	30	2	.79	+	2.53	1.98E-01	1.00E00
peptidyl-arginine modification (GO:0018195)	15	1	.39	+	2.53	3.40E-01	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	30	2	.79	+	2.53	1.98E-01	1.00E00
protein localization to chromatin (GO:0071168)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of oligodendrocyte differentiation (GO:0048714)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of protein localization to cell surface (GO:2000010)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of developmental growth (GO:0048639)	135	9	3.55	+	2.53	1.17E-02	8.15E-01
negative chemotaxis (GO:0050919)	30	2	.79	+	2.53	1.98E-01	1.00E00
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	15	1	.39	+	2.53	3.40E-01	1.00E00
activation of protein kinase B activity (GO:0032148)	15	1	.39	+	2.53	3.40E-01	1.00E00
negative regulation of cold-induced thermogenesis (GO:0120163)	30	2	.79	+	2.53	1.98E-01	1.00E00
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of blood vessel endothelial cell migration (GO:0043536)	30	2	.79	+	2.53	1.98E-01	1.00E00
response to mechanical stimulus (GO:0009612)	75	5	1.97	+	2.53	5.42E-02	1.00E00
regulation of excitatory synapse assembly (GO:1904889)	15	1	.39	+	2.53	3.40E-01	1.00E00
clathrin coat assembly (GO:0048268)	15	1	.39	+	2.53	3.40E-01	1.00E00
xenobiotic transport (GO:0042908)	15	1	.39	+	2.53	3.40E-01	1.00E00
regulation of long-term neuronal synaptic plasticity (GO:0048169)	30	2	.79	+	2.53	1.98E-01	1.00E00
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	15	1	.39	+	2.53	3.40E-01	1.00E00
exploration behavior (GO:0035640)	30	2	.79	+	2.53	1.98E-01	1.00E00
negative regulation of vascular permeability (GO:0043116)	15	1	.39	+	2.53	3.40E-01	1.00E00
muscle cell development (GO:0055001)	75	5	1.97	+	2.53	5.42E-02	1.00E00
negative regulation of histone methylation (GO:0031061)	15	1	.39	+	2.53	3.40E-01	1.00E00
neuron maturation (GO:0042551)	30	2	.79	+	2.53	1.98E-01	1.00E00
dosage compensation by inactivation of X chromosome (GO:0009048)	15	1	.39	+	2.53	3.40E-01	1.00E00
regulation of hormone biosynthetic process (GO:0046885)	15	1	.39	+	2.53	3.40E-01	1.00E00
alpha-beta T cell differentiation (GO:0046632)	30	2	.79	+	2.53	1.98E-01	1.00E00
negative regulation of ossification (GO:0030279)	15	1	.39	+	2.53	3.40E-01	1.00E00
cellular response to alcohol (GO:0097306)	45	3	1.18	+	2.53	1.24E-01	1.00E00
keratinocyte differentiation (GO:0030216)	30	2	.79	+	2.53	1.98E-01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of synaptic vesicle recycling (GO:1903423)	15	1	.39	+	2.53	3.40E-01	1.00E00
regulation of synaptic vesicle recycling (GO:1903421)	30	2	.79	+	2.53	1.98E-01	1.00E00
negative regulation of dendritic spine development (GO:0061000)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of protein maturation (GO:1903319)	15	1	.39	+	2.53	3.40E-01	1.00E00
dosage compensation (GO:0007549)	15	1	.39	+	2.53	3.40E-01	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	30	2	.79	+	2.53	1.98E-01	1.00E00
positive regulation of cation transmembrane transport (GO:1904064)	106	7	2.79	+	2.51	2.60E-02	1.00E00
regulation of neurogenesis (GO:0050767)	288	19	7.58	+	2.51	3.40E-04	2.82E-01
negative regulation of cell motility (GO:2000146)	182	12	4.79	+	2.51	4.20E-03	6.14E-01
regulation of neurotransmitter secretion (GO:0046928)	91	6	2.39	+	2.51	3.82E-02	1.00E00
positive regulation of cell-substrate adhesion (GO:0010811)	76	5	2.00	+	2.50	5.66E-02	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	61	4	1.60	+	2.49	8.50E-02	1.00E00
regulation of organ growth (GO:0046620)	61	4	1.60	+	2.49	8.50E-02	1.00E00
positive regulation of neuron projection development (GO:0010976)	168	11	4.42	+	2.49	6.33E-03	6.27E-01
regulation of glial cell differentiation (GO:0045685)	46	3	1.21	+	2.48	1.30E-01	1.00E00
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	46	3	1.21	+	2.48	1.30E-01	1.00E00
mitotic DNA damage checkpoint signaling (GO:0044773)	46	3	1.21	+	2.48	1.30E-01	1.00E00
peptidyl-tyrosine modification (GO:0018212)	46	3	1.21	+	2.48	1.30E-01	1.00E00
receptor internalization (GO:0031623)	46	3	1.21	+	2.48	1.30E-01	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	77	5	2.03	+	2.47	5.91E-02	1.00E00
regulation of mRNA stability (GO:0043488)	108	7	2.84	+	2.46	2.82E-02	1.00E00
learning (GO:0007612)	139	9	3.66	+	2.46	1.38E-02	8.39E-01
face development (GO:0060324)	31	2	.82	+	2.45	2.07E-01	1.00E00
chloride transmembrane transport (GO:1902476)	31	2	.82	+	2.45	2.07E-01	1.00E00
protein targeting to ER (GO:0045047)	31	2	.82	+	2.45	2.07E-01	1.00E00
embryonic pattern specification (GO:0009880)	31	2	.82	+	2.45	2.07E-01	1.00E00
positive regulation of actin filament polymerization (GO:0030838)	31	2	.82	+	2.45	2.07E-01	1.00E00
protein localization to synapse (GO:0035418)	62	4	1.63	+	2.45	8.88E-02	1.00E00
negative regulation of axon extension (GO:0030517)	31	2	.82	+	2.45	2.07E-01	1.00E00
second-messenger-mediated signaling (GO:0019932)	93	6	2.45	+	2.45	4.15E-02	1.00E00
epithelial cell apoptotic process (GO:1904019)	31	2	.82	+	2.45	2.07E-01	1.00E00
cellular monovalent inorganic cation homeostasis (GO:0030004)	62	4	1.63	+	2.45	8.88E-02	1.00E00
positive regulation of transmembrane transport (GO:0034764)	156	10	4.10	+	2.44	1.03E-02	7.55E-01
protein dephosphorylation (GO:0006470)	125	8	3.29	+	2.43	2.10E-02	9.41E-01
long-term synaptic potentiation (GO:0060291)	47	3	1.24	+	2.43	1.36E-01	1.00E00
mitotic DNA integrity checkpoint signaling (GO:0044774)	47	3	1.24	+	2.43	1.36E-01	1.00E00
regulation of interleukin-6 production (GO:0032675)	47	3	1.24	+	2.43	1.36E-01	1.00E00
tissue remodeling (GO:0048771)	47	3	1.24	+	2.43	1.36E-01	1.00E00
positive regulation of ion transport (GO:0043270)	188	12	4.95	+	2.43	5.35E-03	6.08E-01
gonad development (GO:0008406)	94	6	2.47	+	2.43	4.33E-02	1.00E00
regulation of protein localization to plasma membrane (GO:1903076)	79	5	2.08	+	2.41	6.42E-02	1.00E00
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	79	5	2.08	+	2.41	6.42E-02	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	79	5	2.08	+	2.41	6.42E-02	1.00E00
gland development (GO:0048732)	190	12	5.00	+	2.40	5.79E-03	6.20E-01
positive regulation of defense response (GO:0031349)	95	6	2.50	+	2.40	4.51E-02	1.00E00
carbohydrate transmembrane transport (GO:0034219)	16	1	.42	+	2.38	3.57E-01	1.00E00
multicellular organism aging (GO:0010259)	16	1	.42	+	2.38	3.57E-01	1.00E00
endoderm development (GO:0007492)	32	2	.84	+	2.38	2.16E-01	1.00E00
triglyceride biosynthetic process (GO:0019432)	16	1	.42	+	2.38	3.57E-01	1.00E00
muscle contraction (GO:0006936)	80	5	2.10	+	2.38	6.69E-02	1.00E00
spermatid nucleus differentiation (GO:0007289)	16	1	.42	+	2.38	3.57E-01	1.00E00
camera-type eye photoreceptor cell differentiation (GO:0060219)	16	1	.42	+	2.38	3.57E-01	1.00E00
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	16	1	.42	+	2.38	3.57E-01	1.00E00
epithelial to mesenchymal transition (GO:0001837)	32	2	.84	+	2.38	2.16E-01	1.00E00
negative regulation of stem cell population maintenance (GO:1902455)	16	1	.42	+	2.38	3.57E-01	1.00E00
lymphocyte homeostasis (GO:0002260)	32	2	.84	+	2.38	2.16E-01	1.00E00
synapse maturation (GO:0060074)	16	1	.42	+	2.38	3.57E-01	1.00E00
multi-multicellular organism process (GO:0044706)	64	4	1.68	+	2.38	9.65E-02	1.00E00
positive regulation of chemokine production (GO:0032722)	16	1	.42	+	2.38	3.57E-01	1.00E00
development of primary sexual characteristics (GO:0045137)	96	6	2.53	+	2.38	4.69E-02	1.00E00
nucleosome assembly (GO:0006334)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of reproductive process (GO:2000241)	80	5	2.10	+	2.38	6.69E-02	1.00E00
peptidyl-threonine modification (GO:0018210)	64	4	1.68	+	2.38	9.65E-02	1.00E00
negative regulation of axon extension involved in axon guidance (GO:0048843)	16	1	.42	+	2.38	3.57E-01	1.00E00
maintenance of synapse structure (GO:0099558)	16	1	.42	+	2.38	3.57E-01	1.00E00
positive regulation of voltage-gated calcium channel activity (GO:1901387)	16	1	.42	+	2.38	3.57E-01	1.00E00
response to fatty acid (GO:0070542)	16	1	.42	+	2.38	3.57E-01	1.00E00
positive regulation of chemotaxis (GO:0050921)	64	4	1.68	+	2.38	9.65E-02	1.00E00
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	16	1	.42	+	2.38	3.57E-01	1.00E00
regulation of response to nutrient levels (GO:0032107)	16	1	.42	+	2.38	3.57E-01	1.00E00
regulation of response to extracellular stimulus (GO:0032104)	16	1	.42	+	2.38	3.57E-01	1.00E00
positive regulation of phagocytosis (GO:0050766)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of respiratory gaseous exchange (GO:0043576)	16	1	.42	+	2.38	3.57E-01	1.00E00
presynapse assembly (GO:0099054)	16	1	.42	+	2.38	3.57E-01	1.00E00
lung alveolus development (GO:0048286)	32	2	.84	+	2.38	2.16E-01	1.00E00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of cellular pH (GO:0030641)	48	3	1.26	+	2.38	1.42E-01	1.00E00
sodium ion homeostasis (GO:0055078)	16	1	.42	+	2.38	3.57E-01	1.00E00
negative regulation of histone modification (GO:0031057)	32	2	.84	+	2.38	2.16E-01	1.00E00
monosaccharide transmembrane transport (GO:0015749)	16	1	.42	+	2.38	3.57E-01	1.00E00
positive regulation of protein localization to cell periphery (GO:1904377)	48	3	1.26	+	2.38	1.42E-01	1.00E00
lipid localization (GO:0010876)	160	10	4.21	+	2.38	1.21E-02	8.24E-01
positive regulation of glucose transmembrane transport (GO:0010828)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of cell morphogenesis involved in differentiation (GO:0010769)	96	6	2.53	+	2.38	4.69E-02	1.00E00
positive regulation of fibroblast migration (GO:0010763)	16	1	.42	+	2.38	3.57E-01	1.00E00
cholesterol transport (GO:0030301)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of establishment of protein localization to mitochondrion (GO:1903747)	16	1	.42	+	2.38	3.57E-01	1.00E00
glial cell migration (GO:0008347)	32	2	.84	+	2.38	2.16E-01	1.00E00
histone mRNA metabolic process (GO:0008334)	16	1	.42	+	2.38	3.57E-01	1.00E00
heart trabecula morphogenesis (GO:0061384)	16	1	.42	+	2.38	3.57E-01	1.00E00
positive regulation of glycoprotein biosynthetic process (GO:0010560)	16	1	.42	+	2.38	3.57E-01	1.00E00
response to fluid shear stress (GO:0034405)	16	1	.42	+	2.38	3.57E-01	1.00E00
extracellular matrix assembly (GO:0085029)	16	1	.42	+	2.38	3.57E-01	1.00E00
blood circulation (GO:0008015)	192	12	5.05	+	2.38	6.25E-03	6.29E-01
negative regulation of immune effector process (GO:0002698)	32	2	.84	+	2.38	2.16E-01	1.00E00
regulation of cell-substrate adhesion (GO:0010810)	129	8	3.39	+	2.36	2.45E-02	1.00E00
cellular ion homeostasis (GO:0006873)	226	14	5.95	+	2.35	5.32E-03	6.15E-01
ion homeostasis (GO:0050801)	275	17	7.23	+	2.35	1.82E-03	4.74E-01
learning or memory (GO:0007611)	227	14	5.97	+	2.34	5.40E-03	6.09E-01
angiogenesis (GO:0001525)	146	9	3.84	+	2.34	1.82E-02	9.37E-01
myeloid leukocyte differentiation (GO:0002573)	65	4	1.71	+	2.34	1.00E-01	1.00E00
regulation of cell development (GO:0060284)	358	22	9.42	+	2.34	3.41E-04	2.66E-01
cellular calcium ion homeostasis (GO:0006874)	114	7	3.00	+	2.33	3.58E-02	1.00E00
modulation of excitatory postsynaptic potential (GO:0098815)	49	3	1.29	+	2.33	1.48E-01	1.00E00
negative regulation of immune response (GO:0050777)	49	3	1.29	+	2.33	1.48E-01	1.00E00
positive regulation of neuron apoptotic process (GO:0043525)	49	3	1.29	+	2.33	1.48E-01	1.00E00
peptide transport (GO:0015833)	49	3	1.29	+	2.33	1.48E-01	1.00E00
regulation of heart contraction (GO:0008016)	98	6	2.58	+	2.33	5.07E-02	1.00E00
regulation of lamellipodium organization (GO:1902743)	33	2	.87	+	2.30	2.26E-01	1.00E00
cerebellar cortex morphogenesis (GO:0021696)	33	2	.87	+	2.30	2.26E-01	1.00E00
potassium ion transport (GO:0006813)	99	6	2.60	+	2.30	5.27E-02	1.00E00
excitatory postsynaptic potential (GO:0060079)	33	2	.87	+	2.30	2.26E-01	1.00E00
regulation of chromatin organization (GO:1902275)	33	2	.87	+	2.30	2.26E-01	1.00E00
postsynaptic signal transduction (GO:0098926)	33	2	.87	+	2.30	2.26E-01	1.00E00
thymus development (GO:0048538)	33	2	.87	+	2.30	2.26E-01	1.00E00
regulation of lipid kinase activity (GO:0043550)	33	2	.87	+	2.30	2.26E-01	1.00E00
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	33	2	.87	+	2.30	2.26E-01	1.00E00
actin-mediated cell contraction (GO:0070252)	33	2	.87	+	2.30	2.26E-01	1.00E00
negative regulation of MAPK cascade (GO:0043409)	99	6	2.60	+	2.30	5.27E-02	1.00E00
autophagosome maturation (GO:0097352)	33	2	.87	+	2.30	2.26E-01	1.00E00
positive regulation of smooth muscle cell migration (GO:0014911)	33	2	.87	+	2.30	2.26E-01	1.00E00
somite development (GO:0061053)	33	2	.87	+	2.30	2.26E-01	1.00E00
regulation of nervous system process (GO:0031644)	116	7	3.05	+	2.29	3.86E-02	1.00E00
memory (GO:0007613)	116	7	3.05	+	2.29	3.86E-02	1.00E00
blastocyst development (GO:0001824)	83	5	2.18	+	2.29	7.52E-02	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	133	8	3.50	+	2.29	2.85E-02	1.00E00
regulation of heart rate (GO:0002027)	50	3	1.32	+	2.28	1.54E-01	1.00E00
negative regulation of axonogenesis (GO:0050771)	50	3	1.32	+	2.28	1.54E-01	1.00E00
negative regulation of neurogenesis (GO:0050768)	100	6	2.63	+	2.28	5.47E-02	1.00E00
synaptic vesicle exocytosis (GO:0016079)	50	3	1.32	+	2.28	1.54E-01	1.00E00
regulation of ion transmembrane transporter activity (GO:0032412)	184	11	4.84	+	2.27	1.77E-02	9.36E-01
cell chemotaxis (GO:0060326)	67	4	1.76	+	2.27	1.09E-01	1.00E00
regulation of system process (GO:0044057)	336	20	8.84	+	2.26	9.01E-04	3.74E-01
regulation of circadian rhythm (GO:0042752)	84	5	2.21	+	2.26	7.81E-02	1.00E00
regulation of blood pressure (GO:0008217)	84	5	2.21	+	2.26	7.81E-02	1.00E00
inorganic ion homeostasis (GO:0098771)	269	16	7.08	+	2.26	3.26E-03	5.56E-01
negative regulation of nervous system development (GO:0051961)	101	6	2.66	+	2.26	5.68E-02	1.00E00
regulation of protein localization to cell periphery (GO:1904375)	101	6	2.66	+	2.26	5.68E-02	1.00E00
regulation of epithelial cell migration (GO:0010632)	135	8	3.55	+	2.25	3.06E-02	1.00E00
negative regulation of locomotion (GO:0040013)	203	12	5.34	+	2.25	1.29E-02	8.26E-01
metal ion homeostasis (GO:0055065)	220	13	5.79	+	2.25	9.16E-03	7.61E-01
positive regulation of ion transmembrane transporter activity (GO:0032414)	85	5	2.24	+	2.24	8.10E-02	1.00E00
positive regulation of ion transmembrane transport (GO:0034767)	119	7	3.13	+	2.24	4.31E-02	1.00E00
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	85	5	2.24	+	2.24	8.10E-02	1.00E00
cerebellar cortex development (GO:0021695)	51	3	1.34	+	2.24	1.60E-01	1.00E00
negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	51	3	1.34	+	2.24	1.60E-01	1.00E00
positive regulation of glycoprotein metabolic process (GO:1903020)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of fatty acid metabolic process (GO:0019217)	51	3	1.34	+	2.24	1.60E-01	1.00E00
leukocyte mediated cytotoxicity (GO:0001909)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	17	1	.45	+	2.24	3.74E-01	1.00E00
viral release from host cell (GO:0019076)	17	1	.45	+	2.24	3.74E-01	1.00E00
negative regulation of organic acid transport (GO:0032891)	17	1	.45	+	2.24	3.74E-01	1.00E00
columnar/cuboidal epithelial cell development (GO:0002066)	17	1	.45	+	2.24	3.74E-01	1.00E00
branching involved in blood vessel morphogenesis (GO:0001569)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of endothelial cell apoptotic process (GO:2000351)	17	1	.45	+	2.24	3.74E-01	1.00E00
T cell selection (GO:0045058)	17	1	.45	+	2.24	3.74E-01	1.00E00
negative regulation of neural precursor cell proliferation (GO:2000178)	17	1	.45	+	2.24	3.74E-01	1.00E00
negative regulation of type I interferon production (GO:0032480)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of cytokinesis (GO:0032467)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of chromosome separation (GO:1905820)	17	1	.45	+	2.24	3.74E-01	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	34	2	.89	+	2.24	2.35E-01	1.00E00
regulation of stem cell population maintenance (GO:2000036)	51	3	1.34	+	2.24	1.60E-01	1.00E00
positive regulation of stress fiber assembly (GO:0051496)	34	2	.89	+	2.24	2.35E-01	1.00E00
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of establishment of planar polarity (GO:0090175)	17	1	.45	+	2.24	3.74E-01	1.00E00
embryonic axis specification (GO:0000578)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of postsynaptic specialization assembly (GO:0099150)	17	1	.45	+	2.24	3.74E-01	1.00E00
exit from host cell (GO:0035891)	17	1	.45	+	2.24	3.74E-01	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	34	2	.89	+	2.24	2.35E-01	1.00E00
regulation of mRNA polyadenylation (GO:1900363)	17	1	.45	+	2.24	3.74E-01	1.00E00
eating behavior (GO:0042755)	17	1	.45	+	2.24	3.74E-01	1.00E00
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	17	1	.45	+	2.24	3.74E-01	1.00E00
mitochondrial genome maintenance (GO:0000002)	17	1	.45	+	2.24	3.74E-01	1.00E00
neuron projection regeneration (GO:0031102)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of cellular response to hypoxia (GO:1900037)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of BMP signaling pathway (GO:0030513)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of dendrite development (GO:1900006)	17	1	.45	+	2.24	3.74E-01	1.00E00
cell communication involved in cardiac conduction (GO:0086065)	17	1	.45	+	2.24	3.74E-01	1.00E00
hormone secretion (GO:0046879)	51	3	1.34	+	2.24	1.60E-01	1.00E00
eye photoreceptor cell development (GO:0042462)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of fibroblast migration (GO:0010762)	34	2	.89	+	2.24	2.35E-01	1.00E00
positive regulation of cell growth (GO:0030307)	136	8	3.58	+	2.24	3.18E-02	1.00E00
regulation of Rac protein signal transduction (GO:0035020)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of blood circulation (GO:1903524)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of androgen receptor signaling pathway (GO:0060765)	17	1	.45	+	2.24	3.74E-01	1.00E00
lymphocyte migration (GO:0072676)	17	1	.45	+	2.24	3.74E-01	1.00E00
positive regulation of heart contraction (GO:0045823)	17	1	.45	+	2.24	3.74E-01	1.00E00
regulation of cation transmembrane transport (GO:1904062)	239	14	6.29	+	2.23	6.86E-03	6.56E-01
negative regulation of immune system process (GO:0002683)	154	9	4.05	+	2.22	3.83E-02	1.00E00
regulation of developmental growth (GO:0048638)	240	14	6.31	+	2.22	7.02E-03	6.66E-01
negative regulation of mitotic cell cycle (GO:0045930)	120	7	3.16	+	2.22	4.47E-02	1.00E00
positive regulation of growth (GO:0045927)	189	11	4.97	+	2.21	1.92E-02	9.46E-01
postsynapse organization (GO:0099173)	86	5	2.26	+	2.21	8.41E-02	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	190	11	5.00	+	2.20	1.95E-02	9.60E-01
regulation of mRNA catabolic process (GO:0061013)	121	7	3.18	+	2.20	4.63E-02	1.00E00
cellular homeostasis (GO:0019725)	346	20	9.10	+	2.20	1.83E-03	4.69E-01
regulation of neurotransmitter receptor activity (GO:0099601)	52	3	1.37	+	2.19	1.67E-01	1.00E00
receptor localization to synapse (GO:0097120)	52	3	1.37	+	2.19	1.67E-01	1.00E00
inflammatory response (GO:0006954)	139	8	3.66	+	2.19	5.66E-02	1.00E00
response to calcium ion (GO:0051592)	87	5	2.29	+	2.18	8.71E-02	1.00E00
regulation of epithelial cell proliferation (GO:0050678)	174	10	4.58	+	2.18	2.80E-02	1.00E00
circulatory system process (GO:0003013)	209	12	5.50	+	2.18	1.45E-02	8.51E-01
positive regulation of cell-matrix adhesion (GO:0001954)	35	2	.92	+	2.17	2.45E-01	1.00E00
response to fibroblast growth factor (GO:0071774)	35	2	.92	+	2.17	2.45E-01	1.00E00
lens development in camera-type eye (GO:0002088)	35	2	.92	+	2.17	2.45E-01	1.00E00
regulation of response to external stimulus (GO:0032101)	385	22	10.13	+	2.17	1.01E-03	3.72E-01
regulation of defense response to virus (GO:0050688)	35	2	.92	+	2.17	2.45E-01	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	35	2	.92	+	2.17	2.45E-01	1.00E00
adult walking behavior (GO:0007628)	35	2	.92	+	2.17	2.45E-01	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	35	2	.92	+	2.17	2.45E-01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	439	25	11.55	+	2.16	4.08E-04	3.01E-01
regulation of ion transport (GO:0043269)	422	24	11.10	+	2.16	5.60E-04	3.55E-01
potassium ion transmembrane transport (GO:0071805)	88	5	2.32	+	2.16	9.03E-02	1.00E00
regulation of axonogenesis (GO:0050770)	141	8	3.71	+	2.16	5.80E-02	1.00E00
muscle system process (GO:0003012)	106	6	2.79	+	2.15	6.78E-02	1.00E00
regulation of pH (GO:0006885)	53	3	1.39	+	2.15	1.73E-01	1.00E00
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	53	3	1.39	+	2.15	1.73E-01	1.00E00
activation of protein kinase activity (GO:0032147)	53	3	1.39	+	2.15	1.73E-01	1.00E00
cation homeostasis (GO:0055080)	265	15	6.97	+	2.15	6.25E-03	6.34E-01
peptidyl-serine modification (GO:0018209)	159	9	4.18	+	2.15	4.11E-02	1.00E00
cellular chemical homeostasis (GO:0055082)	283	16	7.45	+	2.15	4.72E-03	6.09E-01
blood vessel morphogenesis (GO:0048514)	195	11	5.13	+	2.14	2.15E-02	9.61E-01
regulation of membrane potential (GO:0042391)	303	17	7.97	+	2.13	5.65E-03	6.21E-01
regulation of ion transmembrane transport (GO:0034765)	303	17	7.97	+	2.13	5.65E-03	6.15E-01
dendrite development (GO:0016358)	125	7	3.29	+	2.13	8.47E-02	1.00E00
calcium ion homeostasis (GO:0055074)	125	7	3.29	+	2.13	8.47E-02	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	143	8	3.76	+	2.13	5.96E-02	1.00E00
positive regulation of cell projection organization (GO:0031346)	323	18	8.50	+	2.12	4.19E-03	6.19E-01
positive regulation of blood pressure (GO:0045777)	18	1	.47	+	2.11	3.90E-01	1.00E00
developmental maturation (GO:0021700)	162	9	4.26	+	2.11	4.32E-02	1.00E00
vesicle docking involved in exocytosis (GO:0006904)	36	2	.95	+	2.11	2.55E-01	1.00E00
regulation of osteoclast differentiation (GO:0045670)	36	2	.95	+	2.11	2.55E-01	1.00E00
sodium ion transport (GO:0006814)	72	4	1.89	+	2.11	1.30E-01	1.00E00
central nervous system myelination (GO:0022010)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of neuron migration (GO:2001224)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of double-strand break repair (GO:2000780)	18	1	.47	+	2.11	3.90E-01	1.00E00
dopamine receptor signaling pathway (GO:0007212)	18	1	.47	+	2.11	3.90E-01	1.00E00
one-carbon metabolic process (GO:0006730)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of collagen biosynthetic process (GO:0032965)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of activin receptor signaling pathway (GO:0032925)	18	1	.47	+	2.11	3.90E-01	1.00E00
biological phase (GO:0044848)	18	1	.47	+	2.11	3.90E-01	1.00E00
cardiac muscle cell proliferation (GO:0060038)	18	1	.47	+	2.11	3.90E-01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	72	4	1.89	+	2.11	1.30E-01	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of calcium ion transport (GO:0051926)	36	2	.95	+	2.11	2.55E-01	1.00E00
regulation of calcium ion transport (GO:0051924)	144	8	3.79	+	2.11	6.04E-02	1.00E00
branching involved in ureteric bud morphogenesis (GO:0001658)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	54	3	1.42	+	2.11	1.79E-01	1.00E00
cellular response to glucocorticoid stimulus (GO:0071385)	18	1	.47	+	2.11	3.90E-01	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of viral genome replication (GO:0045071)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of protein exit from endoplasmic reticulum (GO:0070861)	18	1	.47	+	2.11	3.90E-01	1.00E00
dendrite morphogenesis (GO:0048813)	72	4	1.89	+	2.11	1.30E-01	1.00E00
protein hydroxylation (GO:0018126)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of postsynaptic density organization (GO:1905874)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of histone H3-K9 methylation (GO:0051570)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of peptide hormone secretion (GO:0090277)	72	4	1.89	+	2.11	1.30E-01	1.00E00
positive regulation of lipid kinase activity (GO:0090218)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of astrocyte differentiation (GO:0048710)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of lipid transport (GO:0032369)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of DNA damage checkpoint (GO:2000001)	18	1	.47	+	2.11	3.90E-01	1.00E00
hormone transport (GO:0009914)	54	3	1.42	+	2.11	1.79E-01	1.00E00
animal organ formation (GO:0048645)	18	1	.47	+	2.11	3.90E-01	1.00E00
pigment cell differentiation (GO:0050931)	18	1	.47	+	2.11	3.90E-01	1.00E00
axon ensheathment in central nervous system (GO:0032291)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of viral process (GO:0048524)	36	2	.95	+	2.11	2.55E-01	1.00E00
negative regulation of synaptic transmission (GO:0050805)	54	3	1.42	+	2.11	1.79E-01	1.00E00
protein heterooligomerization (GO:0051291)	18	1	.47	+	2.11	3.90E-01	1.00E00
vitamin transport (GO:0051180)	18	1	.47	+	2.11	3.90E-01	1.00E00
mitophagy (GO:0000423)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of smooth muscle cell differentiation (GO:0051150)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of blood vessel endothelial cell migration (GO:0043537)	18	1	.47	+	2.11	3.90E-01	1.00E00
actin filament bundle assembly (GO:0051017)	36	2	.95	+	2.11	2.55E-01	1.00E00
negative regulation of receptor-mediated endocytosis (GO:0048261)	18	1	.47	+	2.11	3.90E-01	1.00E00
midbrain development (GO:0030901)	18	1	.47	+	2.11	3.90E-01	1.00E00
Rac protein signal transduction (GO:0016601)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of mitochondrial membrane permeability (GO:0035794)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of modification of synaptic structure (GO:1905244)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of B cell proliferation (GO:0030890)	18	1	.47	+	2.11	3.90E-01	1.00E00
locomotory exploration behavior (GO:0035641)	18	1	.47	+	2.11	3.90E-01	1.00E00
histone H2A monoubiquitination (GO:0035518)	18	1	.47	+	2.11	3.90E-01	1.00E00
peroxisomal membrane transport (GO:0015919)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of cardiac muscle tissue growth (GO:0055022)	18	1	.47	+	2.11	3.90E-01	1.00E00
T cell homeostasis (GO:0043029)	18	1	.47	+	2.11	3.90E-01	1.00E00
pore complex assembly (GO:0046931)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	18	1	.47	+	2.11	3.90E-01	1.00E00
intracellular steroid hormone receptor signaling pathway (GO:0030518)	36	2	.95	+	2.11	2.55E-01	1.00E00
negative regulation of anion transport (GO:1903792)	18	1	.47	+	2.11	3.90E-01	1.00E00
embryonic hemopoiesis (GO:0035162)	18	1	.47	+	2.11	3.90E-01	1.00E00
alpha-beta T cell activation (GO:0046631)	36	2	.95	+	2.11	2.55E-01	1.00E00
positive regulation of insulin receptor signaling pathway (GO:0046628)	18	1	.47	+	2.11	3.90E-01	1.00E00
regulation of cardiac muscle cell apoptotic process (GO:0010665)	36	2	.95	+	2.11	2.55E-01	1.00E00
regulation of sprouting angiogenesis (GO:1903670)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of Rho protein signal transduction (GO:0035024)	18	1	.47	+	2.11	3.90E-01	1.00E00
neural retina development (GO:0003407)	36	2	.95	+	2.11	2.55E-01	1.00E00
photoreceptor cell differentiation (GO:0046530)	36	2	.95	+	2.11	2.55E-01	1.00E00
cardiac muscle hypertrophy (GO:0003300)	18	1	.47	+	2.11	3.90E-01	1.00E00
postsynaptic density organization (GO:0097106)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of heart growth (GO:0061117)	18	1	.47	+	2.11	3.90E-01	1.00E00
negative regulation of leukocyte mediated immunity (GO:0002704)	18	1	.47	+	2.11	3.90E-01	1.00E00
positive regulation of transporter activity (GO:0032411)	90	5	2.37	+	2.11	9.67E-02	1.00E00
regulation of transporter activity (GO:0032409)	198	11	5.21	+	2.11	2.29E-02	9.89E-01
negative regulation of defense response (GO:0031348)	90	5	2.37	+	2.11	9.67E-02	1.00E00
trans-synaptic signaling (GO:0099537)	272	15	7.16	+	2.10	1.16E-02	8.13E-01
reproductive structure development (GO:0048608)	127	7	3.34	+	2.10	8.67E-02	1.00E00
cognition (GO:0050890)	254	14	6.68	+	2.10	9.96E-03	7.56E-01
ameboidal-type cell migration (GO:0001667)	109	6	2.87	+	2.09	7.50E-02	1.00E00
regulation of transmembrane transport (GO:0034762)	364	20	9.58	+	2.09	2.48E-03	4.78E-01
chemical synaptic transmission (GO:0007268)	255	14	6.71	+	2.09	1.02E-02	7.54E-01
anterograde trans-synaptic signaling (GO:0098916)	255	14	6.71	+	2.09	1.02E-02	7.50E-01
positive regulation of peptide secretion (GO:0002793)	73	4	1.92	+	2.08	1.35E-01	1.00E00
innate immune response (GO:0045087)	201	11	5.29	+	2.08	2.44E-02	1.00E00
signal release (GO:0023061)	128	7	3.37	+	2.08	8.78E-02	1.00E00
protein autoubiquitination (GO:0051865)	55	3	1.45	+	2.07	1.86E-01	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	55	3	1.45	+	2.07	1.86E-01	1.00E00
cellular response to calcium ion (GO:0071277)	55	3	1.45	+	2.07	1.86E-01	1.00E00
synaptic vesicle cycle (GO:0099504)	110	6	2.89	+	2.07	7.74E-02	1.00E00
autophagosome assembly (GO:0000045)	55	3	1.45	+	2.07	1.86E-01	1.00E00
visual learning (GO:0008542)	55	3	1.45	+	2.07	1.86E-01	1.00E00
cellular cation homeostasis (GO:0030003)	220	12	5.79	+	2.07	1.86E-02	9.34E-01
muscle tissue development (GO:0060537)	165	9	4.34	+	2.07	4.55E-02	1.00E00
positive regulation of cell migration (GO:0030335)	276	15	7.26	+	2.07	1.21E-02	8.27E-01
anatomical structure maturation (GO:0071695)	129	7	3.39	+	2.06	8.89E-02	1.00E00
regulation of proteolysis involved in protein catabolic process (GO:1903050)	166	9	4.37	+	2.06	4.63E-02	1.00E00
proton transmembrane transport (GO:1902600)	37	2	.97	+	2.05	2.64E-01	1.00E00
cellular response to interferon-gamma (GO:0071346)	37	2	.97	+	2.05	2.64E-01	1.00E00
spindle localization (GO:0051653)	37	2	.97	+	2.05	2.64E-01	1.00E00
protein destabilization (GO:0031648)	37	2	.97	+	2.05	2.64E-01	1.00E00
regulation of protein localization to membrane (GO:1905475)	148	8	3.89	+	2.05	6.42E-02	1.00E00
actin filament bundle organization (GO:0061572)	37	2	.97	+	2.05	2.64E-01	1.00E00
regulation of striated muscle cell apoptotic process (GO:0010662)	37	2	.97	+	2.05	2.64E-01	1.00E00
protein localization to nucleus (GO:0034504)	148	8	3.89	+	2.05	6.42E-02	1.00E00
protein localization to postsynaptic membrane (GO:1903539)	37	2	.97	+	2.05	2.64E-01	1.00E00
reproductive system development (GO:0061458)	130	7	3.42	+	2.05	9.01E-02	1.00E00
cellular divalent inorganic cation homeostasis (GO:0072503)	130	7	3.42	+	2.05	9.01E-02	1.00E00
regulation of neuron projection development (GO:0010975)	409	22	10.76	+	2.04	2.48E-03	4.84E-01
regulation of synapse assembly (GO:0051963)	93	5	2.45	+	2.04	1.07E-01	1.00E00
vascular process in circulatory system (GO:0003018)	112	6	2.95	+	2.04	1.28E-01	1.00E00
single fertilization (GO:0007338)	56	3	1.47	+	2.04	1.92E-01	1.00E00
positive regulation of mitotic cell cycle phase transition (GO:1901992)	56	3	1.47	+	2.04	1.92E-01	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	56	3	1.47	+	2.04	1.92E-01	1.00E00
positive regulation of dendrite morphogenesis (GO:0050775)	56	3	1.47	+	2.04	1.92E-01	1.00E00
regulation of calcium ion transmembrane transporter activity (GO:1901019)	56	3	1.47	+	2.04	1.92E-01	1.00E00
negative regulation of neuron projection development (GO:0010977)	112	6	2.95	+	2.04	1.28E-01	1.00E00
positive regulation of calcium ion transmembrane transport (GO:1904427)	56	3	1.47	+	2.04	1.92E-01	1.00E00
positive regulation of macroautophagy (GO:0016239)	56	3	1.47	+	2.04	1.92E-01	1.00E00
regulation of regulated secretory pathway (GO:1903305)	112	6	2.95	+	2.04	1.28E-01	1.00E00
synaptic signaling (GO:0099536)	299	16	7.87	+	2.03	9.44E-03	7.30E-01
positive regulation of phosphorylation (GO:0042327)	431	23	11.34	+	2.03	1.90E-03	4.69E-01
synapse assembly (GO:0007416)	75	4	1.97	+	2.03	1.44E-01	1.00E00
activation of immune response (GO:0002253)	75	4	1.97	+	2.03	1.44E-01	1.00E00
negative regulation of cell projection organization (GO:0031345)	150	8	3.95	+	2.03	6.63E-02	1.00E00
epithelial cell differentiation (GO:0030855)	225	12	5.92	+	2.03	2.09E-02	9.43E-01
positive regulation of cell motility (GO:2000147)	283	15	7.45	+	2.01	1.33E-02	8.31E-01
negative regulation of DNA repair (GO:0045738)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of neutrophil migration (GO:1902622)	19	1	.50	+	2.00	4.05E-01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	19	1	.50	+	2.00	4.05E-01	1.00E00
vasculature development (GO:0001944)	266	14	7.00	+	2.00	1.84E-02	9.43E-01
regulation of leukocyte mediated cytotoxicity (GO:0001910)	19	1	.50	+	2.00	4.05E-01	1.00E00
acyl-CoA biosynthetic process (GO:0071616)	19	1	.50	+	2.00	4.05E-01	1.00E00
response to amino acid starvation (GO:1990928)	38	2	1.00	+	2.00	2.74E-01	1.00E00
morphogenesis of a polarized epithelium (GO:0001738)	38	2	1.00	+	2.00	2.74E-01	1.00E00
cell fate specification (GO:0001708)	19	1	.50	+	2.00	4.05E-01	1.00E00
neurotrophin signaling pathway (GO:0038179)	19	1	.50	+	2.00	4.05E-01	1.00E00
response to transforming growth factor beta (GO:0071559)	76	4	2.00	+	2.00	1.49E-01	1.00E00
cellular response to chemokine (GO:1990869)	19	1	.50	+	2.00	4.05E-01	1.00E00
response to chemokine (GO:1990868)	19	1	.50	+	2.00	4.05E-01	1.00E00
walking behavior (GO:0090659)	38	2	1.00	+	2.00	2.74E-01	1.00E00
modulation by host of viral process (GO:0044788)	19	1	.50	+	2.00	4.05E-01	1.00E00
cellular response to osmotic stress (GO:0071470)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of isotype switching (GO:0045191)	19	1	.50	+	2.00	4.05E-01	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	38	2	1.00	+	2.00	2.74E-01	1.00E00
positive regulation of signal transduction by p53 class mediator (GO:1901798)	19	1	.50	+	2.00	4.05E-01	1.00E00
response to dietary excess (GO:0002021)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	19	1	.50	+	2.00	4.05E-01	1.00E00
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	19	1	.50	+	2.00	4.05E-01	1.00E00
anterior/posterior axis specification (GO:0009948)	19	1	.50	+	2.00	4.05E-01	1.00E00
axon extension (GO:0048675)	38	2	1.00	+	2.00	2.74E-01	1.00E00
neuron fate commitment (GO:0048663)	19	1	.50	+	2.00	4.05E-01	1.00E00
positive regulation of smooth muscle cell proliferation (GO:0048661)	57	3	1.50	+	2.00	1.99E-01	1.00E00
calcium ion import (GO:0070509)	19	1	.50	+	2.00	4.05E-01	1.00E00
musculoskeletal movement (GO:0050881)	19	1	.50	+	2.00	4.05E-01	1.00E00
multicellular organismal movement (GO:0050879)	19	1	.50	+	2.00	4.05E-01	1.00E00
digestive tract morphogenesis (GO:0048546)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of digestive system process (GO:0044058)	19	1	.50	+	2.00	4.05E-01	1.00E00
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	57	3	1.50	+	2.00	1.99E-01	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	38	2	1.00	+	2.00	2.74E-01	1.00E00
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	19	1	.50	+	2.00	4.05E-01	1.00E00
prostate gland development (GO:0030850)	19	1	.50	+	2.00	4.05E-01	1.00E00
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	57	3	1.50	+	2.00	1.99E-01	1.00E00
long-chain fatty acid transport (GO:0015909)	19	1	.50	+	2.00	4.05E-01	1.00E00
protein localization to postsynapse (GO:0062237)	38	2	1.00	+	2.00	2.74E-01	1.00E00
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	19	1	.50	+	2.00	4.05E-01	1.00E00
BMP signaling pathway (GO:0030509)	38	2	1.00	+	2.00	2.74E-01	1.00E00
thioester biosynthetic process (GO:0035384)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of heart rate by cardiac conduction (GO:0086091)	19	1	.50	+	2.00	4.05E-01	1.00E00
inner ear auditory receptor cell differentiation (GO:0042491)	19	1	.50	+	2.00	4.05E-01	1.00E00
response to alcohol (GO:0097305)	76	4	2.00	+	2.00	1.49E-01	1.00E00
negative regulation of Ras protein signal transduction (GO:0046580)	38	2	1.00	+	2.00	2.74E-01	1.00E00
acylglycerol biosynthetic process (GO:0046463)	19	1	.50	+	2.00	4.05E-01	1.00E00
neutral lipid biosynthetic process (GO:0046460)	19	1	.50	+	2.00	4.05E-01	1.00E00
striated muscle hypertrophy (GO:0014897)	19	1	.50	+	2.00	4.05E-01	1.00E00
muscle hypertrophy (GO:0014896)	19	1	.50	+	2.00	4.05E-01	1.00E00
actin filament polymerization (GO:0030041)	19	1	.50	+	2.00	4.05E-01	1.00E00
negative regulation of exocytosis (GO:0045920)	19	1	.50	+	2.00	4.05E-01	1.00E00
visual behavior (GO:0007632)	57	3	1.50	+	2.00	1.99E-01	1.00E00
regulation of protein polyubiquitination (GO:1902914)	19	1	.50	+	2.00	4.05E-01	1.00E00
lactation (GO:0007595)	19	1	.50	+	2.00	4.05E-01	1.00E00
regulation of protein maturation (GO:1903317)	38	2	1.00	+	2.00	2.74E-01	1.00E00
regulation of mRNA metabolic process (GO:1903311)	228	12	6.00	+	2.00	3.43E-02	1.00E00
response to bacterium (GO:0009617)	172	9	4.52	+	1.99	5.20E-02	1.00E00
regulation of immune response (GO:0050776)	287	15	7.55	+	1.99	1.41E-02	8.46E-01
positive regulation of protein phosphorylation (GO:0001934)	383	20	10.08	+	1.98	5.23E-03	6.31E-01
blood vessel development (GO:0001568)	249	13	6.55	+	1.98	2.55E-02	1.00E00
cell-cell adhesion (GO:0098609)	230	12	6.05	+	1.98	3.49E-02	1.00E00
sex differentiation (GO:0007548)	115	6	3.03	+	1.98	1.33E-01	1.00E00
positive regulation of intracellular signal transduction (GO:1902533)	500	26	13.15	+	1.98	1.48E-03	4.46E-01
neurotransmitter secretion (GO:0007269)	77	4	2.03	+	1.97	1.54E-01	1.00E00
signal release from synapse (GO:0099643)	77	4	2.03	+	1.97	1.54E-01	1.00E00
negative regulation of developmental growth (GO:0048640)	77	4	2.03	+	1.97	1.54E-01	1.00E00
positive regulation of neuron death (GO:1901216)	77	4	2.03	+	1.97	1.54E-01	1.00E00
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	77	4	2.03	+	1.97	1.54E-01	1.00E00
regulation of anatomical structure morphogenesis (GO:0022603)	559	29	14.71	+	1.97	6.37E-04	3.68E-01
positive regulation of phosphorus metabolic process (GO:0010562)	482	25	12.68	+	1.97	2.02E-03	4.88E-01
positive regulation of phosphate metabolic process (GO:0045937)	482	25	12.68	+	1.97	2.02E-03	4.80E-01
positive regulation of developmental process (GO:0051094)	773	40	20.34	+	1.97	6.06E-05	2.69E-01
negative regulation of multicellular organismal process (GO:0051241)	522	27	13.73	+	1.97	1.14E-03	3.88E-01
Notch signaling pathway (GO:0007219)	58	3	1.53	+	1.97	2.05E-01	1.00E00
regulation of cell migration (GO:0030334)	504	26	13.26	+	1.96	1.55E-03	4.28E-01
regulation of cell projection organization (GO:0031344)	543	28	14.28	+	1.96	8.86E-04	4.06E-01
positive regulation of locomotion (GO:0040017)	291	15	7.66	+	1.96	1.51E-02	8.74E-01
defense response (GO:0006952)	409	21	10.76	+	1.95	4.34E-03	6.13E-01
regulation of multicellular organismal development (GO:2000026)	760	39	19.99	+	1.95	8.85E-05	1.96E-01
positive regulation of osteoblast differentiation (GO:0045669)	39	2	1.03	+	1.95	2.83E-01	1.00E00
regulation of stem cell proliferation (GO:0072091)	39	2	1.03	+	1.95	2.83E-01	1.00E00
cellular response to monosaccharide stimulus (GO:0071326)	39	2	1.03	+	1.95	2.83E-01	1.00E00
regulation of viral genome replication (GO:0045069)	39	2	1.03	+	1.95	2.83E-01	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	78	4	2.05	+	1.95	1.59E-01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	39	2	1.03	+	1.95	2.83E-01	1.00E00
stress-activated MAPK cascade (GO:0051403)	39	2	1.03	+	1.95	2.83E-01	1.00E00
leukocyte migration (GO:0050900)	78	4	2.05	+	1.95	1.59E-01	1.00E00
positive regulation of actin filament bundle assembly (GO:0032233)	39	2	1.03	+	1.95	2.83E-01	1.00E00
regulation of cold-induced thermogenesis (GO:0120161)	78	4	2.05	+	1.95	1.59E-01	1.00E00
positive regulation of TOR signaling (GO:0032008)	39	2	1.03	+	1.95	2.83E-01	1.00E00
biomineral tissue development (GO:0031214)	39	2	1.03	+	1.95	2.83E-01	1.00E00
negative regulation of muscle cell apoptotic process (GO:0010656)	39	2	1.03	+	1.95	2.83E-01	1.00E00
stem cell population maintenance (GO:0019827)	78	4	2.05	+	1.95	1.59E-01	1.00E00
morphogenesis of a branching epithelium (GO:0061138)	78	4	2.05	+	1.95	1.59E-01	1.00E00
regulation of mitotic cell cycle (GO:0007346)	293	15	7.71	+	1.95	1.57E-02	8.99E-01
cellular response to metal ion (GO:0071248)	98	5	2.58	+	1.94	1.93E-01	1.00E00
regulation of cell junction assembly (GO:1901888)	157	8	4.13	+	1.94	7.51E-02	1.00E00
regulation of angiogenesis (GO:0045765)	118	6	3.10	+	1.93	1.38E-01	1.00E00
regulation of neuron differentiation (GO:0045664)	118	6	3.10	+	1.93	1.38E-01	1.00E00
cell-cell junction assembly (GO:0007043)	59	3	1.55	+	1.93	2.12E-01	1.00E00
regulation of nuclear division (GO:0051783)	59	3	1.55	+	1.93	2.12E-01	1.00E00
mammary gland development (GO:0030879)	59	3	1.55	+	1.93	2.12E-01	1.00E00
regulation of cell-cell adhesion (GO:0022407)	197	10	5.18	+	1.93	4.48E-02	1.00E00
negative regulation of cellular amide metabolic process (GO:0034249)	138	7	3.63	+	1.93	1.02E-01	1.00E00
positive regulation of protein localization to membrane (GO:1905477)	79	4	2.08	+	1.92	1.64E-01	1.00E00
regulation of plasma membrane bounded cell projection organization (GO:0120035)	534	27	14.05	+	1.92	1.39E-03	4.39E-01
negative regulation of secretion (GO:0051048)	99	5	2.60	+	1.92	1.95E-01	1.00E00
positive regulation of transport (GO:0051050)	595	30	15.65	+	1.92	8.91E-04	3.95E-01
muscle cell differentiation (GO:0042692)	139	7	3.66	+	1.91	1.03E-01	1.00E00
multicellular organismal response to stress (GO:0033555)	60	3	1.58	+	1.90	2.19E-01	1.00E00
protein folding (GO:0006457)	120	6	3.16	+	1.90	1.42E-01	1.00E00
positive regulation of protein polymerization (GO:0032273)	60	3	1.58	+	1.90	2.19E-01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	120	6	3.16	+	1.90	1.42E-01	1.00E00
positive regulation of insulin secretion (GO:0032024)	60	3	1.58	+	1.90	2.19E-01	1.00E00
DNA damage checkpoint signaling (GO:0000077)	60	3	1.58	+	1.90	2.19E-01	1.00E00
inorganic anion transport (GO:0015698)	60	3	1.58	+	1.90	2.19E-01	1.00E00
olfactory bulb development (GO:0021772)	20	1	.53	+	1.90	4.21E-01	1.00E00
lung epithelial cell differentiation (GO:0060487)	20	1	.53	+	1.90	4.21E-01	1.00E00
lung cell differentiation (GO:0060479)	20	1	.53	+	1.90	4.21E-01	1.00E00
ER-nucleus signaling pathway (GO:0006984)	20	1	.53	+	1.90	4.21E-01	1.00E00
homotypic cell-cell adhesion (GO:0034109)	20	1	.53	+	1.90	4.21E-01	1.00E00
face morphogenesis (GO:0060325)	20	1	.53	+	1.90	4.21E-01	1.00E00
cell volume homeostasis (GO:0006884)	20	1	.53	+	1.90	4.21E-01	1.00E00
cellular metal ion homeostasis (GO:0006875)	180	9	4.74	+	1.90	6.12E-02	1.00E00
cerebellum morphogenesis (GO:0021587)	40	2	1.05	+	1.90	2.93E-01	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	20	1	.53	+	1.90	4.21E-01	1.00E00
regulation of receptor recycling (GO:0001919)	20	1	.53	+	1.90	4.21E-01	1.00E00
cellular response to BMP stimulus (GO:0071773)	40	2	1.05	+	1.90	2.93E-01	1.00E00
response to BMP (GO:0071772)	40	2	1.05	+	1.90	2.93E-01	1.00E00
cytokine production involved in immune response (GO:0002367)	20	1	.53	+	1.90	4.21E-01	1.00E00
stem cell proliferation (GO:0072089)	40	2	1.05	+	1.90	2.93E-01	1.00E00
negative regulation of cell junction assembly (GO:1901889)	20	1	.53	+	1.90	4.21E-01	1.00E00
regulation of T cell migration (GO:2000404)	20	1	.53	+	1.90	4.21E-01	1.00E00
glandular epithelial cell differentiation (GO:0002067)	20	1	.53	+	1.90	4.21E-01	1.00E00
positive regulation of RNA splicing (GO:0033120)	40	2	1.05	+	1.90	2.93E-01	1.00E00
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	20	1	.53	+	1.90	4.21E-01	1.00E00
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	20	1	.53	+	1.90	4.21E-01	1.00E00
actin nucleation (GO:0045010)	20	1	.53	+	1.90	4.21E-01	1.00E00
cellular response to mechanical stimulus (GO:0071260)	20	1	.53	+	1.90	4.21E-01	1.00E00
cellular response to misfolded protein (GO:0071218)	20	1	.53	+	1.90	4.21E-01	1.00E00
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	40	2	1.05	+	1.90	2.93E-01	1.00E00
positive regulation of calcium-mediated signaling (GO:0050850)	20	1	.53	+	1.90	4.21E-01	1.00E00
olefinic compound metabolic process (GO:0120254)	20	1	.53	+	1.90	4.21E-01	1.00E00
maintenance of cell number (GO:0098727)	80	4	2.10	+	1.90	1.69E-01	1.00E00
positive regulation of axonogenesis (GO:0050772)	80	4	2.10	+	1.90	1.69E-01	1.00E00
presynapse organization (GO:0099172)	20	1	.53	+	1.90	4.21E-01	1.00E00
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	20	1	.53	+	1.90	4.21E-01	1.00E00
peroxisomal transport (GO:0043574)	20	1	.53	+	1.90	4.21E-01	1.00E00
smooth muscle cell differentiation (GO:0051145)	20	1	.53	+	1.90	4.21E-01	1.00E00
postsynaptic specialization organization (GO:0099084)	20	1	.53	+	1.90	4.21E-01	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	20	1	.53	+	1.90	4.21E-01	1.00E00
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	20	1	.53	+	1.90	4.21E-01	1.00E00
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	20	1	.53	+	1.90	4.21E-01	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	20	1	.53	+	1.90	4.21E-01	1.00E00
positive regulation of phosphatase activity (GO:0010922)	20	1	.53	+	1.90	4.21E-01	1.00E00
cellular amino acid catabolic process (GO:0009063)	40	2	1.05	+	1.90	2.93E-01	1.00E00
cardiac muscle cell action potential (GO:0086001)	20	1	.53	+	1.90	4.21E-01	1.00E00
bone remodeling (GO:0046849)	20	1	.53	+	1.90	4.21E-01	1.00E00
negative regulation of mitochondrion organization (GO:0010823)	40	2	1.05	+	1.90	2.93E-01	1.00E00
regulation of collagen metabolic process (GO:0010712)	20	1	.53	+	1.90	4.21E-01	1.00E00
dendritic spine morphogenesis (GO:0060997)	20	1	.53	+	1.90	4.21E-01	1.00E00
striated muscle cell proliferation (GO:0014855)	20	1	.53	+	1.90	4.21E-01	1.00E00
central nervous system neuron axonogenesis (GO:0021955)	40	2	1.05	+	1.90	2.93E-01	1.00E00
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	20	1	.53	+	1.90	4.21E-01	1.00E00
placenta blood vessel development (GO:0060674)	20	1	.53	+	1.90	4.21E-01	1.00E00
response to interferon-gamma (GO:0034341)	40	2	1.05	+	1.90	2.93E-01	1.00E00
forebrain neuron development (GO:0021884)	20	1	.53	+	1.90	4.21E-01	1.00E00
behavior (GO:0007610)	461	23	12.13	+	1.90	4.39E-03	6.08E-01
positive regulation of cell adhesion (GO:0045785)	221	11	5.81	+	1.89	5.28E-02	1.00E00
negative regulation of cellular catabolic process (GO:0031330)	161	8	4.24	+	1.89	8.10E-02	1.00E00
regulation of vasculature development (GO:1901342)	121	6	3.18	+	1.88	1.44E-01	1.00E00
modulation of chemical synaptic transmission (GO:0050804)	404	20	10.63	+	1.88	7.28E-03	6.86E-01
regulation of trans-synaptic signaling (GO:0099177)	405	20	10.65	+	1.88	1.07E-02	7.68E-01
regulation of response to wounding (GO:1903034)	81	4	2.13	+	1.88	1.74E-01	1.00E00
protein import into nucleus (GO:0006606)	81	4	2.13	+	1.88	1.74E-01	1.00E00
response to steroid hormone (GO:0048545)	81	4	2.13	+	1.88	1.74E-01	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	81	4	2.13	+	1.88	1.74E-01	1.00E00
regulation of cell motility (GO:2000145)	528	26	13.89	+	1.87	3.15E-03	5.58E-01
vesicle budding from membrane (GO:0006900)	61	3	1.60	+	1.87	2.26E-01	1.00E00
DNA integrity checkpoint signaling (GO:0031570)	61	3	1.60	+	1.87	2.26E-01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	61	3	1.60	+	1.87	2.26E-01	1.00E00
response to monosaccharide (GO:0034284)	61	3	1.60	+	1.87	2.26E-01	1.00E00
negative regulation of cell differentiation (GO:0045596)	366	18	9.63	+	1.87	1.24E-02	8.36E-01
positive regulation of cell differentiation (GO:0045597)	509	25	13.39	+	1.87	4.24E-03	6.12E-01
protein stabilization (GO:0050821)	143	7	3.76	+	1.86	1.11E-01	1.00E00
negative regulation of cell cycle (GO:0045786)	184	9	4.84	+	1.86	9.94E-02	1.00E00
regulation of neuron migration (GO:2001222)	41	2	1.08	+	1.85	3.02E-01	1.00E00
hindbrain morphogenesis (GO:0021575)	41	2	1.08	+	1.85	3.02E-01	1.00E00
canonical Wnt signaling pathway (GO:0060070)	41	2	1.08	+	1.85	3.02E-01	1.00E00
regulation of dendrite morphogenesis (GO:0048814)	82	4	2.16	+	1.85	2.85E-01	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	82	4	2.16	+	1.85	2.85E-01	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	41	2	1.08	+	1.85	3.02E-01	1.00E00
inner ear morphogenesis (GO:0042472)	41	2	1.08	+	1.85	3.02E-01	1.00E00
synaptic vesicle localization (GO:0097479)	41	2	1.08	+	1.85	3.02E-01	1.00E00
negative regulation of epithelial cell migration (GO:0010633)	41	2	1.08	+	1.85	3.02E-01	1.00E00
insulin receptor signaling pathway (GO:0008286)	41	2	1.08	+	1.85	3.02E-01	1.00E00
cell junction assembly (GO:0034329)	164	8	4.31	+	1.85	8.59E-02	1.00E00
negative regulation of developmental process (GO:0051093)	513	25	13.50	+	1.85	4.37E-03	6.11E-01
chemical homeostasis (GO:0048878)	473	23	12.44	+	1.85	5.21E-03	6.35E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	103	5	2.71	+	1.85	2.03E-01	1.00E00
protein polyubiquitination (GO:0000209)	165	8	4.34	+	1.84	8.76E-02	1.00E00
regulation of defense response (GO:0031347)	227	11	5.97	+	1.84	5.68E-02	1.00E00
vesicle-mediated transport in synapse (GO:0099003)	124	6	3.26	+	1.84	1.50E-01	1.00E00
regulation of muscle cell apoptotic process (GO:0010660)	62	3	1.63	+	1.84	2.32E-01	1.00E00
calcium-mediated signaling (GO:0019722)	62	3	1.63	+	1.84	2.32E-01	1.00E00
cell-cell signaling (GO:0007267)	518	25	13.63	+	1.83	4.59E-03	6.22E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	83	4	2.18	+	1.83	2.87E-01	1.00E00
morphogenesis of a branching structure (GO:0001763)	83	4	2.18	+	1.83	2.87E-01	1.00E00
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	83	4	2.18	+	1.83	2.87E-01	1.00E00
neuron projection development (GO:0031175)	519	25	13.65	+	1.83	4.64E-03	6.22E-01
regulation of calcium ion transmembrane transport (GO:1903169)	104	5	2.74	+	1.83	2.06E-01	1.00E00
Golgi organization (GO:0007030)	104	5	2.74	+	1.83	2.06E-01	1.00E00
lung development (GO:0030324)	104	5	2.74	+	1.83	2.06E-01	1.00E00
positive regulation of immunoglobulin production (GO:0002639)	21	1	.55	+	1.81	4.36E-01	1.00E00
pigment biosynthetic process (GO:0046148)	21	1	.55	+	1.81	4.36E-01	1.00E00
innervation (GO:0060384)	21	1	.55	+	1.81	4.36E-01	1.00E00
metencephalon development (GO:0022037)	84	4	2.21	+	1.81	2.90E-01	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	42	2	1.10	+	1.81	3.12E-01	1.00E00
cell differentiation in hindbrain (GO:0021533)	21	1	.55	+	1.81	4.36E-01	1.00E00
cell redox homeostasis (GO:0045454)	21	1	.55	+	1.81	4.36E-01	1.00E00
protein localization to cell junction (GO:1902414)	84	4	2.21	+	1.81	2.90E-01	1.00E00
acyl-CoA metabolic process (GO:0006637)	42	2	1.10	+	1.81	3.12E-01	1.00E00
granulocyte chemotaxis (GO:0071621)	21	1	.55	+	1.81	4.36E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	21	1	.55	+	1.81	4.36E-01	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	21	1	.55	+	1.81	4.36E-01	1.00E00
intermediate filament-based process (GO:0045103)	21	1	.55	+	1.81	4.36E-01	1.00E00
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	21	1	.55	+	1.81	4.36E-01	1.00E00
negative regulation of leukocyte differentiation (GO:1902106)	42	2	1.10	+	1.81	3.12E-01	1.00E00
response to misfolded protein (GO:0051788)	21	1	.55	+	1.81	4.36E-01	1.00E00
base-excision repair (GO:0006284)	21	1	.55	+	1.81	4.36E-01	1.00E00
homeostasis of number of cells within a tissue (GO:0048873)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of multicellular organism growth (GO:0040018)	21	1	.55	+	1.81	4.36E-01	1.00E00
protein K48-linked deubiquitination (GO:0071108)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	84	4	2.21	+	1.81	2.90E-01	1.00E00
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	42	2	1.10	+	1.81	3.12E-01	1.00E00
response to estradiol (GO:0032355)	21	1	.55	+	1.81	4.36E-01	1.00E00
maintenance of protein location in nucleus (GO:0051457)	21	1	.55	+	1.81	4.36E-01	1.00E00
cell-cell recognition (GO:0009988)	21	1	.55	+	1.81	4.36E-01	1.00E00
regulation of meiotic cell cycle (GO:0051445)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of membrane permeability (GO:1905710)	21	1	.55	+	1.81	4.36E-01	1.00E00
response to interleukin-1 (GO:0070555)	42	2	1.10	+	1.81	3.12E-01	1.00E00
negative regulation of response to external stimulus (GO:0032102)	168	8	4.42	+	1.81	9.29E-02	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of inflammatory response (GO:0050729)	42	2	1.10	+	1.81	3.12E-01	1.00E00
amyloid precursor protein metabolic process (GO:0042982)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of protein ubiquitination (GO:0031398)	84	4	2.21	+	1.81	2.90E-01	1.00E00
N-terminal protein amino acid modification (GO:0031365)	21	1	.55	+	1.81	4.36E-01	1.00E00
cellular response to amyloid-beta (GO:1904646)	21	1	.55	+	1.81	4.36E-01	1.00E00
regulation of macrophage activation (GO:0043030)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of histone deacetylation (GO:0031065)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of cellular response to insulin stimulus (GO:1900078)	21	1	.55	+	1.81	4.36E-01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	21	1	.55	+	1.81	4.36E-01	1.00E00
thioester metabolic process (GO:0035383)	42	2	1.10	+	1.81	3.12E-01	1.00E00
cardiac muscle cell contraction (GO:0086003)	21	1	.55	+	1.81	4.36E-01	1.00E00
regulation of lipid storage (GO:0010883)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	21	1	.55	+	1.81	4.36E-01	1.00E00
coronary vasculature development (GO:0060976)	42	2	1.10	+	1.81	3.12E-01	1.00E00
ovulation cycle process (GO:0022602)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of epithelial cell migration (GO:0010634)	84	4	2.21	+	1.81	2.90E-01	1.00E00
negative regulation of cardiac muscle hypertrophy (GO:0010614)	21	1	.55	+	1.81	4.36E-01	1.00E00
embryonic heart tube development (GO:0035050)	42	2	1.10	+	1.81	3.12E-01	1.00E00
negative regulation of T cell proliferation (GO:0042130)	21	1	.55	+	1.81	4.36E-01	1.00E00
positive regulation of response to cytokine stimulus (GO:0060760)	21	1	.55	+	1.81	4.36E-01	1.00E00
retrograde axonal transport (GO:0008090)	21	1	.55	+	1.81	4.36E-01	1.00E00
glial cell development (GO:0021782)	63	3	1.66	+	1.81	2.39E-01	1.00E00
regulation of cation channel activity (GO:2001257)	126	6	3.31	+	1.81	1.55E-01	1.00E00
positive regulation of synapse assembly (GO:0051965)	63	3	1.66	+	1.81	2.39E-01	1.00E00
regulation of chemotaxis (GO:0050920)	105	5	2.76	+	1.81	2.08E-01	1.00E00
striated muscle cell differentiation (GO:0051146)	105	5	2.76	+	1.81	2.08E-01	1.00E00
regulation of muscle adaptation (GO:0043502)	63	3	1.66	+	1.81	2.39E-01	1.00E00
autophagosome organization (GO:1905037)	63	3	1.66	+	1.81	2.39E-01	1.00E00
regulation of canonical Wnt signaling pathway (GO:0060828)	148	7	3.89	+	1.80	1.21E-01	1.00E00
divalent inorganic cation homeostasis (GO:0072507)	148	7	3.89	+	1.80	1.21E-01	1.00E00
negative regulation of cell adhesion (GO:0007162)	127	6	3.34	+	1.80	1.57E-01	1.00E00
positive regulation of protein-containing complex assembly (GO:0031334)	127	6	3.34	+	1.80	1.57E-01	1.00E00
respiratory tube development (GO:0030323)	106	5	2.79	+	1.79	2.11E-01	1.00E00
import into nucleus (GO:0051170)	85	4	2.24	+	1.79	2.92E-01	1.00E00
dephosphorylation (GO:0016311)	170	8	4.47	+	1.79	1.42E-01	1.00E00
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	85	4	2.24	+	1.79	2.92E-01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	64	3	1.68	+	1.78	2.46E-01	1.00E00
enzyme-linked receptor protein signaling pathway (GO:0007167)	320	15	8.42	+	1.78	3.29E-02	1.00E00
regulation of locomotion (GO:0040012)	555	26	14.60	+	1.78	6.08E-03	6.41E-01
positive regulation of multicellular organismal process (GO:0051240)	794	37	20.89	+	1.77	7.94E-04	4.40E-01
biomineralization (GO:0110148)	43	2	1.13	+	1.77	3.21E-01	1.00E00
positive regulation of endothelial cell proliferation (GO:0001938)	43	2	1.13	+	1.77	3.21E-01	1.00E00
positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	43	2	1.13	+	1.77	3.21E-01	1.00E00
cellular response to xenobiotic stimulus (GO:0071466)	43	2	1.13	+	1.77	3.21E-01	1.00E00
inner ear development (GO:0048839)	86	4	2.26	+	1.77	2.95E-01	1.00E00
negative regulation of ion transmembrane transporter activity (GO:0032413)	43	2	1.13	+	1.77	3.21E-01	1.00E00
regulation of filopodium assembly (GO:0051489)	43	2	1.13	+	1.77	3.21E-01	1.00E00
positive regulation of T cell activation (GO:0050870)	86	4	2.26	+	1.77	2.95E-01	1.00E00
T cell receptor signaling pathway (GO:0050852)	43	2	1.13	+	1.77	3.21E-01	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	43	2	1.13	+	1.77	3.21E-01	1.00E00
spliceosomal complex assembly (GO:0000245)	43	2	1.13	+	1.77	3.21E-01	1.00E00
regulation of cardiac muscle tissue growth (GO:0055021)	43	2	1.13	+	1.77	3.21E-01	1.00E00
leukocyte chemotaxis (GO:0030595)	43	2	1.13	+	1.77	3.21E-01	1.00E00
artery development (GO:0060840)	43	2	1.13	+	1.77	3.21E-01	1.00E00
negative regulation of cell cycle G1/S phase transition (GO:1902807)	43	2	1.13	+	1.77	3.21E-01	1.00E00
positive regulation of signal transduction (GO:0009967)	796	37	20.94	+	1.77	8.16E-04	4.34E-01
regulation of cellular response to growth factor stimulus (GO:0090287)	173	8	4.55	+	1.76	1.45E-01	1.00E00
rhythmic process (GO:0048511)	173	8	4.55	+	1.76	1.45E-01	1.00E00
regulation of phosphorylation (GO:0042325)	692	32	18.20	+	1.76	2.11E-03	4.83E-01
positive regulation of immune system process (GO:0002684)	325	15	8.55	+	1.75	3.53E-02	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	130	6	3.42	+	1.75	1.65E-01	1.00E00
positive regulation of protein modification process (GO:0031401)	585	27	15.39	+	1.75	5.17E-03	6.36E-01
adult behavior (GO:0030534)	130	6	3.42	+	1.75	1.65E-01	1.00E00
regulation of protein dephosphorylation (GO:0035304)	65	3	1.71	+	1.75	2.53E-01	1.00E00
regulation of cell adhesion (GO:0030155)	369	17	9.71	+	1.75	3.03E-02	1.00E00
regulation of neuron death (GO:1901214)	239	11	6.29	+	1.75	6.77E-02	1.00E00
regulation of anatomical structure size (GO:0090066)	326	15	8.58	+	1.75	3.58E-02	1.00E00
regulation of neuron apoptotic process (GO:0043523)	174	8	4.58	+	1.75	1.46E-01	1.00E00
positive regulation of hormone secretion (GO:0046887)	87	4	2.29	+	1.75	2.98E-01	1.00E00
tube morphogenesis (GO:0035239)	348	16	9.15	+	1.75	3.95E-02	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	131	6	3.45	+	1.74	1.68E-01	1.00E00
inorganic ion transmembrane transport (GO:0098660)	285	13	7.50	+	1.73	5.92E-02	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	110	5	2.89	+	1.73	2.22E-01	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	66	3	1.74	+	1.73	2.60E-01	1.00E00
branching morphogenesis of an epithelial tube (GO:0048754)	66	3	1.74	+	1.73	2.60E-01	1.00E00
positive regulation of MAPK cascade (GO:0043410)	242	11	6.37	+	1.73	1.01E-01	1.00E00
axon development (GO:0061564)	286	13	7.52	+	1.73	5.98E-02	1.00E00
positive regulation of protein localization (GO:1903829)	330	15	8.68	+	1.73	5.28E-02	1.00E00
negative regulation of myeloid cell differentiation (GO:0045638)	44	2	1.16	+	1.73	3.31E-01	1.00E00
myelination in peripheral nervous system (GO:0022011)	22	1	.58	+	1.73	4.50E-01	1.00E00
histone H2A ubiquitination (GO:0033522)	22	1	.58	+	1.73	4.50E-01	1.00E00
establishment of tissue polarity (GO:0007164)	22	1	.58	+	1.73	4.50E-01	1.00E00
mesonephric tubule morphogenesis (GO:0072171)	22	1	.58	+	1.73	4.50E-01	1.00E00
icosanoid metabolic process (GO:0006690)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of granulocyte chemotaxis (GO:0071622)	22	1	.58	+	1.73	4.50E-01	1.00E00
establishment of planar polarity (GO:0001736)	22	1	.58	+	1.73	4.50E-01	1.00E00
positive regulation of focal adhesion assembly (GO:0051894)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of neurotransmitter levels (GO:0001505)	176	8	4.63	+	1.73	1.48E-01	1.00E00
regulation of AMPA receptor activity (GO:2000311)	22	1	.58	+	1.73	4.50E-01	1.00E00
transcription elongation by RNA polymerase II promoter (GO:0006368)	22	1	.58	+	1.73	4.50E-01	1.00E00
cellular response to carbohydrate stimulus (GO:0071322)	44	2	1.16	+	1.73	3.31E-01	1.00E00
regulation of fatty acid transport (GO:2000191)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of hormone metabolic process (GO:0032350)	22	1	.58	+	1.73	4.50E-01	1.00E00
peripheral nervous system axon ensheathment (GO:0032292)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of T cell receptor signaling pathway (GO:0050856)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of heterochromatin organization (GO:0120261)	22	1	.58	+	1.73	4.50E-01	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	22	1	.58	+	1.73	4.50E-01	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	44	2	1.16	+	1.73	3.31E-01	1.00E00
cell maturation (GO:0048469)	88	4	2.32	+	1.73	3.01E-01	1.00E00
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	22	1	.58	+	1.73	4.50E-01	1.00E00
photoperiodism (GO:0009648)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of heterochromatin formation (GO:0031445)	22	1	.58	+	1.73	4.50E-01	1.00E00
phospholipid catabolic process (GO:0009395)	22	1	.58	+	1.73	4.50E-01	1.00E00
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	22	1	.58	+	1.73	4.50E-01	1.00E00
entrainment of circadian clock by photoperiod (GO:0043153)	22	1	.58	+	1.73	4.50E-01	1.00E00
vesicle cargo loading (GO:0035459)	22	1	.58	+	1.73	4.50E-01	1.00E00
regulation of BMP signaling pathway (GO:0030510)	44	2	1.16	+	1.73	3.31E-01	1.00E00
negative regulation of hemopoiesis (GO:1903707)	44	2	1.16	+	1.73	3.31E-01	1.00E00
regulation of Wnt signaling pathway (GO:0030111)	176	8	4.63	+	1.73	1.48E-01	1.00E00
positive regulation of DNA recombination (GO:0045911)	44	2	1.16	+	1.73	3.31E-01	1.00E00
feeding behavior (GO:0007631)	44	2	1.16	+	1.73	3.31E-01	1.00E00
ureteric bud morphogenesis (GO:0060675)	22	1	.58	+	1.73	4.50E-01	1.00E00
negative regulation of muscle hypertrophy (GO:0014741)	22	1	.58	+	1.73	4.50E-01	1.00E00
positive regulation of production of molecular mediator of immune response (GO:0002702)	44	2	1.16	+	1.73	3.31E-01	1.00E00
system process (GO:0003008)	750	34	19.73	+	1.72	2.07E-03	4.84E-01
muscle organ development (GO:0007517)	133	6	3.50	+	1.71	1.73E-01	1.00E00
positive regulation of cell communication (GO:0010647)	934	42	24.57	+	1.71	8.23E-04	4.20E-01
positive regulation of cell junction assembly (GO:1901890)	89	4	2.34	+	1.71	3.04E-01	1.00E00
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	89	4	2.34	+	1.71	3.04E-01	1.00E00
regulation of signaling receptor activity (GO:0010469)	89	4	2.34	+	1.71	3.04E-01	1.00E00
regulation of endocytosis (GO:0030100)	156	7	4.10	+	1.71	2.01E-01	1.00E00
protein targeting to membrane (GO:0006612)	67	3	1.76	+	1.70	4.28E-01	1.00E00
positive regulation of cell cycle phase transition (GO:1901989)	67	3	1.76	+	1.70	4.28E-01	1.00E00
response to carbohydrate (GO:0009743)	67	3	1.76	+	1.70	4.28E-01	1.00E00
positive regulation of signaling (GO:0023056)	938	42	24.68	+	1.70	8.47E-04	4.17E-01
regulation of dendrite development (GO:0050773)	112	5	2.95	+	1.70	2.28E-01	1.00E00
defense response to other organism (GO:0098542)	269	12	7.08	+	1.70	8.06E-02	1.00E00
nerve development (GO:0021675)	45	2	1.18	+	1.69	3.40E-01	1.00E00
lymphocyte mediated immunity (GO:0002449)	45	2	1.18	+	1.69	3.40E-01	1.00E00
leukocyte homeostasis (GO:0001776)	45	2	1.18	+	1.69	3.40E-01	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	45	2	1.18	+	1.69	3.40E-01	1.00E00
neuron projection organization (GO:0106027)	45	2	1.18	+	1.69	3.40E-01	1.00E00
negative regulation of hydrolase activity (GO:0051346)	135	6	3.55	+	1.69	1.79E-01	1.00E00
negative regulation of protein secretion (GO:0050709)	45	2	1.18	+	1.69	3.40E-01	1.00E00
stress-activated protein kinase signaling cascade (GO:0031098)	45	2	1.18	+	1.69	3.40E-01	1.00E00
negative regulation of secretion by cell (GO:1903531)	90	4	2.37	+	1.69	3.07E-01	1.00E00
ventricular septum development (GO:0003281)	45	2	1.18	+	1.69	3.40E-01	1.00E00
chaperone-mediated protein folding (GO:0061077)	45	2	1.18	+	1.69	3.40E-01	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	113	5	2.97	+	1.68	2.32E-01	1.00E00
regulation of actin filament-based process (GO:0032970)	249	11	6.55	+	1.68	1.06E-01	1.00E00
endoplasmic reticulum organization (GO:0007029)	68	3	1.79	+	1.68	4.31E-01	1.00E00
regulation of T cell activation (GO:0050863)	136	6	3.58	+	1.68	1.82E-01	1.00E00
calcium ion transmembrane transport (GO:0070588)	91	4	2.39	+	1.67	3.10E-01	1.00E00
anion transmembrane transport (GO:0098656)	91	4	2.39	+	1.67	3.10E-01	1.00E00
regulation of endothelial cell migration (GO:0010594)	91	4	2.39	+	1.67	3.10E-01	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	114	5	3.00	+	1.67	2.35E-01	1.00E00
cellular response to inorganic substance (GO:0071241)	114	5	3.00	+	1.67	2.35E-01	1.00E00
cell migration (GO:0016477)	457	20	12.02	+	1.66	3.54E-02	1.00E00
response to metal ion (GO:0010038)	160	7	4.21	+	1.66	2.06E-01	1.00E00
regulation of immune system process (GO:0002682)	574	25	15.10	+	1.66	1.54E-02	8.88E-01
positive regulation of cilium assembly (GO:0045724)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of oxidative stress-induced neuron death (GO:1903203)	23	1	.61	+	1.65	4.64E-01	1.00E00
ventricular septum morphogenesis (GO:0060412)	23	1	.61	+	1.65	4.64E-01	1.00E00
iron ion transport (GO:0006826)	23	1	.61	+	1.65	4.64E-01	1.00E00
chloride transport (GO:0006821)	46	2	1.21	+	1.65	3.50E-01	1.00E00
mitotic cell cycle checkpoint signaling (GO:0007093)	69	3	1.82	+	1.65	4.34E-01	1.00E00
sister chromatid cohesion (GO:0007062)	23	1	.61	+	1.65	4.64E-01	1.00E00
synaptic transmission, GABAergic (GO:0051932)	23	1	.61	+	1.65	4.64E-01	1.00E00
cell-cell junction organization (GO:0045216)	92	4	2.42	+	1.65	3.14E-01	1.00E00
Schwann cell development (GO:0014044)	23	1	.61	+	1.65	4.64E-01	1.00E00
positive regulation of wound healing (GO:0090303)	23	1	.61	+	1.65	4.64E-01	1.00E00
inorganic ion import across plasma membrane (GO:0099587)	46	2	1.21	+	1.65	3.50E-01	1.00E00
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of animal organ morphogenesis (GO:2000027)	46	2	1.21	+	1.65	3.50E-01	1.00E00
establishment of epithelial cell polarity (GO:0090162)	23	1	.61	+	1.65	4.64E-01	1.00E00
cochlea development (GO:0090102)	23	1	.61	+	1.65	4.64E-01	1.00E00
positive regulation of cold-induced thermogenesis (GO:0120162)	46	2	1.21	+	1.65	3.50E-01	1.00E00
inorganic cation transmembrane transport (GO:0098662)	253	11	6.66	+	1.65	1.09E-01	1.00E00
inorganic cation import across plasma membrane (GO:0098659)	46	2	1.21	+	1.65	3.50E-01	1.00E00
entrainment of circadian clock (GO:0009649)	23	1	.61	+	1.65	4.64E-01	1.00E00
response to decreased oxygen levels (GO:0036293)	115	5	3.03	+	1.65	2.38E-01	1.00E00
negative regulation of DNA binding (GO:0043392)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of cell killing (GO:0031341)	23	1	.61	+	1.65	4.64E-01	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of vascular associated smooth muscle cell migration (GO:1904752)	23	1	.61	+	1.65	4.64E-01	1.00E00
response to amyloid-beta (GO:1904645)	23	1	.61	+	1.65	4.64E-01	1.00E00
very long-chain fatty acid metabolic process (GO:0000038)	23	1	.61	+	1.65	4.64E-01	1.00E00
transition metal ion homeostasis (GO:0055076)	69	3	1.82	+	1.65	4.34E-01	1.00E00
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	23	1	.61	+	1.65	4.64E-01	1.00E00
protein autophosphorylation (GO:0046777)	138	6	3.63	+	1.65	1.88E-01	1.00E00
ncRNA catabolic process (GO:0034661)	23	1	.61	+	1.65	4.64E-01	1.00E00
cellular response to unfolded protein (GO:0034620)	46	2	1.21	+	1.65	3.50E-01	1.00E00
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	23	1	.61	+	1.65	4.64E-01	1.00E00
epithelial cell morphogenesis (GO:0003382)	23	1	.61	+	1.65	4.64E-01	1.00E00
negative regulation of peptidase activity (GO:0010466)	69	3	1.82	+	1.65	4.34E-01	1.00E00
olfactory lobe development (GO:0021988)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of fatty acid oxidation (GO:0046320)	23	1	.61	+	1.65	4.64E-01	1.00E00
positive regulation of cytokine production involved in immune response (GO:0002720)	23	1	.61	+	1.65	4.64E-01	1.00E00
negative regulation of proteolysis (GO:0045861)	138	6	3.63	+	1.65	1.88E-01	1.00E00
negative regulation of leukocyte migration (GO:0002686)	23	1	.61	+	1.65	4.64E-01	1.00E00
regulation of developmental process (GO:0050793)	1430	62	37.62	+	1.65	7.70E-05	2.56E-01
response to lipid (GO:0033993)	277	12	7.29	+	1.65	8.77E-02	1.00E00
cell adhesion (GO:0007155)	393	17	10.34	+	1.64	5.26E-02	1.00E00
negative regulation of neuron death (GO:1901215)	162	7	4.26	+	1.64	2.10E-01	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	139	6	3.66	+	1.64	2.78E-01	1.00E00
immune response (GO:0006955)	348	15	9.15	+	1.64	6.13E-02	1.00E00
embryonic organ morphogenesis (GO:0048562)	116	5	3.05	+	1.64	2.41E-01	1.00E00
positive regulation of gene expression (GO:0010628)	558	24	14.68	+	1.63	2.05E-02	9.85E-01
positive regulation of immune response (GO:0050778)	163	7	4.29	+	1.63	2.11E-01	1.00E00
developmental growth (GO:0048589)	280	12	7.37	+	1.63	9.08E-02	1.00E00
positive regulation of response to stimulus (GO:0048584)	1050	45	27.62	+	1.63	1.51E-03	4.26E-01
neural precursor cell proliferation (GO:0061351)	70	3	1.84	+	1.63	4.37E-01	1.00E00
neuron projection morphogenesis (GO:0048812)	374	16	9.84	+	1.63	6.86E-02	1.00E00
ossification (GO:0001503)	117	5	3.08	+	1.62	2.45E-01	1.00E00
neuron development (GO:0048666)	611	26	16.07	+	1.62	1.86E-02	9.31E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	94	4	2.47	+	1.62	3.21E-01	1.00E00
regulation of stem cell differentiation (GO:2000736)	47	2	1.24	+	1.62	3.59E-01	1.00E00
protein O-linked glycosylation (GO:0006493)	47	2	1.24	+	1.62	3.59E-01	1.00E00
mRNA catabolic process (GO:0006402)	94	4	2.47	+	1.62	3.21E-01	1.00E00
regulation of protein deacetylation (GO:0090311)	47	2	1.24	+	1.62	3.59E-01	1.00E00
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	188	8	4.95	+	1.62	1.68E-01	1.00E00
regeneration (GO:0031099)	47	2	1.24	+	1.62	3.59E-01	1.00E00
ear morphogenesis (GO:0042471)	47	2	1.24	+	1.62	3.59E-01	1.00E00
chromosome localization (GO:0050000)	47	2	1.24	+	1.62	3.59E-01	1.00E00
positive regulation of cellular component biogenesis (GO:0044089)	353	15	9.29	+	1.62	6.47E-02	1.00E00
regulation of MAPK cascade (GO:0043408)	353	15	9.29	+	1.62	6.47E-02	1.00E00
growth (GO:0040007)	283	12	7.45	+	1.61	1.29E-01	1.00E00
respiratory system development (GO:0060541)	118	5	3.10	+	1.61	2.48E-01	1.00E00
cellular response to lipid (GO:0071396)	189	8	4.97	+	1.61	1.70E-01	1.00E00
plasma membrane bounded cell projection morphogenesis (GO:0120039)	379	16	9.97	+	1.60	7.08E-02	1.00E00
regulation of phosphate metabolic process (GO:0019220)	783	33	20.60	+	1.60	7.61E-03	6.88E-01
leukocyte differentiation (GO:0002521)	190	8	5.00	+	1.60	1.72E-01	1.00E00
regulation of phosphorus metabolic process (GO:0051174)	784	33	20.63	+	1.60	7.68E-03	6.90E-01
response to other organism (GO:0051707)	404	17	10.63	+	1.60	5.75E-02	1.00E00
in utero embryonic development (GO:0001701)	309	13	8.13	+	1.60	1.03E-01	1.00E00
regulation of multicellular organismal process (GO:0051239)	1450	61	38.15	+	1.60	1.84E-04	2.45E-01
response to external biotic stimulus (GO:0043207)	405	17	10.65	+	1.60	5.80E-02	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	143	6	3.76	+	1.59	2.85E-01	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	143	6	3.76	+	1.59	2.85E-01	1.00E00
nervous system process (GO:0050877)	525	22	13.81	+	1.59	3.53E-02	1.00E00
regulation of synaptic plasticity (GO:0048167)	191	8	5.02	+	1.59	1.74E-01	1.00E00
G protein-coupled receptor signaling pathway (GO:0007186)	239	10	6.29	+	1.59	1.50E-01	1.00E00
export from cell (GO:0140352)	287	12	7.55	+	1.59	1.32E-01	1.00E00
negative regulation of transport (GO:0051051)	287	12	7.55	+	1.59	1.32E-01	1.00E00
cell projection morphogenesis (GO:0048858)	383	16	10.08	+	1.59	7.28E-02	1.00E00
regulation of protein phosphorylation (GO:0001932)	599	25	15.76	+	1.59	2.51E-02	1.00E00
positive regulation of Notch signaling pathway (GO:0045747)	24	1	.63	+	1.58	4.78E-01	1.00E00
nucleus organization (GO:0006997)	96	4	2.53	+	1.58	3.28E-01	1.00E00
smooth muscle contraction (GO:0006939)	24	1	.63	+	1.58	4.78E-01	1.00E00
endochondral bone morphogenesis (GO:0060350)	24	1	.63	+	1.58	4.78E-01	1.00E00
telencephalon glial cell migration (GO:0022030)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of cytoplasmic translation (GO:2000765)	24	1	.63	+	1.58	4.78E-01	1.00E00
gamma-aminobutyric acid signaling pathway (GO:0007214)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of transcription regulatory region DNA binding (GO:2000677)	24	1	.63	+	1.58	4.78E-01	1.00E00
columnar/cuboidal epithelial cell differentiation (GO:0002065)	48	2	1.26	+	1.58	3.68E-01	1.00E00
morphogenesis of an epithelial sheet (GO:0002011)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulated exocytosis (GO:0045055)	96	4	2.53	+	1.58	3.28E-01	1.00E00
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	24	1	.63	+	1.58	4.78E-01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	24	1	.63	+	1.58	4.78E-01	1.00E00
negative regulation of cellular response to growth factor stimulus (GO:0090288)	48	2	1.26	+	1.58	3.68E-01	1.00E00
negative regulation of catabolic process (GO:0009895)	216	9	5.68	+	1.58	1.93E-01	1.00E00
digestive tract development (GO:0048565)	48	2	1.26	+	1.58	3.68E-01	1.00E00
spleen development (GO:0048536)	24	1	.63	+	1.58	4.78E-01	1.00E00
establishment of spindle orientation (GO:0051294)	24	1	.63	+	1.58	4.78E-01	1.00E00
negative regulation of neuron apoptotic process (GO:0043524)	120	5	3.16	+	1.58	2.55E-01	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	24	1	.63	+	1.58	4.78E-01	1.00E00
negative regulation of epithelial cell proliferation (GO:0050680)	72	3	1.89	+	1.58	4.44E-01	1.00E00
regulation of morphogenesis of an epithelium (GO:1905330)	24	1	.63	+	1.58	4.78E-01	1.00E00
developmental pigmentation (GO:0048066)	24	1	.63	+	1.58	4.78E-01	1.00E00
RNA 3'-end processing (GO:0031123)	72	3	1.89	+	1.58	4.44E-01	1.00E00
hair cell differentiation (GO:0035315)	24	1	.63	+	1.58	4.78E-01	1.00E00
positive regulation of muscle cell apoptotic process (GO:0010661)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of cellular ketone metabolic process (GO:0010565)	72	3	1.89	+	1.58	4.44E-01	1.00E00
positive regulation of autophagy (GO:0010508)	96	4	2.53	+	1.58	3.28E-01	1.00E00
regulation of immunoglobulin mediated immune response (GO:0002889)	24	1	.63	+	1.58	4.78E-01	1.00E00
positive regulation of vasoconstriction (GO:0045907)	24	1	.63	+	1.58	4.78E-01	1.00E00
central nervous system neuron development (GO:0021954)	72	3	1.89	+	1.58	4.44E-01	1.00E00
ventricular cardiac muscle tissue development (GO:0003229)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of B cell mediated immunity (GO:0002712)	24	1	.63	+	1.58	4.78E-01	1.00E00
regulation of T cell mediated immunity (GO:0002709)	24	1	.63	+	1.58	4.78E-01	1.00E00
negative regulation of innate immune response (GO:0045824)	24	1	.63	+	1.58	4.78E-01	1.00E00
cerebral cortex radial glia-guided migration (GO:0021801)	24	1	.63	+	1.58	4.78E-01	1.00E00
developmental growth involved in morphogenesis (GO:0060560)	96	4	2.53	+	1.58	3.28E-01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	217	9	5.71	+	1.58	1.94E-01	1.00E00
organelle localization (GO:0051640)	386	16	10.15	+	1.58	7.46E-02	1.00E00
homeostatic process (GO:0042592)	748	31	19.68	+	1.58	1.27E-02	8.21E-01
regulation of protein secretion (GO:0050708)	169	7	4.45	+	1.57	2.23E-01	1.00E00
regulation of protein localization (GO:0032880)	628	26	16.52	+	1.57	2.81E-02	1.00E00
regulation of cell projection assembly (GO:0060491)	145	6	3.81	+	1.57	2.88E-01	1.00E00
negative regulation of protein localization (GO:1903828)	145	6	3.81	+	1.57	2.88E-01	1.00E00
axonogenesis (GO:0007409)	266	11	7.00	+	1.57	1.71E-01	1.00E00
negative regulation of translation (GO:0017148)	121	5	3.18	+	1.57	2.59E-01	1.00E00
muscle structure development (GO:0061061)	242	10	6.37	+	1.57	1.54E-01	1.00E00
positive regulation of cellular amide metabolic process (GO:0034250)	121	5	3.18	+	1.57	2.59E-01	1.00E00
positive regulation of cellular component organization (GO:0051130)	775	32	20.39	+	1.57	1.38E-02	8.36E-01
positive regulation of protein metabolic process (GO:0051247)	872	36	22.94	+	1.57	7.79E-03	6.90E-01
positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	97	4	2.55	+	1.57	3.32E-01	1.00E00
external encapsulating structure organization (GO:0045229)	97	4	2.55	+	1.57	3.32E-01	1.00E00
ear development (GO:0043583)	97	4	2.55	+	1.57	3.32E-01	1.00E00
extracellular structure organization (GO:0043062)	97	4	2.55	+	1.57	3.32E-01	1.00E00
extracellular matrix organization (GO:0030198)	97	4	2.55	+	1.57	3.32E-01	1.00E00
mononuclear cell differentiation (GO:1903131)	146	6	3.84	+	1.56	2.90E-01	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	73	3	1.92	+	1.56	4.47E-01	1.00E00
cytokine production (GO:0001816)	73	3	1.92	+	1.56	4.47E-01	1.00E00
protein complex oligomerization (GO:0051259)	146	6	3.84	+	1.56	2.90E-01	1.00E00
regulation of vesicle-mediated transport (GO:0060627)	390	16	10.26	+	1.56	7.72E-02	1.00E00
generation of neurons (GO:0048699)	758	31	19.94	+	1.55	1.79E-02	9.28E-01
regulation of intracellular signal transduction (GO:1902531)	905	37	23.81	+	1.55	8.76E-03	7.46E-01
circulatory system development (GO:0072359)	465	19	12.23	+	1.55	7.40E-02	1.00E00
neuron differentiation (GO:0030182)	710	29	18.68	+	1.55	2.07E-02	9.87E-01
positive regulation of T cell differentiation (GO:0045582)	49	2	1.29	+	1.55	3.77E-01	1.00E00
regulation of mitotic nuclear division (GO:0007088)	49	2	1.29	+	1.55	3.77E-01	1.00E00
epithelial cell proliferation (GO:0050673)	98	4	2.58	+	1.55	3.35E-01	1.00E00
sodium ion transmembrane transport (GO:0035725)	49	2	1.29	+	1.55	3.77E-01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	98	4	2.58	+	1.55	3.35E-01	1.00E00
ion transmembrane transport (GO:0034220)	344	14	9.05	+	1.55	1.21E-01	1.00E00
regulation of immune effector process (GO:0002697)	123	5	3.24	+	1.55	3.87E-01	1.00E00
regulation of T cell differentiation (GO:0045580)	74	3	1.95	+	1.54	4.50E-01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	74	3	1.95	+	1.54	4.50E-01	1.00E00
cell-cell signaling by wnt (GO:0198738)	148	6	3.89	+	1.54	2.94E-01	1.00E00
signal transduction in response to DNA damage (GO:0042770)	74	3	1.95	+	1.54	4.50E-01	1.00E00
Wnt signaling pathway (GO:0016055)	148	6	3.89	+	1.54	2.94E-01	1.00E00
epithelium development (GO:0060429)	494	20	13.00	+	1.54	6.06E-02	1.00E00
mesenchyme development (GO:0060485)	99	4	2.60	+	1.54	3.39E-01	1.00E00
neurotransmitter transport (GO:0006836)	99	4	2.60	+	1.54	3.39E-01	1.00E00
protein deubiquitination (GO:0016579)	99	4	2.60	+	1.54	3.39E-01	1.00E00
regulation of mitochondrion organization (GO:0010821)	99	4	2.60	+	1.54	3.39E-01	1.00E00
organic acid biosynthetic process (GO:0016053)	99	4	2.60	+	1.54	3.39E-01	1.00E00
negative regulation of gene expression (GO:0010629)	520	21	13.68	+	1.54	5.01E-02	1.00E00
response to biotic stimulus (GO:0009607)	421	17	11.08	+	1.53	8.63E-02	1.00E00
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	223	9	5.87	+	1.53	2.02E-01	1.00E00
Unclassified (UNCLASSIFIED)	248	10	6.52	+	1.53	1.63E-01	1.00E00
regulation of cell differentiation (GO:0045595)	893	36	23.49	+	1.53	1.16E-02	8.10E-01
cation transmembrane transport (GO:0098655)	273	11	7.18	+	1.53	1.77E-01	1.00E00
regulation of protein ubiquitination (GO:0031396)	149	6	3.92	+	1.53	2.96E-01	1.00E00
regulation of response to stress (GO:0080134)	721	29	18.97	+	1.53	2.92E-02	1.00E00
positive regulation of kinase activity (GO:0033674)	249	10	6.55	+	1.53	1.65E-01	1.00E00
locomotion (GO:0040011)	249	10	6.55	+	1.53	1.65E-01	1.00E00
mesoderm development (GO:0007498)	50	2	1.32	+	1.52	3.87E-01	1.00E00
lung epithelium development (GO:0060428)	25	1	.66	+	1.52	4.91E-01	1.00E00
lung morphogenesis (GO:0060425)	25	1	.66	+	1.52	4.91E-01	1.00E00
positive regulation of heart growth (GO:0060421)	25	1	.66	+	1.52	4.91E-01	1.00E00
cerebellar cortex formation (GO:0021697)	25	1	.66	+	1.52	4.91E-01	1.00E00
startle response (GO:0001964)	25	1	.66	+	1.52	4.91E-01	1.00E00
heart looping (GO:0001947)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of cytokine production (GO:0001818)	100	4	2.63	+	1.52	3.43E-01	1.00E00
positive regulation of stem cell proliferation (GO:2000648)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of mononuclear cell proliferation (GO:0032945)	25	1	.66	+	1.52	4.91E-01	1.00E00
mitotic G2 DNA damage checkpoint signaling (GO:0007095)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of stress-activated MAPK cascade (GO:0032873)	25	1	.66	+	1.52	4.91E-01	1.00E00
cellular response to hormone stimulus (GO:0032870)	225	9	5.92	+	1.52	2.05E-01	1.00E00
glomerulus development (GO:0032835)	25	1	.66	+	1.52	4.91E-01	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	25	1	.66	+	1.52	4.91E-01	1.00E00
positive regulation of protein deacetylation (GO:0090312)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of transporter activity (GO:0032410)	50	2	1.32	+	1.52	3.87E-01	1.00E00
mesenchymal cell differentiation (GO:0048762)	75	3	1.97	+	1.52	4.54E-01	1.00E00
regulation of oligodendrocyte differentiation (GO:0048713)	25	1	.66	+	1.52	4.91E-01	1.00E00
positive regulation of filopodium assembly (GO:0051491)	25	1	.66	+	1.52	4.91E-01	1.00E00
regulation of calcineurin-mediated signaling (GO:0106056)	25	1	.66	+	1.52	4.91E-01	1.00E00
regulation of phagocytosis (GO:0050764)	50	2	1.32	+	1.52	3.87E-01	1.00E00
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of lymphocyte proliferation (GO:0050672)	25	1	.66	+	1.52	4.91E-01	1.00E00
CD4-positive, alpha-beta T cell activation (GO:0035710)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	25	1	.66	+	1.52	4.91E-01	1.00E00
negative regulation of potassium ion transport (GO:0043267)	25	1	.66	+	1.52	4.91E-01	1.00E00
cytoplasmic microtubule organization (GO:0031122)	50	2	1.32	+	1.52	3.87E-01	1.00E00
positive regulation of cardiac muscle tissue growth (GO:0055023)	25	1	.66	+	1.52	4.91E-01	1.00E00
monocarboxylic acid transport (GO:0015718)	25	1	.66	+	1.52	4.91E-01	1.00E00
positive regulation of protein import into nucleus (GO:0042307)	25	1	.66	+	1.52	4.91E-01	1.00E00
regulation of dendritic spine development (GO:0060998)	75	3	1.97	+	1.52	4.54E-01	1.00E00
negative regulation of striated muscle cell apoptotic process (GO:0010664)	25	1	.66	+	1.52	4.91E-01	1.00E00
cell differentiation (GO:0030154)	1800	72	47.35	+	1.52	2.26E-04	2.31E-01
regulation of transport (GO:0051049)	1126	45	29.62	+	1.52	5.47E-03	6.11E-01
embryo development ending in birth or egg hatching (GO:0009792)	451	18	11.86	+	1.52	9.64E-02	1.00E00
morphogenesis of an epithelium (GO:0002009)	251	10	6.60	+	1.51	2.27E-01	1.00E00
cellular response to growth factor stimulus (GO:0071363)	226	9	5.95	+	1.51	2.07E-01	1.00E00
response to external stimulus (GO:0009605)	905	36	23.81	+	1.51	1.63E-02	9.04E-01
cell surface receptor signaling pathway (GO:0007166)	856	34	22.52	+	1.51	1.87E-02	9.31E-01
intracellular signal transduction (GO:0035556)	831	33	21.86	+	1.51	1.78E-02	9.39E-01
cellular response to peptide hormone stimulus (GO:0071375)	126	5	3.31	+	1.51	3.92E-01	1.00E00
regulation of mitotic cell cycle phase transition (GO:1901990)	202	8	5.31	+	1.51	2.62E-01	1.00E00
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	101	4	2.66	+	1.51	3.47E-01	1.00E00
head development (GO:0060322)	455	18	11.97	+	1.50	9.79E-02	1.00E00
cellular developmental process (GO:0048869)	1822	72	47.93	+	1.50	3.33E-04	2.95E-01
developmental process involved in reproduction (GO:0003006)	405	16	10.65	+	1.50	1.12E-01	1.00E00
regulation of biological quality (GO:0065008)	2101	83	55.27	+	1.50	7.87E-05	2.09E-01
fertilization (GO:0009566)	76	3	2.00	+	1.50	4.58E-01	1.00E00
protein secretion (GO:0009306)	76	3	2.00	+	1.50	4.58E-01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	76	3	2.00	+	1.50	4.58E-01	1.00E00
cell part morphogenesis (GO:0032990)	406	16	10.68	+	1.50	1.13E-01	1.00E00
positive regulation of protein kinase activity (GO:0045860)	203	8	5.34	+	1.50	2.64E-01	1.00E00
regulation of cytokine production (GO:0001817)	280	11	7.37	+	1.49	1.84E-01	1.00E00
nervous system development (GO:0007399)	1248	49	32.83	+	1.49	4.48E-03	6.13E-01
telencephalon cell migration (GO:0022029)	51	2	1.34	+	1.49	3.96E-01	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	51	2	1.34	+	1.49	3.96E-01	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	51	2	1.34	+	1.49	3.96E-01	1.00E00
RNA phosphodiester bond hydrolysis (GO:0090501)	51	2	1.34	+	1.49	3.96E-01	1.00E00
cellular response to peptide (GO:1901653)	153	6	4.03	+	1.49	3.05E-01	1.00E00
regulation of cellular component size (GO:0032535)	255	10	6.71	+	1.49	2.31E-01	1.00E00
cellular response to acid chemical (GO:0071229)	51	2	1.34	+	1.49	3.96E-01	1.00E00
vesicle docking (GO:0048278)	51	2	1.34	+	1.49	3.96E-01	1.00E00
MAPK cascade (GO:0000165)	102	4	2.68	+	1.49	3.51E-01	1.00E00
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	255	10	6.71	+	1.49	2.31E-01	1.00E00
regulation of cardiac muscle hypertrophy (GO:0010611)	51	2	1.34	+	1.49	3.96E-01	1.00E00
regulation of embryonic development (GO:0045995)	51	2	1.34	+	1.49	3.96E-01	1.00E00
positive regulation of cellular catabolic process (GO:0031331)	281	11	7.39	+	1.49	1.85E-01	1.00E00
regulation of localization (GO:0032879)	1357	53	35.70	+	1.48	3.40E-03	5.64E-01
female gamete generation (GO:0007292)	77	3	2.03	+	1.48	4.61E-01	1.00E00
cerebellum development (GO:0021549)	77	3	2.03	+	1.48	4.61E-01	1.00E00
myelination (GO:0042552)	77	3	2.03	+	1.48	4.61E-01	1.00E00
adult locomotory behavior (GO:0008344)	77	3	2.03	+	1.48	4.61E-01	1.00E00
mRNA metabolic process (GO:0016071)	463	18	12.18	+	1.48	1.02E-01	1.00E00
cell development (GO:0048468)	1029	40	27.07	+	1.48	1.34E-02	8.38E-01
transmembrane transport (GO:0055085)	515	20	13.55	+	1.48	8.92E-02	1.00E00
chemotaxis (GO:0006935)	232	9	6.10	+	1.47	2.17E-01	1.00E00
taxis (GO:0042330)	232	9	6.10	+	1.47	2.17E-01	1.00E00
reproductive process (GO:0022414)	593	23	15.60	+	1.47	6.43E-02	1.00E00
heart morphogenesis (GO:0003007)	129	5	3.39	+	1.47	3.98E-01	1.00E00
regulation of peptide hormone secretion (GO:0090276)	129	5	3.39	+	1.47	3.98E-01	1.00E00
positive regulation of cell cycle process (GO:0090068)	129	5	3.39	+	1.47	3.98E-01	1.00E00
regulation of cellular localization (GO:0060341)	698	27	18.36	+	1.47	4.94E-02	1.00E00
epithelial tube morphogenesis (GO:0060562)	181	7	4.76	+	1.47	3.43E-01	1.00E00
neurogenesis (GO:0022008)	854	33	22.47	+	1.47	2.58E-02	1.00E00
negative regulation of phosphorylation (GO:0042326)	233	9	6.13	+	1.47	2.19E-01	1.00E00
central nervous system development (GO:0007417)	544	21	14.31	+	1.47	9.74E-02	1.00E00
response to abiotic stimulus (GO:0009628)	544	21	14.31	+	1.47	9.74E-02	1.00E00
reproduction (GO:0000003)	597	23	15.71	+	1.46	6.59E-02	1.00E00
cation transport (GO:0006812)	390	15	10.26	+	1.46	1.46E-01	1.00E00
positive regulation of cell cycle (GO:0045787)	182	7	4.79	+	1.46	3.44E-01	1.00E00
regulation of osteoblast differentiation (GO:0045667)	78	3	2.05	+	1.46	4.65E-01	1.00E00
cell killing (GO:0001906)	26	1	.68	+	1.46	5.04E-01	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	26	1	.68	+	1.46	5.04E-01	1.00E00
mononuclear cell migration (GO:0071674)	26	1	.68	+	1.46	5.04E-01	1.00E00
nephron epithelium morphogenesis (GO:0072088)	26	1	.68	+	1.46	5.04E-01	1.00E00
nephron tubule morphogenesis (GO:0072078)	26	1	.68	+	1.46	5.04E-01	1.00E00
nephron morphogenesis (GO:0072028)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of lymphocyte migration (GO:2000401)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of dopamine secretion (GO:0014059)	26	1	.68	+	1.46	5.04E-01	1.00E00
Schwann cell differentiation (GO:0014037)	26	1	.68	+	1.46	5.04E-01	1.00E00
translational initiation (GO:0006413)	52	2	1.37	+	1.46	4.05E-01	1.00E00
regulation of chemokine production (GO:0032642)	26	1	.68	+	1.46	5.04E-01	1.00E00
cellular response to retinoic acid (GO:0071300)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of peptide transport (GO:0090087)	130	5	3.42	+	1.46	4.00E-01	1.00E00
response to oxygen levels (GO:0070482)	130	5	3.42	+	1.46	4.00E-01	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	52	2	1.37	+	1.46	4.05E-01	1.00E00
protein homotetramerization (GO:0051289)	26	1	.68	+	1.46	5.04E-01	1.00E00
cellular response to nerve growth factor stimulus (GO:1990090)	26	1	.68	+	1.46	5.04E-01	1.00E00
response to nerve growth factor (GO:1990089)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of actin filament length (GO:0030832)	104	4	2.74	+	1.46	3.60E-01	1.00E00
oligosaccharide metabolic process (GO:0009311)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of vascular permeability (GO:0043114)	26	1	.68	+	1.46	5.04E-01	1.00E00
receptor metabolic process (GO:0043112)	26	1	.68	+	1.46	5.04E-01	1.00E00
cardiac muscle tissue morphogenesis (GO:0055008)	26	1	.68	+	1.46	5.04E-01	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of cytokine production involved in inflammatory response (GO:1900015)	26	1	.68	+	1.46	5.04E-01	1.00E00
positive regulation of cell-substrate junction organization (GO:0150117)	26	1	.68	+	1.46	5.04E-01	1.00E00
granulocyte migration (GO:0097530)	26	1	.68	+	1.46	5.04E-01	1.00E00
regulation of glucose transmembrane transport (GO:0010827)	52	2	1.37	+	1.46	4.05E-01	1.00E00
miRNA processing (GO:0035196)	26	1	.68	+	1.46	5.04E-01	1.00E00
glycerolipid catabolic process (GO:0046503)	26	1	.68	+	1.46	5.04E-01	1.00E00
lymphocyte differentiation (GO:0030098)	130	5	3.42	+	1.46	4.00E-01	1.00E00
regulation of peptide secretion (GO:0002791)	130	5	3.42	+	1.46	4.00E-01	1.00E00
regulation of muscle hypertrophy (GO:0014743)	52	2	1.37	+	1.46	4.05E-01	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	104	4	2.74	+	1.46	3.60E-01	1.00E00
negative regulation of lipid metabolic process (GO:0045833)	52	2	1.37	+	1.46	4.05E-01	1.00E00
forebrain cell migration (GO:0021885)	52	2	1.37	+	1.46	4.05E-01	1.00E00
forebrain neuron differentiation (GO:0021879)	26	1	.68	+	1.46	5.04E-01	1.00E00
clathrin-dependent endocytosis (GO:0072583)	26	1	.68	+	1.46	5.04E-01	1.00E00
cell motility (GO:0048870)	521	20	13.71	+	1.46	9.20E-02	1.00E00
proteasomal protein catabolic process (GO:0010498)	287	11	7.55	+	1.46	1.93E-01	1.00E00
secretion by cell (GO:0032940)	261	10	6.87	+	1.46	2.37E-01	1.00E00
regulation of cell population proliferation (GO:0042127)	784	30	20.63	+	1.45	4.76E-02	1.00E00
response to growth factor (GO:0070848)	236	9	6.21	+	1.45	2.99E-01	1.00E00
anatomical structure formation involved in morphogenesis (GO:0048646)	472	18	12.42	+	1.45	1.39E-01	1.00E00
metal ion transport (GO:0030001)	315	12	8.29	+	1.45	2.09E-01	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	105	4	2.76	+	1.45	3.64E-01	1.00E00
cellular response to endogenous stimulus (GO:0071495)	525	20	13.81	+	1.45	9.42E-02	1.00E00
intrinsic apoptotic signaling pathway (GO:0097193)	105	4	2.76	+	1.45	3.64E-01	1.00E00
tube development (GO:0035295)	473	18	12.44	+	1.45	1.40E-01	1.00E00
regulation of cellular catabolic process (GO:0031329)	500	19	13.15	+	1.44	1.14E-01	1.00E00
ensheathment of neurons (GO:0007272)	79	3	2.08	+	1.44	4.69E-01	1.00E00
cell fate commitment (GO:0045165)	79	3	2.08	+	1.44	4.69E-01	1.00E00
anterior/posterior pattern specification (GO:0009952)	79	3	2.08	+	1.44	4.69E-01	1.00E00
axon ensheathment (GO:0008366)	79	3	2.08	+	1.44	4.69E-01	1.00E00
regulation of cellular amide metabolic process (GO:0034248)	316	12	8.31	+	1.44	2.10E-01	1.00E00
brain development (GO:0007420)	422	16	11.10	+	1.44	1.60E-01	1.00E00
mRNA processing (GO:0006397)	343	13	9.02	+	1.44	1.73E-01	1.00E00
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	132	5	3.47	+	1.44	4.04E-01	1.00E00
regulation of signal transduction by p53 class mediator (GO:1901796)	53	2	1.39	+	1.43	6.53E-01	1.00E00
oogenesis (GO:0048477)	53	2	1.39	+	1.43	6.53E-01	1.00E00
regulation of smooth muscle cell migration (GO:0014910)	53	2	1.39	+	1.43	6.53E-01	1.00E00
regulation of signal transduction (GO:0009966)	1591	60	41.86	+	1.43	3.57E-03	5.72E-01
regulation of growth (GO:0040008)	425	16	11.18	+	1.43	1.62E-01	1.00E00
negative regulation of intracellular signal transduction (GO:1902532)	319	12	8.39	+	1.43	2.13E-01	1.00E00
biological process involved in interspecies interaction between organisms (GO:0044419)	479	18	12.60	+	1.43	1.42E-01	1.00E00
regulation of proteolysis (GO:0030162)	373	14	9.81	+	1.43	1.86E-01	1.00E00
system development (GO:0048731)	2025	76	53.27	+	1.43	9.98E-04	3.79E-01
placenta development (GO:0001890)	80	3	2.10	+	1.43	4.73E-01	1.00E00
protein localization to extracellular region (GO:0071692)	80	3	2.10	+	1.43	4.73E-01	1.00E00
cellular response to leukemia inhibitory factor (GO:1990830)	80	3	2.10	+	1.43	4.73E-01	1.00E00
protein modification by small protein conjugation (GO:0032446)	400	15	10.52	+	1.43	1.55E-01	1.00E00
regulation of exocytosis (GO:0017157)	160	6	4.21	+	1.43	3.24E-01	1.00E00
negative regulation of protein catabolic process (GO:0042177)	80	3	2.10	+	1.43	4.73E-01	1.00E00
negative regulation of response to stimulus (GO:0048585)	882	33	23.20	+	1.42	4.68E-02	1.00E00
response to organic cyclic compound (GO:0014070)	321	12	8.44	+	1.42	2.15E-01	1.00E00
hindbrain development (GO:0030902)	107	4	2.81	+	1.42	3.73E-01	1.00E00
sensory organ development (GO:0007423)	268	10	7.05	+	1.42	2.47E-01	1.00E00
regulation of cellular response to stress (GO:0080135)	483	18	12.71	+	1.42	1.44E-01	1.00E00
exocytosis (GO:0006887)	161	6	4.24	+	1.42	3.26E-01	1.00E00
cell morphogenesis involved in differentiation (GO:0000904)	403	15	10.60	+	1.41	2.02E-01	1.00E00
regulation of cell communication (GO:0010646)	1881	70	49.48	+	1.41	2.23E-03	4.85E-01
protein phosphorylation (GO:0006468)	457	17	12.02	+	1.41	1.77E-01	1.00E00
vesicle coating (GO:0006901)	27	1	.71	+	1.41	5.17E-01	1.00E00
negative regulation of cation channel activity (GO:2001258)	27	1	.71	+	1.41	5.17E-01	1.00E00
pallium development (GO:0021543)	108	4	2.84	+	1.41	5.37E-01	1.00E00
fatty acid biosynthetic process (GO:0006633)	54	2	1.42	+	1.41	6.55E-01	1.00E00
neural crest cell migration (GO:0001755)	27	1	.71	+	1.41	5.17E-01	1.00E00
peroxisome organization (GO:0007031)	27	1	.71	+	1.41	5.17E-01	1.00E00
negative regulation of RNA splicing (GO:0033119)	27	1	.71	+	1.41	5.17E-01	1.00E00
mRNA splice site selection (GO:0006376)	27	1	.71	+	1.41	5.17E-01	1.00E00
DNA-templated transcription elongation (GO:0006354)	27	1	.71	+	1.41	5.17E-01	1.00E00
muscle cell proliferation (GO:0033002)	27	1	.71	+	1.41	5.17E-01	1.00E00
positive regulation of signaling receptor activity (GO:2000273)	27	1	.71	+	1.41	5.17E-01	1.00E00
positive regulation of leukocyte proliferation (GO:0070665)	54	2	1.42	+	1.41	6.55E-01	1.00E00
negative regulation of leukocyte proliferation (GO:0070664)	27	1	.71	+	1.41	5.17E-01	1.00E00
astrocyte differentiation (GO:0048708)	27	1	.71	+	1.41	5.17E-01	1.00E00
peptidyl-lysine trimethylation (GO:0018023)	27	1	.71	+	1.41	5.17E-01	1.00E00
oocyte development (GO:0048599)	27	1	.71	+	1.41	5.17E-01	1.00E00
protein polymerization (GO:0051258)	54	2	1.42	+	1.41	6.55E-01	1.00E00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	27	1	.71	+	1.41	5.17E-01	1.00E00
cellular response to virus (GO:0098586)	27	1	.71	+	1.41	5.17E-01	1.00E00
negative regulation of lipid biosynthetic process (GO:0051055)	27	1	.71	+	1.41	5.17E-01	1.00E00
regulation of B cell proliferation (GO:0030888)	27	1	.71	+	1.41	5.17E-01	1.00E00
fibroblast proliferation (GO:0048144)	27	1	.71	+	1.41	5.17E-01	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	27	1	.71	+	1.41	5.17E-01	1.00E00
positive regulation of protein localization to nucleus (GO:1900182)	54	2	1.42	+	1.41	6.55E-01	1.00E00
cardiac muscle tissue growth (GO:0055017)	27	1	.71	+	1.41	5.17E-01	1.00E00
regulation of signaling (GO:0023051)	1890	70	49.72	+	1.41	2.30E-03	4.77E-01
regulation of T cell proliferation (GO:0042129)	54	2	1.42	+	1.41	6.55E-01	1.00E00
positive regulation of T cell proliferation (GO:0042102)	27	1	.71	+	1.41	5.17E-01	1.00E00
positive regulation of glucose import (GO:0046326)	27	1	.71	+	1.41	5.17E-01	1.00E00
cell junction maintenance (GO:0034331)	27	1	.71	+	1.41	5.17E-01	1.00E00
positive regulation of dendritic spine morphogenesis (GO:0061003)	27	1	.71	+	1.41	5.17E-01	1.00E00
anatomical structure homeostasis (GO:0060249)	135	5	3.55	+	1.41	4.11E-01	1.00E00
response to leukemia inhibitory factor (GO:1990823)	81	3	2.13	+	1.41	4.77E-01	1.00E00
peptidyl-amino acid modification (GO:0018193)	540	20	14.21	+	1.41	1.28E-01	1.00E00
negative regulation of protein metabolic process (GO:0051248)	596	22	15.68	+	1.40	1.13E-01	1.00E00
cell morphogenesis (GO:0000902)	515	19	13.55	+	1.40	1.56E-01	1.00E00
regulation of secretion (GO:0051046)	408	15	10.73	+	1.40	2.05E-01	1.00E00
negative regulation of signaling (GO:0023057)	790	29	20.78	+	1.40	8.16E-02	1.00E00
positive regulation of supramolecular fiber organization (GO:1902905)	109	4	2.87	+	1.39	5.39E-01	1.00E00
protein localization to membrane (GO:0072657)	355	13	9.34	+	1.39	2.36E-01	1.00E00
cell junction organization (GO:0034330)	355	13	9.34	+	1.39	2.36E-01	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	82	3	2.16	+	1.39	4.81E-01	1.00E00
T cell differentiation (GO:0030217)	82	3	2.16	+	1.39	4.81E-01	1.00E00
secretion (GO:0046903)	301	11	7.92	+	1.39	2.71E-01	1.00E00
purine nucleoside bisphosphate metabolic process (GO:0034032)	55	2	1.45	+	1.38	6.58E-01	1.00E00
circadian regulation of gene expression (GO:0032922)	55	2	1.45	+	1.38	6.58E-01	1.00E00
kidney epithelium development (GO:0072073)	55	2	1.45	+	1.38	6.58E-01	1.00E00
response to hypoxia (GO:0001666)	110	4	2.89	+	1.38	5.40E-01	1.00E00
establishment of protein localization to membrane (GO:0090150)	165	6	4.34	+	1.38	4.56E-01	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	110	4	2.89	+	1.38	5.40E-01	1.00E00
digestive system development (GO:0055123)	55	2	1.45	+	1.38	6.58E-01	1.00E00
actomyosin structure organization (GO:0031032)	55	2	1.45	+	1.38	6.58E-01	1.00E00
actin filament-based movement (GO:0030048)	55	2	1.45	+	1.38	6.58E-01	1.00E00
mRNA destabilization (GO:0061157)	55	2	1.45	+	1.38	6.58E-01	1.00E00
positive regulation of proteolysis (GO:0045862)	220	8	5.79	+	1.38	3.90E-01	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	55	2	1.45	+	1.38	6.58E-01	1.00E00
ribonucleoside bisphosphate metabolic process (GO:0033875)	55	2	1.45	+	1.38	6.58E-01	1.00E00
nucleoside bisphosphate metabolic process (GO:0033865)	55	2	1.45	+	1.38	6.58E-01	1.00E00
synapse organization (GO:0050808)	248	9	6.52	+	1.38	3.14E-01	1.00E00
cellular component morphogenesis (GO:0032989)	442	16	11.63	+	1.38	2.22E-01	1.00E00
regulation of cellular component organization (GO:0051128)	1604	58	42.20	+	1.37	1.05E-02	7.63E-01
multicellular organism development (GO:0007275)	2406	87	63.30	+	1.37	1.16E-03	3.87E-01
positive regulation of apoptotic signaling pathway (GO:2001235)	83	3	2.18	+	1.37	4.86E-01	1.00E00
cerebral cortex development (GO:0021987)	83	3	2.18	+	1.37	4.86E-01	1.00E00
chordate embryonic development (GO:0043009)	443	16	11.65	+	1.37	2.23E-01	1.00E00
tissue development (GO:0009888)	803	29	21.12	+	1.37	8.47E-02	1.00E00
regulation of kinase activity (GO:0043549)	416	15	10.94	+	1.37	2.11E-01	1.00E00
ion transport (GO:0006811)	555	20	14.60	+	1.37	1.71E-01	1.00E00
regulation of insulin secretion (GO:0050796)	111	4	2.92	+	1.37	5.42E-01	1.00E00
skin development (GO:0043588)	111	4	2.92	+	1.37	5.42E-01	1.00E00
membrane organization (GO:0061024)	444	16	11.68	+	1.37	2.23E-01	1.00E00
signaling (GO:0023052)	2082	75	54.77	+	1.37	3.25E-03	5.60E-01
developmental process (GO:0032502)	2888	104	75.98	+	1.37	2.17E-04	2.40E-01
cell morphogenesis involved in neuron differentiation (GO:0048667)	334	12	8.79	+	1.37	2.94E-01	1.00E00
anatomical structure development (GO:0048856)	2673	96	70.32	+	1.37	6.08E-04	3.67E-01
protein ubiquitination (GO:0016567)	362	13	9.52	+	1.37	2.43E-01	1.00E00
cellular response to organic substance (GO:0071310)	947	34	24.91	+	1.36	6.91E-02	1.00E00
regulation of cell growth (GO:0001558)	279	10	7.34	+	1.36	3.40E-01	1.00E00
post-transcriptional regulation of gene expression (GO:0010608)	335	12	8.81	+	1.36	2.95E-01	1.00E00
regulation of protein modification process (GO:0031399)	922	33	24.26	+	1.36	8.32E-02	1.00E00
signal transduction (GO:0007165)	1873	67	49.27	+	1.36	7.84E-03	6.90E-01
regulation of protein metabolic process (GO:0051246)	1483	53	39.01	+	1.36	2.17E-02	9.59E-01
heart growth (GO:0060419)	28	1	.74	+	1.36	5.30E-01	1.00E00
muscle tissue morphogenesis (GO:0060415)	28	1	.74	+	1.36	5.30E-01	1.00E00
humoral immune response (GO:0006959)	28	1	.74	+	1.36	5.30E-01	1.00E00
regulation of toll-like receptor signaling pathway (GO:0034121)	28	1	.74	+	1.36	5.30E-01	1.00E00
negative regulation of calcium ion transmembrane transport (GO:1903170)	28	1	.74	+	1.36	5.30E-01	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	56	2	1.47	+	1.36	6.61E-01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	28	1	.74	+	1.36	5.30E-01	1.00E00
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	28	1	.74	+	1.36	5.30E-01	1.00E00
response to ethanol (GO:0045471)	28	1	.74	+	1.36	5.30E-01	1.00E00
adaptive immune response (GO:0002250)	84	3	2.21	+	1.36	4.90E-01	1.00E00
mitotic metaphase plate congression (GO:0007080)	28	1	.74	+	1.36	5.30E-01	1.00E00
positive regulation of ATP-dependent activity (GO:0032781)	28	1	.74	+	1.36	5.30E-01	1.00E00
small regulatory ncRNA processing (GO:0070918)	28	1	.74	+	1.36	5.30E-01	1.00E00
regulation of interferon-gamma production (GO:0032649)	28	1	.74	+	1.36	5.30E-01	1.00E00
mesenchymal cell migration (GO:0090497)	28	1	.74	+	1.36	5.30E-01	1.00E00
stem cell differentiation (GO:0048863)	84	3	2.21	+	1.36	4.90E-01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	84	3	2.21	+	1.36	4.90E-01	1.00E00
oocyte differentiation (GO:0009994)	28	1	.74	+	1.36	5.30E-01	1.00E00
negative regulation of inflammatory response (GO:0050728)	56	2	1.47	+	1.36	6.61E-01	1.00E00
regulation of actin nucleation (GO:0051125)	28	1	.74	+	1.36	5.30E-01	1.00E00
spliceosomal snRNP assembly (GO:0000387)	28	1	.74	+	1.36	5.30E-01	1.00E00
protein kinase B signaling (GO:0043491)	28	1	.74	+	1.36	5.30E-01	1.00E00
cell cycle checkpoint signaling (GO:0000075)	84	3	2.21	+	1.36	4.90E-01	1.00E00
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	28	1	.74	+	1.36	5.30E-01	1.00E00
pancreas development (GO:0031016)	28	1	.74	+	1.36	5.30E-01	1.00E00
regulation of axon extension (GO:0030516)	84	3	2.21	+	1.36	4.90E-01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	28	1	.74	+	1.36	5.30E-01	1.00E00
photoreceptor cell development (GO:0042461)	28	1	.74	+	1.36	5.30E-01	1.00E00
pigment metabolic process (GO:0042440)	28	1	.74	+	1.36	5.30E-01	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	28	1	.74	+	1.36	5.30E-01	1.00E00
positive regulation of organ growth (GO:0046622)	28	1	.74	+	1.36	5.30E-01	1.00E00
determination of heart left/right asymmetry (GO:0061371)	28	1	.74	+	1.36	5.30E-01	1.00E00
B cell differentiation (GO:0030183)	56	2	1.47	+	1.36	6.61E-01	1.00E00
negative regulation of endothelial cell migration (GO:0010596)	28	1	.74	+	1.36	5.30E-01	1.00E00
negative regulation of epithelial cell apoptotic process (GO:1904036)	28	1	.74	+	1.36	5.30E-01	1.00E00
response to ischemia (GO:0002931)	28	1	.74	+	1.36	5.30E-01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	28	1	.74	+	1.36	5.30E-01	1.00E00
labyrinthine layer development (GO:0060711)	28	1	.74	+	1.36	5.30E-01	1.00E00
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	56	2	1.47	+	1.36	6.61E-01	1.00E00
central nervous system projection neuron axonogenesis (GO:0021952)	28	1	.74	+	1.36	5.30E-01	1.00E00
immune response-activating signal transduction (GO:0002757)	56	2	1.47	+	1.36	6.61E-01	1.00E00
positive regulation of biological process (GO:0048518)	3418	122	89.92	+	1.36	4.37E-05	2.91E-01
cellular response to chemical stimulus (GO:0070887)	1206	43	31.73	+	1.36	4.33E-02	1.00E00
negative regulation of cell communication (GO:0010648)	788	28	20.73	+	1.35	1.05E-01	1.00E00
positive regulation of cellular process (GO:0048522)	3156	112	83.03	+	1.35	1.77E-04	2.61E-01
regulation of cell cycle phase transition (GO:1901987)	254	9	6.68	+	1.35	3.24E-01	1.00E00
regulation of response to stimulus (GO:0048583)	2033	72	53.48	+	1.35	6.29E-03	6.29E-01
positive regulation of cellular metabolic process (GO:0031325)	1751	62	46.06	+	1.35	1.32E-02	8.34E-01
RNA catabolic process (GO:0006401)	113	4	2.97	+	1.35	5.46E-01	1.00E00
response to inorganic substance (GO:0010035)	255	9	6.71	+	1.34	3.26E-01	1.00E00
developmental cell growth (GO:0048588)	85	3	2.24	+	1.34	4.94E-01	1.00E00
response to topologically incorrect protein (GO:0035966)	85	3	2.24	+	1.34	4.94E-01	1.00E00
multicellular organism reproduction (GO:0032504)	397	14	10.44	+	1.34	2.62E-01	1.00E00
positive regulation of transcription by RNA polymerase II (GO:0045944)	683	24	17.97	+	1.34	1.72E-01	1.00E00
negative regulation of signal transduction (GO:0009968)	712	25	18.73	+	1.33	1.45E-01	1.00E00
anion transport (GO:0006820)	171	6	4.50	+	1.33	4.65E-01	1.00E00
telencephalon development (GO:0021537)	171	6	4.50	+	1.33	4.65E-01	1.00E00
positive regulation of cytokine production (GO:0001819)	171	6	4.50	+	1.33	4.65E-01	1.00E00
response to peptide hormone (GO:0043434)	171	6	4.50	+	1.33	4.65E-01	1.00E00
positive regulation of lymphocyte differentiation (GO:0045621)	57	2	1.50	+	1.33	6.64E-01	1.00E00
action potential (GO:0001508)	57	2	1.50	+	1.33	6.64E-01	1.00E00
protein modification by small protein conjugation or removal (GO:0070647)	513	18	13.50	+	1.33	2.04E-01	1.00E00
nucleosome organization (GO:0034728)	57	2	1.50	+	1.33	6.64E-01	1.00E00
positive regulation of endothelial cell migration (GO:0010595)	57	2	1.50	+	1.33	6.64E-01	1.00E00
response to organic substance (GO:0010033)	1227	43	32.28	+	1.33	5.61E-02	1.00E00
immune system process (GO:0002376)	799	28	21.02	+	1.33	1.33E-01	1.00E00
plasma membrane bounded cell projection organization (GO:0120036)	771	27	20.28	+	1.33	1.28E-01	1.00E00
positive regulation of catabolic process (GO:0009896)	343	12	9.02	+	1.33	3.03E-01	1.00E00
regulation of leukocyte differentiation (GO:1902105)	143	5	3.76	+	1.33	4.33E-01	1.00E00
positive regulation of nitrogen compound metabolic process (GO:0051173)	1776	62	46.72	+	1.33	1.73E-02	9.21E-01
cell communication (GO:0007154)	2149	75	56.53	+	1.33	7.40E-03	6.78E-01
response to cytokine (GO:0034097)	344	12	9.05	+	1.33	3.04E-01	1.00E00
associative learning (GO:0008306)	86	3	2.26	+	1.33	4.98E-01	1.00E00
positive regulation of immune effector process (GO:0002699)	86	3	2.26	+	1.33	4.98E-01	1.00E00
positive regulation of macromolecule metabolic process (GO:0010604)	1922	67	50.56	+	1.33	1.35E-02	8.36E-01
multicellular organismal reproductive process (GO:0048609)	373	13	9.81	+	1.32	3.20E-01	1.00E00
response to peptide (GO:1901652)	201	7	5.29	+	1.32	3.79E-01	1.00E00
regulation of protein stability (GO:0031647)	230	8	6.05	+	1.32	4.03E-01	1.00E00
cell projection organization (GO:0030030)	805	28	21.18	+	1.32	1.35E-01	1.00E00
regulation of cell cycle (GO:0051726)	633	22	16.65	+	1.32	1.98E-01	1.00E00
chromosome segregation (GO:0007059)	144	5	3.79	+	1.32	4.36E-01	1.00E00
negative regulation of metabolic process (GO:0009892)	1643	57	43.22	+	1.32	2.77E-02	1.00E00
regulation of actin filament organization (GO:0110053)	173	6	4.55	+	1.32	4.68E-01	1.00E00
multicellular organismal process (GO:0032501)	3068	106	80.71	+	1.31	9.86E-04	3.85E-01
regulation of lymphocyte differentiation (GO:0045619)	87	3	2.29	+	1.31	5.03E-01	1.00E00
positive regulation of proteasomal protein catabolic process (GO:1901800)	87	3	2.29	+	1.31	5.03E-01	1.00E00
epigenetic regulation of gene expression (GO:0040029)	87	3	2.29	+	1.31	5.03E-01	1.00E00
phospholipid biosynthetic process (GO:0008654)	145	5	3.81	+	1.31	4.39E-01	1.00E00
positive regulation of angiogenesis (GO:0045766)	58	2	1.53	+	1.31	6.67E-01	1.00E00
mammary gland morphogenesis (GO:0060443)	29	1	.76	+	1.31	5.42E-01	1.00E00
cellular iron ion homeostasis (GO:0006879)	29	1	.76	+	1.31	5.42E-01	1.00E00
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	29	1	.76	+	1.31	5.42E-01	1.00E00
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	29	1	.76	+	1.31	5.42E-01	1.00E00
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	29	1	.76	+	1.31	5.42E-01	1.00E00
regulation of cytokine-mediated signaling pathway (GO:0001959)	58	2	1.53	+	1.31	6.67E-01	1.00E00
cell cycle G2/M phase transition (GO:0044839)	29	1	.76	+	1.31	5.42E-01	1.00E00
nephron development (GO:0072006)	58	2	1.53	+	1.31	6.67E-01	1.00E00
oligodendrocyte development (GO:0014003)	29	1	.76	+	1.31	5.42E-01	1.00E00
regulation of cilium assembly (GO:1902017)	58	2	1.53	+	1.31	6.67E-01	1.00E00
regulation of stress fiber assembly (GO:0051492)	58	2	1.53	+	1.31	6.67E-01	1.00E00
epidermal cell differentiation (GO:0009913)	58	2	1.53	+	1.31	6.67E-01	1.00E00
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	29	1	.76	+	1.31	5.42E-01	1.00E00
inositol phosphate metabolic process (GO:0043647)	29	1	.76	+	1.31	5.42E-01	1.00E00
hormone-mediated signaling pathway (GO:0009755)	58	2	1.53	+	1.31	6.67E-01	1.00E00
RNA destabilization (GO:0050779)	58	2	1.53	+	1.31	6.67E-01	1.00E00
negative regulation of protein binding (GO:0032091)	58	2	1.53	+	1.31	6.67E-01	1.00E00
aorta development (GO:0035904)	29	1	.76	+	1.31	5.42E-01	1.00E00
negative regulation of mRNA processing (GO:0050686)	29	1	.76	+	1.31	5.42E-01	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	29	1	.76	+	1.31	5.42E-01	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	58	2	1.53	+	1.31	6.67E-01	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	29	1	.76	+	1.31	5.42E-01	1.00E00
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	29	1	.76	+	1.31	5.42E-01	1.00E00
regulation of cellular response to insulin stimulus (GO:1900076)	58	2	1.53	+	1.31	6.67E-01	1.00E00
positive regulation of dendritic spine development (GO:0060999)	58	2	1.53	+	1.31	6.67E-01	1.00E00
response to cocaine (GO:0042220)	29	1	.76	+	1.31	5.42E-01	1.00E00
sphingolipid biosynthetic process (GO:0030148)	58	2	1.53	+	1.31	6.67E-01	1.00E00
positive regulation of vasculature development (GO:1904018)	58	2	1.53	+	1.31	6.67E-01	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	29	1	.76	+	1.31	5.42E-01	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	58	2	1.53	+	1.31	6.67E-01	1.00E00
nucleoside bisphosphate biosynthetic process (GO:0033866)	29	1	.76	+	1.31	5.42E-01	1.00E00
embryonic heart tube morphogenesis (GO:0003143)	29	1	.76	+	1.31	5.42E-01	1.00E00
regulation of transcription elongation by RNA polymerase II (GO:0034243)	58	2	1.53	+	1.31	6.67E-01	1.00E00
sexual reproduction (GO:0019953)	378	13	9.94	+	1.31	3.25E-01	1.00E00
cellular response to organonitrogen compound (GO:0071417)	291	10	7.66	+	1.31	3.54E-01	1.00E00
protein localization to organelle (GO:0033365)	524	18	13.79	+	1.31	2.61E-01	1.00E00
negative regulation of biological process (GO:0048519)	2946	101	77.50	+	1.30	2.26E-03	4.84E-01
positive regulation of apoptotic process (GO:0043065)	321	11	8.44	+	1.30	3.74E-01	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	438	15	11.52	+	1.30	2.86E-01	1.00E00
regulation of cell size (GO:0008361)	146	5	3.84	+	1.30	4.42E-01	1.00E00
positive regulation of metabolic process (GO:0009893)	2105	72	55.38	+	1.30	1.67E-02	9.00E-01
positive regulation of cell-cell adhesion (GO:0022409)	117	4	3.08	+	1.30	5.55E-01	1.00E00
defense response to symbiont (GO:0140546)	88	3	2.32	+	1.30	5.07E-01	1.00E00
regulation of lipid localization (GO:1905952)	88	3	2.32	+	1.30	5.07E-01	1.00E00
defense response to virus (GO:0051607)	88	3	2.32	+	1.30	5.07E-01	1.00E00
skeletal system morphogenesis (GO:0048705)	88	3	2.32	+	1.30	5.07E-01	1.00E00
regulation of protein modification by small protein conjugation or removal (GO:1903320)	176	6	4.63	+	1.30	4.74E-01	1.00E00
animal organ development (GO:0048513)	1556	53	40.93	+	1.29	4.68E-02	1.00E00
response to endogenous stimulus (GO:0009719)	617	21	16.23	+	1.29	2.41E-01	1.00E00
positive regulation of programmed cell death (GO:0043068)	324	11	8.52	+	1.29	3.77E-01	1.00E00
regulation of endothelial cell proliferation (GO:0001936)	59	2	1.55	+	1.29	6.70E-01	1.00E00
positive regulation of response to DNA damage stimulus (GO:2001022)	118	4	3.10	+	1.29	5.57E-01	1.00E00
protein modification by small protein removal (GO:0070646)	118	4	3.10	+	1.29	5.57E-01	1.00E00
response to glucose (GO:0009749)	59	2	1.55	+	1.29	6.70E-01	1.00E00
response to hexose (GO:0009746)	59	2	1.55	+	1.29	6.70E-01	1.00E00
regulation of anion transport (GO:0044070)	59	2	1.55	+	1.29	6.70E-01	1.00E00
response to virus (GO:0009615)	118	4	3.10	+	1.29	5.57E-01	1.00E00
gene silencing by RNA (GO:0031047)	59	2	1.55	+	1.29	6.70E-01	1.00E00
regulation of viral life cycle (GO:1903900)	59	2	1.55	+	1.29	6.70E-01	1.00E00
negative regulation of cation transmembrane transport (GO:1904063)	59	2	1.55	+	1.29	6.70E-01	1.00E00
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	59	2	1.55	+	1.29	6.70E-01	1.00E00
regulation of myeloid leukocyte differentiation (GO:0002761)	59	2	1.55	+	1.29	6.70E-01	1.00E00
regulation of secretion by cell (GO:1903530)	384	13	10.10	+	1.29	3.30E-01	1.00E00
embryonic organ development (GO:0048568)	207	7	5.45	+	1.29	5.06E-01	1.00E00
negative regulation of cell population proliferation (GO:0008285)	326	11	8.58	+	1.28	3.79E-01	1.00E00
response to chemical (GO:0042221)	1660	56	43.67	+	1.28	5.23E-02	1.00E00
sphingolipid metabolic process (GO:0006665)	89	3	2.34	+	1.28	5.12E-01	1.00E00
regulation of actin filament polymerization (GO:0030833)	89	3	2.34	+	1.28	5.12E-01	1.00E00
regulation of dephosphorylation (GO:0035303)	89	3	2.34	+	1.28	5.12E-01	1.00E00
locomotory behavior (GO:0007626)	178	6	4.68	+	1.28	4.78E-01	1.00E00
carboxylic acid catabolic process (GO:0046395)	89	3	2.34	+	1.28	5.12E-01	1.00E00
tissue morphogenesis (GO:0048729)	297	10	7.81	+	1.28	4.59E-01	1.00E00
axon guidance (GO:0007411)	149	5	3.92	+	1.28	6.00E-01	1.00E00
heart development (GO:0007507)	298	10	7.84	+	1.28	4.59E-01	1.00E00
gamete generation (GO:0007276)	328	11	8.63	+	1.27	3.81E-01	1.00E00
urogenital system development (GO:0001655)	179	6	4.71	+	1.27	4.80E-01	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	418	14	11.00	+	1.27	3.48E-01	1.00E00
regulation of cellular component biogenesis (GO:0044087)	659	22	17.34	+	1.27	2.56E-01	1.00E00
negative regulation of macromolecule metabolic process (GO:0010605)	1499	50	39.43	+	1.27	7.90E-02	1.00E00
nucleocytoplasmic transport (GO:0006913)	180	6	4.74	+	1.27	4.82E-01	1.00E00
fatty acid beta-oxidation (GO:0006635)	30	1	.79	+	1.27	5.53E-01	1.00E00
protein export from nucleus (GO:0006611)	30	1	.79	+	1.27	5.53E-01	1.00E00
negative regulation of cell cycle phase transition (GO:1901988)	120	4	3.16	+	1.27	5.62E-01	1.00E00
semaphorin-plexin signaling pathway (GO:0071526)	30	1	.79	+	1.27	5.53E-01	1.00E00
regulation of lipid catabolic process (GO:0050994)	30	1	.79	+	1.27	5.53E-01	1.00E00
regulation of smooth muscle cell proliferation (GO:0048660)	90	3	2.37	+	1.27	5.16E-01	1.00E00
muscle organ morphogenesis (GO:0048644)	30	1	.79	+	1.27	5.53E-01	1.00E00
negative regulation of chemotaxis (GO:0050922)	30	1	.79	+	1.27	5.53E-01	1.00E00
nuclear transport (GO:0051169)	180	6	4.74	+	1.27	4.82E-01	1.00E00
positive regulation of JUN kinase activity (GO:0043507)	30	1	.79	+	1.27	5.53E-01	1.00E00
negative regulation of binding (GO:0051100)	90	3	2.37	+	1.27	5.16E-01	1.00E00
mesoderm morphogenesis (GO:0048332)	30	1	.79	+	1.27	5.53E-01	1.00E00
response to xenobiotic stimulus (GO:0009410)	120	4	3.16	+	1.27	5.62E-01	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	60	2	1.58	+	1.27	6.74E-01	1.00E00
positive regulation of lipid biosynthetic process (GO:0046889)	60	2	1.58	+	1.27	6.74E-01	1.00E00
neuron projection guidance (GO:0097485)	150	5	3.95	+	1.27	6.02E-01	1.00E00
organic acid catabolic process (GO:0016054)	90	3	2.37	+	1.27	5.16E-01	1.00E00
negative regulation of insulin secretion (GO:0046676)	30	1	.79	+	1.27	5.53E-01	1.00E00
positive regulation of cardiac muscle hypertrophy (GO:0010613)	30	1	.79	+	1.27	5.53E-01	1.00E00
cardiac conduction (GO:0061337)	30	1	.79	+	1.27	5.53E-01	1.00E00
cardiac ventricle morphogenesis (GO:0003208)	30	1	.79	+	1.27	5.53E-01	1.00E00
positive regulation of muscle hypertrophy (GO:0014742)	30	1	.79	+	1.27	5.53E-01	1.00E00
negative regulation of endocytosis (GO:0045806)	30	1	.79	+	1.27	5.53E-01	1.00E00
cellular response to dopamine (GO:1903351)	30	1	.79	+	1.27	5.53E-01	1.00E00
response to dopamine (GO:1903350)	30	1	.79	+	1.27	5.53E-01	1.00E00
embryo development (GO:0009790)	631	21	16.60	+	1.27	2.50E-01	1.00E00
negative regulation of cellular process (GO:0048523)	2678	89	70.45	+	1.26	1.26E-02	8.47E-01
negative regulation of phosphorus metabolic process (GO:0010563)	271	9	7.13	+	1.26	4.41E-01	1.00E00
negative regulation of phosphate metabolic process (GO:0045936)	271	9	7.13	+	1.26	4.41E-01	1.00E00
regulation of cellular metabolic process (GO:0031323)	3052	101	80.29	+	1.26	7.36E-03	6.79E-01
regulation of metabolic process (GO:0019222)	3538	117	93.08	+	1.26	2.28E-03	4.80E-01
epidermis development (GO:0008544)	121	4	3.18	+	1.26	5.64E-01	1.00E00
negative regulation of mitotic cell cycle phase transition (GO:1901991)	91	3	2.39	+	1.25	5.21E-01	1.00E00
regulation of catabolic process (GO:0009894)	637	21	16.76	+	1.25	3.05E-01	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	91	3	2.39	+	1.25	5.21E-01	1.00E00
positive regulation of cell death (GO:0010942)	364	12	9.58	+	1.25	4.04E-01	1.00E00
cell growth (GO:0016049)	91	3	2.39	+	1.25	5.21E-01	1.00E00
regulation of gene expression (GO:0010468)	2488	82	65.45	+	1.25	2.38E-02	1.00E00
regulation of macromolecule metabolic process (GO:0060255)	3249	107	85.47	+	1.25	5.56E-03	6.15E-01
forebrain development (GO:0030900)	243	8	6.39	+	1.25	5.39E-01	1.00E00
germ cell development (GO:0007281)	152	5	4.00	+	1.25	6.04E-01	1.00E00
cellular response to cytokine stimulus (GO:0071345)	304	10	8.00	+	1.25	4.65E-01	1.00E00
positive regulation of transferase activity (GO:0051347)	304	10	8.00	+	1.25	4.65E-01	1.00E00
negative regulation of cellular metabolic process (GO:0031324)	1308	43	34.41	+	1.25	1.37E-01	1.00E00
protein localization (GO:0008104)	1402	46	36.88	+	1.25	1.25E-01	1.00E00
exocytic process (GO:0140029)	61	2	1.60	+	1.25	6.77E-01	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	61	2	1.60	+	1.25	6.77E-01	1.00E00
regulation of inflammatory response (GO:0050727)	122	4	3.21	+	1.25	5.67E-01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	61	2	1.60	+	1.25	6.77E-01	1.00E00
organic acid transmembrane transport (GO:1903825)	61	2	1.60	+	1.25	6.77E-01	1.00E00
regulation of response to cytokine stimulus (GO:0060759)	61	2	1.60	+	1.25	6.77E-01	1.00E00
modification-dependent protein catabolic process (GO:0019941)	427	14	11.23	+	1.25	3.57E-01	1.00E00
cellular macromolecule localization (GO:0070727)	1405	46	36.96	+	1.24	1.25E-01	1.00E00
regulation of endopeptidase activity (GO:0052548)	153	5	4.03	+	1.24	6.06E-01	1.00E00
protein-DNA complex assembly (GO:0065004)	92	3	2.42	+	1.24	7.37E-01	1.00E00
cardiac muscle tissue development (GO:0048738)	92	3	2.42	+	1.24	7.37E-01	1.00E00
regulation of macroautophagy (GO:0016241)	92	3	2.42	+	1.24	7.37E-01	1.00E00
sensory perception (GO:0007600)	184	6	4.84	+	1.24	4.91E-01	1.00E00
macromolecule localization (GO:0033036)	1597	52	42.01	+	1.24	1.04E-01	1.00E00
cellular macromolecule catabolic process (GO:0044265)	553	18	14.55	+	1.24	3.39E-01	1.00E00
endomembrane system organization (GO:0010256)	338	11	8.89	+	1.24	4.87E-01	1.00E00
positive regulation of cytoskeleton organization (GO:0051495)	123	4	3.24	+	1.24	5.69E-01	1.00E00
central nervous system neuron differentiation (GO:0021953)	123	4	3.24	+	1.24	5.69E-01	1.00E00
regulation of hormone secretion (GO:0046883)	154	5	4.05	+	1.23	6.07E-01	1.00E00
response to oxygen-containing compound (GO:1901700)	678	22	17.84	+	1.23	3.19E-01	1.00E00
phosphorylation (GO:0016310)	586	19	15.42	+	1.23	3.51E-01	1.00E00
regulation of immunoglobulin production (GO:0002637)	31	1	.82	+	1.23	5.65E-01	1.00E00
limbic system development (GO:0021761)	62	2	1.63	+	1.23	6.80E-01	1.00E00
cerebellar Purkinje cell layer development (GO:0021680)	31	1	.82	+	1.23	5.65E-01	1.00E00
kidney development (GO:0001822)	155	5	4.08	+	1.23	6.09E-01	1.00E00
reproductive behavior (GO:0019098)	31	1	.82	+	1.23	5.65E-01	1.00E00
cellular response to insulin stimulus (GO:0032869)	93	3	2.45	+	1.23	7.38E-01	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	62	2	1.63	+	1.23	6.80E-01	1.00E00
regulation of synaptic transmission, GABAergic (GO:0032228)	31	1	.82	+	1.23	5.65E-01	1.00E00
response to glucocorticoid (GO:0051384)	31	1	.82	+	1.23	5.65E-01	1.00E00
regulation of cell division (GO:0051302)	93	3	2.45	+	1.23	7.38E-01	1.00E00
nuclear export (GO:0051168)	93	3	2.45	+	1.23	7.38E-01	1.00E00
regulation of mRNA processing (GO:0050684)	124	4	3.26	+	1.23	5.72E-01	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	62	2	1.63	+	1.23	6.80E-01	1.00E00
regulation of GTPase activity (GO:0043087)	248	8	6.52	+	1.23	5.44E-01	1.00E00
cardiac muscle cell development (GO:0055013)	31	1	.82	+	1.23	5.65E-01	1.00E00
renal tubule morphogenesis (GO:0061333)	31	1	.82	+	1.23	5.65E-01	1.00E00
regulation of glycoprotein biosynthetic process (GO:0010559)	31	1	.82	+	1.23	5.65E-01	1.00E00
negative regulation of response to cytokine stimulus (GO:0060761)	31	1	.82	+	1.23	5.65E-01	1.00E00
lamellipodium assembly (GO:0030032)	31	1	.82	+	1.23	5.65E-01	1.00E00
regulation of production of molecular mediator of immune response (GO:0002700)	62	2	1.63	+	1.23	6.80E-01	1.00E00
forebrain generation of neurons (GO:0021872)	31	1	.82	+	1.23	5.65E-01	1.00E00
response to stress (GO:0006950)	1495	48	39.33	+	1.22	1.36E-01	1.00E00
eye development (GO:0001654)	187	6	4.92	+	1.22	6.41E-01	1.00E00
proteolysis involved in protein catabolic process (GO:0051603)	468	15	12.31	+	1.22	4.58E-01	1.00E00
negative regulation of cellular component organization (GO:0051129)	468	15	12.31	+	1.22	4.58E-01	1.00E00
actin filament organization (GO:0007015)	156	5	4.10	+	1.22	6.10E-01	1.00E00
response to hormone (GO:0009725)	312	10	8.21	+	1.22	4.73E-01	1.00E00
positive regulation of nucleic acid-templated transcription (GO:1903508)	905	29	23.81	+	1.22	2.75E-01	1.00E00
positive regulation of DNA-templated transcription (GO:0045893)	905	29	23.81	+	1.22	2.75E-01	1.00E00
T cell activation (GO:0042110)	125	4	3.29	+	1.22	5.75E-01	1.00E00
positive regulation of RNA biosynthetic process (GO:1902680)	907	29	23.86	+	1.22	2.76E-01	1.00E00
tissue homeostasis (GO:0001894)	94	3	2.47	+	1.21	7.40E-01	1.00E00
positive regulation of protein secretion (GO:0050714)	94	3	2.47	+	1.21	7.40E-01	1.00E00
visual system development (GO:0150063)	188	6	4.95	+	1.21	6.42E-01	1.00E00
regulation of extent of cell growth (GO:0061387)	94	3	2.47	+	1.21	7.40E-01	1.00E00
striated muscle tissue development (GO:0014706)	94	3	2.47	+	1.21	7.40E-01	1.00E00
positive regulation of lipid metabolic process (GO:0045834)	94	3	2.47	+	1.21	7.40E-01	1.00E00
positive regulation of organelle organization (GO:0010638)	346	11	9.10	+	1.21	4.93E-01	1.00E00
regulation of protein kinase activity (GO:0045859)	346	11	9.10	+	1.21	4.93E-01	1.00E00
regulation of nitrogen compound metabolic process (GO:0051171)	3021	96	79.47	+	1.21	3.28E-02	1.00E00
calcium ion transport (GO:0006816)	126	4	3.31	+	1.21	5.77E-01	1.00E00
regulation of actomyosin structure organization (GO:0110020)	63	2	1.66	+	1.21	6.83E-01	1.00E00
vacuole organization (GO:0007033)	126	4	3.31	+	1.21	5.77E-01	1.00E00
sensory system development (GO:0048880)	189	6	4.97	+	1.21	6.42E-01	1.00E00
hematopoietic or lymphoid organ development (GO:0048534)	378	12	9.94	+	1.21	5.10E-01	1.00E00
positive regulation of RNA metabolic process (GO:0051254)	1008	32	26.52	+	1.21	2.54E-01	1.00E00
neuron projection extension (GO:1990138)	63	2	1.66	+	1.21	6.83E-01	1.00E00
negative regulation of leukocyte activation (GO:0002695)	63	2	1.66	+	1.21	6.83E-01	1.00E00
establishment of localization (GO:0051234)	2274	72	59.82	+	1.20	8.42E-02	1.00E00
protein catabolic process (GO:0030163)	537	17	14.13	+	1.20	4.06E-01	1.00E00
cell division (GO:0051301)	316	10	8.31	+	1.20	4.79E-01	1.00E00
regulation of protein transport (GO:0051223)	348	11	9.15	+	1.20	4.95E-01	1.00E00
protein modification process (GO:0036211)	1646	52	43.30	+	1.20	1.51E-01	1.00E00
receptor-mediated endocytosis (GO:0006898)	95	3	2.50	+	1.20	7.41E-01	1.00E00
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	95	3	2.50	+	1.20	7.41E-01	1.00E00
response to lipopolysaccharide (GO:0032496)	95	3	2.50	+	1.20	7.41E-01	1.00E00
positive regulation of peptidase activity (GO:0010952)	95	3	2.50	+	1.20	7.41E-01	1.00E00
response to stimulus (GO:0050896)	3389	107	89.16	+	1.20	2.28E-02	9.94E-01
localization within membrane (GO:0051668)	412	13	10.84	+	1.20	5.28E-01	1.00E00
regulation of actin cytoskeleton organization (GO:0032956)	222	7	5.84	+	1.20	5.29E-01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	127	4	3.34	+	1.20	5.80E-01	1.00E00
regulation of primary metabolic process (GO:0080090)	3115	98	81.95	+	1.20	3.45E-02	1.00E00
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1147	36	30.17	+	1.19	2.79E-01	1.00E00
cardiac septum morphogenesis (GO:0060411)	32	1	.84	+	1.19	5.76E-01	1.00E00
regulation of glycoprotein metabolic process (GO:1903018)	32	1	.84	+	1.19	5.76E-01	1.00E00
nephron tubule development (GO:0072080)	32	1	.84	+	1.19	5.76E-01	1.00E00
regulation of interferon-beta production (GO:0032648)	32	1	.84	+	1.19	5.76E-01	1.00E00
TOR signaling (GO:0031929)	32	1	.84	+	1.19	5.76E-01	1.00E00
anatomical structure morphogenesis (GO:0009653)	1216	38	31.99	+	1.19	2.51E-01	1.00E00
negative regulation of MAP kinase activity (GO:0043407)	32	1	.84	+	1.19	5.76E-01	1.00E00
neuron cellular homeostasis (GO:0070050)	32	1	.84	+	1.19	5.76E-01	1.00E00
platelet-derived growth factor receptor signaling pathway (GO:0048008)	32	1	.84	+	1.19	5.76E-01	1.00E00
camera-type eye development (GO:0043010)	160	5	4.21	+	1.19	6.17E-01	1.00E00
negative regulation of ion transmembrane transport (GO:0034766)	64	2	1.68	+	1.19	6.87E-01	1.00E00
osteoclast differentiation (GO:0030316)	32	1	.84	+	1.19	5.76E-01	1.00E00
tube formation (GO:0035148)	96	3	2.53	+	1.19	7.42E-01	1.00E00
gliogenesis (GO:0042063)	160	5	4.21	+	1.19	6.17E-01	1.00E00
hemopoiesis (GO:0030097)	352	11	9.26	+	1.19	5.00E-01	1.00E00
regulation of adaptive immune response (GO:0002819)	64	2	1.68	+	1.19	6.87E-01	1.00E00
regulation of reactive oxygen species biosynthetic process (GO:1903426)	32	1	.84	+	1.19	5.76E-01	1.00E00
establishment of protein localization (GO:0045184)	929	29	24.44	+	1.19	3.32E-01	1.00E00
regulation of protein catabolic process (GO:0042176)	257	8	6.76	+	1.18	5.55E-01	1.00E00
negative regulation of nitrogen compound metabolic process (GO:0051172)	1318	41	34.67	+	1.18	2.66E-01	1.00E00
regulation of lymphocyte activation (GO:0051249)	193	6	5.08	+	1.18	6.47E-01	1.00E00
regulation of hemopoiesis (GO:1903706)	193	6	5.08	+	1.18	6.47E-01	1.00E00
renal system development (GO:0072001)	161	5	4.24	+	1.18	6.19E-01	1.00E00
cellular localization (GO:0051641)	1868	58	49.14	+	1.18	1.71E-01	1.00E00
phosphate-containing compound metabolic process (GO:0006796)	1128	35	29.67	+	1.18	3.22E-01	1.00E00
positive regulation of intracellular protein transport (GO:0090316)	97	3	2.55	+	1.18	7.44E-01	1.00E00
localization (GO:0051179)	2656	82	69.87	+	1.17	1.01E-01	1.00E00
phospholipid metabolic process (GO:0006644)	227	7	5.97	+	1.17	6.72E-01	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	65	2	1.71	+	1.17	6.90E-01	1.00E00
positive regulation of organelle assembly (GO:1902117)	65	2	1.71	+	1.17	6.90E-01	1.00E00
response to acid chemical (GO:0001101)	65	2	1.71	+	1.17	6.90E-01	1.00E00
nucleobase-containing compound transport (GO:0015931)	130	4	3.42	+	1.17	7.79E-01	1.00E00
cardiac septum development (GO:0003279)	65	2	1.71	+	1.17	6.90E-01	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	65	2	1.71	+	1.17	6.90E-01	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	65	2	1.71	+	1.17	6.90E-01	1.00E00
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	65	2	1.71	+	1.17	6.90E-01	1.00E00
macromolecule catabolic process (GO:0009057)	683	21	17.97	+	1.17	4.57E-01	1.00E00
regulation of transferase activity (GO:0051338)	488	15	12.84	+	1.17	5.60E-01	1.00E00
positive regulation of biosynthetic process (GO:0009891)	1139	35	29.96	+	1.17	3.25E-01	1.00E00
positive regulation of cellular biosynthetic process (GO:0031328)	1107	34	29.12	+	1.17	3.69E-01	1.00E00
organic substance transport (GO:0071702)	1206	37	31.73	+	1.17	3.36E-01	1.00E00
response to molecule of bacterial origin (GO:0002237)	98	3	2.58	+	1.16	7.45E-01	1.00E00
regulation of autophagy (GO:0010506)	196	6	5.16	+	1.16	6.50E-01	1.00E00
positive regulation of secretion by cell (GO:1903532)	196	6	5.16	+	1.16	6.50E-01	1.00E00
phosphorus metabolic process (GO:0006793)	1144	35	30.10	+	1.16	3.27E-01	1.00E00
sensory organ morphogenesis (GO:0090596)	131	4	3.45	+	1.16	7.80E-01	1.00E00
regulation of peptidase activity (GO:0052547)	164	5	4.31	+	1.16	6.24E-01	1.00E00
regulation of transcription by RNA polymerase II (GO:0006357)	1313	40	34.54	+	1.16	3.09E-01	1.00E00
regulation of RNA metabolic process (GO:0051252)	1939	59	51.01	+	1.16	2.33E-01	1.00E00
regulation of hormone levels (GO:0010817)	263	8	6.92	+	1.16	6.94E-01	1.00E00
cellular response to nitrogen compound (GO:1901699)	329	10	8.66	+	1.16	5.99E-01	1.00E00
transport (GO:0006810)	2175	66	57.22	+	1.15	1.95E-01	1.00E00
positive regulation of DNA replication (GO:0045740)	33	1	.87	+	1.15	5.87E-01	1.00E00
cerebral cortex radially oriented cell migration (GO:0021799)	33	1	.87	+	1.15	5.87E-01	1.00E00
response to unfolded protein (GO:0006986)	66	2	1.74	+	1.15	6.94E-01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	66	2	1.74	+	1.15	6.94E-01	1.00E00
negative regulation of fat cell differentiation (GO:0045599)	33	1	.87	+	1.15	5.87E-01	1.00E00
neural tube closure (GO:0001843)	66	2	1.74	+	1.15	6.94E-01	1.00E00
triglyceride metabolic process (GO:0006641)	33	1	.87	+	1.15	5.87E-01	1.00E00
toxin transport (GO:1901998)	33	1	.87	+	1.15	5.87E-01	1.00E00
viral life cycle (GO:0019058)	66	2	1.74	+	1.15	6.94E-01	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	33	1	.87	+	1.15	5.87E-01	1.00E00
positive regulation of amine transport (GO:0051954)	33	1	.87	+	1.15	5.87E-01	1.00E00
regulation of gluconeogenesis (GO:0006111)	33	1	.87	+	1.15	5.87E-01	1.00E00
carbohydrate derivative transport (GO:1901264)	33	1	.87	+	1.15	5.87E-01	1.00E00
negative regulation of transcription by RNA polymerase II (GO:0000122)	495	15	13.02	+	1.15	5.63E-01	1.00E00
regulation of centrosome duplication (GO:0010824)	33	1	.87	+	1.15	5.87E-01	1.00E00
erythrocyte differentiation (GO:0030218)	66	2	1.74	+	1.15	6.94E-01	1.00E00
regulation of cytokine production involved in immune response (GO:0002718)	33	1	.87	+	1.15	5.87E-01	1.00E00
regulation of apoptotic process (GO:0042981)	828	25	21.78	+	1.15	4.95E-01	1.00E00
regulation of cellular process (GO:0050794)	5554	167	146.11	+	1.14	8.93E-03	7.51E-01
protein-containing complex assembly (GO:0065003)	733	22	19.28	+	1.14	5.48E-01	1.00E00
immune system development (GO:0002520)	400	12	10.52	+	1.14	6.31E-01	1.00E00
regulation of lipid metabolic process (GO:0019216)	200	6	5.26	+	1.14	6.55E-01	1.00E00
lymphocyte activation (GO:0046649)	200	6	5.26	+	1.14	6.55E-01	1.00E00
regulation of biological process (GO:0050789)	5802	174	152.64	+	1.14	6.71E-03	6.56E-01
animal organ morphogenesis (GO:0009887)	467	14	12.29	+	1.14	5.55E-01	1.00E00
biological regulation (GO:0065007)	6082	182	160.00	+	1.14	3.86E-03	5.90E-01
cellular response to stimulus (GO:0051716)	2811	84	73.95	+	1.14	1.82E-01	1.00E00
positive regulation of protein transport (GO:0051222)	201	6	5.29	+	1.13	6.57E-01	1.00E00
cytoskeleton-dependent cytokinesis (GO:0061640)	67	2	1.76	+	1.13	6.97E-01	1.00E00
tube closure (GO:0060606)	67	2	1.76	+	1.13	6.97E-01	1.00E00
regulation of apoptotic signaling pathway (GO:2001233)	235	7	6.18	+	1.13	6.79E-01	1.00E00
regulation of leukocyte activation (GO:0002694)	235	7	6.18	+	1.13	6.79E-01	1.00E00
regulation of establishment of protein localization (GO:0070201)	370	11	9.73	+	1.13	6.20E-01	1.00E00
mitotic cell cycle process (GO:1903047)	303	9	7.97	+	1.13	7.14E-01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	202	6	5.31	+	1.13	6.58E-01	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	101	3	2.66	+	1.13	7.50E-01	1.00E00
positive regulation of molecular function (GO:0044093)	877	26	23.07	+	1.13	5.07E-01	1.00E00
regulation of programmed cell death (GO:0043067)	844	25	22.20	+	1.13	5.01E-01	1.00E00
regulation of nucleobase-containing compound metabolic process (GO:0019219)	2130	63	56.03	+	1.12	3.18E-01	1.00E00
macromolecule modification (GO:0043412)	1761	52	46.33	+	1.12	3.65E-01	1.00E00
negative regulation of molecular function (GO:0044092)	508	15	13.36	+	1.12	6.68E-01	1.00E00
regulation of cell death (GO:0010941)	950	28	24.99	+	1.12	5.22E-01	1.00E00
positive regulation of macromolecule biosynthetic process (GO:0010557)	1053	31	27.70	+	1.12	4.77E-01	1.00E00
leukocyte mediated immunity (GO:0002443)	68	2	1.79	+	1.12	7.01E-01	1.00E00
inner ear receptor cell differentiation (GO:0060113)	34	1	.89	+	1.12	5.98E-01	1.00E00
positive regulation of stress-activated MAPK cascade (GO:0032874)	68	2	1.79	+	1.12	7.01E-01	1.00E00
response to corticosteroid (GO:0031960)	34	1	.89	+	1.12	5.98E-01	1.00E00
embryonic skeletal system morphogenesis (GO:0048704)	34	1	.89	+	1.12	5.98E-01	1.00E00
regulation of actin filament bundle assembly (GO:0032231)	68	2	1.79	+	1.12	7.01E-01	1.00E00
metaphase plate congression (GO:0051310)	34	1	.89	+	1.12	5.98E-01	1.00E00
establishment of spindle localization (GO:0051293)	34	1	.89	+	1.12	5.98E-01	1.00E00
protein insertion into membrane (GO:0051205)	34	1	.89	+	1.12	5.98E-01	1.00E00
regulation of calcium ion-dependent exocytosis (GO:0017158)	34	1	.89	+	1.12	5.98E-01	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	34	1	.89	+	1.12	5.98E-01	1.00E00
cardiac cell development (GO:0055006)	34	1	.89	+	1.12	5.98E-01	1.00E00
regulation of histone deacetylation (GO:0031063)	34	1	.89	+	1.12	5.98E-01	1.00E00
regulation of mitochondrial membrane permeability (GO:0046902)	34	1	.89	+	1.12	5.98E-01	1.00E00
carbohydrate transport (GO:0008643)	34	1	.89	+	1.12	5.98E-01	1.00E00
connective tissue development (GO:0061448)	102	3	2.68	+	1.12	7.52E-01	1.00E00
positive regulation of Ras protein signal transduction (GO:0046579)	34	1	.89	+	1.12	5.98E-01	1.00E00
actin polymerization or depolymerization (GO:0008154)	34	1	.89	+	1.12	5.98E-01	1.00E00
long-term memory (GO:0007616)	34	1	.89	+	1.12	5.98E-01	1.00E00
body fluid secretion (GO:0007589)	34	1	.89	+	1.12	5.98E-01	1.00E00
maintenance of protein localization in organelle (GO:0072595)	34	1	.89	+	1.12	5.98E-01	1.00E00
response to extracellular stimulus (GO:0009991)	205	6	5.39	+	1.11	6.62E-01	1.00E00
negative regulation of RNA metabolic process (GO:0051253)	755	22	19.86	+	1.11	6.35E-01	1.00E00
histone modification (GO:0016570)	275	8	7.23	+	1.11	7.02E-01	1.00E00
intracellular protein transport (GO:0006886)	516	15	13.57	+	1.11	6.71E-01	1.00E00
regulation of DNA-templated transcription elongation (GO:0032784)	69	2	1.82	+	1.10	7.04E-01	1.00E00
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	69	2	1.82	+	1.10	7.04E-01	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	69	2	1.82	+	1.10	7.04E-01	1.00E00
cardiac ventricle development (GO:0003231)	69	2	1.82	+	1.10	7.04E-01	1.00E00
small GTPase mediated signal transduction (GO:0007264)	173	5	4.55	+	1.10	8.08E-01	1.00E00
DNA replication (GO:0006260)	104	3	2.74	+	1.10	7.55E-01	1.00E00
regulation of biosynthetic process (GO:0009889)	2185	63	57.48	+	1.10	4.03E-01	1.00E00
regulation of protein polymerization (GO:0032271)	139	4	3.66	+	1.09	7.87E-01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	278	8	7.31	+	1.09	7.05E-01	1.00E00
organonitrogen compound catabolic process (GO:1901565)	662	19	17.42	+	1.09	7.05E-01	1.00E00
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	35	1	.92	+	1.09	6.08E-01	1.00E00
positive regulation of myoblast differentiation (GO:0045663)	35	1	.92	+	1.09	6.08E-01	1.00E00
Rho protein signal transduction (GO:0007266)	35	1	.92	+	1.09	6.08E-01	1.00E00
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	35	1	.92	+	1.09	6.08E-01	1.00E00
primary neural tube formation (GO:0014020)	70	2	1.84	+	1.09	7.08E-01	1.00E00
DNA-templated DNA replication (GO:0006261)	70	2	1.84	+	1.09	7.08E-01	1.00E00
sister chromatid segregation (GO:0000819)	70	2	1.84	+	1.09	7.08E-01	1.00E00
negative regulation of viral process (GO:0048525)	35	1	.92	+	1.09	6.08E-01	1.00E00
synaptic vesicle transport (GO:0048489)	35	1	.92	+	1.09	6.08E-01	1.00E00
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	70	2	1.84	+	1.09	7.08E-01	1.00E00
positive regulation of MAP kinase activity (GO:0043406)	70	2	1.84	+	1.09	7.08E-01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	35	1	.92	+	1.09	6.08E-01	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	35	1	.92	+	1.09	6.08E-01	1.00E00
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	35	1	.92	+	1.09	6.08E-01	1.00E00
dendritic spine organization (GO:0097061)	35	1	.92	+	1.09	6.08E-01	1.00E00
positive regulation of GTPase activity (GO:0043547)	175	5	4.60	+	1.09	8.10E-01	1.00E00
regulation of cellular biosynthetic process (GO:0031326)	2137	61	56.22	+	1.09	4.90E-01	1.00E00
protein-containing complex organization (GO:0043933)	841	24	22.12	+	1.08	6.52E-01	1.00E00
regulation of DNA-templated transcription (GO:0006355)	1721	49	45.28	+	1.08	5.60E-01	1.00E00
positive regulation of secretion (GO:0051047)	211	6	5.55	+	1.08	8.26E-01	1.00E00
regulation of nucleic acid-templated transcription (GO:1903506)	1724	49	45.35	+	1.08	5.61E-01	1.00E00
regulation of RNA biosynthetic process (GO:2001141)	1726	49	45.41	+	1.08	5.61E-01	1.00E00
cellular component organization (GO:0016043)	3206	91	84.34	+	1.08	3.79E-01	1.00E00
negative regulation of kinase activity (GO:0033673)	141	4	3.71	+	1.08	7.89E-01	1.00E00
establishment of protein localization to organelle (GO:0072594)	247	7	6.50	+	1.08	8.39E-01	1.00E00
nitrogen compound transport (GO:0071705)	1059	30	27.86	+	1.08	6.84E-01	1.00E00
response to oxidative stress (GO:0006979)	212	6	5.58	+	1.08	8.27E-01	1.00E00
protein homooligomerization (GO:0051260)	106	3	2.79	+	1.08	7.59E-01	1.00E00
glycerophospholipid metabolic process (GO:0006650)	177	5	4.66	+	1.07	8.11E-01	1.00E00
cell cycle (GO:0007049)	708	20	18.63	+	1.07	7.14E-01	1.00E00
plasma membrane organization (GO:0007009)	71	2	1.87	+	1.07	7.11E-01	1.00E00
cytokinesis (GO:0000910)	71	2	1.87	+	1.07	7.11E-01	1.00E00
import across plasma membrane (GO:0098739)	71	2	1.87	+	1.07	7.11E-01	1.00E00
glycerolipid metabolic process (GO:0046486)	213	6	5.60	+	1.07	8.27E-01	1.00E00
positive regulation of hydrolase activity (GO:0051345)	320	9	8.42	+	1.07	8.58E-01	1.00E00
negative regulation of biosynthetic process (GO:0009890)	890	25	23.41	+	1.07	7.41E-01	1.00E00
cellular component assembly (GO:0022607)	1390	39	36.57	+	1.07	6.51E-01	1.00E00
regulation of stress-activated MAPK cascade (GO:0032872)	107	3	2.81	+	1.07	7.61E-01	1.00E00
regulation of MAP kinase activity (GO:0043405)	107	3	2.81	+	1.07	7.61E-01	1.00E00
viral process (GO:0016032)	107	3	2.81	+	1.07	7.61E-01	1.00E00
regionalization (GO:0003002)	143	4	3.76	+	1.06	7.91E-01	1.00E00
fatty acid metabolic process (GO:0006631)	143	4	3.76	+	1.06	7.91E-01	1.00E00
negative regulation of apoptotic process (GO:0043066)	501	14	13.18	+	1.06	7.74E-01	1.00E00
positive regulation of establishment of protein localization (GO:1904951)	215	6	5.66	+	1.06	8.28E-01	1.00E00
negative regulation of cellular biosynthetic process (GO:0031327)	860	24	22.62	+	1.06	7.38E-01	1.00E00
cellular response to amino acid starvation (GO:0034198)	36	1	.95	+	1.06	6.18E-01	1.00E00
phenol-containing compound metabolic process (GO:0018958)	36	1	.95	+	1.06	6.18E-01	1.00E00
erythrocyte homeostasis (GO:0034101)	72	2	1.89	+	1.06	7.15E-01	1.00E00
bone morphogenesis (GO:0060349)	36	1	.95	+	1.06	6.18E-01	1.00E00
mesonephric tubule development (GO:0072164)	36	1	.95	+	1.06	6.18E-01	1.00E00
mesonephric epithelium development (GO:0072163)	36	1	.95	+	1.06	6.18E-01	1.00E00
ureteric bud development (GO:0001657)	36	1	.95	+	1.06	6.18E-01	1.00E00
negative regulation of reactive oxygen species metabolic process (GO:2000378)	36	1	.95	+	1.06	6.18E-01	1.00E00
T cell differentiation in thymus (GO:0033077)	36	1	.95	+	1.06	6.18E-01	1.00E00
negative regulation of peptide hormone secretion (GO:0090278)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of protein processing (GO:0070613)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of ubiquitin-protein transferase activity (GO:0051438)	36	1	.95	+	1.06	6.18E-01	1.00E00
nuclear chromosome segregation (GO:0098813)	108	3	2.84	+	1.06	7.63E-01	1.00E00
positive regulation of B cell activation (GO:0050871)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of steroid biosynthetic process (GO:0050810)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of viral process (GO:0050792)	72	2	1.89	+	1.06	7.15E-01	1.00E00
negative regulation of muscle cell differentiation (GO:0051148)	36	1	.95	+	1.06	6.18E-01	1.00E00
positive regulation of fibroblast proliferation (GO:0048146)	36	1	.95	+	1.06	6.18E-01	1.00E00
regulation of catecholamine secretion (GO:0050433)	36	1	.95	+	1.06	6.18E-01	1.00E00
mRNA transcription by RNA polymerase II (GO:0042789)	36	1	.95	+	1.06	6.18E-01	1.00E00
ribonucleoprotein complex assembly (GO:0022618)	144	4	3.79	+	1.06	7.92E-01	1.00E00
T cell proliferation (GO:0042098)	36	1	.95	+	1.06	6.18E-01	1.00E00
positive regulation of lymphocyte mediated immunity (GO:0002708)	36	1	.95	+	1.06	6.18E-01	1.00E00
positive regulation of leukocyte activation (GO:0002696)	144	4	3.79	+	1.06	7.92E-01	1.00E00
intracellular transport (GO:0046907)	1014	28	26.68	+	1.05	7.56E-01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	145	4	3.81	+	1.05	7.94E-01	1.00E00
response to radiation (GO:0009314)	254	7	6.68	+	1.05	8.42E-01	1.00E00
proteolysis (GO:0006508)	729	20	19.18	+	1.04	8.10E-01	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	73	2	1.92	+	1.04	7.19E-01	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	73	2	1.92	+	1.04	7.19E-01	1.00E00
camera-type eye morphogenesis (GO:0048593)	73	2	1.92	+	1.04	7.19E-01	1.00E00
negative regulation of cell cycle process (GO:0010948)	146	4	3.84	+	1.04	7.95E-01	1.00E00
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	840	23	22.10	+	1.04	8.21E-01	1.00E00
response to organonitrogen compound (GO:0010243)	475	13	12.50	+	1.04	8.83E-01	1.00E00
negative regulation of programmed cell death (GO:0043069)	512	14	13.47	+	1.04	8.87E-01	1.00E00
immune effector process (GO:0002252)	110	3	2.89	+	1.04	7.67E-01	1.00E00
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	110	3	2.89	+	1.04	7.67E-01	1.00E00
neural tube development (GO:0021915)	110	3	2.89	+	1.04	7.67E-01	1.00E00
regulation of cell activation (GO:0050865)	257	7	6.76	+	1.04	8.43E-01	1.00E00
cellular catabolic process (GO:0044248)	959	26	25.23	+	1.03	8.32E-01	1.00E00
cellular component organization or biogenesis (GO:0071840)	3362	91	88.45	+	1.03	7.38E-01	1.00E00
mesonephros development (GO:0001823)	37	1	.97	+	1.03	1.00E00	1.00E00
secretory granule organization (GO:0033363)	37	1	.97	+	1.03	1.00E00	1.00E00
regulation of response to DNA damage stimulus (GO:2001020)	222	6	5.84	+	1.03	8.32E-01	1.00E00
cellular biogenic amine metabolic process (GO:0006576)	37	1	.97	+	1.03	1.00E00	1.00E00
cellular component maintenance (GO:0043954)	37	1	.97	+	1.03	1.00E00	1.00E00
cellular amine metabolic process (GO:0044106)	37	1	.97	+	1.03	1.00E00	1.00E00
axis specification (GO:0009798)	37	1	.97	+	1.03	1.00E00	1.00E00
regulation of JUN kinase activity (GO:0043506)	37	1	.97	+	1.03	1.00E00	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	74	2	1.95	+	1.03	7.22E-01	1.00E00
positive regulation of DNA metabolic process (GO:0051054)	222	6	5.84	+	1.03	8.32E-01	1.00E00
histone deubiquitination (GO:0016578)	37	1	.97	+	1.03	1.00E00	1.00E00
amine metabolic process (GO:0009308)	37	1	.97	+	1.03	1.00E00	1.00E00
regulation of DNA recombination (GO:0000018)	74	2	1.95	+	1.03	7.22E-01	1.00E00
organic acid transport (GO:0015849)	111	3	2.92	+	1.03	7.69E-01	1.00E00
snRNA metabolic process (GO:0016073)	37	1	.97	+	1.03	1.00E00	1.00E00
renal tubule development (GO:0061326)	37	1	.97	+	1.03	1.00E00	1.00E00
cellular response to glucose starvation (GO:0042149)	37	1	.97	+	1.03	1.00E00	1.00E00
cellular component disassembly (GO:0022411)	185	5	4.87	+	1.03	8.17E-01	1.00E00
negative regulation of peptide secretion (GO:0002792)	37	1	.97	+	1.03	1.00E00	1.00E00
adherens junction organization (GO:0034332)	37	1	.97	+	1.03	1.00E00	1.00E00
negative regulation of cell death (GO:0060548)	594	16	15.63	+	1.02	8.95E-01	1.00E00
regulation of molecular function (GO:0065009)	1413	38	37.17	+	1.02	8.57E-01	1.00E00
myeloid cell differentiation (GO:0030099)	149	4	3.92	+	1.02	7.99E-01	1.00E00
negative regulation of growth (GO:0045926)	149	4	3.92	+	1.02	7.99E-01	1.00E00
regulation of macromolecule biosynthetic process (GO:0010556)	2049	55	53.90	+	1.02	8.76E-01	1.00E00
establishment of localization in cell (GO:0051649)	1267	34	33.33	+	1.02	9.25E-01	1.00E00
positive regulation of catalytic activity (GO:0043085)	634	17	16.68	+	1.02	8.98E-01	1.00E00
membrane lipid metabolic process (GO:0006643)	112	3	2.95	+	1.02	7.71E-01	1.00E00
lipid biosynthetic process (GO:0008610)	299	8	7.87	+	1.02	8.55E-01	1.00E00
pattern specification process (GO:0007389)	187	5	4.92	+	1.02	8.19E-01	1.00E00
negative regulation of cell activation (GO:0050866)	75	2	1.97	+	1.01	1.00E00	1.00E00
post-embryonic development (GO:0009791)	75	2	1.97	+	1.01	1.00E00	1.00E00
histone methylation (GO:0016571)	75	2	1.97	+	1.01	1.00E00	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	75	2	1.97	+	1.01	1.00E00	1.00E00
cellular response to stress (GO:0033554)	939	25	24.70	+	1.01	9.15E-01	1.00E00
positive regulation of protein serine/threonine kinase activity (GO:0071902)	113	3	2.97	+	1.01	1.00E00	1.00E00
ribonucleoprotein complex subunit organization (GO:0071826)	151	4	3.97	+	1.01	1.00E00	1.00E00
positive regulation of cell activation (GO:0050867)	151	4	3.97	+	1.01	1.00E00	1.00E00
regulation of cell cycle process (GO:0010564)	416	11	10.94	+	1.01	1.00E00	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	76	2	2.00	+	1.00	1.00E00	1.00E00
retina morphogenesis in camera-type eye (GO:0060042)	38	1	1.00	+	1.00	1.00E00	1.00E00
cellular response to glucose stimulus (GO:0071333)	38	1	1.00	+	1.00	1.00E00	1.00E00
cellular response to hexose stimulus (GO:0071331)	38	1	1.00	+	1.00	1.00E00	1.00E00
regulation of lipid transport (GO:0032368)	76	2	2.00	+	1.00	1.00E00	1.00E00
sensory perception of light stimulus (GO:0050953)	38	1	1.00	+	1.00	1.00E00	1.00E00
negative regulation of T cell activation (GO:0050868)	38	1	1.00	+	1.00	1.00E00	1.00E00
movement in host (GO:0044000)	38	1	1.00	+	1.00	1.00E00	1.00E00
regulation of actin filament depolymerization (GO:0030834)	38	1	1.00	+	1.00	1.00E00	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	152	4	4.00	+	1.00	1.00E00	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	38	1	1.00	+	1.00	1.00E00	1.00E00
visual perception (GO:0007601)	38	1	1.00	+	1.00	1.00E00	1.00E00
organic substance catabolic process (GO:1901575)	952	25	25.04	-	1.00	1.00E00	1.00E00
cell cycle process (GO:0022402)	457	12	12.02	-	1.00	1.00E00	1.00E00
cellular process (GO:0009987)	7580	199	199.41	-	1.00	9.36E-01	1.00E00
cytoskeleton organization (GO:0007010)	688	18	18.10	-	.99	1.00E00	1.00E00
response to insulin (GO:0032868)	115	3	3.03	-	.99	1.00E00	1.00E00
cell activation (GO:0001775)	269	7	7.08	-	.99	1.00E00	1.00E00
cellular lipid metabolic process (GO:0044255)	462	12	12.15	-	.99	1.00E00	1.00E00
biological_process (GO:0008150)	9217	239	242.48	-	.99	1.63E-01	1.00E00
cellular response to abiotic stimulus (GO:0071214)	155	4	4.08	-	.98	1.00E00	1.00E00
cellular response to environmental stimulus (GO:0104004)	155	4	4.08	-	.98	1.00E00	1.00E00
transcription by RNA polymerase II (GO:0006366)	194	5	5.10	-	.98	1.00E00	1.00E00
response to nutrient levels (GO:0031667)	194	5	5.10	-	.98	1.00E00	1.00E00
cellular response to oxygen-containing compound (GO:1901701)	505	13	13.29	-	.98	1.00E00	1.00E00
RNA splicing (GO:0008380)	272	7	7.16	-	.98	1.00E00	1.00E00
RNA metabolic process (GO:0016070)	1012	26	26.62	-	.98	1.00E00	1.00E00
mitotic cell cycle (GO:0000278)	351	9	9.23	-	.97	1.00E00	1.00E00
response to ionizing radiation (GO:0010212)	78	2	2.05	-	.97	1.00E00	1.00E00
positive regulation of fat cell differentiation (GO:0045600)	39	1	1.03	-	.97	1.00E00	1.00E00
gastrulation (GO:0007369)	78	2	2.05	-	.97	1.00E00	1.00E00
positive regulation of stem cell population maintenance (GO:1902459)	39	1	1.03	-	.97	1.00E00	1.00E00
nephron epithelium development (GO:0072009)	39	1	1.03	-	.97	1.00E00	1.00E00
regulation of chromosome segregation (GO:0051983)	78	2	2.05	-	.97	1.00E00	1.00E00
response to retinoic acid (GO:0032526)	39	1	1.03	-	.97	1.00E00	1.00E00
regulation of ATP-dependent activity (GO:0043462)	39	1	1.03	-	.97	1.00E00	1.00E00
negative regulation of catalytic activity (GO:0043086)	312	8	8.21	-	.97	1.00E00	1.00E00
mechanoreceptor differentiation (GO:0042490)	39	1	1.03	-	.97	1.00E00	1.00E00
lamellipodium organization (GO:0097581)	39	1	1.03	-	.97	1.00E00	1.00E00
protein localization to lysosome (GO:0061462)	39	1	1.03	-	.97	1.00E00	1.00E00
positive regulation of adaptive immune response (GO:0002821)	39	1	1.03	-	.97	1.00E00	1.00E00
anterograde axonal transport (GO:0008089)	39	1	1.03	-	.97	1.00E00	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	78	2	2.05	-	.97	1.00E00	1.00E00
reactive oxygen species metabolic process (GO:0072593)	39	1	1.03	-	.97	1.00E00	1.00E00
actin filament-based process (GO:0030029)	352	9	9.26	-	.97	1.00E00	1.00E00
response to light stimulus (GO:0009416)	196	5	5.16	-	.97	1.00E00	1.00E00
cell population proliferation (GO:0008283)	392	10	10.31	-	.97	1.00E00	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	196	5	5.16	-	.97	1.00E00	1.00E00
glial cell differentiation (GO:0010001)	118	3	3.10	-	.97	1.00E00	1.00E00
organic anion transport (GO:0015711)	118	3	3.10	-	.97	1.00E00	1.00E00
protein transport (GO:0015031)	867	22	22.81	-	.96	1.00E00	1.00E00
regulation of translation (GO:0006417)	276	7	7.26	-	.96	1.00E00	1.00E00
negative regulation of macromolecule biosynthetic process (GO:0010558)	829	21	21.81	-	.96	1.00E00	1.00E00
retina development in camera-type eye (GO:0060041)	79	2	2.08	-	.96	1.00E00	1.00E00
membrane lipid biosynthetic process (GO:0046467)	79	2	2.08	-	.96	1.00E00	1.00E00
negative regulation of DNA-templated transcription (GO:0045892)	672	17	17.68	-	.96	1.00E00	1.00E00
protein metabolic process (GO:0019538)	2418	61	63.61	-	.96	7.68E-01	1.00E00
protein-DNA complex subunit organization (GO:0071824)	119	3	3.13	-	.96	1.00E00	1.00E00
leukocyte activation (GO:0045321)	238	6	6.26	-	.96	1.00E00	1.00E00
cytosolic transport (GO:0016482)	119	3	3.13	-	.96	1.00E00	1.00E00
negative regulation of RNA biosynthetic process (GO:1902679)	676	17	17.78	-	.96	1.00E00	1.00E00
negative regulation of nucleic acid-templated transcription (GO:1903507)	676	17	17.78	-	.96	1.00E00	1.00E00
establishment of organelle localization (GO:0051656)	279	7	7.34	-	.95	1.00E00	1.00E00
nucleic acid metabolic process (GO:0090304)	1356	34	35.67	-	.95	8.54E-01	1.00E00
catabolic process (GO:0009056)	1118	28	29.41	-	.95	8.43E-01	1.00E00
cellular amino acid metabolic process (GO:0006520)	120	3	3.16	-	.95	1.00E00	1.00E00
fatty acid oxidation (GO:0019395)	40	1	1.05	-	.95	1.00E00	1.00E00
negative regulation of response to wounding (GO:1903035)	40	1	1.05	-	.95	1.00E00	1.00E00
vacuolar localization (GO:1990849)	40	1	1.05	-	.95	1.00E00	1.00E00
cellular response to external stimulus (GO:0071496)	160	4	4.21	-	.95	1.00E00	1.00E00
neural crest cell development (GO:0014032)	40	1	1.05	-	.95	1.00E00	1.00E00
lysosome localization (GO:0032418)	40	1	1.05	-	.95	1.00E00	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	40	1	1.05	-	.95	1.00E00	1.00E00
positive regulation of small GTPase mediated signal transduction (GO:0051057)	40	1	1.05	-	.95	1.00E00	1.00E00
kidney morphogenesis (GO:0060993)	40	1	1.05	-	.95	1.00E00	1.00E00
regulation of centrosome cycle (GO:0046605)	40	1	1.05	-	.95	1.00E00	1.00E00
lipid oxidation (GO:0034440)	40	1	1.05	-	.95	1.00E00	1.00E00
regulation of TORC1 signaling (GO:1903432)	40	1	1.05	-	.95	1.00E00	1.00E00
negative regulation of protein modification process (GO:0031400)	321	8	8.44	-	.95	1.00E00	1.00E00
organonitrogen compound metabolic process (GO:1901564)	2931	73	77.11	-	.95	6.27E-01	1.00E00
response to nitrogen compound (GO:1901698)	523	13	13.76	-	.94	1.00E00	1.00E00
cellular component biogenesis (GO:0044085)	1575	39	41.43	-	.94	7.31E-01	1.00E00
neural tube formation (GO:0001841)	81	2	2.13	-	.94	1.00E00	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	81	2	2.13	-	.94	1.00E00	1.00E00
negative regulation of transferase activity (GO:0051348)	162	4	4.26	-	.94	1.00E00	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	163	4	4.29	-	.93	1.00E00	1.00E00
macromolecule metabolic process (GO:0043170)	3553	87	93.47	-	.93	4.27E-01	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	41	1	1.08	-	.93	1.00E00	1.00E00
cellular response to catecholamine stimulus (GO:0071870)	41	1	1.08	-	.93	1.00E00	1.00E00
response to catecholamine (GO:0071869)	41	1	1.08	-	.93	1.00E00	1.00E00
cellular response to monoamine stimulus (GO:0071868)	41	1	1.08	-	.93	1.00E00	1.00E00
response to monoamine (GO:0071867)	41	1	1.08	-	.93	1.00E00	1.00E00
cellular response to ionizing radiation (GO:0071479)	41	1	1.08	-	.93	1.00E00	1.00E00
chondrocyte differentiation (GO:0002062)	41	1	1.08	-	.93	1.00E00	1.00E00
modulation by host of symbiont process (GO:0051851)	41	1	1.08	-	.93	1.00E00	1.00E00
meiotic chromosome segregation (GO:0045132)	41	1	1.08	-	.93	1.00E00	1.00E00
regulation of cellular macromolecule biosynthetic process (GO:2000112)	328	8	8.63	-	.93	1.00E00	1.00E00
mRNA transcription (GO:0009299)	41	1	1.08	-	.93	1.00E00	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	41	1	1.08	-	.93	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	41	1	1.08	-	.93	1.00E00	1.00E00
regulation of protein import into nucleus (GO:0042306)	41	1	1.08	-	.93	1.00E00	1.00E00
B cell activation (GO:0042113)	82	2	2.16	-	.93	1.00E00	1.00E00
regulation of protein targeting (GO:1903533)	41	1	1.08	-	.93	1.00E00	1.00E00
endocytosis (GO:0006897)	246	6	6.47	-	.93	1.00E00	1.00E00
nitrogen compound metabolic process (GO:0006807)	3936	96	103.55	-	.93	3.62E-01	1.00E00
vesicle-mediated transport (GO:0016192)	821	20	21.60	-	.93	8.20E-01	1.00E00
spermatogenesis (GO:0007283)	247	6	6.50	-	.92	1.00E00	1.00E00
regulation of organelle assembly (GO:1902115)	165	4	4.34	-	.92	1.00E00	1.00E00
response to starvation (GO:0042594)	124	3	3.26	-	.92	1.00E00	1.00E00
regulation of organelle organization (GO:0033043)	786	19	20.68	-	.92	8.16E-01	1.00E00
regulation of TOR signaling (GO:0032006)	83	2	2.18	-	.92	1.00E00	1.00E00
multicellular organism growth (GO:0035264)	83	2	2.18	-	.92	1.00E00	1.00E00
negative regulation of transmembrane transport (GO:0034763)	83	2	2.18	-	.92	1.00E00	1.00E00
immune response-regulating signaling pathway (GO:0002764)	83	2	2.18	-	.92	1.00E00	1.00E00
cell death (GO:0008219)	583	14	15.34	-	.91	8.93E-01	1.00E00
Ras protein signal transduction (GO:0007265)	125	3	3.29	-	.91	1.00E00	1.00E00
cellular metabolic process (GO:0044237)	3885	93	102.20	-	.91	2.67E-01	1.00E00
regulation of membrane permeability (GO:0090559)	42	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of leukocyte differentiation (GO:1902107)	84	2	2.21	-	.91	1.00E00	1.00E00
establishment of chromosome localization (GO:0051303)	42	1	1.10	-	.91	1.00E00	1.00E00
heterochromatin formation (GO:0031507)	42	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of hemopoiesis (GO:1903708)	84	2	2.21	-	.91	1.00E00	1.00E00
regulation of glucose import (GO:0046324)	42	1	1.10	-	.91	1.00E00	1.00E00
positive regulation of leukocyte mediated immunity (GO:0002705)	42	1	1.10	-	.91	1.00E00	1.00E00
regulation of supramolecular fiber organization (GO:1902903)	253	6	6.66	-	.90	1.00E00	1.00E00
regulation of hydrolase activity (GO:0051336)	507	12	13.34	-	.90	8.86E-01	1.00E00
DNA-templated transcription (GO:0006351)	296	7	7.79	-	.90	1.00E00	1.00E00
nucleic acid-templated transcription (GO:0097659)	296	7	7.79	-	.90	1.00E00	1.00E00
male gamete generation (GO:0048232)	254	6	6.68	-	.90	1.00E00	1.00E00
organic substance metabolic process (GO:0071704)	4409	104	115.99	-	.90	1.39E-01	1.00E00
primary metabolic process (GO:0044238)	4200	99	110.49	-	.90	1.55E-01	1.00E00
regulation of fat cell differentiation (GO:0045598)	85	2	2.24	-	.89	1.00E00	1.00E00
spermatid development (GO:0007286)	85	2	2.24	-	.89	1.00E00	1.00E00
eye morphogenesis (GO:0048592)	85	2	2.24	-	.89	1.00E00	1.00E00
mRNA transport (GO:0051028)	85	2	2.24	-	.89	1.00E00	1.00E00
glycerolipid biosynthetic process (GO:0045017)	128	3	3.37	-	.89	1.00E00	1.00E00
regulation of Ras protein signal transduction (GO:0046578)	128	3	3.37	-	.89	1.00E00	1.00E00
regulation of catalytic activity (GO:0050790)	983	23	25.86	-	.89	6.73E-01	1.00E00
mRNA splicing, via spliceosome (GO:0000398)	171	4	4.50	-	.89	1.00E00	1.00E00
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	171	4	4.50	-	.89	1.00E00	1.00E00
RNA splicing, via transesterification reactions (GO:0000375)	171	4	4.50	-	.89	1.00E00	1.00E00
RNA biosynthetic process (GO:0032774)	300	7	7.89	-	.89	1.00E00	1.00E00
cerebral cortex cell migration (GO:0021795)	43	1	1.13	-	.88	1.00E00	1.00E00
regulation of myoblast differentiation (GO:0045661)	43	1	1.13	-	.88	1.00E00	1.00E00
intracellular protein transmembrane transport (GO:0065002)	43	1	1.13	-	.88	1.00E00	1.00E00
embryonic epithelial tube formation (GO:0001838)	86	2	2.26	-	.88	1.00E00	1.00E00
regulation of miRNA metabolic process (GO:2000628)	43	1	1.13	-	.88	1.00E00	1.00E00
transcription preinitiation complex assembly (GO:0070897)	43	1	1.13	-	.88	1.00E00	1.00E00
regulation of DNA replication (GO:0006275)	86	2	2.26	-	.88	1.00E00	1.00E00
stem cell development (GO:0048864)	43	1	1.13	-	.88	1.00E00	1.00E00
positive regulation of intracellular transport (GO:0032388)	129	3	3.39	-	.88	1.00E00	1.00E00
positive regulation of histone methylation (GO:0031062)	43	1	1.13	-	.88	1.00E00	1.00E00
apoptotic mitochondrial changes (GO:0008637)	43	1	1.13	-	.88	1.00E00	1.00E00
odontogenesis (GO:0042476)	43	1	1.13	-	.88	1.00E00	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	86	2	2.26	-	.88	1.00E00	1.00E00
protein localization to chromosome (GO:0034502)	43	1	1.13	-	.88	1.00E00	1.00E00
aging (GO:0007568)	43	1	1.13	-	.88	1.00E00	1.00E00
metabolic process (GO:0008152)	4618	107	121.49	-	.88	7.23E-02	1.00E00
heterocycle catabolic process (GO:0046700)	173	4	4.55	-	.88	1.00E00	1.00E00
carboxylic acid metabolic process (GO:0019752)	347	8	9.13	-	.88	8.64E-01	1.00E00
chromatin organization (GO:0006325)	391	9	10.29	-	.87	8.71E-01	1.00E00
cellular nitrogen compound catabolic process (GO:0044270)	174	4	4.58	-	.87	1.00E00	1.00E00
import into cell (GO:0098657)	87	2	2.29	-	.87	1.00E00	1.00E00
positive regulation of histone modification (GO:0031058)	87	2	2.29	-	.87	1.00E00	1.00E00
establishment of cell polarity (GO:0030010)	87	2	2.29	-	.87	1.00E00	1.00E00
nucleobase-containing compound metabolic process (GO:0006139)	1660	38	43.67	-	.87	3.98E-01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	219	5	5.76	-	.87	1.00E00	1.00E00
positive regulation of axon extension (GO:0045773)	44	1	1.16	-	.86	1.00E00	1.00E00
aromatic compound catabolic process (GO:0019439)	176	4	4.63	-	.86	1.00E00	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	44	1	1.16	-	.86	1.00E00	1.00E00
protein transmembrane transport (GO:0071806)	44	1	1.16	-	.86	1.00E00	1.00E00
epithelial tube formation (GO:0072175)	88	2	2.32	-	.86	1.00E00	1.00E00
myeloid cell homeostasis (GO:0002262)	88	2	2.32	-	.86	1.00E00	1.00E00
cellular response to amino acid stimulus (GO:0071230)	44	1	1.16	-	.86	1.00E00	1.00E00
cellular lipid catabolic process (GO:0044242)	88	2	2.32	-	.86	1.00E00	1.00E00
regulation of calcium-mediated signaling (GO:0050848)	44	1	1.16	-	.86	1.00E00	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	44	1	1.16	-	.86	1.00E00	1.00E00
regulation of potassium ion transmembrane transporter activity (GO:1901016)	44	1	1.16	-	.86	1.00E00	1.00E00
positive regulation of lymphocyte proliferation (GO:0050671)	44	1	1.16	-	.86	1.00E00	1.00E00
fatty acid catabolic process (GO:0009062)	44	1	1.16	-	.86	1.00E00	1.00E00
negative regulation of hormone secretion (GO:0046888)	44	1	1.16	-	.86	1.00E00	1.00E00
calcium ion transmembrane import into cytosol (GO:0097553)	44	1	1.16	-	.86	1.00E00	1.00E00
apoptotic signaling pathway (GO:0097190)	176	4	4.63	-	.86	1.00E00	1.00E00
heterocycle metabolic process (GO:0046483)	1719	39	45.22	-	.86	3.59E-01	1.00E00
homeostasis of number of cells (GO:0048872)	177	4	4.66	-	.86	1.00E00	1.00E00
cellular response to DNA damage stimulus (GO:0006974)	443	10	11.65	-	.86	7.61E-01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	133	3	3.50	-	.86	1.00E00	1.00E00
macroautophagy (GO:0016236)	133	3	3.50	-	.86	1.00E00	1.00E00
oxoacid metabolic process (GO:0043436)	355	8	9.34	-	.86	8.65E-01	1.00E00
negative regulation of protein transport (GO:0051224)	89	2	2.34	-	.85	1.00E00	1.00E00
response to reactive oxygen species (GO:0000302)	89	2	2.34	-	.85	1.00E00	1.00E00
cellular aromatic compound metabolic process (GO:0006725)	1737	39	45.70	-	.85	3.19E-01	1.00E00
organic acid metabolic process (GO:0006082)	358	8	9.42	-	.85	8.65E-01	1.00E00
positive regulation of lipid transport (GO:0032370)	45	1	1.18	-	.84	1.00E00	1.00E00
cardiac muscle cell differentiation (GO:0055007)	45	1	1.18	-	.84	1.00E00	1.00E00
positive regulation of nucleocytoplasmic transport (GO:0046824)	45	1	1.18	-	.84	1.00E00	1.00E00
myeloid leukocyte migration (GO:0097529)	45	1	1.18	-	.84	1.00E00	1.00E00
RNA processing (GO:0006396)	631	14	16.60	-	.84	6.06E-01	1.00E00
apoptotic process (GO:0006915)	541	12	14.23	-	.84	6.77E-01	1.00E00
cellular nitrogen compound metabolic process (GO:0034641)	2083	46	54.80	-	.84	2.14E-01	1.00E00
actin cytoskeleton organization (GO:0030036)	318	7	8.37	-	.84	8.57E-01	1.00E00
spermatid differentiation (GO:0048515)	91	2	2.39	-	.84	1.00E00	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	91	2	2.39	-	.84	1.00E00	1.00E00
positive regulation of small molecule metabolic process (GO:0062013)	91	2	2.39	-	.84	1.00E00	1.00E00
wound healing (GO:0042060)	91	2	2.39	-	.84	1.00E00	1.00E00
organic cyclic compound metabolic process (GO:1901360)	1827	40	48.06	-	.83	2.22E-01	1.00E00
organelle organization (GO:0006996)	1829	40	48.12	-	.83	2.22E-01	1.00E00
organophosphate biosynthetic process (GO:0090407)	321	7	8.44	-	.83	8.58E-01	1.00E00
hippocampus development (GO:0021766)	46	1	1.21	-	.83	1.00E00	1.00E00
positive regulation of mononuclear cell proliferation (GO:0032946)	46	1	1.21	-	.83	1.00E00	1.00E00
protein targeting (GO:0006605)	184	4	4.84	-	.83	1.00E00	1.00E00
positive regulation of DNA biosynthetic process (GO:2000573)	46	1	1.21	-	.83	1.00E00	1.00E00
cell cycle G1/S phase transition (GO:0044843)	46	1	1.21	-	.83	1.00E00	1.00E00
roof of mouth development (GO:0060021)	46	1	1.21	-	.83	1.00E00	1.00E00
neural crest cell differentiation (GO:0014033)	46	1	1.21	-	.83	1.00E00	1.00E00
autophagy of mitochondrion (GO:0000422)	46	1	1.21	-	.83	1.00E00	1.00E00
regulation of DNA metabolic process (GO:0051052)	368	8	9.68	-	.83	7.39E-01	1.00E00
selective autophagy (GO:0061912)	46	1	1.21	-	.83	1.00E00	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	46	1	1.21	-	.83	1.00E00	1.00E00
response to temperature stimulus (GO:0009266)	92	2	2.42	-	.83	1.00E00	1.00E00
mitochondrion disassembly (GO:0061726)	46	1	1.21	-	.83	1.00E00	1.00E00
supramolecular fiber organization (GO:0097435)	276	6	7.26	-	.83	8.48E-01	1.00E00
organic cyclic compound catabolic process (GO:1901361)	186	4	4.89	-	.82	1.00E00	1.00E00
negative regulation of establishment of protein localization (GO:1904950)	93	2	2.45	-	.82	1.00E00	1.00E00
regulation of protein localization to nucleus (GO:1900180)	93	2	2.45	-	.82	1.00E00	1.00E00
circadian rhythm (GO:0007623)	93	2	2.45	-	.82	1.00E00	1.00E00
cardiac chamber development (GO:0003205)	93	2	2.45	-	.82	1.00E00	1.00E00
programmed cell death (GO:0012501)	560	12	14.73	-	.81	5.85E-01	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	47	1	1.24	-	.81	1.00E00	1.00E00
negative regulation of response to DNA damage stimulus (GO:2001021)	47	1	1.24	-	.81	1.00E00	1.00E00
spindle organization (GO:0007051)	94	2	2.47	-	.81	1.00E00	1.00E00
regulation of translational initiation (GO:0006446)	47	1	1.24	-	.81	1.00E00	1.00E00
heterochromatin organization (GO:0070828)	47	1	1.24	-	.81	1.00E00	1.00E00
neuromuscular process controlling balance (GO:0050885)	47	1	1.24	-	.81	1.00E00	1.00E00
cellular response to extracellular stimulus (GO:0031668)	141	3	3.71	-	.81	1.00E00	1.00E00
regulation of histone modification (GO:0031056)	141	3	3.71	-	.81	1.00E00	1.00E00
carboxylic acid transport (GO:0046942)	94	2	2.47	-	.81	1.00E00	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	47	1	1.24	-	.81	1.00E00	1.00E00
embryonic morphogenesis (GO:0048598)	283	6	7.45	-	.81	8.49E-01	1.00E00
regulation of binding (GO:0051098)	236	5	6.21	-	.81	8.36E-01	1.00E00
protein-containing complex localization (GO:0031503)	142	3	3.74	-	.80	1.00E00	1.00E00
regulation of protein binding (GO:0043393)	142	3	3.74	-	.80	1.00E00	1.00E00
DNA metabolic process (GO:0006259)	427	9	11.23	-	.80	6.41E-01	1.00E00
regulation of double-strand break repair (GO:2000779)	95	2	2.50	-	.80	1.00E00	1.00E00
morphogenesis of embryonic epithelium (GO:0016331)	95	2	2.50	-	.80	1.00E00	1.00E00
regulation of protein serine/threonine kinase activity (GO:0071900)	192	4	5.05	-	.79	8.20E-01	1.00E00
positive regulation of transcription initiation by RNA polymerase II (GO:0060261)	48	1	1.26	-	.79	1.00E00	1.00E00
protein-containing complex disassembly (GO:0032984)	96	2	2.53	-	.79	1.00E00	1.00E00
myeloid leukocyte activation (GO:0002274)	48	1	1.26	-	.79	1.00E00	1.00E00
biological process involved in interaction with symbiont (GO:0051702)	48	1	1.26	-	.79	1.00E00	1.00E00
regulation of NIK/NF-kappaB signaling (GO:1901222)	48	1	1.26	-	.79	1.00E00	1.00E00
inositol lipid-mediated signaling (GO:0048017)	48	1	1.26	-	.79	1.00E00	1.00E00
phosphatidylinositol-mediated signaling (GO:0048015)	48	1	1.26	-	.79	1.00E00	1.00E00
regulation of Notch signaling pathway (GO:0008593)	48	1	1.26	-	.79	1.00E00	1.00E00
lymphocyte proliferation (GO:0046651)	48	1	1.26	-	.79	1.00E00	1.00E00
gene expression (GO:0010467)	1443	30	37.96	-	.79	1.80E-01	1.00E00
regulation of small molecule metabolic process (GO:0062012)	193	4	5.08	-	.79	8.20E-01	1.00E00
cellular response to radiation (GO:0071478)	97	2	2.55	-	.78	1.00E00	1.00E00
DNA repair (GO:0006281)	291	6	7.66	-	.78	7.09E-01	1.00E00
small molecule biosynthetic process (GO:0044283)	194	4	5.10	-	.78	8.21E-01	1.00E00
positive regulation of mRNA metabolic process (GO:1903313)	97	2	2.55	-	.78	1.00E00	1.00E00
small molecule catabolic process (GO:0044282)	146	3	3.84	-	.78	1.00E00	1.00E00
embryonic placenta development (GO:0001892)	49	1	1.29	-	.78	1.00E00	1.00E00
mitotic cell cycle phase transition (GO:0044772)	98	2	2.58	-	.78	1.00E00	1.00E00
histone H4 acetylation (GO:0043967)	49	1	1.29	-	.78	1.00E00	1.00E00
embryonic skeletal system development (GO:0048706)	49	1	1.29	-	.78	1.00E00	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	49	1	1.29	-	.78	1.00E00	1.00E00
regulation of epithelial cell apoptotic process (GO:1904035)	49	1	1.29	-	.78	1.00E00	1.00E00
lipid metabolic process (GO:0006629)	590	12	15.52	-	.77	4.25E-01	1.00E00
regulation of cytoskeleton organization (GO:0051493)	346	7	9.10	-	.77	6.07E-01	1.00E00
positive regulation of DNA repair (GO:0045739)	99	2	2.60	-	.77	1.00E00	1.00E00
protein methylation (GO:0006479)	99	2	2.60	-	.77	1.00E00	1.00E00
protein alkylation (GO:0008213)	99	2	2.60	-	.77	1.00E00	1.00E00
vesicle localization (GO:0051648)	149	3	3.92	-	.77	1.00E00	1.00E00
regulation of oxidative stress-induced cell death (GO:1903201)	50	1	1.32	-	.76	1.00E00	1.00E00
regulation of steroid metabolic process (GO:0019218)	50	1	1.32	-	.76	1.00E00	1.00E00
biological process involved in interaction with host (GO:0051701)	50	1	1.32	-	.76	1.00E00	1.00E00
presynaptic endocytosis (GO:0140238)	50	1	1.32	-	.76	1.00E00	1.00E00
multicellular organismal homeostasis (GO:0048871)	150	3	3.95	-	.76	1.00E00	1.00E00
regulation of multicellular organism growth (GO:0040014)	50	1	1.32	-	.76	1.00E00	1.00E00
negative regulation of protein polymerization (GO:0032272)	50	1	1.32	-	.76	1.00E00	1.00E00
synaptic vesicle endocytosis (GO:0048488)	50	1	1.32	-	.76	1.00E00	1.00E00
mitotic cytokinesis (GO:0000281)	50	1	1.32	-	.76	1.00E00	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	151	3	3.97	-	.76	1.00E00	1.00E00
protein localization to cell periphery (GO:1990778)	202	4	5.31	-	.75	8.22E-01	1.00E00
vesicle targeting (GO:0006903)	51	1	1.34	-	.75	1.00E00	1.00E00
production of molecular mediator of immune response (GO:0002440)	51	1	1.34	-	.75	1.00E00	1.00E00
mononuclear cell proliferation (GO:0032943)	51	1	1.34	-	.75	1.00E00	1.00E00
negative regulation of protein depolymerization (GO:1901880)	51	1	1.34	-	.75	1.00E00	1.00E00
regulation of type I interferon production (GO:0032479)	51	1	1.34	-	.75	1.00E00	1.00E00
regulation of cytokinesis (GO:0032465)	51	1	1.34	-	.75	1.00E00	1.00E00
cellular macromolecule metabolic process (GO:0044260)	1632	32	42.93	-	.75	7.34E-02	1.00E00
response to alkaloid (GO:0043279)	51	1	1.34	-	.75	1.00E00	1.00E00
regulation of phosphatase activity (GO:0010921)	51	1	1.34	-	.75	1.00E00	1.00E00
male gonad development (GO:0008584)	51	1	1.34	-	.75	1.00E00	1.00E00
positive regulation of mitochondrion organization (GO:0010822)	51	1	1.34	-	.75	1.00E00	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	51	1	1.34	-	.75	1.00E00	1.00E00
positive regulation of JNK cascade (GO:0046330)	51	1	1.34	-	.75	1.00E00	1.00E00
negative regulation of gene expression, epigenetic (GO:0045814)	51	1	1.34	-	.75	1.00E00	1.00E00
regulation of intracellular protein transport (GO:0033157)	154	3	4.05	-	.74	8.01E-01	1.00E00
regulation of small GTPase mediated signal transduction (GO:0051056)	154	3	4.05	-	.74	8.01E-01	1.00E00
positive regulation of translation (GO:0045727)	103	2	2.71	-	.74	1.00E00	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	206	4	5.42	-	.74	8.23E-01	1.00E00
chromatin remodeling (GO:0006338)	206	4	5.42	-	.74	8.23E-01	1.00E00
peptidyl-lysine modification (GO:0018205)	206	4	5.42	-	.74	8.23E-01	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	103	2	2.71	-	.74	1.00E00	1.00E00
cell cycle phase transition (GO:0044770)	104	2	2.74	-	.73	1.00E00	1.00E00
organelle assembly (GO:0070925)	468	9	12.31	-	.73	4.55E-01	1.00E00
maintenance of protein location in cell (GO:0032507)	52	1	1.37	-	.73	1.00E00	1.00E00
positive regulation of DNA-templated transcription initiation (GO:2000144)	52	1	1.37	-	.73	1.00E00	1.00E00
oligodendrocyte differentiation (GO:0048709)	52	1	1.37	-	.73	1.00E00	1.00E00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	52	1	1.37	-	.73	1.00E00	1.00E00
cellular response to chemical stress (GO:0062197)	156	3	4.10	-	.73	8.01E-01	1.00E00
response to hydrogen peroxide (GO:0042542)	52	1	1.37	-	.73	1.00E00	1.00E00
development of primary male sexual characteristics (GO:0046546)	52	1	1.37	-	.73	1.00E00	1.00E00
regulation of wound healing (GO:0061041)	52	1	1.37	-	.73	1.00E00	1.00E00
RNA transport (GO:0050658)	105	2	2.76	-	.72	1.00E00	1.00E00
nucleic acid transport (GO:0050657)	105	2	2.76	-	.72	1.00E00	1.00E00
regulation of transcription initiation by RNA polymerase II (GO:0060260)	53	1	1.39	-	.72	1.00E00	1.00E00
regulation of mitochondrial membrane potential (GO:0051881)	53	1	1.39	-	.72	1.00E00	1.00E00
transcription initiation at RNA polymerase II promoter (GO:0006367)	53	1	1.39	-	.72	1.00E00	1.00E00
axonal transport (GO:0098930)	53	1	1.39	-	.72	1.00E00	1.00E00
regulation of DNA repair (GO:0006282)	159	3	4.18	-	.72	8.01E-01	1.00E00
protein localization to plasma membrane (GO:0072659)	159	3	4.18	-	.72	8.01E-01	1.00E00
cellular biosynthetic process (GO:0044249)	1382	26	36.36	-	.72	6.81E-02	1.00E00
sulfur compound metabolic process (GO:0006790)	160	3	4.21	-	.71	8.01E-01	1.00E00
organophosphate metabolic process (GO:0019637)	534	10	14.05	-	.71	3.28E-01	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	107	2	2.81	-	.71	1.00E00	1.00E00
neuromuscular process (GO:0050905)	107	2	2.81	-	.71	1.00E00	1.00E00
establishment of RNA localization (GO:0051236)	107	2	2.81	-	.71	1.00E00	1.00E00
aromatic compound biosynthetic process (GO:0019438)	538	10	14.15	-	.71	3.29E-01	1.00E00
acylglycerol metabolic process (GO:0006639)	54	1	1.42	-	.70	1.00E00	1.00E00
mitotic spindle organization (GO:0007052)	54	1	1.42	-	.70	1.00E00	1.00E00
regulation of organic acid transport (GO:0032890)	54	1	1.42	-	.70	1.00E00	1.00E00
cellular glucose homeostasis (GO:0001678)	54	1	1.42	-	.70	1.00E00	1.00E00
positive regulation of lipid localization (GO:1905954)	54	1	1.42	-	.70	1.00E00	1.00E00
regulation of B cell activation (GO:0050864)	54	1	1.42	-	.70	1.00E00	1.00E00
cellular transition metal ion homeostasis (GO:0046916)	54	1	1.42	-	.70	1.00E00	1.00E00
vesicle organization (GO:0016050)	216	4	5.68	-	.70	6.65E-01	1.00E00
regulation of insulin receptor signaling pathway (GO:0046626)	54	1	1.42	-	.70	1.00E00	1.00E00
cellular response to UV (GO:0034644)	54	1	1.42	-	.70	1.00E00	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	54	1	1.42	-	.70	1.00E00	1.00E00
cellular amide metabolic process (GO:0043603)	489	9	12.86	-	.70	3.80E-01	1.00E00
meiotic cell cycle (GO:0051321)	109	2	2.87	-	.70	1.00E00	1.00E00
microtubule cytoskeleton organization (GO:0000226)	329	6	8.66	-	.69	4.80E-01	1.00E00
organic substance biosynthetic process (GO:1901576)	1429	26	37.59	-	.69	4.72E-02	1.00E00
neutral lipid metabolic process (GO:0006638)	55	1	1.45	-	.69	1.00E00	1.00E00
regulation of behavior (GO:0050795)	55	1	1.45	-	.69	1.00E00	1.00E00
regulation of cellular response to oxidative stress (GO:1900407)	55	1	1.45	-	.69	1.00E00	1.00E00
response to heat (GO:0009408)	55	1	1.45	-	.69	1.00E00	1.00E00
response to amino acid (GO:0043200)	55	1	1.45	-	.69	1.00E00	1.00E00
negative regulation of autophagy (GO:0010507)	55	1	1.45	-	.69	1.00E00	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	111	2	2.92	-	.68	1.00E00	1.00E00
biosynthetic process (GO:0009058)	1454	26	38.25	-	.68	3.19E-02	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	224	4	5.89	-	.68	6.68E-01	1.00E00
histone lysine methylation (GO:0034968)	56	1	1.47	-	.68	1.00E00	1.00E00
glycerophospholipid biosynthetic process (GO:0046474)	112	2	2.95	-	.68	1.00E00	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	56	1	1.47	-	.68	1.00E00	1.00E00
protein localization to vacuole (GO:0072665)	56	1	1.47	-	.68	1.00E00	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	505	9	13.29	-	.68	3.13E-01	1.00E00
skeletal system development (GO:0001501)	225	4	5.92	-	.68	6.69E-01	1.00E00
cellular response to starvation (GO:0009267)	113	2	2.97	-	.67	1.00E00	1.00E00
glucose homeostasis (GO:0042593)	113	2	2.97	-	.67	1.00E00	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	113	2	2.97	-	.67	1.00E00	1.00E00
negative regulation of protein serine/threonine kinase activity (GO:0071901)	57	1	1.50	-	.67	1.00E00	1.00E00
carbohydrate homeostasis (GO:0033500)	114	2	3.00	-	.67	7.72E-01	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	57	1	1.50	-	.67	1.00E00	1.00E00
mitotic sister chromatid segregation (GO:0000070)	57	1	1.50	-	.67	1.00E00	1.00E00
transition metal ion transport (GO:0000041)	57	1	1.50	-	.67	1.00E00	1.00E00
cardiocyte differentiation (GO:0035051)	57	1	1.50	-	.67	1.00E00	1.00E00
cardiac chamber morphogenesis (GO:0003206)	57	1	1.50	-	.67	1.00E00	1.00E00
purine nucleotide metabolic process (GO:0006163)	231	4	6.08	-	.66	5.31E-01	1.00E00
determination of left/right symmetry (GO:0007368)	58	1	1.53	-	.66	1.00E00	1.00E00
regulation of tumor necrosis factor production (GO:0032680)	58	1	1.53	-	.66	1.00E00	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	58	1	1.53	-	.66	1.00E00	1.00E00
negative regulation of cell growth (GO:0030308)	116	2	3.05	-	.66	7.72E-01	1.00E00
negative regulation of organelle organization (GO:0010639)	232	4	6.10	-	.66	5.31E-01	1.00E00
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	58	1	1.53	-	.66	1.00E00	1.00E00
polyol metabolic process (GO:0019751)	58	1	1.53	-	.66	1.00E00	1.00E00
ribonucleotide metabolic process (GO:0009259)	234	4	6.16	-	.65	5.32E-01	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	587	10	15.44	-	.65	1.81E-01	1.00E00
positive regulation of cation channel activity (GO:2001259)	59	1	1.55	-	.64	1.00E00	1.00E00
regulation of DNA-templated transcription initiation (GO:2000142)	59	1	1.55	-	.64	1.00E00	1.00E00
synaptic vesicle recycling (GO:0036465)	59	1	1.55	-	.64	1.00E00	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	59	1	1.55	-	.64	1.00E00	1.00E00
cellular nitrogen compound biosynthetic process (GO:0044271)	888	15	23.36	-	.64	7.64E-02	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	119	2	3.13	-	.64	7.72E-01	1.00E00
positive regulation of binding (GO:0051099)	119	2	3.13	-	.64	7.72E-01	1.00E00
endosomal transport (GO:0016197)	179	3	4.71	-	.64	6.33E-01	1.00E00
ribose phosphate metabolic process (GO:0019693)	239	4	6.29	-	.64	5.34E-01	1.00E00
peptidyl-lysine methylation (GO:0018022)	60	1	1.58	-	.63	1.00E00	1.00E00
sulfur compound biosynthetic process (GO:0044272)	60	1	1.58	-	.63	1.00E00	1.00E00
regulation of carbohydrate biosynthetic process (GO:0043255)	60	1	1.58	-	.63	1.00E00	1.00E00
lipid catabolic process (GO:0016042)	120	2	3.16	-	.63	7.72E-01	1.00E00
heterocycle biosynthetic process (GO:0018130)	542	9	14.26	-	.63	2.09E-01	1.00E00
purine-containing compound metabolic process (GO:0072521)	241	4	6.34	-	.63	5.35E-01	1.00E00
small molecule metabolic process (GO:0044281)	785	13	20.65	-	.63	1.00E-01	1.00E00
amide biosynthetic process (GO:0043604)	363	6	9.55	-	.63	3.13E-01	1.00E00
non-membrane-bounded organelle assembly (GO:0140694)	182	3	4.79	-	.63	6.35E-01	1.00E00
smoothened signaling pathway (GO:0007224)	61	1	1.60	-	.62	1.00E00	1.00E00
cellular response to light stimulus (GO:0071482)	61	1	1.60	-	.62	1.00E00	1.00E00
RNA localization (GO:0006403)	122	2	3.21	-	.62	7.73E-01	1.00E00
mitochondrial transmembrane transport (GO:1990542)	61	1	1.60	-	.62	1.00E00	1.00E00
leukocyte proliferation (GO:0070661)	61	1	1.60	-	.62	1.00E00	1.00E00
pigmentation (GO:0043473)	61	1	1.60	-	.62	1.00E00	1.00E00
ubiquitin-dependent ERAD pathway (GO:0030433)	61	1	1.60	-	.62	1.00E00	1.00E00
regulation of response to oxidative stress (GO:1902882)	61	1	1.60	-	.62	1.00E00	1.00E00
negative regulation of protein kinase activity (GO:0006469)	123	2	3.24	-	.62	7.73E-01	1.00E00
regulation of body fluid levels (GO:0050878)	123	2	3.24	-	.62	7.73E-01	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	246	4	6.47	-	.62	4.20E-01	1.00E00
determination of bilateral symmetry (GO:0009855)	62	1	1.63	-	.61	1.00E00	1.00E00
specification of symmetry (GO:0009799)	62	1	1.63	-	.61	1.00E00	1.00E00
regulation of DNA binding (GO:0051101)	62	1	1.63	-	.61	1.00E00	1.00E00
male sex differentiation (GO:0046661)	62	1	1.63	-	.61	1.00E00	1.00E00
cell projection assembly (GO:0030031)	250	4	6.58	-	.61	4.20E-01	1.00E00
microtubule-based process (GO:0007017)	503	8	13.23	-	.60	1.93E-01	1.00E00
positive regulation of double-strand break repair (GO:2000781)	64	1	1.68	-	.59	1.00E00	1.00E00
regulation of sister chromatid segregation (GO:0033045)	64	1	1.68	-	.59	1.00E00	1.00E00
regulation of fibroblast proliferation (GO:0048145)	64	1	1.68	-	.59	1.00E00	1.00E00
positive regulation of exocytosis (GO:0045921)	64	1	1.68	-	.59	1.00E00	1.00E00
organonitrogen compound biosynthetic process (GO:1901566)	838	13	22.05	-	.59	5.23E-02	1.00E00
regulation of amine transport (GO:0051952)	65	1	1.71	-	.58	1.00E00	1.00E00
protein lipidation (GO:0006497)	65	1	1.71	-	.58	1.00E00	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	65	1	1.71	-	.58	1.00E00	1.00E00
detection of stimulus (GO:0051606)	65	1	1.71	-	.58	1.00E00	1.00E00
cellular response to nutrient levels (GO:0031669)	130	2	3.42	-	.58	7.77E-01	1.00E00
regulation of histone methylation (GO:0031060)	65	1	1.71	-	.58	1.00E00	1.00E00
regulation of glucose metabolic process (GO:0010906)	65	1	1.71	-	.58	1.00E00	1.00E00
regulation of protein depolymerization (GO:1901879)	66	1	1.74	-	.58	1.00E00	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	132	2	3.47	-	.58	5.88E-01	1.00E00
lipoprotein biosynthetic process (GO:0042158)	66	1	1.74	-	.58	1.00E00	1.00E00
cellular response to oxidative stress (GO:0034599)	133	2	3.50	-	.57	5.88E-01	1.00E00
response to wounding (GO:0009611)	134	2	3.53	-	.57	5.88E-01	1.00E00
sensory perception of sound (GO:0007605)	67	1	1.76	-	.57	1.00E00	1.00E00
protein glycosylation (GO:0006486)	135	2	3.55	-	.56	5.88E-01	1.00E00
macromolecule glycosylation (GO:0043413)	135	2	3.55	-	.56	5.88E-01	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	136	2	3.58	-	.56	5.88E-01	1.00E00
regulation of chromosome separation (GO:1905818)	68	1	1.79	-	.56	1.00E00	1.00E00
meiotic nuclear division (GO:0140013)	68	1	1.79	-	.56	1.00E00	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	137	2	3.60	-	.55	5.88E-01	1.00E00
autophagy (GO:0006914)	206	3	5.42	-	.55	3.80E-01	1.00E00
process utilizing autophagic mechanism (GO:0061919)	206	3	5.42	-	.55	3.80E-01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	69	1	1.82	-	.55	1.00E00	1.00E00
cartilage development (GO:0051216)	69	1	1.82	-	.55	1.00E00	1.00E00
establishment of vesicle localization (GO:0051650)	139	2	3.66	-	.55	5.89E-01	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	139	2	3.66	-	.55	5.89E-01	1.00E00
maintenance of location in cell (GO:0051651)	70	1	1.84	-	.54	1.00E00	1.00E00
positive regulation of protein binding (GO:0032092)	70	1	1.84	-	.54	1.00E00	1.00E00
nucleotide metabolic process (GO:0009117)	282	4	7.42	-	.54	2.55E-01	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	141	2	3.71	-	.54	5.90E-01	1.00E00
chromosome organization (GO:0051276)	212	3	5.58	-	.54	3.81E-01	1.00E00
mitochondrial membrane organization (GO:0007006)	71	1	1.87	-	.54	1.00E00	1.00E00
DNA-templated transcription initiation (GO:0006352)	71	1	1.87	-	.54	1.00E00	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	71	1	1.87	-	.54	1.00E00	1.00E00
respiratory electron transport chain (GO:0022904)	71	1	1.87	-	.54	1.00E00	1.00E00
axo-dendritic transport (GO:0008088)	71	1	1.87	-	.54	1.00E00	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	285	4	7.50	-	.53	2.56E-01	1.00E00
ERAD pathway (GO:0036503)	72	1	1.89	-	.53	1.00E00	1.00E00
neuron apoptotic process (GO:0051402)	73	1	1.92	-	.52	1.00E00	1.00E00
macromolecule biosynthetic process (GO:0009059)	885	12	23.28	-	.52	1.41E-02	8.45E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	74	1	1.95	-	.51	1.00E00	1.00E00
protein acylation (GO:0043543)	148	2	3.89	-	.51	5.96E-01	1.00E00
peptide metabolic process (GO:0006518)	371	5	9.76	-	.51	1.35E-01	1.00E00
organelle disassembly (GO:1903008)	75	1	1.97	-	.51	1.00E00	1.00E00
maintenance of protein location (GO:0045185)	75	1	1.97	-	.51	1.00E00	1.00E00
protein maturation (GO:0051604)	150	2	3.95	-	.51	4.43E-01	1.00E00
multicellular organismal signaling (GO:0035637)	75	1	1.97	-	.51	1.00E00	1.00E00
regulation of RNA splicing (GO:0043484)	151	2	3.97	-	.50	4.43E-01	1.00E00
activation of GTPase activity (GO:0090630)	76	1	2.00	-	.50	7.25E-01	1.00E00
nuclear division (GO:0000280)	152	2	4.00	-	.50	4.43E-01	1.00E00
glycosylation (GO:0070085)	152	2	4.00	-	.50	4.43E-01	1.00E00
Golgi vesicle transport (GO:0048193)	228	3	6.00	-	.50	2.91E-01	1.00E00
meiotic cell cycle process (GO:1903046)	77	1	2.03	-	.49	7.25E-01	1.00E00
regulation of reactive oxygen species metabolic process (GO:2000377)	77	1	2.03	-	.49	7.25E-01	1.00E00
nucleotide biosynthetic process (GO:0009165)	155	2	4.08	-	.49	4.44E-01	1.00E00
lipoprotein metabolic process (GO:0042157)	78	1	2.05	-	.49	7.25E-01	1.00E00
regulation of intracellular transport (GO:0032386)	235	3	6.18	-	.49	2.94E-01	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	157	2	4.13	-	.48	4.45E-01	1.00E00
electron transport chain (GO:0022900)	79	1	2.08	-	.48	7.25E-01	1.00E00
organophosphate catabolic process (GO:0046434)	79	1	2.08	-	.48	7.25E-01	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	317	4	8.34	-	.48	1.50E-01	1.00E00
regulation of JNK cascade (GO:0046328)	81	1	2.13	-	.47	7.26E-01	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	327	4	8.60	-	.46	1.53E-01	1.00E00
neuron death (GO:0070997)	82	1	2.16	-	.46	7.26E-01	1.00E00
macromolecule methylation (GO:0043414)	165	2	4.34	-	.46	4.51E-01	1.00E00
mitochondrion organization (GO:0007005)	332	4	8.73	-	.46	1.14E-01	1.00E00
regulation of DNA biosynthetic process (GO:2000278)	83	1	2.18	-	.46	7.27E-01	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	83	1	2.18	-	.46	7.27E-01	1.00E00
regulation of muscle cell differentiation (GO:0051147)	84	1	2.21	-	.45	7.27E-01	1.00E00
lipid homeostasis (GO:0055088)	85	1	2.24	-	.45	7.28E-01	1.00E00
regulation of nucleocytoplasmic transport (GO:0046822)	86	1	2.26	-	.44	7.29E-01	1.00E00
organelle fission (GO:0048285)	173	2	4.55	-	.44	3.32E-01	1.00E00
glycoprotein biosynthetic process (GO:0009101)	174	2	4.58	-	.44	3.32E-01	1.00E00
regulation of mRNA splicing, via spliceosome (GO:0048024)	90	1	2.37	-	.42	7.32E-01	1.00E00
regulation of cellular carbohydrate metabolic process (GO:0010675)	90	1	2.37	-	.42	7.32E-01	1.00E00
cilium assembly (GO:0060271)	182	2	4.79	-	.42	3.38E-01	1.00E00
membrane fusion (GO:0061025)	91	1	2.39	-	.42	7.33E-01	1.00E00
biological process involved in symbiotic interaction (GO:0044403)	92	1	2.42	-	.41	7.34E-01	1.00E00
mitotic nuclear division (GO:0140014)	92	1	2.42	-	.41	7.34E-01	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	370	4	9.73	-	.41	6.49E-02	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	558	6	14.68	-	.41	1.85E-02	9.44E-01
response to UV (GO:0009411)	93	1	2.45	-	.41	7.36E-01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	93	1	2.45	-	.41	7.36E-01	1.00E00
methylation (GO:0032259)	190	2	5.00	-	.40	2.46E-01	1.00E00
cell-substrate adhesion (GO:0031589)	96	1	2.53	-	.40	5.22E-01	1.00E00
histone acetylation (GO:0016573)	96	1	2.53	-	.40	5.22E-01	1.00E00
mitochondrial transport (GO:0006839)	97	1	2.55	-	.39	5.22E-01	1.00E00
negative regulation of protein-containing complex assembly (GO:0031333)	97	1	2.55	-	.39	5.22E-01	1.00E00
monosaccharide metabolic process (GO:0005996)	99	1	2.60	-	.38	5.23E-01	1.00E00
organic hydroxy compound metabolic process (GO:1901615)	198	2	5.21	-	.38	2.51E-01	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	99	1	2.60	-	.38	5.23E-01	1.00E00
lipid modification (GO:0030258)	99	1	2.60	-	.38	5.23E-01	1.00E00
cilium organization (GO:0044782)	200	2	5.26	-	.38	2.53E-01	1.00E00
internal protein amino acid acetylation (GO:0006475)	100	1	2.63	-	.38	5.24E-01	1.00E00
internal peptidyl-lysine acetylation (GO:0018393)	100	1	2.63	-	.38	5.24E-01	1.00E00
protein processing (GO:0016485)	100	1	2.63	-	.38	5.24E-01	1.00E00
peptide biosynthetic process (GO:0043043)	301	3	7.92	-	.38	9.35E-02	1.00E00
peptidyl-lysine acetylation (GO:0018394)	102	1	2.68	-	.37	5.25E-01	1.00E00
cellular carbohydrate metabolic process (GO:0044262)	103	1	2.71	-	.37	5.26E-01	1.00E00
phosphatidylinositol metabolic process (GO:0046488)	103	1	2.71	-	.37	5.26E-01	1.00E00
glycoprotein metabolic process (GO:0009100)	213	2	5.60	-	.36	1.84E-01	1.00E00
cellular macromolecule biosynthetic process (GO:0034645)	547	5	14.39	-	.35	7.77E-03	6.93E-01
regulation of carbohydrate metabolic process (GO:0006109)	110	1	2.89	-	.35	5.35E-01	1.00E00
bone development (GO:0060348)	111	1	2.92	-	.34	3.74E-01	1.00E00
maintenance of location (GO:0051235)	111	1	2.92	-	.34	3.74E-01	1.00E00
protein acetylation (GO:0006473)	113	1	2.97	-	.34	3.74E-01	1.00E00
ATP metabolic process (GO:0046034)	114	1	3.00	-	.33	3.74E-01	1.00E00
microtubule-based movement (GO:0007018)	231	2	6.08	-	.33	1.36E-01	1.00E00
double-strand break repair (GO:0006302)	118	1	3.10	-	.32	3.76E-01	1.00E00
DNA recombination (GO:0006310)	122	1	3.21	-	.31	3.80E-01	1.00E00
carbohydrate metabolic process (GO:0005975)	257	2	6.76	-	.30	7.00E-02	1.00E00
tRNA metabolic process (GO:0006399)	130	1	3.42	-	.29	2.66E-01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	131	1	3.45	-	.29	2.67E-01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	134	1	3.53	-	.28	2.68E-01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	134	1	3.53	-	.28	2.68E-01	1.00E00
cellular respiration (GO:0045333)	138	1	3.63	-	.28	2.71E-01	1.00E00
alcohol metabolic process (GO:0006066)	138	1	3.63	-	.28	2.71E-01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	143	1	3.76	-	.27	2.77E-01	1.00E00
translation (GO:0006412)	289	2	7.60	-	.26	3.62E-02	1.00E00
transport along microtubule (GO:0010970)	146	1	3.84	-	.26	1.89E-01	1.00E00
microtubule-based transport (GO:0099111)	162	1	4.26	-	.23	1.33E-01	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	169	1	4.45	-	.22	1.36E-01	1.00E00
regulation of chromosome organization (GO:0033044)	173	1	4.55	-	.22	1.38E-01	1.00E00
regulation of microtubule-based process (GO:0032886)	180	1	4.74	-	.21	9.42E-02	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	182	1	4.79	-	.21	9.46E-02	1.00E00
ncRNA metabolic process (GO:0034660)	364	2	9.58	-	.21	6.50E-03	6.40E-01
rRNA metabolic process (GO:0016072)	183	1	4.81	-	.21	9.49E-02	1.00E00
generation of precursor metabolites and energy (GO:0006091)	229	1	6.02	-	.17	3.24E-02	1.00E00
ncRNA processing (GO:0034470)	291	1	7.66	-	.13	7.49E-03	6.82E-01
respiratory burst involved in defense response (GO:0002679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to lead ion (GO:0010288)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of chronic inflammatory response (GO:0002677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heat acclimation (GO:0010286)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response (GO:0002676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein hexamerization (GO:0034214)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell anergy (GO:0002669)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T cell anergy (GO:0002667)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell tolerance induction (GO:0002666)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T cell tolerance induction (GO:0002664)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detoxification of copper ion (GO:0010273)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
amyloid-beta formation (GO:0034205)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
glycolipid translocation (GO:0034203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to oleic acid (GO:0034201)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to selenium ion (GO:0010269)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
SCF complex assembly (GO:0010265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal cholesterol absorption (GO:0045797)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell volume (GO:0045795)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell volume (GO:0045794)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell size (GO:0045793)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell size (GO:0045792)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
NADH dehydrogenase complex assembly (GO:0010257)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
glucose mediated signaling pathway (GO:0010255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tolerance induction (GO:0002645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tolerance induction (GO:0002643)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunoglobulin production (GO:0002638)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of germinal center formation (GO:0002636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of germinal center formation (GO:0002635)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of germinal center formation (GO:0002634)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood pressure (GO:0045776)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
vascular transport (GO:0010232)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amino acid metabolic process (GO:0045764)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amino acid metabolic process (GO:0045763)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of action potential (GO:0045760)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to lithium ion (GO:0010226)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to UV-C (GO:0010225)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to UV-B (GO:0010224)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of action potential (GO:0045759)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of Toll signaling pathway (GO:0045751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA methylation (GO:0010216)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate secretion, neurotransmission (GO:1903294)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi membrane (GO:1903292)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium:sodium antiporter activity (GO:1903281)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium:sodium antiporter activity (GO:1903280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory burst (GO:0045730)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to glucagon (GO:0033762)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
forebrain dorsal/ventral pattern formation (GO:0021798)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebral cortex regionalization (GO:0021796)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium:sodium antiporter activity (GO:1903279)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium ion export across plasma membrane (GO:1903278)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
beta-alanine catabolic process (GO:0019484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory burst after phagocytosis (GO:0045728)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sodium ion export across plasma membrane (GO:1903277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium ion export across plasma membrane (GO:1903276)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
beta-alanine metabolic process (GO:0019482)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin biosynthetic process (GO:0045726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen biosynthetic process (GO:0045725)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of gluconeogenesis (GO:0045722)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of gluconeogenesis (GO:0045721)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin biosynthetic process (GO:0045720)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ribosome localization (GO:0033750)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
postganglionic parasympathetic fiber development (GO:0021784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell fate commitment (GO:0021781)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen biosynthetic process (GO:0045719)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid biosynthetic process (GO:0045717)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striatal medium spiny neuron differentiation (GO:0021773)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lateral geniculate nucleus development (GO:0021771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exon-exon junction complex disassembly (GO:1903259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine decarboxylation via glycine cleavage system (GO:0019464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multi-ciliated epithelial cell differentiation (GO:1903251)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
orbitofrontal cortex development (GO:0021769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammillary body development (GO:0021767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amygdala development (GO:0021764)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of citrulline biosynthetic process (GO:1903249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of citrulline biosynthetic process (GO:1903248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process to taurine (GO:0019452)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
U2-type prespliceosome assembly (GO:1903241)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
globus pallidus development (GO:0021759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putamen development (GO:0021758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
caudate nucleus development (GO:0021757)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striatum development (GO:0021756)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
pronephric nephron tubule development (GO:0039020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-cysteine catabolic process (GO:0019448)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibular nucleus development (GO:0021750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte tethering or rolling (GO:1903238)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte tethering or rolling (GO:1903237)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte tethering or rolling (GO:1903236)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanosome assembly (GO:1903232)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
pronephric nephron development (GO:0039019)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cochlear nucleus development (GO:0021747)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint development (GO:0072498)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
principal sensory nucleus of trigeminal nerve development (GO:0021740)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal stem cell differentiation (GO:0072497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride catabolic process (GO:0019433)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of endodermal cell differentiation (GO:1903226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endodermal cell differentiation (GO:1903225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endodermal cell differentiation (GO:1903224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
removal of superoxide radicals (GO:0019430)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
DNA integration (GO:0015074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pronephric nephron morphogenesis (GO:0039007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipid efflux (GO:0033700)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from acetate (GO:0019427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trigeminal sensory nucleus development (GO:0021730)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein targeting to mitochondrion (GO:1903215)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
podocyte apoptotic process (GO:1903210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by chemical signal (GO:0003099)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal water transport (GO:0003097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal sodium ion transport (GO:0003096)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular filtration (GO:0003094)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular filtration (GO:0003093)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
renal water homeostasis (GO:0003091)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus maturation (GO:0021722)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sulfur oxidation (GO:0019417)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced neuron death (GO:1903207)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
acetate biosynthetic process (GO:0019413)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced cell death (GO:1903205)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron death (GO:1903204)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced cell death (GO:1903202)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindgut morphogenesis (GO:0007442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of systemic arterial blood pressure (GO:0003085)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
superior olivary nucleus development (GO:0021718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of behavioral fear response (GO:2000987)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
dolichol biosynthetic process (GO:0019408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavioral fear response (GO:2000986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hexitol biosynthetic process (GO:0019406)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alditol catabolic process (GO:0019405)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ATP citrate synthase activity (GO:2000983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alditol biosynthetic process (GO:0019401)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
alditol metabolic process (GO:0019400)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ectodermal digestive tract development (GO:0007439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in lung development (GO:0060495)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lung induction (GO:0060492)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral sprouting involved in lung morphogenesis (GO:0060490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of forebrain neuron differentiation (GO:2000978)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell differentiation (GO:0021702)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of forebrain neuron differentiation (GO:2000977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pro-B cell differentiation (GO:2000973)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung-associated mesenchyme development (GO:0060484)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lobar bronchus development (GO:0060482)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lobar bronchus epithelium development (GO:0060481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate by epinephrine (GO:0003065)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate by acetylcholine (GO:0003063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heart rate by chemical signal (GO:0003062)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by norepinephrine (GO:0003061)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA receptor activity (GO:2000969)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
ventral midline development (GO:0007418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axon target recognition (GO:0007412)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cortical granule exocytosis (GO:0060471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of the force of heart contraction by chemical signal (GO:0003057)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prevention of polyspermy (GO:0060468)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of fertilization (GO:0060467)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pharynx development (GO:0060465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell fate determination (GO:0007403)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
lung lobe morphogenesis (GO:0060463)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lung lobe development (GO:0060462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
aldehyde catabolic process (GO:0046185)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to intra-S DNA damage checkpoint signaling (GO:0072429)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
aldehyde biosynthetic process (GO:0046184)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to DNA damage checkpoint signaling (GO:0072423)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of digestive system process (GO:0060456)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
somatic sex determination (GO:0018993)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastric acid secretion (GO:0060455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
germ-line sex determination (GO:0018992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastric acid secretion (GO:0060454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gastric acid secretion (GO:0060453)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle contraction (GO:0060452)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of hindgut contraction (GO:0060450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of oxygen (GO:0003032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyol catabolic process (GO:0046174)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
polyol biosynthetic process (GO:0046173)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bud outgrowth involved in lung branching (GO:0060447)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branching involved in mammary gland duct morphogenesis (GO:0060444)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
late endosome to lysosome transport (GO:1902774)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
branching involved in prostate gland morphogenesis (GO:0060442)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trachea formation (GO:0060440)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of choline O-acetyltransferase activity (GO:1902771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerol-3-phosphate biosynthetic process (GO:0046167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
alcohol biosynthetic process (GO:0046165)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
alcohol catabolic process (GO:0046164)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
heme a metabolic process (GO:0046160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase A activity (GO:0034199)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to DNA integrity checkpoint signaling (GO:0072402)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
triglyceride transport (GO:0034197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acylglycerol transport (GO:0034196)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trachea morphogenesis (GO:0060439)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
trachea development (GO:0060438)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of choline O-acetyltransferase activity (GO:1902769)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchiole morphogenesis (GO:0060436)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process via mevalonate (GO:1902767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchiole development (GO:0060435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchus morphogenesis (GO:0060434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bronchus development (GO:0060433)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lung pattern specification process (GO:0060432)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary lung bud formation (GO:0060431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lung saccule development (GO:0060430)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte development (GO:1902761)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lymph circulation (GO:0003017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
respiratory system process (GO:0003016)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
renal system process (GO:0003014)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
involuntary skeletal muscle contraction (GO:0003011)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA methylation (GO:0080009)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lung connective tissue development (GO:0060427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
propylene metabolic process (GO:0018964)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
nuclear envelope organization (GO:0006998)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
positive regulation of cell cycle G2/M phase transition (GO:1902751)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen starvation (GO:0006995)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to sterol depletion (GO:0006991)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pigment catabolic process (GO:0046149)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin metabolic process (GO:0046146)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lens fiber cell differentiation (GO:1902748)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound catabolic process (GO:0052805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrial septum morphogenesis (GO:0060413)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium organization (GO:1902744)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
imidazole-containing compound metabolic process (GO:0052803)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ER overload response (GO:0006983)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin metabolic process (GO:0046137)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin metabolic process (GO:0046136)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside catabolic process (GO:0046135)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside biosynthetic process (GO:0046134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside catabolic process (GO:0046133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside metabolic process (GO:0046131)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside catabolic process (GO:0046130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine metabolic process (GO:0060409)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine metabolic process (GO:0060408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 9 signaling pathway (GO:0034162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of penile erection (GO:0060406)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of penile erection (GO:0060405)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
calcium ion transport into cytosol (GO:0060402)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte proliferation (GO:1902732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte proliferation (GO:1902731)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteoglycan biosynthetic process (GO:1902730)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA damage induced protein phosphorylation (GO:0006975)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hyperosmotic response (GO:0006972)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside biosynthetic process (GO:0046129)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside metabolic process (GO:0046128)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside catabolic process (GO:0046124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside metabolic process (GO:0046122)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside catabolic process (GO:0046121)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside biosynthetic process (GO:0046120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 8 signaling pathway (GO:0034159)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of satellite cell differentiation (GO:1902725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin secretion (GO:1902722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular defense response (GO:0006968)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of prolactin secretion (GO:1902721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleobase catabolic process (GO:0046113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleobase biosynthetic process (GO:0046112)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein localization to spindle pole body (GO:0071988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
multivesicular body sorting pathway (GO:0071985)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
complement activation, classical pathway (GO:0006958)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
complement activation, alternative pathway (GO:0006957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
complement activation (GO:0006956)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
acute-phase response (GO:0006953)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
uridine metabolic process (GO:0046108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine biosynthetic process (GO:0046105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine metabolic process (GO:0046104)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inosine biosynthetic process (GO:0046103)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inosine metabolic process (GO:0046102)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypoxanthine biosynthetic process (GO:0046101)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypoxanthine metabolic process (GO:0046100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 3 signaling pathway (GO:0034138)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nitrobenzene metabolic process (GO:0018916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
toll-like receptor 2 signaling pathway (GO:0034134)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
extracellular exosome assembly (GO:0071971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
syncytium formation (GO:0006949)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide antigen (GO:0002583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of toll-like receptor signaling pathway (GO:0034122)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion, centromeric (GO:0071962)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dichloromethane metabolic process (GO:0018900)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen processing and presentation (GO:0002579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration, cell extension (GO:0006930)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of antigen processing and presentation (GO:0002577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
platelet degranulation (GO:0002576)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thrombocyte differentiation (GO:0002574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sugar mediated signaling pathway (GO:0010182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pro-T cell differentiation (GO:0002572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
recycling endosome to Golgi transport (GO:0071955)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of homotypic cell-cell adhesion (GO:0034112)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of homotypic cell-cell adhesion (GO:0034111)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of homotypic cell-cell adhesion (GO:0034110)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cell migration (GO:0006929)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
inflammatory cell apoptotic process (GO:0006925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation-induced cell death of T cells (GO:0006924)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
somatic diversification of T cell receptor genes (GO:0002568)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via somatic mutation (GO:0002566)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
basophil degranulation (GO:0002561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basophil mediated immunity (GO:0002560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte clearance (GO:0034107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte clearance (GO:0034106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tissue remodeling (GO:0034105)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nitrogen cycle metabolic process (GO:0071941)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
phagocytosis, engulfment (GO:0006911)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
phagocytosis, recognition (GO:0006910)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
histamine secretion by mast cell (GO:0002553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mast cell chemotaxis (GO:0002551)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine transmembrane transport (GO:0071934)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
replication fork reversal (GO:0071932)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagocytosis (GO:0006909)	61	0	1.60	-	 < 0.01	4.10E-01	1.00E00
pinocytosis (GO:0006907)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
vesicle fusion (GO:0006906)	74	0	1.95	-	 < 0.01	2.67E-01	1.00E00
monocyte chemotaxis (GO:0002548)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to chlorate (GO:0010157)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chronic inflammatory response (GO:0002544)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of blood coagulation via clotting cascade (GO:0002543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell differentiation (GO:0045686)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
alpha-tubulin acetylation (GO:0071929)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermis development (GO:0045684)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermis development (GO:0045683)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of epidermis development (GO:0045682)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
endocannabinoid signaling pathway (GO:0071926)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cohesin loading (GO:0071922)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cohesin loading (GO:0071921)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
respiratory burst involved in inflammatory response (GO:0002536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytokine production involved in inflammatory response (GO:0002534)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
production of molecular mediator involved in inflammatory response (GO:0002532)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA formation (GO:0071919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
urea transmembrane transport (GO:0071918)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast differentiation (GO:0045672)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
synchronous neurotransmitter secretion (GO:0071911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of liver left/right asymmetry (GO:0071910)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide salvage (GO:0010138)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response (GO:0002526)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
hypersensitivity (GO:0002524)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proline catabolic process to glutamate (GO:0010133)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leukocyte migration involved in immune response (GO:0002522)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast differentiation (GO:0045668)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
determination of stomach left/right asymmetry (GO:0071909)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of intestine left/right asymmetry (GO:0071908)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of digestive tract left/right asymmetry (GO:0071907)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast differentiation (GO:0045662)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neurofilament bundle assembly (GO:0033693)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular polysaccharide biosynthetic process (GO:0033692)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoblast proliferation (GO:0033690)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
T cell tolerance induction (GO:0002517)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenylacetate catabolic process (GO:0010124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tolerance induction to self antigen (GO:0002513)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte differentiation (GO:0045657)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte differentiation (GO:0045656)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte differentiation (GO:0045655)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of megakaryocyte differentiation (GO:0045654)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of megakaryocyte differentiation (GO:0045653)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of megakaryocyte differentiation (GO:0045652)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage differentiation (GO:0045651)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage differentiation (GO:0045650)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of osteoblast proliferation (GO:0033689)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of osteoblast proliferation (GO:0033688)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
osteoblast proliferation (GO:0033687)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of luteinizing hormone secretion (GO:0033686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of luteinizing hormone secretion (GO:0033684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision (GO:0033683)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
tolerance induction (GO:0002507)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of polysaccharide antigen via MHC class II (GO:0002505)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC class II protein complex (GO:0002503)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC class I protein complex (GO:0002502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptide antigen assembly with MHC protein complex (GO:0002501)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage differentiation (GO:0045649)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of erythrocyte differentiation (GO:0045648)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of erythrocyte differentiation (GO:0045647)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of erythrocyte differentiation (GO:0045646)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil differentiation (GO:0045645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil differentiation (GO:0045643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyoxal metabolic process (GO:1903189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
positive regulation of melanocyte differentiation (GO:0045636)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
glucuronoside catabolic process (GO:0019391)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of melanocyte differentiation (GO:0045634)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of SUMO transferase activity (GO:1903182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine biosynthetic process (GO:1903181)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 2 cell differentiation (GO:0045630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation by symbiont of host apoptotic process (GO:0033668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar cortex maturation (GO:0021699)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer formation (GO:0021694)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
glucuronoside metabolic process (GO:0019389)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process (GO:0019388)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine biosynthetic process (GO:1903179)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 2 cell differentiation (GO:0045629)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell differentiation (GO:0045628)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 cell differentiation (GO:0045627)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 cell differentiation (GO:0045625)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper cell differentiation (GO:0045624)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
fatty alcohol metabolic process (GO:1903173)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper cell differentiation (GO:0045623)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper cell differentiation (GO:0045622)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte differentiation (GO:0045620)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer morphogenesis (GO:0021687)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granular layer maturation (GO:0021686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nerve maturation (GO:0021682)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolipid catabolic process (GO:0019377)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
galactolipid catabolic process (GO:0019376)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
galactolipid biosynthetic process (GO:0019375)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
galactolipid metabolic process (GO:0019374)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte differentiation (GO:0045618)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte differentiation (GO:0045617)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to polycyclic arene (GO:1903166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoxygenase pathway (GO:0019372)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte differentiation (GO:0045616)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to polycyclic arene (GO:1903165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene biosynthetic process (GO:0019370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebellar molecular layer development (GO:0021679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
third ventricle development (GO:0021678)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lysobisphosphatidic acid metabolic process (GO:2001311)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, unsaturated fatty acid (GO:0019368)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, saturated fatty acid (GO:0019367)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lateral ventricle development (GO:0021670)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide catabolic process (GO:0019364)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide biosynthetic process (GO:0019363)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of epidermal cell differentiation (GO:0045606)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal cell differentiation (GO:0045605)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of epidermal cell differentiation (GO:0045604)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell differentiation (GO:0045603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ectoderm development (GO:0007398)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion mediated by integrin (GO:0033631)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion mediated by integrin (GO:0033630)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide biosynthetic process (GO:0019359)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagy of mitochondrion (GO:1903147)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of endothelial barrier (GO:1903142)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell adhesion mediated by integrin (GO:0033627)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin activation (GO:0033625)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
specification of segmental identity, head (GO:0007380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin activation (GO:0033624)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of integrin activation (GO:0033623)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
integrin activation (GO:0033622)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
dolichol metabolic process (GO:0019348)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transsulfuration (GO:0019346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
segment specification (GO:0007379)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
membrane protein proteolysis (GO:0033619)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve structural organization (GO:0021649)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve morphogenesis (GO:0021648)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vagus nerve morphogenesis (GO:0021644)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phenol-containing compound catabolic process (GO:0019336)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to cell cycle checkpoint signaling (GO:0072396)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring at microtubule organizing center (GO:0072393)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine secretion (GO:0033604)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine secretion (GO:0033602)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
optic nerve structural organization (GO:0021633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic nerve morphogenesis (GO:0021631)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory nerve maturation (GO:0021630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plus-end-directed organelle transport along microtubule (GO:0072386)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to actin cytoskeleton (GO:1903119)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
minus-end-directed organelle transport along microtubule (GO:0072385)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
organelle transport along microtubule (GO:0072384)	69	0	1.82	-	 < 0.01	4.26E-01	1.00E00
pentose catabolic process (GO:0019323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plus-end-directed vesicle transport along microtubule (GO:0072383)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament-based movement (GO:1903116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pentose metabolic process (GO:0019321)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hexose catabolic process (GO:0019320)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
zygotic specification of dorsal/ventral axis (GO:0007352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system maturation (GO:0021626)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
hexose biosynthetic process (GO:0019319)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
hexose metabolic process (GO:0019318)	92	0	2.42	-	 < 0.01	1.78E-01	1.00E00
blood coagulation, fibrin clot formation (GO:0072378)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
blood coagulation, common pathway (GO:0072377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein activation cascade (GO:0072376)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial transcription (GO:1903109)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial transcription (GO:1903108)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
penetration of zona pellucida (GO:0007341)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve morphogenesis (GO:0021615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-ribose catabolic process (GO:0019303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
binding of sperm to zona pellucida (GO:0007339)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of growth hormone receptor signaling pathway (GO:0060398)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein signal transduction (GO:0060392)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of SMAD protein signal transduction (GO:0060391)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of SMAD protein signal transduction (GO:0060390)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cranial nerve maturation (GO:0021605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cranial nerve formation (GO:0021603)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chromosome passenger complex localization to kinetochore (GO:0072356)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone secretion (GO:2000872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone secretion (GO:2000870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid metabolic process (GO:0072350)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
pathway-restricted SMAD protein phosphorylation (GO:0060389)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
synapse assembly involved in innervation (GO:0060386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA strand elongation (GO:0060383)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand elongation (GO:0060382)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insemination (GO:0007320)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfur compound transport (GO:0072348)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of estradiol secretion (GO:2000866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to anesthetic (GO:0072347)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of estradiol secretion (GO:2000864)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rescue of stalled ribosome (GO:0072344)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell myoblast differentiation (GO:0060379)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytosol to Golgi apparatus transport (GO:0140820)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of brood size (GO:0060378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell differentiation (GO:0060377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell differentiation (GO:0060376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pole plasm assembly (GO:0007315)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell differentiation (GO:0060375)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oocyte anterior/posterior axis specification (GO:0007314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mast cell differentiation (GO:0060374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
susceptibility to T cell mediated cytotoxicity (GO:0060370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
guanine biosynthetic process (GO:0046099)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine metabolic process (GO:0046098)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modified amino acid transport (GO:0072337)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
deoxycytidine metabolic process (GO:0046092)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticosterone secretion (GO:2000853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-galactose transmembrane transport (GO:0072334)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of corticosterone secretion (GO:2000852)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid secretion (GO:2000850)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
signal transduction by p53 class mediator (GO:0072331)	46	0	1.21	-	 < 0.01	6.33E-01	1.00E00
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
oocyte axis specification (GO:0007309)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
oocyte construction (GO:0007308)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
coronal suture morphogenesis (GO:0060365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cranial suture morphogenesis (GO:0060363)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytidine metabolic process (GO:0046087)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid secretion (GO:2000849)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
adenosine biosynthetic process (GO:0046086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adenosine metabolic process (GO:0046085)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of corticosteroid hormone secretion (GO:2000847)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
adenine biosynthetic process (GO:0046084)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of corticosteroid hormone secretion (GO:2000846)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
adenine metabolic process (GO:0046083)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of testosterone secretion (GO:2000845)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dUTP catabolic process (GO:0046081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone secretion (GO:2000843)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dUTP metabolic process (GO:0046080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to ammonium ion (GO:0060359)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of leucine import (GO:0060358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leucine import (GO:0060357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inositol phosphorylation (GO:0052746)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell adhesion molecule production (GO:0060355)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor localization to synapse (GO:1902685)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion molecule production (GO:0060353)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor localization to synapse (GO:1902684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell adhesion molecule production (GO:0060352)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dUMP catabolic process (GO:0046079)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dUMP metabolic process (GO:0046078)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
dUDP metabolic process (GO:0046077)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dTTP metabolic process (GO:0046075)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle uncoating (GO:0072319)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
dTMP catabolic process (GO:0046074)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin coat disassembly (GO:0072318)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
dTMP metabolic process (GO:0046073)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dTDP metabolic process (GO:0046072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone secretion (GO:2000833)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dGTP metabolic process (GO:0046070)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of steroid hormone secretion (GO:2000832)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of steroid hormone secretion (GO:2000831)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of parathyroid hormone secretion (GO:2000830)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular epithelial cell differentiation (GO:0072311)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glomerular epithelial cell development (GO:0072310)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
heart trabecula formation (GO:0060347)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cGMP catabolic process (GO:0046069)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cGMP metabolic process (GO:0046068)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
dGDP metabolic process (GO:0046066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of parathyroid hormone secretion (GO:2000828)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA surveillance (GO:2000827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dCMP metabolic process (GO:0046063)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of androgen receptor activity (GO:2000825)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dCDP metabolic process (GO:0046062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dATP catabolic process (GO:0046061)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dATP metabolic process (GO:0046060)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of behavioral fear response (GO:2000822)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
type I interferon signaling pathway (GO:0060337)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon guidance (GO:1902668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of sister chromatid cohesion (GO:0034091)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
arsonoacetate metabolic process (GO:0018872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interferon-gamma-mediated signaling pathway (GO:0060333)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to interferon-gamma (GO:0060332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to interferon-gamma (GO:0060331)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of response to interferon-gamma (GO:0060330)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose mediated signaling pathway (GO:1902661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-excision repair (GO:2000819)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
dGMP catabolic process (GO:0046055)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dGMP metabolic process (GO:0046054)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
dAMP metabolic process (GO:0046053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UTP catabolic process (GO:0046052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of barbed-end actin filament capping (GO:2000814)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UTP metabolic process (GO:0046051)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of barbed-end actin filament capping (GO:2000813)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UMP catabolic process (GO:0046050)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of barbed-end actin filament capping (GO:2000812)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of bicellular tight junction assembly (GO:2000810)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
maintenance of mitotic sister chromatid cohesion (GO:0034088)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of mitotic sister chromatid cohesion (GO:0034087)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of sister chromatid cohesion (GO:0034086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of sister chromatid cohesion (GO:0034085)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glucose mediated signaling pathway (GO:1902659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CENP-A containing chromatin assembly (GO:0034080)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
secondary alcohol metabolic process (GO:1902652)	63	0	1.66	-	 < 0.01	4.13E-01	1.00E00
Golgi to vacuole transport (GO:0006896)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
Golgi to endosome transport (GO:0006895)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane transport (GO:0006893)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	82	0	2.16	-	 < 0.01	2.77E-01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
UMP metabolic process (GO:0046049)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
UDP metabolic process (GO:0046048)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ITP metabolic process (GO:0046041)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
IMP metabolic process (GO:0046040)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
definitive erythrocyte differentiation (GO:0060318)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol biosynthetic process (GO:1902645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel remodeling (GO:0060313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tertiary alcohol metabolic process (GO:1902644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel remodeling (GO:0060312)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular zinc ion homeostasis (GO:0006882)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
intracellular sequestering of iron ion (GO:0006880)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GTP metabolic process (GO:0046039)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
GMP catabolic process (GO:0046038)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
GMP metabolic process (GO:0046037)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
CTP metabolic process (GO:0046036)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
CMP metabolic process (GO:0046035)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
AMP metabolic process (GO:0046033)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
ADP catabolic process (GO:0046032)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ADP metabolic process (GO:0046031)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
protein localization to Golgi apparatus (GO:0034067)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
methylguanosine-cap decapping (GO:0110156)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
elastin catabolic process (GO:0060309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NAD-cap decapping (GO:0110155)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA decapping (GO:0110154)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization (GO:0060306)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of cell diameter (GO:0060305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineralization (GO:0110150)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane hyperpolarization (GO:1902632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytokine activity (GO:0060300)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane hyperpolarization (GO:1902631)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular copper ion homeostasis (GO:0006878)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of membrane hyperpolarization (GO:1902630)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endosomal vesicle fusion (GO:0034058)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
DNA biosynthetic process (GO:0071897)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
protein localization to adherens junction (GO:0071896)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
odontoblast differentiation (GO:0071895)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
programmed cell death induced by symbiont (GO:0034050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil migration (GO:1902623)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamine transport (GO:0006868)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
amino acid transport (GO:0006865)	66	0	1.74	-	 < 0.01	4.18E-01	1.00E00
positive regulation of transcription by glucose (GO:0046016)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by glucose (GO:0046015)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Norrin signaling pathway (GO:0110135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukocyte apoptotic process (GO:0071887)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
extracellular transport (GO:0006858)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
oligopeptide transport (GO:0006857)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion transmembrane transport (GO:0006851)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
mitochondrial pyruvate transmembrane transport (GO:0006850)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated T cell proliferation (GO:0046007)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of activated T cell proliferation (GO:0046006)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleoside bisphosphate catabolic process (GO:0034034)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
adrenergic receptor signaling pathway (GO:0071875)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to norepinephrine stimulus (GO:0071874)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside bisphosphate catabolic process (GO:0034031)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to norepinephrine (GO:0071873)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to epinephrine stimulus (GO:0071872)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to epinephrine (GO:0071871)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
carnitine transmembrane transport (GO:1902603)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyruvate transport (GO:0006848)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transport (GO:0006842)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transporter activity (GO:0110113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process in bone marrow cell (GO:0071865)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transporter activity (GO:0110112)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation in bone marrow (GO:0071864)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of animal organ morphogenesis (GO:0110111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation in bone marrow (GO:0071863)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of animal organ morphogenesis (GO:0110110)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
serotonin transport (GO:0006837)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid transport (GO:0006835)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
water transport (GO:0006833)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation via MHC class Ib (GO:0002475)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to triglyceride (GO:0034014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zinc ion transport (GO:0006829)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
manganese ion transport (GO:0006828)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
copper ion transport (GO:0006825)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cobalt ion transport (GO:0006824)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
germinal center formation (GO:0002467)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
zygote asymmetric cell division (GO:0010070)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
TNFSF11-mediated signaling pathway (GO:0071847)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
actin filament debranching (GO:0071846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
corpus callosum development (GO:0022038)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
T cell antigen processing and presentation (GO:0002457)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
apoptotic process in bone marrow cell (GO:0071839)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation in bone marrow (GO:0071838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of regulatory T cell differentiation (GO:0045590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle clearance (GO:0071830)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nitric oxide biosynthetic process (GO:0006809)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
interkinetic nuclear migration (GO:0022027)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of nitrogen utilization (GO:0006808)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
xenobiotic metabolic process (GO:0006805)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA catabolic process (GO:2001294)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
superoxide metabolic process (GO:0006801)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
malonyl-CoA metabolic process (GO:2001293)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell mediated immunity (GO:0002448)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
eosinophil mediated immunity (GO:0002447)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated immunity (GO:0002446)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte mediated immunity (GO:0002444)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
histamine secretion involved in inflammatory response (GO:0002441)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-delta T cell differentiation (GO:0045588)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytotoxic T cell differentiation (GO:0045585)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cytotoxic T cell differentiation (GO:0045583)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle organization (GO:0071827)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell differentiation (GO:0045581)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex subunit organization (GO:0071825)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of caveolin-mediated endocytosis (GO:2001288)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of caveolin-mediated endocytosis (GO:2001286)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
acute inflammatory response to antigenic stimulus (GO:0002438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to mycotoxin (GO:0010046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to nickel cation (GO:0010045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to aluminum ion (GO:0010044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune complex clearance (GO:0002434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to zinc ion (GO:0010043)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
response to manganese ion (GO:0010042)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to iron(III) ion (GO:0010041)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to iron(II) ion (GO:0010040)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell differentiation (GO:0045579)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
complement receptor mediated signaling pathway (GO:0002430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell differentiation (GO:0045578)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of B cell differentiation (GO:0045577)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mast cell activation (GO:0045576)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
basophil activation (GO:0045575)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in neural plate elongation (GO:0022007)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome condensation (GO:0010032)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of podosome assembly (GO:0071803)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell proliferation (GO:0033598)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of podosome assembly (GO:0071802)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of podosome assembly (GO:0071801)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
podosome assembly (GO:0071800)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to L-ascorbic acid (GO:0033591)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
immune response to tumor cell (GO:0002418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of semaphorin-plexin signaling pathway (GO:2001260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 trimethylation (GO:2001255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 trimethylation (GO:2001253)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome organization (GO:2001252)	83	0	2.18	-	 < 0.01	2.78E-01	1.00E00
negative regulation of chromosome organization (GO:2001251)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
dendritic cell chemotaxis (GO:0002407)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol biosynthetic process (GO:0045542)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol biosynthetic process (GO:0045541)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol biosynthetic process (GO:0045540)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
response to testosterone (GO:0033574)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cardioblast differentiation (GO:0010002)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to condensed chromosome (GO:1903083)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
gamma-tubulin complex localization (GO:0033566)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior/posterior axon guidance (GO:0033564)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axon guidance (GO:0033563)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of water loss via skin (GO:0033561)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
abducens nerve formation (GO:0021599)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
abducens nerve morphogenesis (GO:0021598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fourth ventricle development (GO:0021592)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ventricular system development (GO:0021591)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum maturation (GO:0021590)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to gamma radiation (GO:2001229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to gamma radiation (GO:2001228)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chloride transport (GO:2001226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum structural organization (GO:0021589)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chloride transport (GO:2001225)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pons maturation (GO:0021586)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylgalactosamine metabolic process (GO:0019276)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of reverse cholesterol transport (GO:1903064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of reverse cholesterol transport (GO:1903062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein lipidation (GO:1903061)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein lipidation (GO:1903060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hindbrain maturation (GO:0021578)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of vasculogenesis (GO:2001214)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hindbrain structural organization (GO:0021577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rhombomere 6 development (GO:0021572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere 5 development (GO:0021571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein lipidation (GO:1903059)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of melanosome organization (GO:1903056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix organization (GO:1903055)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate catabolic process (GO:0019262)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix organization (GO:1903054)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix organization (GO:1903053)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by hormone (GO:0001990)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
vitellogenesis (GO:0007296)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
spermatid nucleus elongation (GO:0007290)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast development (GO:2001206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypoglossal nerve development (GO:0021566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vagus nerve development (GO:0021564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell differentiation (GO:2001200)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glossopharyngeal nerve development (GO:0021563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibulocochlear nerve development (GO:0021562)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
abducens nerve development (GO:0021560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine-gated cation channel activity (GO:1903048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose 1-phosphate metabolic process (GO:0019255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure (GO:0001988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process, CoA-linked (GO:0019254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure (GO:0001987)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to membrane raft (GO:1903044)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chondrocyte hypertrophy (GO:1903043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
baroreceptor response to decreased systemic arterial blood pressure (GO:0001982)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sperm axoneme assembly (GO:0007288)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermatogonial cell division (GO:0007284)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary morphogenesis (GO:0021555)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic nerve development (GO:0021554)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process (GO:0019249)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lactate biosynthetic process from pyruvate (GO:0019244)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal system process involved in regulation of blood volume (GO:0001977)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
methylglyoxal biosynthetic process (GO:0019242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to amphetamine (GO:0001975)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule plus-end binding (GO:1903033)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
citrulline biosynthetic process (GO:0019240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule plus-end binding (GO:1903031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, cholinergic (GO:0007271)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neuron-neuron synaptic transmission (GO:0007270)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhombomere development (GO:0021546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
subpallium development (GO:0021544)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
dentate gyrus development (GO:0021542)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
ammon gyrus development (GO:0021541)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
corpus callosum morphogenesis (GO:0021540)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to pheromone (GO:0019236)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of opsonization (GO:1903028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of opsonization (GO:1903027)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thigmotaxis (GO:0001966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proprioception (GO:0019230)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, dopaminergic (GO:0001963)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nitric oxide mediated signal transduction (GO:0007263)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
floor plate morphogenesis (GO:0033505)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
floor plate development (GO:0033504)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
subthalamus development (GO:0021539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithalamus development (GO:0021538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration in hindbrain (GO:0021535)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
cell proliferation in hindbrain (GO:0021534)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neural tube patterning (GO:0021532)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule formation (GO:0072289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal action potential (GO:0019228)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
neuronal action potential propagation (GO:0019227)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein metabolic process (GO:1903019)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
transmission of nerve impulse (GO:0019226)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
metanephric connecting tubule development (GO:0072286)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
siRNA-mediated gene silencing (GO:0140766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endochondral ossification (GO:0001958)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
intramembranous ossification (GO:0001957)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric renal vesicle morphogenesis (GO:0072283)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter secretion (GO:0001956)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule morphogenesis (GO:0072282)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-matrix adhesion (GO:0001953)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
JUN phosphorylation (GO:0007258)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of bone development (GO:1903010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal D-glucose absorption (GO:0001951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of NF-kappaB (GO:0007253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
I-kappaB phosphorylation (GO:0007252)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
activation of NF-kappaB-inducing kinase activity (GO:0007250)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
spinal cord association neuron differentiation (GO:0021527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatic motor neuron differentiation (GO:0021523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron differentiation (GO:0021522)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron specification (GO:0021521)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron cell fate specification (GO:0021520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sebaceous gland cell differentiation (GO:0001949)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked deubiquitination (GO:1903006)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric nephron morphogenesis (GO:0072273)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein K63-linked deubiquitination (GO:1903004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein deubiquitination (GO:1903003)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord development (GO:0021517)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
dorsal spinal cord development (GO:0021516)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell differentiation in spinal cord (GO:0021515)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron differentiation (GO:0021514)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spinal cord dorsal/ventral patterning (GO:0021513)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome assembly (GO:2000786)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
spinal cord patterning (GO:0021511)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome assembly (GO:2000785)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
spinal cord development (GO:0021510)	40	0	1.05	-	 < 0.01	6.27E-01	1.00E00
regulation of ncRNA transcription (GO:0140747)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of cell polarity regulating cell shape (GO:2000784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of cell polarity regulating cell shape (GO:2000782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular endothelium development (GO:0072264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lncRNA transcription (GO:0140744)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell proliferation (GO:0001937)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of lncRNA transcription (GO:0140743)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sarcomere organization (GO:0060299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sarcomere organization (GO:0060297)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cilium movement involved in cell motility (GO:0060295)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cilium movement involved in cell motility (GO:0060294)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
long-term synaptic depression (GO:0060292)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
osmosensory signaling pathway (GO:0007231)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transdifferentiation (GO:0060290)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
floor plate formation (GO:0021508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterior neuropore closure (GO:0021506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural fold bending (GO:0021503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural fold elevation formation (GO:0021502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prechordal plate formation (GO:0021501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular senescence (GO:2000774)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular senescence (GO:2000773)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell development (GO:0072255)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular senescence (GO:2000772)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
regulation of exocyst assembly (GO:0001928)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangial cell differentiation (GO:0072254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B-1 B cell differentiation (GO:0001923)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B-1 B cell homeostasis (GO:0001922)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor recycling (GO:0001921)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
signal transduction downstream of smoothened (GO:0007227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor recycling (GO:0001920)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
patched ligand maturation (GO:0007225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cilium-dependent cell motility (GO:0060285)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
positive regulation of oocyte development (GO:0060282)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte development (GO:0060281)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Notch receptor processing (GO:0007220)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translation (GO:2000767)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular epithelium development (GO:0072244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric nephron epithelium development (GO:0072243)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated cytotoxicity (GO:0001916)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
metanephric DCT cell differentiation (GO:0072240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ovulation (GO:0060279)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of ovulation (GO:0060278)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tachykinin receptor signaling pathway (GO:0007217)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal joint morphogenesis (GO:0060272)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
serotonin receptor signaling pathway (GO:0007210)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-lysine acetylation (GO:2000758)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine acetylation (GO:2000757)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus vasculature development (GO:0072239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
constitutive heterochromatin formation (GO:0140719)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-lysine acetylation (GO:2000756)	56	0	1.47	-	 < 0.01	4.06E-01	1.00E00
facultative heterochromatin formation (GO:0140718)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingomyelin catabolic process (GO:2000755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sphingomyelin catabolic process (GO:2000754)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric loop of Henle development (GO:0072236)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric distal tubule development (GO:0072235)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric nephron tubule development (GO:0072234)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
metanephric thick ascending limb development (GO:0072233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst (GO:0060268)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory burst (GO:0060267)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA replication origin binding (GO:1902595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory burst involved in inflammatory response (GO:0060264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of respiratory burst (GO:0060263)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase C activity (GO:0007202)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol catabolic process (GO:0052651)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
metanephric macula densa development (GO:0072227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterior head development (GO:2000744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-containing complex localization to centriolar satellite (GO:0140706)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of anterior head development (GO:2000742)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric glomerulus development (GO:0072224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephric glomerular mesangium development (GO:0072223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric distal convoluted tubule development (GO:0072221)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of feeding behavior (GO:0060259)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
alditol phosphate metabolic process (GO:0052646)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell differentiation (GO:2000739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric ascending thin limb development (GO:0072218)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium import into the mitochondrion (GO:0110099)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase I transcription (GO:2000730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium import into the mitochondrion (GO:0110097)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to aldehyde (GO:0110096)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
metanephric nephron development (GO:0072210)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of aldehyde (GO:0110095)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippocampal neuron apoptotic process (GO:0110091)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
contact inhibition (GO:0060242)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleolus (GO:1902570)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell differentiation (GO:2000727)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
metanephric mesangial cell differentiation (GO:0072209)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell differentiation (GO:2000726)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell differentiation (GO:2000725)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
metanephric epithelium development (GO:0072207)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric collecting duct development (GO:0072205)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in metanephros development (GO:0072204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hippocampal neuron apoptotic process (GO:0110089)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in metanephros development (GO:0072203)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hippocampal neuron apoptotic process (GO:0110088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in metanephros development (GO:0072202)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil activation (GO:1902568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle organization (GO:0060236)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil activation (GO:1902566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens induction in camera-type eye (GO:0060235)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil activation (GO:1902565)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil activation (GO:1902564)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil activation (GO:1902563)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
delamination (GO:0060232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesenchymal to epithelial transition (GO:0060231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000719)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000718)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated intercellular transport (GO:0110077)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ferroptosis (GO:0110076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ferroptosis (GO:0110075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catalase activity (GO:1902553)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of catalase activity (GO:1902551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyphosphate catabolic process (GO:0006798)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyphosphate metabolic process (GO:0006797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule biogenesis (GO:2000707)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule biogenesis (GO:2000705)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lncRNA catabolic process (GO:0110064)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell differentiation (GO:0060218)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
definitive hemopoiesis (GO:0060216)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin-activated signaling pathway (GO:0110061)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardium formation (GO:0060214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
heme oxidation (GO:0006788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound catabolic process (GO:0006787)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heme A biosynthetic process (GO:0006784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heme biosynthetic process (GO:0006783)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX biosynthetic process (GO:0006782)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III biosynthetic process (GO:0006780)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metabolite repair (GO:0110051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound biosynthetic process (GO:0006779)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein linear polyubiquitination (GO:1902530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vitamin A metabolic process (GO:0006776)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin metabolic process (GO:0006775)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
thiamine metabolic process (GO:0006772)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein linear polyubiquitination (GO:1902528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein monoubiquitination (GO:1902527)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein monoubiquitination (GO:1902525)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K48-linked ubiquitination (GO:1902524)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein K63-linked ubiquitination (GO:1902523)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of organelle transport along microtubule (GO:1902513)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic DNA fragmentation (GO:1902512)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic DNA fragmentation (GO:1902511)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic DNA fragmentation (GO:1902510)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ATP generation from ADP (GO:0006757)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
AMP phosphorylation (GO:0006756)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ATP biosynthetic process (GO:0006754)	67	0	1.76	-	 < 0.01	4.21E-01	1.00E00
glutathione catabolic process (GO:0006751)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
MHC class II protein complex assembly (GO:0002399)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutathione biosynthetic process (GO:0006750)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
MHC class Ib protein complex assembly (GO:0002398)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
MHC class I protein complex assembly (GO:0002397)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
MHC protein complex assembly (GO:0002396)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand resection involved in replication fork processing (GO:0110025)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
glutathione metabolic process (GO:0006749)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
FAD biosynthetic process (GO:0006747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquinone biosynthetic process (GO:0006744)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ubiquinone metabolic process (GO:0006743)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
NADP catabolic process (GO:0006742)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NADP biosynthetic process (GO:0006741)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NADPH regeneration (GO:0006740)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
immune response in gut-associated lymphoid tissue (GO:0002387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mucosal immune response (GO:0002385)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
cap-independent translational initiation of linear mRNA (GO:0110017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear inner membrane organization (GO:0071765)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear membrane organization (GO:0071763)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane organization (GO:0110011)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
basolateral protein secretion (GO:0110010)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NADP metabolic process (GO:0006739)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
NADH regeneration (GO:0006735)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
NADH metabolic process (GO:0006734)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
immunoglobulin production (GO:0002377)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable organization (GO:0110009)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ncRNA deadenylation (GO:0110008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetrahydrobiopterin biosynthetic process (GO:0006729)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
triterpenoid metabolic process (GO:0006722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terpenoid metabolic process (GO:0006721)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
isoprenoid metabolic process (GO:0006720)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
leukocyte activation involved in immune response (GO:0002366)	64	0	1.68	-	 < 0.01	4.14E-01	1.00E00
NK T cell lineage commitment (GO:0002364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell lineage commitment (GO:0002363)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sesquiterpenoid metabolic process (GO:0006714)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid catabolic process (GO:0006713)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
androgen catabolic process (GO:0006710)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell homeostatic proliferation (GO:0002358)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to tumor cell (GO:0002357)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
plasma kallikrein-kinin cascade (GO:0002353)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell negative selection (GO:0002352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell maintenance (GO:0045494)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
cellular response to nitric oxide (GO:0071732)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to nitric oxide (GO:0071731)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cholesterol catabolic process (GO:0006707)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell differentiation (GO:2001199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
steroid catabolic process (GO:0006706)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell differentiation (GO:2001198)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid biosynthetic process (GO:0006705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid biosynthetic process (GO:0006704)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
estrogen biosynthetic process (GO:0006703)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
androgen biosynthetic process (GO:0006702)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
progesterone biosynthetic process (GO:0006701)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histamine production involved in inflammatory response (GO:0002349)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone biosynthetic process (GO:0006700)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to tumor cell (GO:0002347)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell affinity maturation (GO:0002344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral B cell selection (GO:0002343)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell selection (GO:0002339)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B-1a B cell differentiation (GO:0002337)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mature B cell differentiation (GO:0002335)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
transitional two stage B cell differentiation (GO:0002334)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transitional one stage B cell differentiation (GO:0002333)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transitional stage B cell differentiation (GO:0002332)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pre-B cell allelic exclusion (GO:0002331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
locomotor rhythm (GO:0045475)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
leukotriene transport (GO:0071716)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ER-associated misfolded protein catabolic process (GO:0071712)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
basement membrane organization (GO:0071711)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of mediator complex assembly (GO:2001178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mediator complex assembly (GO:2001176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pre-B cell differentiation (GO:0002329)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pro-B cell differentiation (GO:0002328)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP biosynthetic process (GO:2001171)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
immature B cell differentiation (GO:0002327)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP biosynthetic process (GO:2001170)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell lineage commitment (GO:0002326)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation involved in immune response (GO:0002323)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
B cell proliferation involved in immune response (GO:0002322)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphoid progenitor cell differentiation (GO:0002320)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor superfamily cytokine production (GO:0071706)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
galactose catabolic process via UDP-galactose (GO:0033499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of MAPK export from nucleus (GO:0071701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ATP biosynthetic process (GO:2001169)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H2B ubiquitination (GO:2001168)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via lathosterol (GO:0033490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H2B ubiquitination (GO:2001166)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
memory B cell differentiation (GO:0002319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma cell differentiation (GO:0002317)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K79 methylation (GO:2001160)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
marginal zone B cell differentiation (GO:0002315)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
germinal center B cell differentiation (GO:0002314)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mature B cell differentiation involved in immune response (GO:0002313)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
B cell activation involved in immune response (GO:0002312)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
bone resorption (GO:0045453)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via desmosterol (GO:0033489)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide homeostasis (GO:0033484)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gas homeostasis (GO:0033483)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal water transport (GO:2001153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell proliferation involved in immune response (GO:0002309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of renal water transport (GO:2001151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gamma-delta intraepithelial T cell differentiation (GO:0002304)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation (GO:0045445)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid transport (GO:2001139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endocytic recycling (GO:2001137)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of endocytic recycling (GO:2001136)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endocytic recycling (GO:2001135)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex assembly (GO:0065005)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
specification of axis polarity (GO:0065001)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nonribosomal peptide biosynthetic process (GO:0019184)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational frameshifting (GO:2001125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational frameshifting (GO:2001124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lens epithelial cell proliferation (GO:2001111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retina homeostasis (GO:0001895)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of lens epithelial cell proliferation (GO:2001109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenium compound metabolic process (GO:0001887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell morphogenesis (GO:0001886)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
receptor recycling (GO:0001881)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
Mullerian duct regression (GO:0001880)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SMAD protein complex assembly (GO:0007183)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
common-partner SMAD protein phosphorylation (GO:0007182)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta receptor complex assembly (GO:0007181)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to yeast (GO:0001878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor catabolic process (GO:0007174)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ureter morphogenesis (GO:0072197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle cell differentiation (GO:0072195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney smooth muscle tissue development (GO:0072194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
complement activation, lectin pathway (GO:0001867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle cell differentiation (GO:0072193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle development (GO:0072191)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor guanylyl cyclase signaling pathway (GO:0007168)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-matrix adhesion (GO:0007161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-matrix adhesion (GO:0007160)	60	0	1.58	-	 < 0.01	4.08E-01	1.00E00
ureter development (GO:0072189)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesonephric duct development (GO:0072177)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric tubule formation (GO:0072174)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric tubule morphogenesis (GO:0072173)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesonephric tubule formation (GO:0072172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly (GO:0001845)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric tubule development (GO:0072170)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
futile creatine cycle (GO:0140651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
radial glia-guided pyramidal neuron migration (GO:0140650)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neural fold formation (GO:0001842)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neural plate development (GO:0001840)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
meiotic recombination nodule assembly (GO:0007146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female meiosis I (GO:0007144)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
female meiotic nuclear division (GO:0007143)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
male meiosis I (GO:0007141)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
male meiotic nuclear division (GO:0007140)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring assembly actin filament organization (GO:2000689)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate morphogenesis (GO:0001839)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
male somatic sex determination (GO:0019102)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchymal cell differentiation (GO:0072162)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blastocyst hatching (GO:0001835)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in kidney development (GO:0072161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trophectodermal cell proliferation (GO:0001834)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
male germ-line sex determination (GO:0019100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nephron tubule epithelial cell differentiation (GO:0072160)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell proliferation (GO:0001833)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
blastocyst growth (GO:0001832)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
meiosis II (GO:0007135)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipase activity (GO:0060193)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipase activity (GO:0060192)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
reciprocal meiotic recombination (GO:0007131)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of lipase activity (GO:0060191)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
synaptonemal complex assembly (GO:0007130)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription regulatory region DNA binding (GO:2000679)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell apoptotic process (GO:2000674)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
distal tubule morphogenesis (GO:0072156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of motor neuron apoptotic process (GO:2000673)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of motor neuron apoptotic process (GO:2000672)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
inner cell mass cellular morphogenesis (GO:0001828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron apoptotic process (GO:2000671)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell fate commitment (GO:0001827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell apoptotic process (GO:2000670)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inner cell mass cell differentiation (GO:0001826)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inflammasome complex assembly (GO:0140632)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
meiotic prophase I (GO:0007128)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
meiosis I (GO:0007127)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
serotonin secretion (GO:0001820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle switching (GO:0060184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female mating behavior (GO:0060180)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic cell apoptotic process (GO:2000669)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell apoptotic process (GO:2000668)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the C-end degron rule pathway (GO:0140627)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell development (GO:0072144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesangial cell development (GO:0072143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male mating behavior (GO:0060179)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of exocyst localization (GO:0060178)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
limb bud formation (GO:0060174)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endomitotic cell cycle (GO:0007113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
limb development (GO:0060173)	92	0	2.42	-	 < 0.01	1.78E-01	1.00E00
ribonucleoprotein complex disassembly (GO:0032988)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex disassembly (GO:0032986)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apolipoprotein binding (GO:2000656)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
condensed mesenchymal cell proliferation (GO:0072137)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of genetic imprinting (GO:2000653)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme morphogenesis (GO:0072134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme morphogenesis (GO:0072133)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
type IV hypersensitivity (GO:0001806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme morphogenesis (GO:0072131)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein autoubiquitination (GO:1902499)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenosine receptor signaling pathway (GO:0060168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein autoubiquitination (GO:1902498)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of adenosine receptor signaling pathway (GO:0060167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster transmembrane transport (GO:1902497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of timing of neuron differentiation (GO:0060164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine receptor signaling pathway (GO:0060161)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitotic centrosome separation (GO:0007100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine receptor signaling pathway (GO:0060160)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein insertion into membrane from inner side (GO:0032978)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
release of matrix enzymes from mitochondria (GO:0032976)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid transmembrane export from vacuole (GO:0032974)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of muscle filament sliding (GO:0032971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor catabolic process (GO:2000646)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor catabolic process (GO:2000645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of receptor catabolic process (GO:2000644)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of early endosome to late endosome transport (GO:2000643)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glomerular mesangial cell proliferation (GO:0072124)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to late endosome transport (GO:2000641)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine receptor signaling pathway (GO:0060159)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
milk ejection reflex (GO:0060156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
platelet dense granule organization (GO:0060155)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
microtubule-based peroxisome localization (GO:0060152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peroxisome localization (GO:0060151)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen biosynthetic process (GO:0032966)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
collagen biosynthetic process (GO:0032964)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
collagen metabolic process (GO:0032963)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of SREBP signaling pathway (GO:2000639)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SREBP signaling pathway (GO:2000638)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of primary miRNA processing (GO:2000635)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of primary miRNA processing (GO:2000634)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of pre-miRNA processing (GO:2000632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pronephros morphogenesis (GO:0072114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pre-miRNA processing (GO:2000631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA metabolic process (GO:2000630)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
podocyte differentiation (GO:0072112)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cell proliferation involved in kidney development (GO:0072111)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell proliferation (GO:0072110)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of post-transcriptional gene silencing (GO:0060149)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to synapse (GO:1902474)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
inositol trisphosphate biosynthetic process (GO:0032959)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inositol phosphate biosynthetic process (GO:0032958)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA catabolic process (GO:2000627)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glomerular mesangium development (GO:0072109)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ureteric peristalsis (GO:0072105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
glomerular capillary formation (GO:0072104)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature morphogenesis (GO:0072103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H4-K16 acetylation (GO:2000620)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal process involved in parturition (GO:0060137)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K27 trimethylation (GO:1902466)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 trimethylation (GO:1902464)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to cell leading edge (GO:1902463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal stem cell proliferation (GO:1902460)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H4-K16 acetylation (GO:2000619)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H4-K16 acetylation (GO:2000618)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
secretion by tissue (GO:0032941)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K9 acetylation (GO:2000617)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 acetylation (GO:2000616)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 acetylation (GO:2000615)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid-stimulating hormone secretion (GO:2000614)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid-stimulating hormone secretion (GO:2000612)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatotropin secreting cell differentiation (GO:0060126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of growth hormone secretion (GO:0060125)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inner ear receptor cell stereocilium organization (GO:0060122)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
bile acid biosynthetic process (GO:0006699)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell stereocilium organization (GO:0060121)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol biosynthetic process (GO:0006695)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
steroid biosynthetic process (GO:0006694)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukotriene metabolic process (GO:0006691)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
SREBP signaling pathway (GO:0032933)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of superoxide anion generation (GO:0032930)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
inner ear receptor cell development (GO:0060119)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell development (GO:0060118)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell development (GO:0060117)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell morphogenesis (GO:0060116)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vestibular receptor cell differentiation (GO:0060114)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
generation of ovulation cycle rhythm (GO:0060112)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ganglioside catabolic process (GO:0006689)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
protein localization to mitotic spindle pole body (GO:1902440)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycosphingolipid metabolic process (GO:0006687)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
sphingomyelin catabolic process (GO:0006685)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of superoxide anion generation (GO:0032929)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide anion generation (GO:0032928)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
galactosylceramide catabolic process (GO:0006683)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of activin receptor signaling pathway (GO:0032927)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
galactosylceramide biosynthetic process (GO:0006682)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
galactosylceramide metabolic process (GO:0006681)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glucosylceramide catabolic process (GO:0006680)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activin receptor signaling pathway (GO:0032924)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
putrescine acetylation (GO:0032920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of male mating behavior (GO:1902437)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of male mating behavior (GO:1902435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucosylceramide biosynthetic process (GO:0006679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phagocytosis, engulfment (GO:0060101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucosylceramide metabolic process (GO:0006678)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of phagocytosis, engulfment (GO:0060100)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glycosylceramide metabolic process (GO:0006677)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
spermine acetylation (GO:0032919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermidine acetylation (GO:0032918)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyamine acetylation (GO:0032917)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ceramide metabolic process (GO:0006672)	57	0	1.50	-	 < 0.01	4.06E-01	1.00E00
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phytosphingosine metabolic process (GO:0006671)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingosine metabolic process (GO:0006670)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta1 production (GO:0032914)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta1 production (GO:0032911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta3 production (GO:0032910)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
olfactory placode morphogenesis (GO:0071699)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory placode development (GO:0071698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in extracellular region (GO:0071694)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cardiac muscle thin filament assembly (GO:0071691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sphinganine-1-phosphate metabolic process (GO:0006668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphinganine metabolic process (GO:0006667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolipid metabolic process (GO:0006664)	59	0	1.55	-	 < 0.01	4.07E-01	1.00E00
regulation of transforming growth factor beta1 production (GO:0032908)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
platelet activating factor biosynthetic process (GO:0006663)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	67	0	1.76	-	 < 0.01	4.21E-01	1.00E00
transforming growth factor beta1 production (GO:0032905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine catabolic process (GO:0006660)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nerve growth factor production (GO:0032902)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotrophin production (GO:0032901)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurotrophin production (GO:0032900)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
TORC2 signaling (GO:0038203)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
organism emergence from protective structure (GO:0071684)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA binding (GO:1902416)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA binding (GO:1902415)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular response to indole-3-methanol (GO:0071681)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to indole-3-methanol (GO:0071680)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cytokinesis (GO:1902412)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine biosynthetic process (GO:0006659)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinetic process (GO:1902410)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
CDP-choline pathway (GO:0006657)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol biosynthetic process (GO:0006655)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
phosphatidic acid biosynthetic process (GO:0006654)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
diacylglycerol biosynthetic process (GO:0006651)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell lineage commitment (GO:0002296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper cell lineage commitment (GO:0002295)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell differentiation involved in immune response (GO:0002293)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
T cell differentiation involved in immune response (GO:0002292)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
olfactory bulb axon guidance (GO:0071678)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell chemotaxis (GO:0071671)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell chemotaxis (GO:0071670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride mobilization (GO:0006642)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol biosynthetic process (GO:0006640)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell activation involved in immune response (GO:0002287)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
T cell activation involved in immune response (GO:0002286)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
neutrophil activation involved in immune response (GO:0002283)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
microglial cell activation involved in immune response (GO:0002282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macrophage activation involved in immune response (GO:0002281)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA demethylation (GO:1990983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mast cell activation involved in immune response (GO:0002279)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
eosinophil activation involved in immune response (GO:0002278)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myeloid dendritic cell activation involved in immune response (GO:0002277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basophil activation involved in immune response (GO:0002276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myeloid cell activation involved in immune response (GO:0002275)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell differentiation (GO:0002273)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasmacytoid dendritic cell activation (GO:0002270)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte colony-stimulating factor production (GO:0071655)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein targeting to mitochondrion (GO:0006626)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
protein targeting to peroxisome (GO:0006625)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
vacuolar protein processing (GO:0006624)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole (GO:0006623)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome (GO:0006622)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
protein retention in ER lumen (GO:0006621)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
leukocyte activation involved in inflammatory response (GO:0002269)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
follicular dendritic cell differentiation (GO:0002268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
follicular dendritic cell activation (GO:0002266)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
astrocyte activation involved in immune response (GO:0002265)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell activation involved in immune response (GO:0002263)	67	0	1.76	-	 < 0.01	4.21E-01	1.00E00
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
modulation by host of RNA binding by virus (GO:1990968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
ATP generation from poly-ADP-D-ribose (GO:1990966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
xenobiotic transport across blood-brain barrier (GO:1990962)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ribosomal protein import into nucleus (GO:0006610)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
kinin cascade (GO:0002254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organ or tissue specific immune response (GO:0002251)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte chemotactic protein-1 production (GO:0071637)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta production (GO:0071635)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
eosinophil homeostasis (GO:1990959)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiotic cell cycle phase transition (GO:1901995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle phase transition (GO:1901994)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphocreatine metabolic process (GO:0006603)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle phase transition (GO:1901993)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intramanchette transport (GO:1990953)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
creatine biosynthetic process (GO:0006601)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte anergy (GO:0002249)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
creatine metabolic process (GO:0006600)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
wound healing involved in inflammatory response (GO:0002246)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte chemotaxis (GO:0071624)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte chemotaxis (GO:0071623)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphorylation of RNA polymerase II C-terminal domain serine 5 residues (GO:0071620)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein acetylation (GO:1901985)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein acetylation (GO:1901984)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of protein acetylation (GO:1901983)	64	0	1.68	-	 < 0.01	4.14E-01	1.00E00
positive regulation of defense response to virus by host (GO:0002230)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:0071619)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inward rectifier potassium channel activity (GO:1901979)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell cycle checkpoint (GO:1901978)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell cycle checkpoint (GO:1901977)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated immunity (GO:0002228)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
innate immune response in mucosa (GO:0002227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
toll-like receptor signaling pathway (GO:0002224)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta production (GO:0071604)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endothelial cell-cell adhesion (GO:0071603)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phytosphingosine biosynthetic process (GO:0071602)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
otic vesicle morphogenesis (GO:0071600)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium ion regulated lysosome exocytosis (GO:1990927)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
short-term synaptic potentiation (GO:1990926)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
defense response to nematode (GO:0002215)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
geranylgeranyl diphosphate metabolic process (GO:0033385)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
geranyl diphosphate metabolic process (GO:0033383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair involved in meiotic recombination (GO:1990918)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde dense core granule transport (GO:1901956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reactive nitrogen species metabolic process (GO:2001057)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde dense core granule transport (GO:1901954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	77	0	2.03	-	 < 0.01	2.69E-01	1.00E00
positive regulation of anterograde dense core granule transport (GO:1901953)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde dense core granule transport (GO:1901951)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal cell apoptotic process (GO:2001053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule transport (GO:1901950)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to psychosocial stress (GO:1990911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immune receptors (GO:0002200)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
positive regulation of MHC class II biosynthetic process (GO:0045348)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class II biosynthetic process (GO:0045347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class II biosynthetic process (GO:0045346)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of MHC class I biosynthetic process (GO:0045345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of MHC class I biosynthetic process (GO:0045343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of integrin-mediated signaling pathway (GO:2001046)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of integrin-mediated signaling pathway (GO:2001045)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of integrin-mediated signaling pathway (GO:2001044)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate catabolic process (GO:0045339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate metabolic process (GO:0045338)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
farnesyl diphosphate biosynthetic process (GO:0045337)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to secretory granule (GO:0033366)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mast cell secretory granule organization (GO:0033364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular glucuronidation (GO:2001031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
late viral transcription (GO:0019086)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
early viral transcription (GO:0019085)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carnitine biosynthetic process (GO:0045329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral transcription (GO:0019083)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport (GO:0045324)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of cellular glucuronidation (GO:2001029)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to drug (GO:2001025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to drug (GO:2001023)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
virus maturation (GO:0019075)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
viral RNA genome packaging (GO:0019074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
viral genome packaging (GO:0019072)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cholesterol efflux (GO:0033344)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde axon cargo transport (GO:2001019)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen binding (GO:0033342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collagen binding (GO:0033341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde axon cargo transport (GO:2001017)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle cell differentiation (GO:2001016)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell differentiation (GO:2001015)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell differentiation (GO:2001014)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in renal system development (GO:2001012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
virion assembly (GO:0019068)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis of virus by host cell (GO:0019065)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fusion of virus membrane with host plasma membrane (GO:0019064)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
virion attachment to host cell (GO:0019062)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
centriole replication (GO:0007099)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
centrosome cycle (GO:0007098)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
regulation of exit from mitosis (GO:0007096)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitotic spindle assembly checkpoint signaling (GO:0007094)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate catabolic process (GO:1901909)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine hexaphosphate metabolic process (GO:1901908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine pentaphosphate catabolic process (GO:1901907)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine pentaphosphate metabolic process (GO:1901906)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host cellular process (GO:0019054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell proliferation (GO:0001787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
suppression by virus of host apoptotic process (GO:0019050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell apoptotic process (GO:0001783)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
traversing start control point of mitotic cell cycle (GO:0007089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell homeostasis (GO:0001782)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
neutrophil homeostasis (GO:0001780)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear membrane reassembly (GO:0007084)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Leydig cell differentiation (GO:0033327)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid secretion (GO:0033326)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host process (GO:0019048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chromatin looping (GO:0140588)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
release from viral latency (GO:0019046)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
natural killer cell differentiation (GO:0001779)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
latent virus replication (GO:0019045)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
plasma membrane repair (GO:0001778)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
T cell homeostatic proliferation (GO:0001777)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of viral latency (GO:0019043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral latency (GO:0019042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere trimming (GO:0090737)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
microglial cell activation (GO:0001774)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
DNA repair complex assembly (GO:0090735)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitotic chromosome movement towards spindle pole (GO:0007079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic chromosome condensation (GO:0007076)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
UDP-D-xylose metabolic process (GO:0033319)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication checkpoint signaling (GO:0033314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle checkpoint signaling (GO:0033313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ascorbate homeostasis (GO:0140576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of T cell polarity (GO:0001768)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of lymphocyte polarity (GO:0001767)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metanephric renal vesicle formation (GO:0072093)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ureteric bud invasion (GO:0072092)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane raft assembly (GO:0001765)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
beta-alanine transport (GO:0001762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female meiosis sister chromatid cohesion (GO:0007066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response involving T cells and B cells (GO:0090721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary adaptive immune response (GO:0090720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of sister chromatid cohesion (GO:0007063)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
phytol metabolic process (GO:0033306)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male meiosis chromosome segregation (GO:0007060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extraction of mislocalized protein from ER membrane (GO:0140569)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal vesicle development (GO:0072087)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
organ induction (GO:0001759)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
somite specification (GO:0001757)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immunological memory formation process (GO:0090715)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
immunological memory process (GO:0090713)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spindle assembly involved in female meiosis (GO:0007056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nephron tubule formation (GO:0072079)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal vesicle morphogenesis (GO:0072077)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nephrogenic mesenchyme development (GO:0072076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric mesenchyme development (GO:0072075)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
kidney mesenchyme development (GO:0072074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
loop of Henle development (GO:0072070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens placode formation (GO:0001743)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction assembly (GO:0007044)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
lysosomal lumen acidification (GO:0007042)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
lysosomal transport (GO:0007041)	99	0	2.60	-	 < 0.01	1.86E-01	1.00E00
lysosome organization (GO:0007040)	62	0	1.63	-	 < 0.01	4.11E-01	1.00E00
regulation of metanephric mesenchymal cell migration (GO:2000589)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DCT cell differentiation (GO:0072069)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inner medullary collecting duct development (GO:0072061)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein catabolic process in the vacuole (GO:0007039)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of phagocytosis, engulfment (GO:0060099)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
formation of cytoplasmic translation initiation complex (GO:0001732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
formation of translation preinitiation complex (GO:0001731)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitotic cytokinesis checkpoint signaling (GO:0044878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
serotonin secretion, neurotransmission (GO:0060096)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuolar transport (GO:0007034)	128	0	3.37	-	 < 0.01	8.15E-02	1.00E00
endosome organization (GO:0007032)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
lipoprotein localization to membrane (GO:0044873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal outer medulla development (GO:0072054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal inner medulla development (GO:0072053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
juxtaglomerular apparatus development (GO:0072051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasm organization (GO:0007028)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell stereocilium organization (GO:0060088)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
relaxation of vascular associated smooth muscle (GO:0060087)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule depolymerization (GO:0007026)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral molecular function (GO:0044868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circadian temperature homeostasis (GO:0060086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic transmission involved in micturition (GO:0060084)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-chaperonin tubulin folding pathway (GO:0007023)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
smooth muscle contraction involved in micturition (GO:0060083)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eye blink reflex (GO:0060082)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tubulin complex assembly (GO:0007021)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
modulation by host of symbiont transcription (GO:0052472)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation (GO:0007020)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
inhibitory postsynaptic potential (GO:0060080)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
protein transport into plasma membrane raft (GO:0044861)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to plasma membrane raft (GO:0044860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neurotrophin production (GO:0032899)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neurotrophin production (GO:0032898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral transcription (GO:0032897)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of organic acid transport (GO:0032892)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell activation (GO:2000568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell activation (GO:2000567)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
reciprocal homologous recombination (GO:0140527)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
collecting duct development (GO:0072044)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
microtubule depolymerization (GO:0007019)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
ectodermal cell fate commitment (GO:0001712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endodermal cell fate commitment (GO:0001711)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate commitment (GO:0001710)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft organization (GO:0044857)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of resting membrane potential (GO:0060075)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
actin ubiquitination (GO:0007014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
micturition (GO:0060073)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
plasma membrane raft assembly (GO:0044854)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle elongation (GO:0032888)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spindle elongation (GO:0032887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polysaccharide biosynthetic process (GO:0032885)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
cholecystokinin signaling pathway (GO:0038188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polysaccharide metabolic process (GO:0032881)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell fate determination (GO:0001709)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
renal vesicle induction (GO:0072034)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 2 cell cytokine production (GO:2000551)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesoderm formation (GO:0001707)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
renal vesicle formation (GO:0072033)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endoderm formation (GO:0001706)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
ectoderm formation (GO:0001705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formation of primary germ layer (GO:0001704)	44	0	1.16	-	 < 0.01	6.30E-01	1.00E00
gastrulation with mouth forming second (GO:0001702)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
outer mitochondrial membrane organization (GO:0007008)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
vagina development (GO:0060068)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inner mitochondrial membrane organization (GO:0007007)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
oviduct development (GO:0060066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to bicellular tight junction (GO:1902396)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
uterus development (GO:0060065)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomerase (GO:0007004)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
nucleolus organization (GO:0007000)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment or maintenance of cell polarity (GO:0032878)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of DNA endoreduplication (GO:0032875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
connecting tubule development (GO:0072027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-17A-mediated signaling pathway (GO:0038173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granzyme-mediated programmed cell death signaling pathway (GO:0140507)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastrulation (GO:2000543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-33-mediated signaling pathway (GO:0038172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
distal convoluted tubule development (GO:0072025)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cannabinoid signaling pathway (GO:0038171)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
macula densa development (GO:0072024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein geranylgeranylation (GO:2000541)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thick ascending limb development (GO:0072023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ascending thin limb development (GO:0072021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic retina morphogenesis in camera-type eye (GO:0060059)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in mammary gland involution (GO:0060057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell quiescence (GO:0044838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammary gland involution (GO:0060056)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring organization (GO:0044837)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein glycosylation (GO:0060051)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein glycosylation (GO:0060050)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral RNA genome replication (GO:0044830)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein geranylgeranylation (GO:2000539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell chemotaxis (GO:2000538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of B cell chemotaxis (GO:2000537)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of entry of bacterium into host cell (GO:2000536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oncostatin-M-mediated signaling pathway (GO:0038165)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of entry of bacterium into host cell (GO:2000535)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
distal tubule development (GO:0072017)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thrombopoietin-mediated signaling pathway (GO:0038163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
erythropoietin-mediated signaling pathway (GO:0038162)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
podocyte development (GO:0072015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proximal tubule development (GO:0072014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CXCL12-activated CXCR4 signaling pathway (GO:0038160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerulus vasculature development (GO:0072012)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glomerular endothelium development (GO:0072011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular epithelium development (GO:0072010)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of protein glycosylation (GO:0060049)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA catabolic process (GO:1902374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of tRNA catabolic process (GO:1902371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal bipolar neuron differentiation (GO:0060040)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA catabolic process (GO:1902370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic telomere tethering at nuclear periphery (GO:0044821)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glomerular mesangial cell differentiation (GO:0072008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell costimulation (GO:2000525)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesangial cell differentiation (GO:0072007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell costimulation (GO:2000523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pericardium development (GO:0060039)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
pharyngeal system development (GO:0060037)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anatomical structure regression (GO:0060033)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte apoptotic process (GO:1902362)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by host of symbiont catalytic activity (GO:0052422)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular pH reduction (GO:0032848)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell chemotaxis (GO:2000510)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in organogenesis (GO:0060029)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in axis elongation (GO:0060028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
convergent extension involved in gastrulation (GO:0060027)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
convergent extension (GO:0060026)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic activity (GO:0060025)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
G-quadruplex DNA unwinding (GO:0044806)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
rhythmic synaptic transmission (GO:0060024)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
late nucleophagy (GO:0044805)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
soft palate development (GO:0060023)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
autophagy of nucleus (GO:0044804)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
phosphagen metabolic process (GO:0006599)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
polyamine catabolic process (GO:0006598)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Bergmann glial cell differentiation (GO:0060020)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
spermine biosynthetic process (GO:0006597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ornithine biosynthetic process (GO:0006592)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glomerular basement membrane development (GO:0032836)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
thyroid hormone generation (GO:0006590)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell chemotaxis (GO:2000508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ERBB2-ERBB4 signaling pathway (GO:0038135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ERBB2-EGFR signaling pathway (GO:0038134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel remodeling (GO:2000504)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ERBB2-ERBB3 signaling pathway (GO:0038133)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell chemotaxis (GO:2000503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell chemotaxis (GO:2000501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
radial glial cell differentiation (GO:0060019)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
astrocyte fate commitment (GO:0060018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
parathyroid gland development (GO:0060017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
righting reflex (GO:0060013)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of symbiont catalytic activity (GO:0052403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glycinergic (GO:0060012)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Sertoli cell proliferation (GO:0060011)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome condensation (GO:1902340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
indolalkylamine metabolic process (GO:0006586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catecholamine metabolic process (GO:0006584)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
acetylcholine catabolic process (GO:0006581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell differentiation (GO:0032825)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ethanolamine metabolic process (GO:0006580)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell differentiation (GO:0032823)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ERBB3 signaling pathway (GO:0038129)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERBB2 signaling pathway (GO:0038128)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in morphogenesis (GO:1902337)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vestibular reflex (GO:0060005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reflex (GO:0060004)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
copper ion export (GO:0060003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine biosynthetic process (GO:0006578)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine metabolic process (GO:0006577)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell proliferation (GO:0032819)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
valine catabolic process (GO:0006574)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
valine metabolic process (GO:0006573)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell proliferation (GO:0032817)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tyrosine catabolic process (GO:0006572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell activation (GO:0032816)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell activation (GO:0032815)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tyrosine metabolic process (GO:0006570)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell activation (GO:0032814)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of epinephrine secretion (GO:0032812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epinephrine secretion (GO:0032811)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-2-mediated signaling pathway (GO:0038110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
otic vesicle development (GO:0071599)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lymphocyte aggregation (GO:0071593)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tryptophan metabolic process (GO:0006568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-serine biosynthetic process (GO:0006564)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lacrimal gland development (GO:0032808)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-serine metabolic process (GO:0006563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proline catabolic process (GO:0006562)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proline biosynthetic process (GO:0006561)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proline metabolic process (GO:0006560)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Kit signaling pathway (GO:0038109)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
receptor catabolic process (GO:0032801)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein processing (GO:0071586)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detoxification of cadmium ion (GO:0071585)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication termination (GO:1902317)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transmembrane transport (GO:0071583)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nuclear cell cycle DNA replication initiation (GO:1902315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of zinc ion transport (GO:0071582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transmembrane import (GO:0071581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transmembrane transport (GO:0071580)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine catabolic process (GO:0006559)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-phenylalanine metabolic process (GO:0006558)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethionine biosynthetic process (GO:0006556)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
methionine metabolic process (GO:0006555)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
lysine metabolic process (GO:0006553)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leucine catabolic process (GO:0006552)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
leucine metabolic process (GO:0006551)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
isoleucine catabolic process (GO:0006550)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
IRES-dependent translational initiation of linear mRNA (GO:0002192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cap-dependent translational initiation (GO:0002191)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cap-independent translational initiation (GO:0002190)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of zinc ion transport (GO:0071579)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
zinc ion import across plasma membrane (GO:0071578)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
zinc ion transmembrane transport (GO:0071577)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-serine dephosphorylation (GO:1902308)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isoleucine metabolic process (GO:0006549)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histidine metabolic process (GO:0006547)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycine catabolic process (GO:0006546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine metabolic process (GO:0006544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamine biosynthetic process (GO:0006542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
translation reinitiation (GO:0002188)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational termination (GO:0002184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational initiation (GO:0002183)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translational elongation (GO:0002182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasmic translation (GO:0002181)	104	0	2.74	-	 < 0.01	1.17E-01	1.00E00
protein ufmylation (GO:0071569)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process (GO:0006538)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cysteine metabolic process (GO:0006534)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome segregation (GO:0051985)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
aspartate catabolic process (GO:0006533)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome segregation (GO:0051984)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
RNA acetylation (GO:1990884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aspartate biosynthetic process (GO:0006532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aspartate metabolic process (GO:0006531)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation (GO:1990882)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine catabolic process (GO:0006530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male germ cell proliferation (GO:0002176)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to paranode region of axon (GO:0002175)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
death-inducing signaling complex assembly (GO:0071550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine biosynthetic process (GO:0006529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
asparagine metabolic process (GO:0006528)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
arginine catabolic process (GO:0006527)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
arginine metabolic process (GO:0006525)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomerase activity (GO:0051974)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell proliferation (GO:1990874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
alanine metabolic process (GO:0006522)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase activity (GO:0051973)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amino acid metabolic process (GO:0006521)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase activity (GO:0051972)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
positive regulation of transmission of nerve impulse (GO:0051971)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of transmission of nerve impulse (GO:0051970)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
inositol phosphate catabolic process (GO:0071545)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diphosphoinositol polyphosphate metabolic process (GO:0071543)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transmission of nerve impulse (GO:0051969)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation (GO:0006517)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
glycoprotein catabolic process (GO:0006516)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
acinar cell proliferation (GO:1990863)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
desmosome assembly (GO:0002159)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
osteoclast proliferation (GO:0002158)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of thyroid hormone mediated signaling pathway (GO:0002157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid hormone mediated signaling pathway (GO:0002155)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
thyroid hormone mediated signaling pathway (GO:0002154)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
otolith mineralization (GO:0045299)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to centrosome (GO:0071539)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of cardiac muscle (GO:1901899)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to endothelin (GO:1990859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GPI anchor release (GO:0006507)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of cardiac muscle (GO:1901897)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
GPI anchor biosynthetic process (GO:0006506)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid transport (GO:0051957)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
GPI anchor metabolic process (GO:0006505)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of amino acid transport (GO:0051956)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid transport (GO:0051955)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of amine transport (GO:0051953)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
C-terminal protein lipidation (GO:0006501)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
N-terminal protein palmitoylation (GO:0006500)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA wobble position uridine thiolation (GO:0002143)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cementum mineralization (GO:0071529)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA re-export from nucleus (GO:0071528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adaptive thermogenesis (GO:1990845)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein depolymerization (GO:1901881)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinoic acid biosynthetic process (GO:0002138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
genomic imprinting (GO:0071514)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid import (GO:0051939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to endothelin (GO:1990839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-glutamate import (GO:0051938)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
catecholamine transport (GO:0051937)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of post-translational protein modification (GO:1901874)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake involved in synaptic transmission (GO:0051934)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of post-translational protein modification (GO:1901873)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to odorant (GO:1990834)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
slow axonal transport (GO:1990832)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base cytosine methylation (GO:0002127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal aggressive behavior (GO:0002125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inter-male aggressive behavior (GO:0002121)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to mycophenolic acid (GO:0071506)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to mycophenolic acid (GO:0071505)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to heparin (GO:0071504)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
secretion of lysosomal enzymes (GO:0033299)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to heparin (GO:0071503)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to temperature stimulus (GO:0071502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol depletion (GO:0071501)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrosative stress (GO:0071500)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle tissue development (GO:1901863)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
sulfation (GO:0051923)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle tissue development (GO:1901862)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of muscle tissue development (GO:1901861)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
basic amino acid transmembrane transport (GO:1990822)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
aggressive behavior (GO:0002118)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
store-operated calcium entry (GO:0002115)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA metabolic process (GO:1901859)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA metabolic process (GO:1901858)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibrinolysis (GO:0051918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular respiration (GO:1901857)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of fibrinolysis (GO:0051917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular respiration (GO:1901856)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to vitamin D (GO:0033280)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA wobble cytosine modification (GO:0002101)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
abortive mitotic cell cycle (GO:0033277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin-myosin filament sliding (GO:0033275)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to vitamin (GO:0033273)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
establishment of pigment granule localization (GO:0051905)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pigment granule transport (GO:0051904)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial depolarization (GO:0051902)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of high voltage-gated calcium channel activity (GO:1901841)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial depolarization (GO:0051901)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial depolarization (GO:0051900)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
protein palmitoleylation (GO:0045234)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA localization to nucleus (GO:0090685)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear cell cycle DNA replication (GO:0033262)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
nuclear DNA replication (GO:0033260)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
extracellular polysaccharide biosynthetic process (GO:0045226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4 production (GO:0045225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD4 production (GO:0045223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelial cell-matrix adhesion (GO:0090673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA localization to Cajal body (GO:0090670)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
zonula adherens maintenance (GO:0045218)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telomerase RNA stabilization (GO:0090669)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell-cell junction maintenance (GO:0045217)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
scaRNA localization to Cajal body (GO:0090666)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sarcomere organization (GO:0045214)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cerebrospinal fluid circulation (GO:0090660)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amine catabolic process (GO:0033242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amine catabolic process (GO:0033241)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amine metabolic process (GO:0033240)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
gastrin-induced gastric acid secretion (GO:0001698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine-induced gastric acid secretion (GO:0001697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gastric acid secretion (GO:0001696)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telomeric loop disassembly (GO:0090657)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
histamine catabolic process (GO:0001695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
t-circle formation (GO:0090656)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
MAPK export from nucleus (GO:0045204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histamine metabolic process (GO:0001692)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of neuroblast polarity (GO:0045200)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amine metabolic process (GO:0033239)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen-glucose deprivation (GO:0090650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amine metabolic process (GO:0033238)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein sumoylation (GO:0033235)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein sumoylation (GO:0033234)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of protein sumoylation (GO:0033233)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
beta-glucoside catabolic process (GO:1901805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
beta-glucoside metabolic process (GO:1901804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic spindle assembly checkpoint signaling (GO:0140499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to oxygen-glucose deprivation (GO:0090649)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid beta-oxidation (GO:0140493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA processing (GO:0090646)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-leader removal (GO:0001682)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dsRNA transport (GO:0033227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acrosome assembly (GO:0001675)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
iron import into cell (GO:0033212)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
adiponectin-activated signaling pathway (GO:0033211)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
leptin-mediated signaling pathway (GO:0033210)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
siRNA-mediated gene silencing by mRNA destabilization (GO:0090625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
conditioned taste aversion (GO:0001661)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
GCN2-mediated signaling (GO:0140469)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
HRI-mediated signaling (GO:0140468)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
integrated stress response signaling (GO:0140467)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
temperature homeostasis (GO:0001659)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster export from the mitochondrion (GO:0140466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA clamp unloading (GO:0090618)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metanephros development (GO:0001656)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin organization (GO:0140462)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA processing (GO:0090615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
suppression of viral release by host (GO:0044790)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-18-mediated signaling pathway (GO:2000493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoblast differentiation (GO:0001649)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
regulation of interleukin-18-mediated signaling pathway (GO:2000492)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytoplasm protein quality control (GO:0140455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatic stellate cell activation (GO:2000491)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein aggregate center assembly (GO:0140454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell activation (GO:2000490)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein targeting to Golgi apparatus (GO:0140450)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication (GO:0044786)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell activation (GO:2000489)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
signaling receptor ligand precursor processing (GO:0140448)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cytokine precursor processing (GO:0140447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
meiotic spindle checkpoint signaling (GO:0044779)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cAMP-dependent protein kinase activity (GO:2000479)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
protein stearoylation (GO:0140438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of opioid receptor signaling pathway (GO:2000474)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxidase activity (GO:2000470)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of entry into host (GO:0052372)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
uropod organization (GO:0032796)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of CREB transcription factor activity (GO:0032792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sequestering of BMP from receptor via BMP binding (GO:0038098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peroxidase activity (GO:2000468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen (starch) synthase activity (GO:2000467)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ribosome disassembly (GO:0032790)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen (starch) synthase activity (GO:2000466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Fc-epsilon receptor signaling pathway (GO:0038095)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen (starch) synthase activity (GO:2000465)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Fc receptor signaling pathway (GO:0038093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway (GO:0038092)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription, elongation (GO:0032785)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
bile acid secretion (GO:0032782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP-dependent activity (GO:0032780)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication termination (GO:1902294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle DNA replication initiation (GO:1902292)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
DNA methylation on cytosine (GO:0032776)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA methylation on adenine (GO:0032775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of tyrosinase activity (GO:0032773)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tyrosinase activity (GO:0032771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of monooxygenase activity (GO:0032770)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of primary amine oxidase activity (GO:1902283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of monooxygenase activity (GO:0032769)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of monooxygenase activity (GO:0032768)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell cytokine production (GO:0032765)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell cytokine production (GO:0032764)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell cytokine production (GO:0032763)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mast cell cytokine production (GO:0032762)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor production (GO:0032760)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein neddylation (GO:2000436)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
collagen-activated signaling pathway (GO:0038065)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein neddylation (GO:2000435)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protein neddylation (GO:2000434)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
NIK/NF-kappaB signaling (GO:0038061)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic amylase secretion (GO:1902277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA methylation or demethylation (GO:0044728)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic amylase secretion (GO:1902276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA demethylation of male pronucleus (GO:0044727)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chromatin reprogramming in the zygote (GO:0044725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
(R)-carnitine transmembrane transport (GO:1902270)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, substrate release (GO:0044721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-8 production (GO:0032757)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-5 production (GO:0032754)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-4 production (GO:0032753)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic cell clearance (GO:2000427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic cell clearance (GO:2000426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic cell clearance (GO:2000425)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil extravasation (GO:2000420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of polyamine transmembrane transport (GO:1902268)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-23 production (GO:0032747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-21 production (GO:0032745)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-2 production (GO:0032743)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil extravasation (GO:2000419)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-18 production (GO:0032741)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of eosinophil migration (GO:2000417)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-17 production (GO:0032740)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil migration (GO:2000416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of delayed rectifier potassium channel activity (GO:1902259)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-15 production (GO:0032738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-13 production (GO:0032736)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
N-glycan processing (GO:0006491)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-10 production (GO:0032733)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell extravasation (GO:2000409)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 production (GO:0032732)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 beta production (GO:0032731)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of T cell extravasation (GO:2000407)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-1 alpha production (GO:0032730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell migration (GO:2000405)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
signal transduction in absence of ligand (GO:0038034)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte migration (GO:2000402)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
geranylgeranyl diphosphate catabolic process (GO:1902247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate biosynthetic process (GO:0006489)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation (GO:0006487)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
positive regulation of interferon-gamma production (GO:0032729)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-beta production (GO:0032728)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of interferon-alpha production (GO:0032727)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
C-terminal protein methylation (GO:0006481)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal protein amino acid methylation (GO:0006480)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue growth factor production (GO:0032723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apolipoprotein A-I-mediated signaling pathway (GO:0038027)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor production (GO:0032720)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
reelin-mediated signaling pathway (GO:0038026)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
insulin receptor recycling (GO:0038020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of positive thymic T cell selection (GO:1902232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine sulfation (GO:0006478)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
protein sulfation (GO:0006477)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein deacetylation (GO:0006476)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
N-terminal protein amino acid acetylation (GO:0006474)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-8 production (GO:0032717)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein ADP-ribosylation (GO:0006471)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-6 production (GO:0032715)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-5 production (GO:0032714)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-4 production (GO:0032713)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Wnt receptor catabolic process (GO:0038018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin receptor internalization (GO:0038016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to laminar fluid shear stress (GO:0071499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to freezing (GO:0071497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-C (GO:0071494)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-B (GO:0071493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to UV-A (GO:0071492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ketone body metabolic process (GO:1902224)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to amine (GO:0014075)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to purine-containing compound (GO:0014074)	58	0	1.53	-	 < 0.01	4.07E-01	1.00E00
steroid hormone receptor complex assembly (GO:0006463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to isoquinoline alkaloid (GO:0014072)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-23 production (GO:0032707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-2 production (GO:0032703)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
TRAF-mediated signal transduction (GO:0038008)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
netrin-activated signaling pathway (GO:0038007)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-17 production (GO:0032700)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epidermal growth factor receptor ligand maturation (GO:0038004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocrine signaling (GO:0038002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
paracrine signaling (GO:0038001)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to high light intensity (GO:0071486)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to absence of light (GO:0071485)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid poly-ADP-ribosylation (GO:0018424)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to light intensity (GO:0071484)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to X-ray (GO:0071481)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of prolactin signaling pathway (GO:1902213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to gamma radiation (GO:0071480)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of prolactin signaling pathway (GO:1902211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 3-kinase signaling (GO:0014065)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of serotonin secretion (GO:0014064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of serotonin secretion (GO:0014063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin secretion (GO:0014062)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine secretion (GO:0014061)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
translational readthrough (GO:0006451)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of epinephrine secretion (GO:0014060)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of translational fidelity (GO:0006450)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
tRNA wobble uridine modification (GO:0002098)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base modification (GO:0002097)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
auditory receptor cell morphogenesis (GO:0002093)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor internalization (GO:0002091)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular hypotonic salinity response (GO:0071477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular hypotonic response (GO:0071476)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic salinity response (GO:0071475)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular hyperosmotic response (GO:0071474)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to salt stress (GO:0071472)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
C-terminal protein amino acid modification (GO:0018410)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translational termination (GO:0006449)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of translational elongation (GO:0006448)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane depolarization (GO:0051899)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine secretion, neurotransmission (GO:0014056)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of focal adhesion assembly (GO:0051895)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of gamma-aminobutyric acid secretion (GO:0014052)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid secretion (GO:0014051)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamate secretion (GO:0014050)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardioblast differentiation (GO:0051892)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glial cell derived neurotrophic factor (GO:1990792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens morphogenesis in camera-type eye (GO:0002089)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardioblast differentiation (GO:0051891)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion development (GO:1990791)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast differentiation (GO:0051890)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to glial cell derived neurotrophic factor (GO:1990790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diaphragm contraction (GO:0002086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein depalmitoylation (GO:0002084)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation (GO:0002082)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular response to alkaline pH (GO:0071469)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to acidic pH (GO:0071468)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to pH (GO:0071467)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrostatic pressure (GO:0071464)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to water stimulus (GO:0071462)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to redox state (GO:0071461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate secretion (GO:0014049)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate secretion (GO:0014048)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
valyl-tRNA aminoacylation (GO:0006438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamate secretion (GO:0014047)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
tyrosyl-tRNA aminoacylation (GO:0006437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dopamine secretion (GO:0014046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of endothelial blood-brain barrier (GO:0014045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hh target transcription factor activity (GO:1990787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
threonyl-tRNA aminoacylation (GO:0006435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to dsDNA (GO:1990786)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
seryl-tRNA aminoacylation (GO:0006434)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron maturation (GO:0014043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to water-immersion restraint stress (GO:1990785)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prolyl-tRNA aminoacylation (GO:0006433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron maturation (GO:0014042)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of timing of anagen (GO:0051884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to dsDNA (GO:1990784)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phenylalanyl-tRNA aminoacylation (GO:0006432)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of neuron maturation (GO:0014041)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
methionyl-tRNA aminoacylation (GO:0006431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell differentiation (GO:0014040)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
osteoblast development (GO:0002076)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell maturation (GO:0002071)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to hyperoxia (GO:0071455)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to superoxide (GO:0071451)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular response to oxygen radical (GO:0071450)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
leucyl-tRNA aminoacylation (GO:0006429)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell differentiation (GO:0014038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histidyl-tRNA aminoacylation (GO:0006427)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral element assembly (GO:0051878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNA aminoacylation (GO:0006425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glutamyl-tRNA aminoacylation (GO:0006424)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment granule localization (GO:0051875)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aspartyl-tRNA aminoacylation (GO:0006422)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell development (GO:0014031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
killing by host of symbiont cells (GO:0051873)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
asparaginyl-tRNA aminoacylation (GO:0006421)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell fate commitment (GO:0014030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
columnar/cuboidal epithelial cell maturation (GO:0002069)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
arginyl-tRNA aminoacylation (GO:0006420)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glandular epithelial cell development (GO:0002068)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
chondrocyte development (GO:0002063)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular response to hydroperoxide (GO:0071447)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K14 acetylation (GO:0071442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest formation (GO:0014029)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K14 acetylation (GO:0071440)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
alanyl-tRNA aminoacylation (GO:0006419)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for protein translation (GO:0006418)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
general adaptation syndrome, behavioral process (GO:0051867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
translational termination (GO:0006415)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
general adaptation syndrome (GO:0051866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
translational elongation (GO:0006414)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
neural plate elongation (GO:0014022)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myofibroblast contraction (GO:1990764)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoblast fate commitment (GO:0002051)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
maintenance of epithelial cell apical/basal polarity (GO:0045199)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity (GO:0045198)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of neuroblast polarity (GO:0045196)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
isotype switching (GO:0045190)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
tRNA export from nucleus (GO:0006409)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA export from nucleus (GO:0006408)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA export from nucleus (GO:0006407)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuroblast differentiation (GO:0014016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of signal transduction by p53 class mediator (GO:1901797)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus (GO:0006406)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
RNA export from nucleus (GO:0006405)	53	0	1.39	-	 < 0.01	6.47E-01	1.00E00
RNA import into nucleus (GO:0006404)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic spindle microtubule depolymerization (GO:1990755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system axon regeneration (GO:0014012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Schwann cell proliferation (GO:0014010)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tRNA modification (GO:0006400)	63	0	1.66	-	 < 0.01	4.13E-01	1.00E00
blood vessel endothelial cell migration involved in intussusceptive angiogenesis (GO:0002044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intussusceptive angiogenesis (GO:0002041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
zonula adherens assembly (GO:0045186)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell proliferation (GO:0071425)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
malate transmembrane transport (GO:0071423)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
succinate transmembrane transport (GO:0071422)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
manganese ion transmembrane transport (GO:0071421)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glial cell proliferation (GO:0014009)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
cellular response to histamine (GO:0071420)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular detoxification (GO:1990748)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
microglia development (GO:0014005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microglia differentiation (GO:0014004)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein sialylation (GO:1990743)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of L-glutamate import across plasma membrane (GO:0002038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of L-glutamate import across plasma membrane (GO:0002037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of L-glutamate import across plasma membrane (GO:0002036)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
brain renin-angiotensin system (GO:0002035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor internalization (GO:0002031)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
inhibitory G protein-coupled receptor phosphorylation (GO:0002030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to amine stimulus (GO:0071418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to purine-containing compound (GO:0071415)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
granulosa cell proliferation (GO:1990739)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytolysis by host of symbiont cells (GO:0051838)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of synapse structural plasticity (GO:0051835)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diet induced thermogenesis (GO:0002024)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
reduction of food intake in response to dietary excess (GO:0002023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cell fate commitment (GO:0045168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated sodium channels (GO:0045162)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to high density lipoprotein particle stimulus (GO:0071403)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to ATP (GO:0033198)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
cellular response to lipoprotein particle stimulus (GO:0071402)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
cellular response to triglyceride (GO:0071401)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to oleic acid (GO:0071400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to hydroperoxide (GO:0033194)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of synapse structural plasticity (GO:0051823)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of blood volume by renal aldosterone (GO:0002017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blood volume by renin-angiotensin (GO:0002016)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure (GO:0002014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone ubiquitination (GO:0033184)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
angiotensin maturation (GO:0002003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of angiotensin levels in blood (GO:0002002)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male anatomical structure morphogenesis (GO:0090598)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid segregation (GO:0045144)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
homologous chromosome segregation (GO:0045143)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
inflammatory response to wounding (GO:0090594)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
meiotic telomere clustering (GO:0045141)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone organization (GO:1990709)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
conditioned place preference (GO:1990708)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cholangiocyte proliferation (GO:1990705)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lactose biosynthetic process (GO:0005989)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myoblast fusion (GO:1901741)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lactose metabolic process (GO:0005988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of myoblast fusion (GO:1901740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleolar chromatin organization (GO:1990700)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen catabolic process (GO:0005981)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycogen catabolic process (GO:0005980)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
development of secondary sexual characteristics (GO:0045136)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of myoblast fusion (GO:1901739)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin A metabolic process (GO:1901738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen biosynthetic process (GO:0005979)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet aggregation (GO:1901731)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycogen biosynthetic process (GO:0005978)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
glycogen metabolic process (GO:0005977)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
polysaccharide metabolic process (GO:0005976)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
cellular extravasation (GO:0045123)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
T cell receptor V(D)J recombination (GO:0033153)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
NADPH oxidation (GO:0070995)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
immunoglobulin V(D)J recombination (GO:0033152)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
detection of oxidative stress (GO:0070994)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone deacetylase activity (GO:1901726)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
V(D)J recombination (GO:0033151)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in kidney development (GO:1901724)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in kidney development (GO:1901723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in kidney development (GO:1901722)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
azole transmembrane transport (GO:0045117)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein neddylation (GO:0045116)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of integrin biosynthetic process (GO:0045113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
integrin biosynthetic process (GO:0045112)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate filament bundle assembly (GO:0045110)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
oxidative demethylation (GO:0070989)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
error-free translesion synthesis (GO:0070987)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
left/right axis specification (GO:0070986)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-asparagine metabolic process (GO:0070982)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermediate filament organization (GO:0045109)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
intermediate filament polymerization or depolymerization (GO:0045105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K11-linked ubiquitination (GO:0070979)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
bone maturation (GO:0070977)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucokinase activity (GO:0033132)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in bone development (GO:1901706)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid transport (GO:0001579)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
microtubule bundle formation (GO:0001578)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
globoside biosynthetic process (GO:0001576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
globoside metabolic process (GO:0001575)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ganglioside biosynthetic process (GO:0001574)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
ganglioside metabolic process (GO:0001573)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
lactosylceramide biosynthetic process (GO:0001572)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell septum assembly (GO:0090529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament reorganization (GO:0090527)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to protozoan (GO:0001562)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fatty acid alpha-oxidation (GO:0001561)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle tethering involved in exocytosis (GO:0090522)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of cell growth by extracellular stimulus (GO:0001560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
podocyte cell migration (GO:0090521)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sphingolipid mediated signaling pathway (GO:0090520)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	76	0	2.00	-	 < 0.01	2.68E-01	1.00E00
neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of bacterium (GO:0070944)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil-mediated killing of symbiont cell (GO:0070943)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil mediated cytotoxicity (GO:0070942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
antibacterial innate immune response (GO:0140367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oocyte growth (GO:0001555)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ovarian cumulus expansion (GO:0001550)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tooth eruption (GO:0044691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CRD-mediated mRNA stabilization (GO:0070934)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
histone H4 deacetylation (GO:0070933)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
histone H3 deacetylation (GO:0070932)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lamellipodium morphogenesis (GO:2000394)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lamellipodium morphogenesis (GO:2000392)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil extravasation (GO:2000391)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
antral ovarian follicle growth (GO:0001547)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lipid import into cell (GO:0140354)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
primary ovarian follicle growth (GO:0001545)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ovarian follicle rupture (GO:0001543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ovulation from ovarian follicle (GO:0001542)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RISC complex assembly (GO:0070922)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of siRNA production (GO:0070921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil extravasation (GO:2000389)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of antral ovarian follicle growth (GO:2000388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antral ovarian follicle growth (GO:2000387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ovarian follicle development (GO:2000386)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of ectoderm development (GO:2000384)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ectoderm development (GO:2000383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
regulation of mesoderm development (GO:2000380)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UV-damage excision repair (GO:0070914)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of reactive oxygen species metabolic process (GO:2000379)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxygen metabolic process (GO:2000376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oxygen metabolic process (GO:2000374)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin-dependent endocytosis (GO:2000370)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
aminophospholipid translocation (GO:0140331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinoid metabolic process (GO:0001523)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pseudouridine synthesis (GO:0001522)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA methylation (GO:0070901)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-13 production (GO:0032696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA modification (GO:0070900)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-12 production (GO:0032695)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-10 production (GO:0032693)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin-dependent endocytosis (GO:2000369)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 production (GO:0032692)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 beta production (GO:0032691)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of acrosomal vesicle exocytosis (GO:2000367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-1 alpha production (GO:0032690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptide amidation (GO:0001519)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenocysteine incorporation (GO:0001514)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA methylation (GO:0001510)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
adhesion of symbiont to host cell (GO:0044650)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-gamma production (GO:0032689)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of interferon-alpha production (GO:0032687)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine production (GO:0032682)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of ovarian follicle development (GO:2000354)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell apoptotic process (GO:2000353)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neurotransmitter uptake (GO:0001504)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cartilage condensation (GO:0001502)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 dimethylation (GO:0044648)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-8 production (GO:0032677)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-5 production (GO:0032674)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-4 production (GO:0032673)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of CD40 signaling pathway (GO:2000348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte proliferation (GO:2000346)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
serine import into mitochondrion (GO:0140300)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-23 production (GO:0032667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-21 production (GO:0032665)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-2 production (GO:0032663)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-18 production (GO:0032661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-17 production (GO:0032660)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte apoptotic process (GO:1902174)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte apoptotic process (GO:1902173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte apoptotic process (GO:1902172)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to reactive nitrogen species (GO:1902170)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-15 production (GO:0032658)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-13 production (GO:0032656)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 production (GO:0032652)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 beta production (GO:0032651)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-1 alpha production (GO:0032650)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 cell differentiation (GO:2000321)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 cell differentiation (GO:2000320)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of interferon-alpha production (GO:0032647)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue growth factor production (GO:0032643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 cell differentiation (GO:2000319)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 17 type immune response (GO:2000318)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of T-helper 17 type immune response (GO:2000317)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tumor necrosis factor production (GO:0032640)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 17 type immune response (GO:2000316)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine methylation (GO:0018364)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-9 production (GO:0032638)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
termination of mitochondrial transcription (GO:0006393)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-8 production (GO:0032637)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription initiation at mitochondrial promoter (GO:0006391)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-6 production (GO:0032635)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial transcription (GO:0006390)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of ceramide biosynthetic process (GO:2000304)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of ceramide biosynthetic process (GO:2000303)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle exocytosis (GO:2000302)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein-pyridoxal-5-phosphate linkage (GO:0018352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to host defenses (GO:0052200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase III transcription (GO:0006386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcription initiation at RNA polymerase III promoter (GO:0006384)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase III (GO:0006383)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
adenosine to inosine editing (GO:0006382)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-21 production (GO:0032625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-2 production (GO:0032623)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein palmitoylation (GO:0018345)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
protein farnesylation (GO:0018343)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-12 production (GO:0032615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-10 production (GO:0032613)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-1 production (GO:0032612)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-1 beta production (GO:0032611)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
interleukin-1 alpha production (GO:0032610)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cholesterol (GO:0071397)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein succinylation (GO:0018335)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to testosterone stimulus (GO:0071394)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to progesterone stimulus (GO:0071393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to estradiol stimulus (GO:0071392)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cellular response to estrogen stimulus (GO:0071391)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase II transcription (GO:0006369)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
interferon-gamma production (GO:0032609)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
rRNA processing (GO:0006364)	164	0	4.31	-	 < 0.01	2.32E-02	1.00E00
interferon-beta production (GO:0032608)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
termination of RNA polymerase I transcription (GO:0006363)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interferon-alpha production (GO:0032607)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transcription elongation by RNA polymerase I (GO:0006362)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
transcription initiation at RNA polymerase I promoter (GO:0006361)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
transcription by RNA polymerase I (GO:0006360)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
chemokine production (GO:0032602)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to mineralocorticoid stimulus (GO:0071389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to cortisol stimulus (GO:0071387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to corticosterone stimulus (GO:0071386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of organelle assembly (GO:1902116)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin E stimulus (GO:0071380)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by RNA polymerase III (GO:0006359)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription termination (GO:0006353)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
intracellular transport of virus (GO:0075733)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral penetration into host nucleus (GO:0075732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to prostaglandin stimulus (GO:0071379)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein C-linked glycosylation via tryptophan (GO:0018317)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to glucagon stimulus (GO:0071377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to parathyroid hormone stimulus (GO:0071374)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine ADP-ribosylation (GO:0018312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to gonadotropin stimulus (GO:0071371)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hair follicle development (GO:0051799)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle development (GO:0051798)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA methylation-dependent heterochromatin formation (GO:0006346)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle development (GO:0051797)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid catabolic process (GO:0051793)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid biosynthetic process (GO:0051792)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty acid metabolic process (GO:0051791)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid biosynthetic process (GO:0051790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to epidermal growth factor stimulus (GO:0071364)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
cellular response to ethanol (GO:0071361)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to exogenous dsRNA (GO:0071360)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleosome disassembly (GO:0006337)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
DNA replication-dependent chromatin assembly (GO:0006335)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear division (GO:0051784)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break attachment to nuclear envelope (GO:1990683)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell division (GO:0051782)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
behavioral response to nutrient (GO:0051780)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to melanocyte-stimulating hormone (GO:1990680)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dsRNA (GO:0071359)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cellular response to type I interferon (GO:0071357)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	63	0	1.66	-	 < 0.01	4.13E-01	1.00E00
cellular response to interleukin-6 (GO:0071354)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-4 (GO:0071353)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-2 (GO:0071352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-18 (GO:0071351)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H4-K12 deacetylation (GO:1990679)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H4-K16 deacetylation (GO:1990678)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to redox state (GO:0051775)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-11 (GO:0071348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diphosphate metabolic process (GO:0071344)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
transposition, DNA-mediated (GO:0006313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin crosslink formation (GO:0051764)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitotic recombination (GO:0006312)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of hair follicle cell proliferation (GO:0071338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle cell proliferation (GO:0071336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
hair follicle cell proliferation (GO:0071335)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to fructose stimulus (GO:0071332)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
apoptotic DNA fragmentation (GO:0006309)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process (GO:0006308)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
DNA dealkylation involved in DNA repair (GO:0006307)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA methylation (GO:0006306)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
DNA alkylation (GO:0006305)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
DNA modification (GO:0006304)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion, centromeric (GO:0051754)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
postreplication repair (GO:0006301)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
cellular response to cGMP (GO:0071321)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to cAMP (GO:0071320)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
response to iron ion starvation (GO:1990641)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to ATP (GO:0071318)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to isoquinoline alkaloid (GO:0071317)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to nicotine (GO:0071316)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to morphine (GO:0071315)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to cocaine (GO:0071314)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to caffeine (GO:0071313)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to alkaloid (GO:0071312)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
iron coordination entity transport (GO:1901678)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K27 acetylation (GO:1901675)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
reproductive senescence (GO:1990636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 acetylation (GO:1901674)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic spindle assembly (GO:1901673)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of superoxide dismutase activity (GO:1901671)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulatory T cell differentiation (GO:0045066)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell differentiation (GO:0045064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell differentiation (GO:0045063)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin K (GO:0071307)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymic T cell selection (GO:0045061)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin D (GO:0071305)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative thymic T cell selection (GO:0045060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide dismutase activity (GO:1901668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of immature T cell proliferation in thymus (GO:0033092)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of immature T cell proliferation (GO:0033091)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein de-ADP-ribosylation (GO:0051725)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
quinone biosynthetic process (GO:1901663)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
quinone catabolic process (GO:1901662)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
quinone metabolic process (GO:1901661)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive thymic T cell selection (GO:0045059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
constitutive secretory pathway (GO:0045054)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein retention in Golgi apparatus (GO:0045053)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation in thymus (GO:0033088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of immature T cell proliferation (GO:0033087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell differentiation in thymus (GO:0033085)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycosyl compound biosynthetic process (GO:1901659)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of immature T cell proliferation in thymus (GO:0033084)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycosyl compound catabolic process (GO:1901658)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of immature T cell proliferation (GO:0033083)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycosyl compound metabolic process (GO:1901657)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
glycoside transport (GO:1901656)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immature T cell proliferation in thymus (GO:0033080)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome membrane (GO:0045046)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dopamine uptake (GO:0090494)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
catecholamine uptake (GO:0090493)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial intermembrane space (GO:0045041)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial outer membrane (GO:0045040)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
immature T cell proliferation (GO:0033079)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of killing of cells of another organism (GO:0051709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoside transmembrane transport (GO:1901642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dark adaptation (GO:1990603)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle membrane organization (GO:1901634)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle membrane organization (GO:1901632)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic membrane organization (GO:1901631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane fusion (GO:0045026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
G0 to G1 transition (GO:0045023)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
early endosome to late endosome transport (GO:0045022)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
dibasic protein processing (GO:0090472)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular pigmentation (GO:0033059)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
directional locomotion (GO:0033058)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic membrane organization (GO:1901629)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of postsynaptic membrane organization (GO:1901628)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposon integration (GO:0070895)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transposon integration (GO:0070894)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic membrane organization (GO:1901626)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial magnesium ion transmembrane transport (GO:0045016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
platelet alpha granule organization (GO:0070889)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
organic hydroxy compound catabolic process (GO:1901616)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle transport along microtubule (GO:1901610)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
DNA deamination (GO:0045006)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA-templated DNA replication maintenance of fidelity (GO:0045005)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via single-strand annealing (GO:0045002)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
polysaccharide localization (GO:0033037)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid cell apoptotic process (GO:0033034)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle transport along microtubule (GO:1901608)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid cell apoptotic process (GO:0033033)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen metabolic process (GO:0070875)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid cell apoptotic process (GO:0033032)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen metabolic process (GO:0070874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil apoptotic process (GO:0033031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen metabolic process (GO:0070873)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil apoptotic process (GO:0033030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamate ADP-deribosylation (GO:0140291)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil apoptotic process (GO:0033029)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
myeloid cell apoptotic process (GO:0033028)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell apoptotic process (GO:0033027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell apoptotic process (GO:0033026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell apoptotic process (GO:0033025)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mast cell apoptotic process (GO:0033024)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell homeostasis (GO:0033023)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein mono-ADP-ribosylation (GO:0140289)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
endosome fission (GO:0140285)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid biosynthetic process (GO:0070859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole catabolic process (GO:0033015)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid biosynthetic process (GO:0070857)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole biosynthetic process (GO:0033014)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
tetrapyrrole metabolic process (GO:0033013)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
hexose import across plasma membrane (GO:0140271)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation involved in immune response (GO:0033008)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell activation involved in immune response (GO:0033007)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to epidermal growth factor (GO:0070849)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell activation involved in immune response (GO:0033006)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell activation (GO:0033005)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell activation (GO:0033004)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Hsp90 deacetylation (GO:0070846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell activation (GO:0033003)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polyubiquitinated protein transport (GO:0070844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
misfolded protein transport (GO:0070843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aggresome assembly (GO:0070842)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
inclusion body assembly (GO:0070841)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
doxorubicin metabolic process (GO:0044598)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
daunorubicin metabolic process (GO:0044597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dehydroascorbic acid transport (GO:0070837)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
caveola assembly (GO:0070836)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
basement membrane assembly (GO:0070831)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of synapse maturation (GO:2000297)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide catabolic process (GO:2000295)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of defecation (GO:2000293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of defecation (GO:2000292)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell fusion (GO:0140253)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
oxidative stress-induced premature senescence (GO:0090403)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oncogene-induced cell senescence (GO:0090402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stress-induced premature senescence (GO:0090400)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
butyryl-CoA catabolic process (GO:0044580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular amino acid biosynthetic process (GO:2000283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein catabolic process at synapse (GO:0140246)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular amino acid biosynthetic process (GO:2000282)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron axonogenesis (GO:0048936)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translation at presynapse (GO:0140244)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron development (GO:0048935)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system neuron differentiation (GO:0048934)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
[2Fe-2S] cluster assembly (GO:0044571)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hydrogen sulfide metabolic process (GO:0070813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA biosynthetic process (GO:2000279)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
postsynaptic endocytosis (GO:0140239)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dIMP salvage (GO:0106385)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dAMP salvage (GO:0106383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of signaling receptor activity (GO:2000272)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of fibroblast apoptotic process (GO:2000271)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide salvage (GO:0106381)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast apoptotic process (GO:2000270)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lateral line system development (GO:0048925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide salvage (GO:0106380)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast hair cell differentiation (GO:0048923)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell proliferation (GO:0044565)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to defenses of other organism (GO:0052173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein transport into membrane raft (GO:0032596)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein transport within lipid bilayer (GO:0032594)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of fibroblast apoptotic process (GO:2000269)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast development (GO:0048919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
posterior lateral line development (GO:0048916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
posterior lateral line system development (GO:0048915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
relaxation of smooth muscle (GO:0044557)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome organization (GO:0032581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of male germ cell proliferation (GO:2000256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of male germ cell proliferation (GO:2000255)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of male germ cell proliferation (GO:2000254)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of feeding behavior (GO:2000253)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of feeding behavior (GO:2000252)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
guanine nucleotide transport (GO:0001408)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin cytoskeleton reorganization (GO:2000251)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-chain fatty acid import into cell (GO:0140214)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin cytoskeleton reorganization (GO:2000250)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import into cell (GO:0140213)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import into cell (GO:0140212)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
NLRP3 inflammasome complex assembly (GO:0044546)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of flagellated sperm motility (GO:1902093)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host apoptotic process (GO:0052150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton reorganization (GO:2000249)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
response to vitamin K (GO:0032571)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dipeptide import across plasma membrane (GO:0140206)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of reproductive process (GO:2000242)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
oligopeptide import across plasma membrane (GO:0140205)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import into cell (GO:0044539)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein-FAD linkage (GO:0018293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
snRNA methylation (GO:0106349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of rRNA processing (GO:2000234)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of rRNA processing (GO:2000233)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA processing (GO:2000232)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
endosome to plasma membrane protein transport (GO:0099638)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of lateral motor column neuron migration (GO:1902078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport (GO:0099637)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial mRNA stability (GO:0044528)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lateral motor column neuron migration (GO:1902076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to salt (GO:1902075)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to salt (GO:1902074)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902072)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor cycle (GO:0099630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pancreatic stellate cell proliferation (GO:2000229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of testosterone biosynthetic process (GO:2000225)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of testosterone biosynthetic process (GO:2000224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor diffusion trapping (GO:0099628)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid mediated signaling pathway (GO:1902068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor cycle (GO:0099627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell membrane repolarization (GO:0099625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to L-glutamate (GO:1902065)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell membrane repolarization (GO:0099624)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell membrane repolarization (GO:0099622)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial translation (GO:0032543)	86	0	2.26	-	 < 0.01	1.76E-01	1.00E00
negative regulation of glutamate metabolic process (GO:2000212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate metabolic process (GO:2000211)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of anoikis (GO:2000210)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to axon (GO:0099612)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing threshold (GO:0099611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mismatch repair (GO:0006298)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
action potential initiation (GO:0099610)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA gap filling (GO:0006297)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, preincision complex assembly (GO:0006294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell projection size (GO:0032536)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair (GO:0006290)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus assembly (GO:0032534)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus length (GO:0032532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of microvillus organization (GO:0032530)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribosomal subunit export from nucleus (GO:2000200)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing pattern (GO:0099608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of action potential firing rate (GO:0099605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Fas signaling pathway (GO:1902045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Fas signaling pathway (GO:1902044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair (GO:0006289)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
base-excision repair, DNA ligation (GO:0006288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
base-excision repair, gap-filling (GO:0006287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
base-excision repair, AP site formation (GO:0006285)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
microvillus organization (GO:0032528)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
transcription-coupled nucleotide-excision repair (GO:0006283)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein exit from endoplasmic reticulum (GO:0032527)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
somite rostral/caudal axis specification (GO:0032525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein-DNA covalent cross-linking repair (GO:0106300)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell differentiation (GO:1902036)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of hematopoietic stem cell proliferation (GO:1902033)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NADP metabolic process (GO:1902031)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA-templated DNA biosynthetic process (GO:0006278)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication termination (GO:0006274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lagging strand elongation (GO:0006273)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leading strand elongation (GO:0006272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
DNA replication initiation (GO:0006270)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
cellular response to vitamin (GO:0071295)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
tRNA exon ligation (GO:0000968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to zinc ion (GO:0071294)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
rRNA 5'-end processing (GO:0000967)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA 5'-end processing (GO:0000966)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
L-histidine transport (GO:1902024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 3'-end processing (GO:0000965)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA 5'-end processing (GO:0000964)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA processing (GO:0000963)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
DNA replication, synthesis of RNA primer (GO:0006269)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial RNA catabolic process (GO:0000960)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
DNA ligation (GO:0006266)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA topological change (GO:0006265)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA replication (GO:0006264)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA duplex unwinding (GO:0032508)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
cytokinetic process (GO:0032506)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
cellular response to mercury ion (GO:0071288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to manganese ion (GO:0071287)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cilium-dependent cell motility (GO:1902019)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular response to magnesium ion (GO:0071286)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cilium assembly (GO:1902018)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
cellular response to lithium ion (GO:0071285)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA catabolic process (GO:0000958)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA catabolic process (GO:0000957)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(III) ion (GO:0071283)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to iron(II) ion (GO:0071282)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to copper ion (GO:0071280)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
UDP-glucose catabolic process (GO:0006258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP catabolic process (GO:0006256)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CTP catabolic process (GO:0006254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cobalt ion (GO:0071279)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cadmium ion (GO:0071276)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
protein carboxylation (GO:0018214)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-tryptophan modification (GO:0018211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dCMP catabolic process (GO:0006249)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
CMP catabolic process (GO:0006248)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein delipidation (GO:0051697)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide catabolic process (GO:0006244)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
actin filament uncapping (GO:0051695)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pointed-end actin filament capping (GO:0051694)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament capping (GO:0051693)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
CTP biosynthetic process (GO:0006241)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular oligosaccharide catabolic process (GO:0051692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K69-linked ufmylation (GO:1990592)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
dCDP biosynthetic process (GO:0006240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular oligosaccharide metabolic process (GO:0051691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage (GO:0071267)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-methionine modification (GO:0018206)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
L-methionine biosynthetic process (GO:0071265)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine modification (GO:0018202)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to starvation (GO:0071262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-glycine modification (GO:0018201)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid modification (GO:0018200)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
dTTP biosynthetic process (GO:0006235)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of ER localization (GO:0051686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of ER location (GO:0051685)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dTDP biosynthetic process (GO:0006233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of Golgi location (GO:0051684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of Golgi localization (GO:0051683)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
dTMP biosynthetic process (GO:0006231)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to electrical stimulus (GO:0071257)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
UTP biosynthetic process (GO:0006228)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dUDP biosynthetic process (GO:0006227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dUMP biosynthetic process (GO:0006226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP biosynthetic process (GO:0006225)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
UMP biosynthetic process (GO:0006222)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide biosynthetic process (GO:0006221)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
cellular response to chromate (GO:0071247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
division septum assembly (GO:0000917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenic-containing substance (GO:0071243)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular response to ammonium ion (GO:0071242)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actomyosin contractile ring assembly (GO:0000915)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutamatergic neuron differentiation (GO:1905962)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
uridine catabolic process (GO:0006218)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytidine catabolic process (GO:0006216)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
actin cortical patch localization (GO:0051666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thymidine catabolic process (GO:0006214)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane raft localization (GO:0051665)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside metabolic process (GO:0006213)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nuclear pore localization (GO:0051664)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein polyufmylation (GO:1990564)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
uracil catabolic process (GO:0006212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
5-methylcytosine catabolic process (GO:0006211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymine catabolic process (GO:0006210)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of centrosome location (GO:0051661)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to antibiotic (GO:0071236)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to alcohol (GO:1905957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to leucine (GO:0071233)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
maintenance of organelle location (GO:0051657)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
IMP catabolic process (GO:0006204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dGTP catabolic process (GO:0006203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of mitochondrion localization (GO:0051654)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
GMP catabolic process to guanine (GO:0006202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to tumor cell (GO:0071228)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to muramyl dipeptide (GO:0071225)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to peptidoglycan (GO:0071224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of response to calcium ion (GO:1905945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to lipoteichoic acid (GO:0071223)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	62	0	1.63	-	 < 0.01	4.11E-01	1.00E00
cellular response to bacterial lipopeptide (GO:0071221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to bacterial lipoprotein (GO:0071220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonad development (GO:1905940)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial NAD transmembrane transport (GO:1990549)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of acid-sensing ion channel activity (GO:1901586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion localization (GO:0051646)	44	0	1.16	-	 < 0.01	6.30E-01	1.00E00
regulation of acid-sensing ion channel activity (GO:1901585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi localization (GO:0051645)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
mitochondrial ATP transmembrane transport (GO:1990544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum localization (GO:0051643)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	65	0	1.71	-	 < 0.01	4.16E-01	1.00E00
positive regulation of germ cell proliferation (GO:1905938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to biotic stimulus (GO:0071216)	78	0	2.05	-	 < 0.01	2.71E-01	1.00E00
negative regulation of germ cell proliferation (GO:1905937)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of germ cell proliferation (GO:1905936)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein targeting to vacuole involved in autophagy (GO:0071211)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament network formation (GO:0051639)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament uncapping (GO:0051638)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative transport (GO:1901571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to juxtaparanode region of axon (GO:0071205)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of acetylcholine biosynthetic process (GO:1905923)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acetylcholine biosynthetic process (GO:1905921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid derivative catabolic process (GO:1901569)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of CoA-transferase activity (GO:1905920)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epinephrine uptake (GO:0051625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to camptothecin (GO:1901563)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to benomyl (GO:1901561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of norepinephrine uptake (GO:0051621)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
norepinephrine uptake (GO:0051620)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CoA-transferase activity (GO:1905918)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion export across plasma membrane (GO:1905913)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion export across plasma membrane (GO:1905912)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to metformin (GO:1901558)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histamine uptake (GO:0051615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell development (GO:1901552)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
piRNA biosynthetic process (GO:1990511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin uptake (GO:0051610)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
replicative senescence (GO:0090399)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular senescence (GO:0090398)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of excitatory postsynaptic potential (GO:0090394)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid fibril formation (GO:1905908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid fibril formation (GO:1905907)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid fibril formation (GO:1905906)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dense core granule exocytosis (GO:1990504)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to electrical stimulus (GO:0051602)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
exocyst localization (GO:0051601)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome fusion (GO:0090385)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
phagosome-lysosome docking (GO:0090384)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagosome acidification (GO:0090383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phagosome maturation (GO:0090382)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
changes to DNA methylation involved in embryo development (GO:1901538)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA demethylation (GO:1901536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol efflux (GO:0090370)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion channel activity (GO:1901529)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitophagy (GO:1901525)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
icosanoid catabolic process (GO:1901523)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to biotin (GO:0070781)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-aspartate import across plasma membrane (GO:0070779)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
L-aspartate transmembrane transport (GO:0070778)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
D-aspartate transport (GO:0070777)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial tube morphogenesis (GO:1901509)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of acylglycerol transport (GO:1901508)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of acylglycerol transport (GO:1901506)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell differentiation (GO:0048886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromast development (GO:0048884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular organofluorine metabolic process (GO:0090346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular organohalogen metabolic process (GO:0090345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral line development (GO:0048882)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mechanosensory lateral line system development (GO:0048881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
homeostasis of number of retina cells (GO:0048877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
host-mediated regulation of intestinal microbiota composition (GO:0048874)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet aggregation (GO:0090331)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of platelet aggregation (GO:0090330)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated DNA replication (GO:0090329)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of locomotion involved in locomotory behavior (GO:0090325)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative phosphorylation (GO:0090324)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
leukemia inhibitory factor signaling pathway (GO:0048861)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of superoxide metabolic process (GO:0090322)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to interleukin-6 (GO:0070741)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
formation of anatomical boundary (GO:0048859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular protein transport (GO:0090317)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
brain morphogenesis (GO:0048854)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
forebrain morphogenesis (GO:0048853)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein targeting to membrane (GO:0090315)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein targeting to membrane (GO:0090314)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of protein targeting to membrane (GO:0090313)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA methylation-dependent heterochromatin formation (GO:0090310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K27 methylation (GO:0070734)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cGMP transport (GO:0070731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cAMP transport (GO:0070730)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ribonucleoprotein complex localization (GO:2000197)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of female gonad development (GO:2000196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of female gonad development (GO:2000195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of female gonad development (GO:2000194)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ammonium import across plasma membrane (GO:0140157)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of fatty acid transport (GO:2000193)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA methylation-dependent heterochromatin formation (GO:0090309)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of DNA methylation-dependent heterochromatin formation (GO:0090308)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
mitotic spindle assembly (GO:0090307)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
meiotic spindle assembly (GO:0090306)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
otolith development (GO:0048840)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of neural crest formation (GO:0090301)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide transport (GO:0070729)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor internalization (GO:0099590)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
response to cholesterol (GO:0070723)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of progesterone biosynthetic process (GO:2000182)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of androgen biosynthetic process (GO:2000180)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial potassium ion transmembrane transport (GO:0140141)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of postsynaptic cytosolic calcium concentration (GO:0099588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sodium-dependent organic cation transport (GO:0070715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pro-T cell differentiation (GO:2000174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite development (GO:2000171)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
formation of extrachromosomal circular DNA (GO:0001325)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte development (GO:0048822)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
erythrocyte development (GO:0048821)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of lipopolysaccharide (GO:0032497)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to muramyl dipeptide (GO:0032495)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to peptidoglycan (GO:0032494)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipoprotein (GO:0032493)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in neural tube closure (GO:2000168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of molecule of bacterial origin (GO:0032490)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000164)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hair follicle maturation (GO:0048819)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytosol to ERGIC protein transport (GO:0106273)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000162)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to ERGIC (GO:0106272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
motile cilium assembly (GO:0044458)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
modification of synaptic structure, modulating synaptic transmission (GO:0099564)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modification of synaptic structure (GO:0099563)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
maintenance of postsynaptic density structure (GO:0099562)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Cdc42 protein signal transduction (GO:0032489)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
Cdc42 protein signal transduction (GO:0032488)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of Rap protein signal transduction (GO:0032487)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Ral protein signal transduction (GO:0032485)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Ral protein signal transduction (GO:0032484)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of Rab protein signal transduction (GO:0032483)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000159)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Rab protein signal transduction (GO:0032482)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin-specific protease activity (GO:2000158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of type I interferon production (GO:0032481)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium-dependent cell motility (GO:2000155)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male genitalia morphogenesis (GO:0048808)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin-specific protease activity (GO:2000152)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
female genitalia morphogenesis (GO:0048807)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
genitalia development (GO:0048806)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular vesicle biogenesis (GO:0140112)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
otolith morphogenesis (GO:0032474)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000149)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion transport (GO:0032472)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated transcription initiation (GO:2000143)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamine modification (GO:0018199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine modification (GO:0018198)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid modification (GO:0018197)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine modification (GO:0018196)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by nitric oxide (GO:0099548)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-alanine modification (GO:0018194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein catabolic process, modulating synaptic transmission (GO:0099546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by soluble gas (GO:0099543)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation by symbiont of host programmed cell death (GO:0052041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by neuropeptide (GO:0099540)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host programmed cell death (GO:0052040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi calcium ion homeostasis (GO:0032468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokinesis (GO:0032466)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein homooligomerization (GO:0032464)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein homooligomerization (GO:0032463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein homooligomerization (GO:0032462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein oligomerization (GO:0032461)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein oligomerization (GO:0032460)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic signaling via neuropeptide (GO:0099538)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle endosomal processing (GO:0099532)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of protein oligomerization (GO:0032459)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
slow endocytic recycling (GO:0032458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocytic recycling (GO:0032456)	54	0	1.42	-	 < 0.01	6.50E-01	1.00E00
regulation of endocannabinoid signaling pathway (GO:2000124)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sodium-dependent phosphate transport (GO:2000120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein depropionylation (GO:0106230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein nucleotidylation (GO:0018175)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
postsynapse to nucleus signaling pathway (GO:0099527)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
presynapse to nucleus signaling pathway (GO:0099526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
translocation of molecules into host (GO:0044417)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
presynaptic dense core vesicle exocytosis (GO:0099525)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine oxidation (GO:0018171)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein urmylation (GO:0032447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sodium-dependent phosphate transport (GO:2000118)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine glutarylation (GO:0106227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of cell polarity (GO:2000114)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage apoptotic process (GO:2000111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage apoptotic process (GO:2000110)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dense core granule cytoskeletal transport (GO:0099519)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	53	0	1.39	-	 < 0.01	6.47E-01	1.00E00
entry into host (GO:0044409)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle transport along microtubule (GO:0099517)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
actin filament-based transport (GO:0099515)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
adhesion of symbiont to host (GO:0044406)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle cytoskeletal transport (GO:0099514)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cAMP catabolic process (GO:0006198)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMP catabolic process (GO:0006196)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleotide catabolic process (GO:0006195)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
melanosome organization (GO:0032438)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
ITP catabolic process (GO:0006193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage apoptotic process (GO:2000109)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte apoptotic process (GO:2000108)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte apoptotic process (GO:2000107)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase A2 activity (GO:0032430)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA C3-cytosine methylation (GO:0106217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte apoptotic process (GO:2000106)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-templated DNA replication (GO:2000105)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA-templated DNA replication (GO:2000104)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein oxidation (GO:0018158)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium-dependent activation of synaptic vesicle fusion (GO:0099502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
'de novo' IMP biosynthetic process (GO:0006189)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
IMP biosynthetic process (GO:0006188)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
dGDP biosynthetic process (GO:0006185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase A2 activity (GO:0032429)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
polar body extrusion after meiotic divisions (GO:0040038)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
GTP biosynthetic process (GO:0006183)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cGMP biosynthetic process (GO:0006182)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mismatch repair (GO:0032425)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mismatch repair (GO:0032423)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
post-embryonic body morphogenesis (GO:0040032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
snRNA modification (GO:0040031)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking (GO:0018149)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
keratan sulfate biosynthetic process (GO:0018146)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleic acid-protein covalent cross-linking (GO:0018143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein-DNA covalent cross-linking (GO:0018142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine salvage (GO:0006178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GMP biosynthetic process (GO:0006177)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
dATP biosynthetic process (GO:0006175)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ADP biosynthetic process (GO:0006172)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dAMP biosynthetic process (GO:0006170)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adenine salvage (GO:0006168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMP biosynthetic process (GO:0006167)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside salvage (GO:0006166)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate phosphorylation (GO:0006165)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of multicellular organism growth (GO:0040015)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
deoxyguanosine catabolic process (GO:0006161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanosome transport (GO:0032402)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
establishment of melanosome localization (GO:0032401)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of growth rate (GO:0040010)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
melanosome localization (GO:0032400)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine methylation (GO:0018125)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of growth rate (GO:0040009)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
adenosine catabolic process (GO:0006154)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleoside catabolic process (GO:0006152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-nitrosylation (GO:0018119)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein adenylylation (GO:0018117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic spindle checkpoint signaling (GO:0071174)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
spindle assembly checkpoint signaling (GO:0071173)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to hydrostatic pressure (GO:0051599)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
guanine catabolic process (GO:0006147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to methylmercury (GO:0051597)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleobase catabolic process (GO:0006145)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process (GO:0051596)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
purine nucleobase metabolic process (GO:0006144)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to methylglyoxal (GO:0051595)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H4-R3 methylation (GO:0043985)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H4-K16 acetylation (GO:0043984)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
response to folic acid (GO:0051593)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H4-K12 acetylation (GO:0043983)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide metabolic process (GO:0006140)	52	0	1.37	-	 < 0.01	6.45E-01	1.00E00
histone H4-K8 acetylation (GO:0043982)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
response to cAMP (GO:0051591)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
histone H4-K5 acetylation (GO:0043981)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter transport (GO:0051590)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
viral translational termination-reinitiation (GO:0075525)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
viral translational frameshifting (GO:0075523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to chromatin (GO:0071169)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ribonucleoprotein complex localization (GO:0071166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride transport (GO:1905885)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein C-linked glycosylation (GO:0018103)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride transport (GO:1905883)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H2B-K5 acetylation (GO:0043979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dopamine uptake involved in synaptic transmission (GO:0051583)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 acetylation (GO:0043973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotransmitter uptake (GO:0051582)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K23 acetylation (GO:0043972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA pseudouridine synthesis (GO:1990481)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 acetylation (GO:0043970)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of oogenesis (GO:1905879)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell leading edge (GO:1905873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell leading edge (GO:1905871)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of arginine metabolic process (GO:0000821)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycerophosphate shuttle (GO:0006127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamine family amino acid metabolic process (GO:0000820)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
histone H2A acetylation (GO:0043968)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
histone H3 acetylation (GO:0043966)	52	0	1.37	-	 < 0.01	6.45E-01	1.00E00
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 methylation (GO:0051573)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K4 methylation (GO:0051572)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 methylation (GO:0051571)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid beta-oxidation (GO:0031999)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocytosis involved in viral entry into host cell (GO:0075509)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mRNA export from nucleus in response to heat stress (GO:0031990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
oxidative phosphorylation (GO:0006119)	90	0	2.37	-	 < 0.01	1.77E-01	1.00E00
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 methylation (GO:0051569)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
acetaldehyde metabolic process (GO:0006117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 methylation (GO:0051568)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
NADH oxidation (GO:0006116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process (GO:0006114)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fermentation (GO:0006113)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
energy reserve metabolic process (GO:0006112)	42	0	1.10	-	 < 0.01	6.28E-01	1.00E00
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of glycolytic process (GO:0006110)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
resolution of recombination intermediates (GO:0071139)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pentose-phosphate shunt (GO:1905857)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of pentose-phosphate shunt (GO:1905856)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate binding (GO:1905855)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate binding (GO:1905853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
malate metabolic process (GO:0006108)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
oxaloacetate metabolic process (GO:0006107)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
fumarate metabolic process (GO:0006106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
succinate metabolic process (GO:0006105)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA metabolic process (GO:0006104)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
2-oxoglutarate metabolic process (GO:0006103)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
isocitrate metabolic process (GO:0006102)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
citrate metabolic process (GO:0006101)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphangiogenesis (GO:1901491)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular stress response to acidic pH (GO:1990451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to gamma radiation (GO:1905843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte migration (GO:0051549)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte migration (GO:0051548)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte migration (GO:0051547)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
keratinocyte migration (GO:0051546)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription factor catabolic process (GO:1901485)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of transcription factor catabolic process (GO:1901483)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
peptidyl-threonine autophosphorylation (GO:1990443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
elastin biosynthetic process (GO:0051542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
elastin metabolic process (GO:0051541)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ossification involved in bone maturation (GO:0043931)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule nucleation (GO:1905833)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of spindle assembly (GO:1905832)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
U6 2'-O-snRNA methylation (GO:1990438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
snRNA 2'-O-methylation (GO:1990437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate transmembrane transport (GO:1901475)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation by host of viral transcription (GO:0043923)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation by host of viral transcription (GO:0043922)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
modulation by host of viral transcription (GO:0043921)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid receptor signaling pathway (GO:0031959)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
corticosteroid receptor signaling pathway (GO:0031958)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autophosphorylation (GO:0031953)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
superior temporal gyrus development (GO:0071109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to parathyroid hormone (GO:0071107)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to interleukin-11 (GO:0071105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA conformation change (GO:0071103)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromosome condensation (GO:1905821)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
miRNA transport (GO:1990428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of tetrapyrrole biosynthetic process (GO:1901465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic recombination-dependent replication fork processing (GO:1990426)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole biosynthetic process (GO:1901463)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromosome separation (GO:1905819)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
response to insulin-like growth factor stimulus (GO:1990418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of biological process involved in symbiotic interaction (GO:0043903)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of unidimensional cell growth (GO:0051511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of unidimensional cell growth (GO:0051510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neural crest formation (GO:0090299)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial DNA replication (GO:0090298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial DNA replication (GO:0090297)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondria-nucleus signaling pathway (GO:0031930)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial DNA replication (GO:0090296)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of osteoclast proliferation (GO:0090290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcitonin gene-related peptide receptor signaling pathway (GO:1990408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic brain development (GO:1990403)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
embryonic liver development (GO:1990402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic lung development (GO:1990401)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of osteoclast proliferation (GO:0090289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion import (GO:0090281)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion import (GO:0090280)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic plasticity (GO:0031914)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of somatostatin secretion (GO:0090275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast growth factor production (GO:0090272)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor production (GO:0090269)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of transcription-coupled nucleotide-excision repair (GO:0090262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inclusion body assembly (GO:0090261)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to alcohol (GO:1901419)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proteasome regulatory particle assembly (GO:0070682)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
animal organ maturation (GO:0048799)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial fission (GO:0090258)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pronephros development (GO:0048793)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spontaneous exocytosis of neurotransmitter (GO:0048792)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of presynaptic active zone structure (GO:0048790)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization involved in establishment of planar polarity (GO:0090251)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intralumenal vesicle formation (GO:0070676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to interleukin-18 (GO:0070673)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of tetrapyrrole metabolic process (GO:1901403)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to interleukin-4 (GO:0070670)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of tetrapyrrole metabolic process (GO:1901401)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell migration involved in somitogenic axis elongation (GO:0090249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axis elongation involved in somitogenesis (GO:0090245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in somitogenesis (GO:0090244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H4 acetylation (GO:0090241)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H4 acetylation (GO:0090240)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to interleukin-2 (GO:0070669)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell proliferation (GO:0070668)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell proliferation (GO:0070667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mast cell proliferation (GO:0070666)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mast cell proliferation (GO:0070662)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H4 acetylation (GO:0090239)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of arachidonic acid secretion (GO:0090238)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of arachidonic acid secretion (GO:0090237)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
erythrophore differentiation (GO:0048773)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of metaphase plate congression (GO:0090235)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of kinetochore assembly (GO:0090234)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of spindle checkpoint (GO:0090233)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of spindle checkpoint (GO:0090232)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of spindle checkpoint (GO:0090231)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of centromere complex assembly (GO:0090230)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin filament bundle distribution (GO:0070650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of spindle organization (GO:0090224)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
centrosome-templated microtubule nucleation (GO:0090222)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
formin-nucleated actin cable assembly (GO:0070649)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vitamin D3 metabolic process (GO:0070640)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine butyrylation (GO:0140067)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine crotonylation (GO:0140066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment granule maturation (GO:0048757)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
branching morphogenesis of a nerve (GO:0048755)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090217)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment granule organization (GO:0048753)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
semicircular canal morphogenesis (GO:0048752)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of blood-brain barrier (GO:0090210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin cortical patch organization (GO:0044396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transepithelial ammonium transport (GO:0070634)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride metabolic process (GO:0090209)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride metabolic process (GO:0090208)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride metabolic process (GO:0090207)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
mitochondrial gene expression (GO:0140053)	105	0	2.76	-	 < 0.01	1.17E-01	1.00E00
negative regulation of cholesterol metabolic process (GO:0090206)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber development (GO:0048743)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol metabolic process (GO:0090205)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber development (GO:0048742)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
glucose import in response to insulin stimulus (GO:0044381)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
zymogen granule exocytosis (GO:0070625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoskeleton (GO:0044380)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
appendage development (GO:0048736)	92	0	2.42	-	 < 0.01	1.78E-01	1.00E00
lipid droplet formation (GO:0140042)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epidermis morphogenesis (GO:0048730)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome size (GO:0044375)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of type B pancreatic cell development (GO:2000078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion in response to extracellular stimulus (GO:0140039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of type B pancreatic cell development (GO:2000074)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of centromeric sister chromatid cohesion (GO:0070602)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
centromeric sister chromatid cohesion (GO:0070601)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA geometric change (GO:0032392)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cortisol biosynthetic process (GO:2000065)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cortisol biosynthetic process (GO:2000064)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte differentiation (GO:0048715)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial ADP transmembrane transport (GO:0140021)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of astrocyte differentiation (GO:0048712)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of astrocyte differentiation (GO:0048711)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of rRNA stability (GO:0044357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macropinocytosis (GO:0044351)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular transport (GO:0032387)	46	0	1.21	-	 < 0.01	6.33E-01	1.00E00
positive regulation of intracellular cholesterol transport (GO:0032385)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular cholesterol transport (GO:0032384)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular cholesterol transport (GO:0032383)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular sterol transport (GO:0032382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular sterol transport (GO:0032381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular sterol transport (GO:0032380)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of non-canonical Wnt signaling pathway (GO:2000050)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
embryonic viscerocranium morphogenesis (GO:0048703)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
embryonic neurocranium morphogenesis (GO:0048702)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic cranial skeleton morphogenesis (GO:0048701)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular lipid transport (GO:0032379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intracellular lipid transport (GO:0032378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular lipid transport (GO:0032377)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol transport (GO:0032376)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol transport (GO:0032375)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol transport (GO:0032374)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol transport (GO:0032373)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol transport (GO:0032372)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of sterol transport (GO:0032371)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
L-aspartate import across plasma membrane (GO:0140009)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein polyglutamylation (GO:0018095)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein polyglycylation (GO:0018094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of wound healing (GO:0044330)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxygen homeostasis (GO:0032364)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate catabolic process (GO:0032361)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of stem cell division (GO:2000035)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to leptin (GO:0044321)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular response to leptin stimulus (GO:0044320)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to follicle-stimulating hormone (GO:0032354)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone metabolic process (GO:0032352)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycine import across plasma membrane (GO:1900924)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glycine import across plasma membrane (GO:1900923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle cell contraction (GO:0106135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle cell contraction (GO:0106134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein K27-linked ubiquitination (GO:0044314)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein K6-linked deubiquitination (GO:0044313)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone biosynthetic process (GO:0032349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of aldosterone biosynthetic process (GO:0032348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aldosterone biosynthetic process (GO:0032347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of aldosterone metabolic process (GO:0032346)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of aldosterone metabolic process (GO:0032345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aldosterone metabolic process (GO:0032344)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of male gonad development (GO:2000019)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aldosterone biosynthetic process (GO:0032342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium entry (GO:0106129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aldosterone metabolic process (GO:0032341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of determination of dorsal identity (GO:2000017)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of determination of dorsal identity (GO:2000016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of determination of dorsal identity (GO:2000015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of adaxial/abaxial pattern formation (GO:2000011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol biosynthetic process (GO:0106120)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cytochrome c-heme linkage (GO:0018063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid cycle (GO:0006099)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt (GO:0006098)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
glyoxylate cycle (GO:0006097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolytic process (GO:0006096)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
gluconeogenesis (GO:0006094)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
pyruvate metabolic process (GO:0006090)	42	0	1.10	-	 < 0.01	6.28E-01	1.00E00
positive regulation of chondrocyte differentiation (GO:0032332)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of sterol biosynthetic process (GO:0106119)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of chondrocyte differentiation (GO:0032331)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of sterol biosynthetic process (GO:0106118)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte differentiation (GO:0032330)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA damage checkpoint (GO:2000003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage checkpoint (GO:2000002)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lactate metabolic process (GO:0006089)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA biosynthetic process (GO:0006085)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
serine transport (GO:0032329)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA metabolic process (GO:0006084)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
alanine transport (GO:0032328)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
acetate metabolic process (GO:0006083)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular aldehyde metabolic process (GO:0006081)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor biosynthetic process (GO:0032324)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cold-induced thermogenesis (GO:0106106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor clustering (GO:0106104)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
ER-dependent peroxisome localization (GO:0106101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular glucan metabolic process (GO:0006073)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glycerol metabolic process (GO:0006071)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
protein amidation (GO:0018032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate biosynthetic process (GO:0006065)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucuronate catabolic process (GO:0006064)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin secretion (GO:0032308)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
uronic acid metabolic process (GO:0006063)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sorbitol biosynthetic process (GO:0006061)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of icosanoid secretion (GO:0032305)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
sorbitol metabolic process (GO:0006060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine dimethylation (GO:0018027)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine monomethylation (GO:0018026)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine methylation (GO:0018021)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hexitol metabolic process (GO:0006059)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-acetylneuraminate metabolic process (GO:0006054)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of intraciliary retrograde transport (GO:1905799)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA 3' uridylation (GO:0071076)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid biosynthetic process (GO:0071073)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid biosynthetic process (GO:0071072)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein localization to pericentriolar material (GO:1905793)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid biosynthetic process (GO:0071071)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of stress fiber assembly (GO:0051497)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
N-acetylglucosamine metabolic process (GO:0006044)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
glucosamine catabolic process (GO:0006043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucosamine biosynthetic process (GO:0006042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucosamine metabolic process (GO:0006041)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
amino sugar metabolic process (GO:0006040)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
protein K33-linked ubiquitination (GO:1990390)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, exonucleolytic (GO:0000738)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA catabolic process, endonucleolytic (GO:0000737)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NMDA selective glutamate receptor signaling pathway (GO:0098989)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905780)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
strand displacement (GO:0000732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
DNA recombinase assembly (GO:0000730)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitotic cleavage furrow ingression (GO:1990386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hyaloid vascular plexus regression (GO:1990384)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of exonuclease activity (GO:1905778)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of exonuclease activity (GO:1905777)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing (GO:0000729)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA helicase activity (GO:1905776)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA helicase activity (GO:1905775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of DNA helicase activity (GO:1905774)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
recombinational repair (GO:0000725)	63	0	1.66	-	 < 0.01	4.13E-01	1.00E00
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	61	0	1.60	-	 < 0.01	4.10E-01	1.00E00
sno(s)RNA polyadenylation (GO:0071050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomere maintenance (GO:0000723)	70	0	1.84	-	 < 0.01	2.66E-01	1.00E00
proteoglycan metabolic process (GO:0006029)	57	0	1.50	-	 < 0.01	4.06E-01	1.00E00
regulation of mesodermal cell differentiation (GO:1905770)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via recombination (GO:0000722)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
lipid transport across blood-brain barrier (GO:1990379)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan catabolic process (GO:0006027)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
aminoglycan catabolic process (GO:0006026)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
postsynaptic actin cytoskeleton organization (GO:0098974)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
aminoglycan biosynthetic process (GO:0006023)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
aminoglycan metabolic process (GO:0006022)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inositol biosynthetic process (GO:0006021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
inositol metabolic process (GO:0006020)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
polyadenylation-dependent mRNA catabolic process (GO:0071047)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear histone mRNA catabolic process (GO:0071045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protection from non-homologous end joining at telomere (GO:1905764)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair, DNA damage recognition (GO:0000715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antisense RNA transcript catabolic process (GO:0071041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
vesicle fusion with vacuole (GO:0051469)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA repair synthesis (GO:0000711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
meiotic mismatch repair (GO:0000710)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
D-ribose metabolic process (GO:0006014)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mannose metabolic process (GO:0006013)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
galactose metabolic process (GO:0006012)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of cortisol secretion (GO:0051463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-glucose metabolic process (GO:0006011)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cortisol secretion (GO:0051462)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic transport of ribonucleoprotein complex (GO:0098961)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of corticotropin secretion (GO:0051461)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic microtubule (GO:1905755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic DNA recombinase assembly (GO:0000707)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break processing (GO:0000706)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin secretion (GO:0051459)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde axonal transport of mitochondrion (GO:0098958)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
stress response to zinc ion (GO:1990359)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process (GO:0006007)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
corticotropin secretion (GO:0051458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of mitochondrion (GO:0098957)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
glucose metabolic process (GO:0006006)	71	0	1.87	-	 < 0.01	2.66E-01	1.00E00
fucose metabolic process (GO:0006004)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta1 activation (GO:1901394)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose 2,6-bisphosphate metabolic process (GO:0006003)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular water homeostasis (GO:0009992)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
intracellular pH elevation (GO:0051454)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
receptor diffusion trapping (GO:0098953)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
fructose 6-phosphate metabolic process (GO:0006002)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta1 activation (GO:1901392)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose metabolic process (GO:0006000)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
myoblast migration (GO:0051451)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta activation (GO:1901390)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast proliferation (GO:0051450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of endosome to plasma membrane protein transport (GO:1905749)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cytoplasmic RNA surveillance (GO:0071026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transforming growth factor beta activation (GO:1901389)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transforming growth factor beta activation (GO:1901388)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
gap junction-mediated intercellular transport (GO:1990349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle (GO:0051447)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of chorionic trophoblast cell proliferation (GO:1901382)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transport (GO:1901380)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
telomeric 3' overhang formation (GO:0031860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
dendritic transport of mitochondrion (GO:0098939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterograde dendritic transport (GO:0098937)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound catabolic process (GO:1901377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organic heteropentacyclic compound metabolic process (GO:1901376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic transport (GO:0098935)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
acetate ester transport (GO:1901374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytidine deamination (GO:0009972)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipid hydroperoxide transport (GO:1901373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule end (GO:1905725)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
presynaptic signal transduction (GO:0098928)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport between endosomal compartments (GO:0098927)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by lipid (GO:0098920)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protection from non-homologous end joining at telomere (GO:0031848)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein localization to perinuclear region of cytoplasm (GO:1905719)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to phosphatidylethanolamine (GO:1905711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule nucleation by microtubule organizing center (GO:0051418)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling (GO:0098917)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
proximal/distal pattern formation (GO:0009954)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral pattern formation (GO:0009953)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cortisol (GO:0051414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to insulin-like growth factor stimulus (GO:1990314)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral axis specification (GO:0009950)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to corticosterone (GO:0051412)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of atrial cardiac muscle cell action potential (GO:0098910)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detoxification of nitrogen compound (GO:0051410)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of release of cytochrome c from mitochondria (GO:0090199)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane permeability (GO:1905709)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerulus development (GO:0090193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glomerulus development (GO:0090192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inhibitory synapse assembly (GO:1905704)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inhibitory synapse assembly (GO:1905702)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to nitrosative stress (GO:0051409)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal action potential (GO:0098908)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
proximal/distal axis specification (GO:0009946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SA node cell action potential (GO:0098907)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of AV node cell action potential (GO:0098904)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to leptomycin B (GO:1901344)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during action potential (GO:0098903)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization during action potential (GO:0098902)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of store-operated calcium channel activity (GO:1901341)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of pancreatic juice secretion (GO:0090187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of kidney development (GO:0090184)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of secretion of lysosomal enzymes (GO:0090182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol metabolic process (GO:0090181)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
regulation of store-operated calcium channel activity (GO:1901339)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
lactone biosynthetic process (GO:1901336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in neural tube closure (GO:0090179)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity involved in neural tube closure (GO:0090177)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
organelle membrane fusion (GO:0090174)	76	0	2.00	-	 < 0.01	2.68E-01	1.00E00
regulation of Golgi inheritance (GO:0090170)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of odontoblast differentiation (GO:1901329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cytochalasin B (GO:1901328)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of spindle assembly (GO:0090169)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
Golgi reassembly (GO:0090168)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Golgi disassembly (GO:0090166)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi ribbon formation (GO:0090161)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
Golgi to lysosome transport (GO:0090160)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to mitochondrion (GO:0070585)	61	0	1.60	-	 < 0.01	4.10E-01	1.00E00
mitochondrion morphogenesis (GO:0070584)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
regulation of flagellated sperm motility (GO:1901317)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of sterol regulatory element binding protein cleavage (GO:1901310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of collateral sprouting of injured axon (GO:0048694)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting of injured axon (GO:0048693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of sphingolipid biosynthetic process (GO:0090155)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II (GO:0001193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of axon extension involved in regeneration (GO:0048692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sphingolipid biosynthetic process (GO:0090154)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
maintenance of transcriptional fidelity during transcription elongation (GO:0001192)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of axon extension involved in regeneration (GO:0048691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of sphingolipid biosynthetic process (GO:0090153)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of axon extension involved in regeneration (GO:0048690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrial membrane (GO:0090151)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of sterol regulatory element binding protein cleavage (GO:1901308)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cadmium ion transmembrane transport (GO:0070574)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nitric-oxide synthase activity (GO:0050999)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid catabolic process (GO:0050995)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting of injured axon (GO:0048688)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase I preinitiation complex assembly (GO:0001188)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sprouting of injured axon (GO:0048687)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial membrane fission (GO:0090149)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of sprouting of injured axon (GO:0048686)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane fission (GO:0090148)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sprouting of injured axon (GO:0048682)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial nucleoid organization (GO:0090144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoid organization (GO:0090143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fission (GO:0090141)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial fission (GO:0090140)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D receptor signaling pathway (GO:0070562)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vitamin D receptor signaling pathway (GO:0070561)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein secretion by platelet (GO:0070560)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus (GO:0050982)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
response to axon injury (GO:0048678)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
axon extension involved in regeneration (GO:0048677)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament branching (GO:0090135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of collateral sprouting (GO:0048672)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of collateral sprouting (GO:0048671)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of collateral sprouting (GO:0048670)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sensory perception of touch (GO:0050975)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception (GO:0050974)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
collateral sprouting in absence of injury (GO:0048669)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuron fate specification (GO:0048665)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neuron fate determination (GO:0048664)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell proliferation (GO:0048662)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
detection of calcium ion (GO:0005513)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell proliferation (GO:0048659)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus involved in sensory perception (GO:0050962)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of temperature stimulus involved in sensory perception (GO:0050961)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
detection of temperature stimulus involved in thermoception (GO:0050960)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated cholesterol transport (GO:0090119)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport of low-density lipoprotein particle (GO:0090117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
C-5 methylation of cytosine (GO:0090116)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
COPII-coated vesicle cargo loading (GO:0090110)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
histone H2A K63-linked ubiquitination (GO:0070535)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K63-linked ubiquitination (GO:0070534)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
equilibrioception (GO:0050957)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thermoception (GO:0050955)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sensory perception of temperature stimulus (GO:0050951)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle assembly (GO:0090107)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue development (GO:0048643)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle tissue development (GO:0048642)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue development (GO:0048641)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
cochlea morphogenesis (GO:0090103)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein kinase C signaling (GO:0070528)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
platelet aggregation (GO:0070527)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of pigment cell differentiation (GO:0050942)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle organ development (GO:0048636)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glial cell projection elongation (GO:0106091)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle organ development (GO:0048635)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of muscle organ development (GO:0048634)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue growth (GO:0048633)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue growth (GO:0048631)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue growth (GO:0048630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular carbohydrate catabolic process (GO:0044275)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
sulfur compound catabolic process (GO:0044273)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of pigment cell differentiation (GO:0050932)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
myoblast fate specification (GO:0048626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast fate commitment (GO:0048625)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein-DNA complex remodeling (GO:0001120)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular polysaccharide metabolic process (GO:0044264)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
cholesterol import (GO:0070508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	119	0	3.13	-	 < 0.01	7.78E-02	1.00E00
positive regulation of DNA-templated DNA replication initiation (GO:0032298)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
induction of negative chemotaxis (GO:0050929)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of positive chemotaxis (GO:0050928)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin formation (GO:0032290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of negative chemotaxis (GO:0050925)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone succinylation (GO:0106077)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of negative chemotaxis (GO:0050924)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial RNA modification (GO:1900864)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of negative chemotaxis (GO:0050923)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic hindgut morphogenesis (GO:0048619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transcription open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated transcription open complex formation (GO:0001112)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic ectodermal digestive tract development (GO:0048611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II promoter clearance (GO:0001111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin formation (GO:0032289)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
myelin assembly (GO:0032288)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
peripheral nervous system myelin maintenance (GO:0032287)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
central nervous system myelin maintenance (GO:0032286)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sensory perception of sweet taste (GO:0050916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of sour taste (GO:0050915)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sensory perception of bitter taste (GO:0050913)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cobalamin metabolic process (GO:0106064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
promoter clearance during DNA-templated transcription (GO:0001109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular polysaccharide catabolic process (GO:0044247)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
lipid digestion (GO:0044241)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of gonadotropin secretion (GO:0032278)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of gonadotropin secretion (GO:0032277)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of gonadotropin secretion (GO:0032276)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
luteinizing hormone secretion (GO:0032275)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gonadotropin secretion (GO:0032274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of taste (GO:0050909)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus involved in visual perception (GO:0050908)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcineurin-mediated signaling (GO:0106057)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
diapedesis (GO:0050904)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesive activation (GO:0050902)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leukocyte tethering or rolling (GO:0050901)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of cellular protein metabolic process (GO:0032268)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
IMP salvage (GO:0032264)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
GMP salvage (GO:0032263)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleotide salvage (GO:0032262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleotide salvage (GO:0032261)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
guanine deglycation (GO:0106044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of GABA-A receptor activity (GO:0106040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sperm flagellum assembly (GO:0120316)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
establishment of secretory granule localization (GO:0032254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule localization (GO:0032253)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
secretory granule localization (GO:0032252)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pigmentation (GO:0120305)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
CTP salvage (GO:0044211)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleoside transport (GO:0032244)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleoside transport (GO:0032242)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleobase-containing compound transport (GO:0032241)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
neuron projection retraction (GO:0106028)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleobase-containing compound transport (GO:0032240)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle docking (GO:0106022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle docking (GO:0106020)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
AMP salvage (GO:0044209)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
'de novo' AMP biosynthetic process (GO:0044208)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
UMP salvage (GO:0044206)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
'de novo' UMP biosynthetic process (GO:0044205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleobase-containing compound transport (GO:0032239)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
activation of store-operated calcium channel activity (GO:0032237)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament bundle assembly (GO:0032232)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of inflammatory response to wounding (GO:0106016)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of inflammatory response to wounding (GO:0106015)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of inflammatory response to wounding (GO:0106014)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic transmission, GABAergic (GO:0032229)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic transmission, cholinergic (GO:0032224)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic transmission, cholinergic (GO:0032222)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal hexose absorption (GO:0106001)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
riboflavin transport (GO:0032218)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance via telomerase (GO:0032212)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomerase (GO:0032211)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomerase (GO:0032210)	41	0	1.08	-	 < 0.01	6.27E-01	1.00E00
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance (GO:0032206)	60	0	1.58	-	 < 0.01	4.08E-01	1.00E00
negative regulation of telomere maintenance (GO:0032205)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance (GO:0032204)	82	0	2.16	-	 < 0.01	2.77E-01	1.00E00
telomere assembly (GO:0032202)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via semi-conservative replication (GO:0032201)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telomere organization (GO:0032200)	74	0	1.95	-	 < 0.01	2.67E-01	1.00E00
positive regulation of polysome binding (GO:1905698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polysome binding (GO:1905696)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidic acid biosynthetic process (GO:1905693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid droplet disassembly (GO:1905691)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane repair (GO:1905684)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
modification of dendritic spine (GO:0098886)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modification of postsynaptic actin cytoskeleton (GO:0098885)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to mineralocorticoid (GO:0051385)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
postsynaptic neurotransmitter receptor internalization (GO:0098884)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
kinetochore organization (GO:0051383)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
kinetochore assembly (GO:0051382)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
maintenance of postsynaptic specialization structure (GO:0098880)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
RNA localization to chromatin (GO:1990280)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of adaptive immune memory response (GO:1905676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adaptive immune memory response (GO:1905674)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosome organization (GO:1905673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosome organization (GO:1905672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome organization (GO:1905671)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neurotransmitter receptor transport to plasma membrane (GO:0098877)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	105	0	2.76	-	 < 0.01	1.17E-01	1.00E00
action potential propagation (GO:0098870)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to endosome (GO:1905667)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular oxidant detoxification (GO:0098869)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to transition metal nanoparticle (GO:1990267)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to potassium ion starvation (GO:0051365)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil migration (GO:1990266)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pre-mRNA catabolic process (GO:1990261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of artery morphogenesis (GO:1905652)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
intestinal lipid absorption (GO:0098856)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
histone glutamine methylation (GO:1990258)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
signal clustering (GO:1990256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidoreductase activity (GO:0051354)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidoreductase activity (GO:0051353)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
positive regulation of ligase activity (GO:0051351)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lyase activity (GO:0051350)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA biosynthetic process (GO:1901290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proline import across plasma membrane (GO:1905647)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA methylation (GO:1905643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA methylation (GO:1905642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of cadmium ion (GO:0098849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
succinyl-CoA catabolic process (GO:1901289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal morphogenesis (GO:0009886)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of oxidoreductase activity (GO:0051341)	44	0	1.16	-	 < 0.01	6.30E-01	1.00E00
regulation of ligase activity (GO:0051340)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromatin (GO:1905634)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
folate transmembrane transport (GO:0098838)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of serotonin biosynthetic process (GO:1905627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic interphase (GO:0051329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
paranodal junction maintenance (GO:1990227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interphase (GO:0051325)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prophase (GO:0051324)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
metaphase (GO:0051323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA cap binding (GO:1905612)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA cap binding (GO:1905610)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G1 phase (GO:0051318)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
evoked excitatory postsynaptic potential (GO:0098817)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage colony-stimulating factor production (GO:1901256)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular transport of viral material (GO:1901252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase plate congression (GO:0051311)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neurotransmitter reuptake (GO:0098810)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung goblet cell differentiation (GO:1901250)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell-matrix adhesion (GO:1905609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynapse assembly (GO:1905608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix disassembly (GO:0090091)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood-brain barrier permeability (GO:1905605)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome separation (GO:0051309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lung goblet cell differentiation (GO:1901249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic chromosome separation (GO:0051307)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitotic sister chromatid separation (GO:0051306)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chromosome separation (GO:0051304)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of renal system process (GO:0098801)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein deubiquitination (GO:0090086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein deubiquitination (GO:0090085)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of inclusion body assembly (GO:0090084)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of inclusion body assembly (GO:0090083)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
abscission (GO:0009838)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
foam cell differentiation (GO:0090077)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
relaxation of skeletal muscle (GO:0090076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein homodimerization activity (GO:0090074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
unidimensional cell growth (GO:0009826)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thrombin-activated receptor signaling pathway (GO:0070493)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
regulation of ribosome biogenesis (GO:0090069)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of thalamus size (GO:0090067)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule nucleation (GO:0090063)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
post-embryonic camera-type eye morphogenesis (GO:0048597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye morphogenesis (GO:0048596)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA base methylation (GO:0070475)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle contraction (GO:0070474)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of heart looping (GO:1901207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle contraction (GO:0070472)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix assembly (GO:1901203)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix assembly (GO:1901201)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
determination of affect (GO:0050894)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory processing (GO:0050893)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal absorption (GO:0050892)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
multicellular organismal water homeostasis (GO:0050891)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of tubulin deacetylation (GO:0090044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of tubulin deacetylation (GO:0090043)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
tubulin deacetylation (GO:0090042)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thyroid-stimulating hormone secretion (GO:0070460)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endocrine process (GO:0050886)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
neuromuscular process controlling posture (GO:0050884)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
musculoskeletal movement, spinal reflex action (GO:0050883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
voluntary musculoskeletal movement (GO:0050882)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid hormone biosynthetic process (GO:0090031)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prolactin secretion (GO:0070459)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular detoxification of nitrogen compound (GO:0070458)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of heme biosynthetic process (GO:0070455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of heme biosynthetic process (GO:0070453)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic digestive tract development (GO:0048566)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of monocyte chemotaxis (GO:0090027)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte chemotaxis (GO:0090026)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
post-embryonic animal organ morphogenesis (GO:0048563)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte chemotaxis (GO:0090025)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil chemotaxis (GO:0090024)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of neutrophil chemotaxis (GO:0090023)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
establishment of anatomical structure orientation (GO:0048560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil chemotaxis (GO:0090022)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell activation (GO:0050869)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell receptor signaling pathway (GO:0050862)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell receptor signaling pathway (GO:0050861)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
embryonic digestive tract morphogenesis (GO:0048557)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell receptor signaling pathway (GO:0050860)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of pinocytosis (GO:0048550)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell receptor signaling pathway (GO:0050859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of B cell receptor signaling pathway (GO:0050855)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
B cell receptor signaling pathway (GO:0050853)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of pinocytosis (GO:0048549)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of pinocytosis (GO:0048548)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
primitive streak formation (GO:0090009)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Peyer's patch development (GO:0048541)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antibiotic metabolic process (GO:0016999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium-mediated signaling (GO:0050849)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
bone marrow development (GO:0048539)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mucosa-associated lymphoid tissue development (GO:0048537)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lymph node development (GO:0048535)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to cold (GO:0070417)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of heterochromatin organization (GO:0120263)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterochromatin organization (GO:0120262)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
defense response to fungus (GO:0050832)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
defense response to Gram-positive bacterium (GO:0050830)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of behavior (GO:0048521)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of behavior (GO:0048520)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
olefinic compound biosynthetic process (GO:0120255)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrocarbon metabolic process (GO:0120252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transposition (GO:0032196)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
response to freezing (GO:0050826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide antigen stabilization (GO:0050823)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide stabilization (GO:0050822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of coagulation (GO:0050820)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
circadian behavior (GO:0048512)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
histone H3-K14 acetylation (GO:0044154)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
septin cytoskeleton organization (GO:0032185)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of coagulation (GO:0050819)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of coagulation (GO:0050818)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
coagulation (GO:0050817)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
doxorubicin transport (GO:1900753)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acyl-CoA biosynthetic process (GO:0050812)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glutathione deglycation (GO:0036531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
(R)-carnitine transport (GO:1900749)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, sleep (GO:0050802)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deglycation, glyoxal removal (GO:0036529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deglycation (GO:0036528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine deglycation (GO:0036527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine deglycation (GO:0036526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deglycation (GO:0036525)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
larynx development (GO:0120224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
larynx morphogenesis (GO:0120223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of blastocyst development (GO:0120222)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
astrocyte-dopaminergic neuron signaling (GO:0036520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
chemorepulsion of dopaminergic neuron axon (GO:0036518)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trimming of terminal mannose on C branch (GO:0036510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation by symbiont of entry into host (GO:0075294)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of uterine smooth muscle relaxation (GO:1900721)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trimming of terminal mannose on B branch (GO:0036509)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein alpha-1,2-demannosylation (GO:0036508)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein demannosylation (GO:0036507)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
maintenance of unfolded protein (GO:0036506)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
formation of structure involved in a symbiotic process (GO:0044111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein desumoylation (GO:0016926)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of uterine smooth muscle relaxation (GO:1900719)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of zinc ion (GO:0032119)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to nutrient levels (GO:0032108)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to extracellular stimulus (GO:0032105)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cell dedifferentiation (GO:0043697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dedifferentiation (GO:0043696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
reverse cholesterol transport (GO:0043691)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
centrosome separation (GO:0051299)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fibronectin fibril organization (GO:1905590)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
centrosome duplication (GO:0051298)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
post-translational protein modification (GO:0043687)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
global gene silencing by mRNA cleavage (GO:0098795)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
co-translational protein modification (GO:0043686)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of meiotic spindle localization (GO:0051295)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
xenophagy (GO:0098792)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
outer hair cell apoptotic process (GO:1905584)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of calcium ion (GO:0051284)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
ncRNA transcription (GO:0098781)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
exosomal secretion (GO:1990182)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-end processing (GO:1990180)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to nucleoplasm (GO:1990173)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor catabolic process (GO:1990172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stress response to cadmium ion (GO:1990170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial cell proliferation (GO:1905564)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial cell proliferation (GO:1905563)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial cell proliferation (GO:1905562)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
stress response to copper ion (GO:1990169)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein K33-linked deubiquitination (GO:1990168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K27-linked deubiquitination (GO:1990167)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle phase (GO:0098764)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
protein localization to site of double-strand break (GO:1990166)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic cell cycle phase (GO:0098763)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
recognition of apoptotic cell (GO:0043654)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic cell cycle phase (GO:0098762)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-7 (GO:0098761)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
engulfment of apoptotic cell (GO:0043652)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein depolymerization (GO:0051261)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
response to interleukin-7 (GO:0098760)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
linoleic acid metabolic process (GO:0043651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood vessel branching (GO:1905555)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of blood vessel branching (GO:1905553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-8 (GO:0098759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to endoplasmic reticulum (GO:1905551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to interleukin-8 (GO:0098758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dicarboxylic acid catabolic process (GO:0043649)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
meiotic spindle midzone assembly (GO:0051257)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic spindle midzone assembly (GO:0051256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spindle midzone assembly (GO:0051255)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
detoxification (GO:0098754)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bone cell development (GO:0098751)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
cellular response to nutrient (GO:0031670)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar neuron development (GO:0098749)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERBB signaling pathway (GO:1901185)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
cell aggregation (GO:0098743)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
maintenance of translational fidelity (GO:1990145)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of postsynapse to nucleus signaling pathway (GO:1905539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leucine import across plasma membrane (GO:1905534)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of leucine import across plasma membrane (GO:1905533)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leucine import across plasma membrane (GO:1905532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of metal ion (GO:0051238)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein insertion into plasma membrane (GO:0098737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
small regulatory ncRNA 3'-end processing (GO:0043628)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction (GO:0098736)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to estrogen (GO:0043627)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of the force of heart contraction (GO:0098735)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
macromolecule depalmitoylation (GO:0098734)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
macromolecule deacylation (GO:0098732)	65	0	1.71	-	 < 0.01	4.16E-01	1.00E00
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic spindle elongation (GO:0051232)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spindle elongation (GO:0051231)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spindle disassembly (GO:0051230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of heat generation (GO:0031651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein autoubiquitination (GO:1905524)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage migration (GO:1905522)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
germline stem cell asymmetric division (GO:0098728)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of presynaptic active zone assembly (GO:1905520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitotic spindle disassembly (GO:0051228)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
keratinocyte proliferation (GO:0043616)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
spindle assembly (GO:0051225)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
astrocyte cell migration (GO:0043615)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of trophoblast cell migration (GO:1901164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
asymmetric stem cell division (GO:0098722)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of protein (GO:0051220)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
primary amino compound metabolic process (GO:1901160)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate utilization (GO:0043610)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heat generation (GO:0031649)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of nervous system process (GO:0031645)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of myelination (GO:0031642)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
killing of cells of another organism (GO:0031640)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic active zone assembly (GO:1905518)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macrophage migration (GO:1905517)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of fertilization (GO:1905516)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
non-motile cilium assembly (GO:1905515)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
sodium ion import across plasma membrane (GO:0098719)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
hexose mediated signaling (GO:0009757)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serine import across plasma membrane (GO:0098718)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xylulose 5-phosphate biosynthetic process (GO:1901159)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carbohydrate mediated signaling (GO:0009756)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell receptor apoptotic signaling pathway (GO:1990117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular amide catabolic process (GO:0043605)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leucine import across plasma membrane (GO:0098713)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-glutamate import across plasma membrane (GO:0098712)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
RNA polymerase II core complex assembly (GO:1990114)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fructose (GO:0009750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitrate catabolic process (GO:0043602)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasminogen activation (GO:0031639)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
zymogen activation (GO:0031638)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule organizing center (GO:1905508)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of motile cilium assembly (GO:1905505)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of motile cilium assembly (GO:1905503)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose import across plasma membrane (GO:0098708)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sequestering of calcium ion (GO:0051208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein linear deubiquitination (GO:1990108)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
copper ion import across plasma membrane (GO:0098705)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carbohydrate import across plasma membrane (GO:0098704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein insertion into mitochondrial membrane (GO:0051204)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
calcium ion import across plasma membrane (GO:0098703)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
insulin catabolic process (GO:1901143)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
insulin metabolic process (GO:1901142)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
neurotransmitter loading into synaptic vesicle (GO:0098700)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
telomeric loop formation (GO:0031627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	73	0	1.92	-	 < 0.01	2.66E-01	1.00E00
homologous chromosome orientation involved in meiotic metaphase I plate congression (GO:0031619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of endogenous stimulus (GO:0009726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to lipoteichoic acid (GO:0070391)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA-guanine transglycosylation (GO:0101030)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic nuclear membrane organization (GO:0101024)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Harderian gland development (GO:0070384)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA cytosine deamination (GO:0070383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound biosynthetic process (GO:0009713)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound metabolic process (GO:0009712)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle membrane organization (GO:0048499)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
maintenance of animal organ identity (GO:0048496)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterograde synaptic vesicle transport (GO:0048490)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of ERK5 cascade (GO:0070376)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ERK5 cascade (GO:0070375)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular heat acclimation (GO:0070370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
activated T cell proliferation (GO:0050798)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
enteric nervous system development (GO:0048484)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hepatocyte differentiation (GO:0070365)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detoxification of mercury ion (GO:0050787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
replication fork protection (GO:0048478)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
actin polymerization-dependent cell motility (GO:0070358)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of white fat cell proliferation (GO:0070352)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of white fat cell proliferation (GO:0070350)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite morphogenesis (GO:0050774)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
PERK-mediated unfolded protein response (GO:0036499)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
IRE1-mediated unfolded protein response (GO:0036498)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mucociliary clearance (GO:0120197)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of brown fat cell proliferation (GO:0070348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of brown fat cell proliferation (GO:0070347)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of fat cell proliferation (GO:0070346)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of fat cell proliferation (GO:0070345)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of RNA polymerase II transcription (GO:0120191)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of fat cell proliferation (GO:0070344)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
white fat cell proliferation (GO:0070343)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brown fat cell proliferation (GO:0070342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fat cell proliferation (GO:0070341)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromatin (GO:0120187)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to bacterial lipopeptide (GO:0070339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of focal adhesion disassembly (GO:0120183)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0036483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of focal adhesion disassembly (GO:0120182)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
focal adhesion disassembly (GO:0120181)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vacuole organization (GO:0044090)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction disassembly (GO:0120180)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vacuole organization (GO:0044088)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
steroid hormone biosynthetic process (GO:0120178)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
neuron death in response to oxidative stress (GO:0036475)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
triglyceride homeostasis (GO:0070328)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cell death in response to hydrogen peroxide (GO:0036474)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thyroid hormone transport (GO:0070327)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF (GO:0099191)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell death in response to oxidative stress (GO:0036473)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
cellular response to glyoxal (GO:0036471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein metabolic process (GO:0050748)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein metabolic process (GO:0050747)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein metabolic process (GO:0050746)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
postsynaptic cytoskeleton organization (GO:0099188)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
presynaptic cytoskeleton organization (GO:0099187)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of cold stimulus involved in thermoception (GO:0120169)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of hot stimulus involved in thermoception (GO:0120168)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle recycling via endosome (GO:0036466)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of G0 to G1 transition (GO:0070318)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of G0 to G1 transition (GO:0070317)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of G0 to G1 transition (GO:0070316)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
zinc ion import into synaptic vesicle (GO:0099180)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
TRAIL-activated apoptotic signaling pathway (GO:0036462)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition involved in cell differentiation (GO:0070315)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
G1 to G0 transition (GO:0070314)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
olefin metabolic process (GO:1900673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host cellular process (GO:0044068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens fiber cell morphogenesis (GO:0070309)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERBB4 signaling pathway (GO:0120154)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lens fiber cell development (GO:0070307)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
presynaptic modulation of chemical synaptic transmission (GO:0099171)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of excretion (GO:0044062)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to cGMP (GO:0070305)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cap mRNA methylation (GO:0036451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endocrine process (GO:0044060)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of appetite (GO:0032099)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrogen peroxide (GO:0070301)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
negative regulation of response to food (GO:0032096)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to food (GO:0032094)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
myofibroblast differentiation (GO:0036446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic signaling by nitric oxide (GO:0099163)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell division (GO:0036445)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium import into the mitochondrion (GO:0036444)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of presynaptic dense core granule exocytosis (GO:0099161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	42	0	1.10	-	 < 0.01	6.28E-01	1.00E00
regulation of modification of postsynaptic structure (GO:0099159)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling via exosome (GO:0099156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of lens transparency (GO:0036438)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, serotonergic (GO:0099153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glucan metabolic process (GO:0044042)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
positive regulation of endodeoxyribonuclease activity (GO:0032079)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of deoxyribonuclease activity (GO:0032077)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of deoxyribonuclease activity (GO:0032076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclease activity (GO:0032075)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclease activity (GO:0032074)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of restriction endodeoxyribonuclease activity (GO:0032072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endodeoxyribonuclease activity (GO:0032071)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of deoxyribonuclease activity (GO:0032070)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic vesicle docking (GO:0099148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic actin cytoskeleton organization (GO:0099140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA methylation (GO:0044030)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of nuclease activity (GO:0032069)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
bleb assembly (GO:0032060)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hypomethylation of CpG island (GO:0044029)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA hypomethylation (GO:0044028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypermethylation of CpG island (GO:0044027)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
DNA hypermethylation (GO:0044026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA stabilization (GO:0036416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA stability (GO:0036415)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational initiation in response to stress (GO:0032058)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational initiation in response to stress (GO:0032057)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation in response to stress (GO:0032056)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of translation in response to stress (GO:0032055)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ciliary basal body organization (GO:0032053)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of monocyte aggregation (GO:1900625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of monocyte aggregation (GO:1900623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiolipin biosynthetic process (GO:0032049)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cardiolipin metabolic process (GO:0032048)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
acetate ester metabolic process (GO:1900619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
tRNA 5'-end processing (GO:0099116)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
box H/ACA RNA 3'-end processing (GO:0000495)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
box C/D RNA 3'-end processing (GO:0000494)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
modulation by symbiont of host process (GO:0044003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
box C/D snoRNP assembly (GO:0000492)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
maturation of 5S rRNA (GO:0000481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to magnesium ion (GO:0032026)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to cobalt ion (GO:0032025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ISG15-protein conjugation (GO:0032020)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA (GO:0000470)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ARF protein signal transduction (GO:0032013)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ARF protein signal transduction (GO:0032012)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
ARF protein signal transduction (GO:0032011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cleavage involved in rRNA processing (GO:0000469)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maturation of 5.8S rRNA (GO:0000460)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate interconversion (GO:0035999)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of TOR signaling (GO:0032007)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
tendon formation (GO:0035992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tendon cell differentiation (GO:0035990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
exonucleolytic trimming involved in rRNA processing (GO:0000459)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA 2'-O-methylation (GO:0000451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tendon development (GO:0035989)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chondrocyte proliferation (GO:0035988)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endodermal cell differentiation (GO:0035987)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cellular response to trichostatin A (GO:0035984)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to trichostatin A (GO:0035983)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to host (GO:0075136)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemoglobin metabolic process (GO:0020027)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching morphogenesis of a nerve (GO:1905492)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
skin morphogenesis (GO:0043589)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tongue morphogenesis (GO:0043587)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
tongue development (GO:0043586)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
nose morphogenesis (GO:0043585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nose development (GO:0043584)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
aggrephagy (GO:0035973)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of motor neuron migration (GO:1905485)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of motor neuron migration (GO:1905483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prosthetic group metabolic process (GO:0051189)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiolipin acyl-chain remodeling (GO:0035965)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
COPI-coated vesicle budding (GO:0035964)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
maintenance of DNA repeat elements (GO:0043570)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cartilage homeostasis (GO:1990079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sulfur metabolic process (GO:0051176)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
polyuridylation-dependent mRNA catabolic process (GO:1990074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to nitrogen levels (GO:0043562)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
wybutosine biosynthetic process (GO:0031591)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
wybutosine metabolic process (GO:0031590)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of clathrin-coated pit assembly (GO:1905469)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin-coated pit assembly (GO:1905468)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K36 methylation (GO:0000416)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA duplex unwinding (GO:1905464)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K36 methylation (GO:0000415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA duplex unwinding (GO:1905463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K36 methylation (GO:0000414)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of DNA duplex unwinding (GO:1905462)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by galactose (GO:0000411)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation in response to stress (GO:0043558)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
xylulose 5-phosphate metabolic process (GO:0051167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to oxidative stress (GO:0043556)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA surveillance (GO:0035946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation in response to stress (GO:0043555)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
activation of phospholipase D activity (GO:0031584)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemidesmosome assembly (GO:0031581)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane raft distribution (GO:0031580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of transcription by galactose (GO:0000409)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lymphoid progenitor cell differentiation (GO:1905456)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid progenitor cell differentiation (GO:1905455)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid progenitor cell differentiation (GO:1905453)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inorganic anion import across plasma membrane (GO:0098658)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of signal transduction in absence of ligand (GO:1901099)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagosome maturation (GO:1901098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome maturation (GO:1901097)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome maturation (GO:1901096)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle cell differentiation (GO:0051155)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
molybdopterin cofactor metabolic process (GO:0043545)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle cell differentiation (GO:0051154)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle cell differentiation (GO:0051153)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
corticosterone secretion (GO:0035934)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell differentiation (GO:0051152)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glucocorticoid secretion (GO:0035933)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of protein kinase C activity (GO:1990051)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
corticosteroid hormone secretion (GO:0035930)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spindle checkpoint signaling (GO:0031577)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of clathrin coat assembly (GO:1905445)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of clathrin coat assembly (GO:1905443)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle cell differentiation (GO:0051149)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
retrograde neuronal dense core vesicle transport (GO:1990049)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
steroid hormone secretion (GO:0035929)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of actin phosphorylation (GO:0043538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde neuronal dense core vesicle transport (GO:1990048)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA import into mitochondrion (GO:0035928)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA import into mitochondrion (GO:0035927)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
stress-induced mitochondrial fusion (GO:1990046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to lipid droplet (GO:1990044)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell proliferation (GO:0051142)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of smooth muscle (GO:1901082)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell proliferation (GO:0051140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of smooth muscle (GO:1901080)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K4 trimethylation (GO:1905437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K4 trimethylation (GO:1905435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of relaxation of muscle (GO:1901079)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to glycine (GO:1905430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell differentiation (GO:0051138)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of relaxation of muscle (GO:1901078)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of relaxation of muscle (GO:1901077)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell differentiation (GO:0051136)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of engulfment of apoptotic cell (GO:1901076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NK T cell activation (GO:0051135)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of engulfment of apoptotic cell (GO:1901074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of NK T cell activation (GO:0051133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound biosynthetic process (GO:1901073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell differentiation (GO:0035914)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound catabolic process (GO:1901072)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
glucosamine-containing compound metabolic process (GO:1901071)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ascending aorta morphogenesis (GO:0035910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of DNA-templated transcription (GO:0031554)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to glycine (GO:1905429)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trans-Golgi network membrane organization (GO:0098629)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of myosin II filament organization (GO:0043519)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin nucleation (GO:0051126)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
descending aorta development (GO:0035906)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic assembly at neuromuscular junction (GO:0051124)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ascending aorta development (GO:0035905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to immobilization stress (GO:0035902)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule exocytosis (GO:1905415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dense core granule exocytosis (GO:1905414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule exocytosis (GO:1905413)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of JUN kinase activity (GO:0043508)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to salt stress (GO:0009651)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitochondrial DNA repair (GO:0043504)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
UV protection (GO:0009650)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
skeletal muscle adaptation (GO:0043501)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of exit from mitosis (GO:0031536)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin cytoskeleton reorganization (GO:0031532)	42	0	1.10	-	 < 0.01	6.28E-01	1.00E00
negative regulation of creatine transmembrane transporter activity (GO:1905408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of creatine transmembrane transporter activity (GO:1905407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to absence of light (GO:0009646)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal cell apoptotic process (GO:1990009)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to high light intensity (GO:0009644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA ligation (GO:0051106)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of DNA ligation (GO:0051105)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to light intensity (GO:0009642)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
DNA ligation involved in DNA repair (GO:0051103)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
amyloid fibril formation (GO:1990000)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ruffle organization (GO:0031529)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
response to toxic substance (GO:0009636)	58	0	1.53	-	 < 0.01	4.07E-01	1.00E00
cold acclimation (GO:0009631)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to reactive oxygen species (GO:1901033)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to reactive oxygen species (GO:1901032)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of response to reactive oxygen species (GO:1901031)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to gravity (GO:0009629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
renal water absorption (GO:0070295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
renal sodium ion absorption (GO:0070294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal absorption (GO:0070293)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly involved in necroptotic process (GO:1901026)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
N-acylethanolamine metabolic process (GO:0070291)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to fungus (GO:0009620)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
subtelomeric heterochromatin formation (GO:0031509)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pericentric heterochromatin formation (GO:0031508)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
axonemal dynein complex assembly (GO:0070286)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
response to symbiotic bacterium (GO:0009609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular matrix constituent secretion (GO:0070278)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to symbiont (GO:0009608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ubiquinone-6 metabolic process (GO:1901004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fermentation (GO:1901003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to salt stress (GO:1901000)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endosomal lumen acidification (GO:0048388)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to virus by host (GO:0050691)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of retinoic acid receptor signaling pathway (GO:0048385)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
retinoic acid receptor signaling pathway (GO:0048384)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
mesendoderm development (GO:0048382)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyroptosis (GO:0070269)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
necroptotic process (GO:0070266)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelial cell activation (GO:1904988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
necrotic cell death (GO:0070265)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell activation (GO:1904987)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine dephosphorylation (GO:0070262)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glycine import into mitochondrion (GO:1904983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to virus by host (GO:0050689)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endosome organization (GO:1904980)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA processing (GO:0050685)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
regulation of lateral mesodermal cell fate specification (GO:0048378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral mesodermal cell differentiation (GO:0048371)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm formation (GO:0048370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mucus secretion (GO:0070257)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of endosome organization (GO:1904979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mucus secretion (GO:0070256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endosome organization (GO:1904978)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mucus secretion (GO:0070255)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
lymphatic endothelial cell migration (GO:1904977)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mucus secretion (GO:0070254)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral translation (GO:1904973)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of viral translation (GO:1904971)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of urothelial cell proliferation (GO:0050677)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of urothelial cell proliferation (GO:0050675)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
urothelial cell proliferation (GO:0050674)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm morphogenesis (GO:0048369)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral mesoderm development (GO:0048368)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amylase secretion (GO:0036394)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of thymocyte apoptotic process (GO:0070245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of thymocyte apoptotic process (GO:0070244)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of thymocyte apoptotic process (GO:0070243)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
thymocyte apoptotic process (GO:0070242)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytochrome-c oxidase activity (GO:1904960)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of homocysteine metabolic process (GO:0050668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
homocysteine metabolic process (GO:0050667)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of homocysteine metabolic process (GO:0050666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide biosynthetic process (GO:0050665)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm structural organization (GO:0048352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytochrome-c oxidase activity (GO:1904959)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of activation-induced cell death of T cells (GO:0070236)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of activation-induced cell death of T cells (GO:0070235)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell apoptotic process (GO:0070234)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell apoptotic process (GO:0070233)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of T cell apoptotic process (GO:0070232)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
T cell apoptotic process (GO:0070231)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte apoptotic process (GO:0070230)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate proteoglycan metabolic process (GO:0050655)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
paraxial mesoderm formation (GO:0048341)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lymphocyte apoptotic process (GO:0070229)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
calcium export from the mitochondrion (GO:0099093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte apoptotic process (GO:0070228)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
lymphocyte apoptotic process (GO:0070227)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
midbrain dopaminergic neuron differentiation (GO:1904948)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
opsin transport (GO:0036372)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
folate import into mitochondrion (GO:1904947)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to T-tubule (GO:0036371)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesoderm structural organization (GO:0048338)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesodermal cell differentiation (GO:0048333)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonal transport of messenger ribonucleoprotein complex (GO:0099088)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anterograde axonal transport of messenger ribonucleoprotein complex (GO:0099087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cone photoresponse recovery (GO:0036368)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
light adaption (GO:0036367)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099083)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde trans-synaptic signaling by neuropeptide (GO:0099082)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transforming growth factor beta activation (GO:0036363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interneuron migration (GO:1904936)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein auto-ADP-ribosylation (GO:0070213)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein poly-ADP-ribosylation (GO:0070212)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
axial mesoderm formation (GO:0048320)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal potassium excretion (GO:0036359)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrion-derived vesicle mediated transport (GO:0099075)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrion to lysosome transport (GO:0099074)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein homotrimerization (GO:0070207)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
histone H2A-K119 monoubiquitination (GO:0036353)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein trimerization (GO:0070206)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
histone H2A-K15 ubiquitination (GO:0036352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H2A-K13 ubiquitination (GO:0036351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to telomere (GO:0070203)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of protein localization to chromosome (GO:0070202)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to telomere (GO:0070200)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
axial mesoderm morphogenesis (GO:0048319)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
axial mesoderm development (GO:0048318)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
Golgi inheritance (GO:0048313)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
intracellular distribution of mitochondria (GO:0048312)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitochondrion distribution (GO:0048311)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
snRNA (adenine-N6)-methylation (GO:0120049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
platelet morphogenesis (GO:0036344)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
psychomotor behavior (GO:0036343)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organelle inheritance (GO:0048308)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgG isotypes (GO:0048304)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgG isotypes (GO:0048302)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
lymphocyte adhesion to endothelial cell of high endothelial venule (GO:0036339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Fas signaling pathway (GO:0036337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell migration (GO:0036336)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
intestinal stem cell homeostasis (GO:0036335)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epidermal stem cell homeostasis (GO:0036334)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hepatocyte homeostasis (GO:0036333)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle scission (GO:0099050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ESCRT III complex disassembly (GO:1904903)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of purine nucleotide metabolic process (GO:1900544)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide metabolic process (GO:1900543)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of purine nucleotide metabolic process (GO:1900542)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
vesicle tethering to endoplasmic reticulum (GO:0099044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle tethering to Golgi (GO:0099041)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ceramide translocation (GO:0099040)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
palmitic acid biosynthetic process (GO:1900535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
palmitic acid metabolic process (GO:1900533)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingolipid translocation (GO:0099039)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to sterol (GO:0036315)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to sterol (GO:0036314)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
intermembrane sphingolipid transfer (GO:0120012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intermembrane lipid transfer (GO:0120009)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to M-band (GO:0036309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane invagination (GO:0099024)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
ameloblast differentiation (GO:0036305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vesicle tethering (GO:0099022)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuronal dense core vesicle exocytosis (GO:0099011)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
modification of postsynaptic structure (GO:0099010)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
spliceosomal complex disassembly (GO:0000390)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mRNA 3'-splice site recognition (GO:0000389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calmodulin dependent kinase signaling pathway (GO:0099004)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	51	0	1.34	-	 < 0.01	6.42E-01	1.00E00
tRNA-type intron splice site recognition and cleavage (GO:0000379)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
RNA exon ligation (GO:0000378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aortic smooth muscle cell differentiation (GO:0035887)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein homodimerization activity (GO:0043496)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
enteroendocrine cell differentiation (GO:0035883)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
amacrine cell differentiation (GO:0035881)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
malate-aspartate shuttle (GO:0043490)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cellular response to flavonoid (GO:1905396)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to flavonoid (GO:1905395)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane lactate transport (GO:0035879)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of helicase activity (GO:0051097)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of helicase activity (GO:0051096)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
histone exchange (GO:0043486)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of helicase activity (GO:0051095)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
endosome to pigment granule transport (GO:0043485)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lactate transmembrane transport (GO:0035873)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular pigment accumulation (GO:0043482)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein K11-linked deubiquitination (GO:0035871)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein deneddylation (GO:0000338)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pigment accumulation (GO:0043476)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
'de novo' cotranslational protein folding (GO:0051083)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
innate vocalization behavior (GO:0098582)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of external biotic stimulus (GO:0098581)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
nuclear membrane disassembly (GO:0051081)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cellular carbohydrate catabolic process (GO:0043471)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of carbohydrate catabolic process (GO:0043470)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ceramide phosphoethanolamine biosynthetic process (GO:1905373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ceramide phosphoethanolamine metabolic process (GO:1905371)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
re-entry into mitotic cell cycle (GO:0000320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of generation of precursor metabolites and energy (GO:0043467)	80	0	2.10	-	 < 0.01	2.73E-01	1.00E00
regulation of fermentation (GO:0043465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
megakaryocyte development (GO:0035855)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in kidney development (GO:0035850)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
chromatin organization (GO:0031497)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of intralumenal vesicle formation (GO:1905366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intralumenal vesicle formation (GO:1905365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dihydrolipoamide metabolic process (GO:0051068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular respiration (GO:0043457)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
regulation of pentose-phosphate shunt (GO:0043456)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
oviduct epithelium development (GO:0035846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell outer segment organization (GO:0035845)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cloaca development (GO:0035844)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spine apparatus assembly (GO:1905355)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to oxygen radical (GO:0000305)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to singlet oxygen (GO:0000304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to superoxide (GO:0000303)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
pericyte cell migration (GO:1905351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retrograde transport, vesicle recycling within Golgi (GO:0000301)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
cellular alkene metabolic process (GO:0043449)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of chemical stimulus (GO:0009593)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ciliary transition zone assembly (GO:1905349)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prostaglandin catabolic process (GO:1905344)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
detection of UV (GO:0009589)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to kinetochore (GO:1905342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-methionine acetylation (GO:0017196)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to kinetochore (GO:1905340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of visible light (GO:0009584)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
detection of light stimulus (GO:0009583)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
detection of abiotic stimulus (GO:0009582)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
response to corticotropin-releasing hormone (GO:0043435)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
detection of other organism (GO:0098543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of external stimulus (GO:0009581)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
homologous recombination (GO:0035825)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of membrane protein ectodomain proteolysis (GO:0051043)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-independent cell-cell adhesion (GO:0051040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
modulation of process of another organism (GO:0035821)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear membrane reassembly (GO:0031468)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
glycine betaine transport (GO:0031460)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aggrephagy (GO:1905337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aggrephagy (GO:1905335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-glutamic acid carboxylation (GO:0017187)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of morphogenesis of an epithelium (GO:1905331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine hydroxylation (GO:0017185)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in meiotic cell cycle (GO:0051037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of endosome size (GO:0051036)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
peptidyl-diphthamide metabolic process (GO:0017182)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
centriole assembly (GO:0098534)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of renal sodium excretion (GO:0035815)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-K27 trimethylation (GO:0098532)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of renal sodium excretion (GO:0035814)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of renal sodium excretion (GO:0035813)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
tRNA transport (GO:0051031)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of strand invasion (GO:0098530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
renal sodium excretion (GO:0035812)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
snRNA transport (GO:0051030)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of urine volume (GO:0035811)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of urine volume (GO:0035810)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of heterochromatin formation (GO:0031453)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of heterochromatin formation (GO:0031452)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
telomerase holoenzyme complex assembly (GO:1905323)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neuromuscular junction development, skeletal muscle fiber (GO:0098529)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA transport (GO:0051029)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of urine volume (GO:0035809)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
homocysteine catabolic process (GO:0043418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chiasma assembly (GO:0051026)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle tissue regeneration (GO:0043416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA 3'-end processing (GO:0031442)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA 3'-end processing (GO:0031441)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
barbed-end actin filament capping (GO:0051016)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
actin filament severing (GO:0051014)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
microtubule severing (GO:0051013)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
skeletal muscle tissue regeneration (GO:0043403)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
microtubule sliding (GO:0051012)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid mediated signaling pathway (GO:0043402)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA cleavage (GO:0031439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA cleavage (GO:0031437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of macropinocytosis (GO:1905303)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of macropinocytosis (GO:1905301)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein lipase activity (GO:0051006)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipase activity (GO:0051005)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipase activity (GO:0051004)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric-oxide synthase activity (GO:0051001)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric-oxide synthase activity (GO:0051000)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
keratinization (GO:0031424)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to chromosome (GO:0070199)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein localization to chromosome, telomeric region (GO:0070198)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
meiotic attachment of telomere to nuclear envelope (GO:0070197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptonemal complex organization (GO:0070193)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
kynurenine metabolic process (GO:0070189)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleologenesis (GO:0017126)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi to plasma membrane protein transport (GO:0042996)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of transcription factor (GO:0042994)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of isotype switching to IgA isotypes (GO:0048298)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgA isotypes (GO:0048296)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching to IgE isotypes (GO:0048294)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of isotype switching to IgE isotypes (GO:0048293)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgG isotypes (GO:0048291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine biosynthetic process (GO:0070179)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine metabolic process (GO:0070178)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatic stellate cell proliferation (GO:1904899)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell proliferation (GO:1904897)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ESCRT complex disassembly (GO:1904896)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of enamel mineralization (GO:0070173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor signaling pathway via STAT (GO:1904894)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of tooth mineralization (GO:0070171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via STAT (GO:1904893)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of tooth mineralization (GO:0070170)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of excitatory synapse assembly (GO:1904891)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of actin monomers (GO:0042989)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein catabolic process (GO:0042987)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
amyloid precursor protein biosynthetic process (GO:0042983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isotype switching to IgE isotypes (GO:0048289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organelle fusion (GO:0048284)	94	0	2.47	-	 < 0.01	1.80E-01	1.00E00
vesicle fusion with Golgi apparatus (GO:0048280)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of biomineral tissue development (GO:0070168)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
enamel mineralization (GO:0070166)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cranial skeletal system development (GO:1904888)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
positive regulation of adiponectin secretion (GO:0070165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Wnt signalosome assembly (GO:1904887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of adiponectin secretion (GO:0070164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
beta-catenin destruction complex disassembly (GO:1904886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of adiponectin secretion (GO:0070163)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to hydrogen sulfide (GO:1904881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to hydrogen sulfide (GO:1904880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of Janus kinase activity (GO:0042976)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA ligase activity (GO:1904877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA ligase activity (GO:1904875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomerase RNA localization to Cajal body (GO:1904872)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to Cajal body (GO:1904871)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
behavioral response to pain (GO:0048266)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
response to pain (GO:0048265)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
determination of ventral identity (GO:0048264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of centriole-centriole cohesion (GO:0030997)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
determination of dorsal identity (GO:0048263)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
determination of dorsal/ventral asymmetry (GO:0048262)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
recombinational interstrand cross-link repair (GO:0036298)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interstrand cross-link repair (GO:0036297)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
response to increased oxygen levels (GO:0036296)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
cellular response to increased oxygen levels (GO:0036295)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to Cajal body (GO:1904869)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA rewinding (GO:0036292)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein trans-autophosphorylation (GO:0036290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to UV-A (GO:0070141)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inhibitory synapse assembly (GO:1904862)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
snoRNA localization (GO:0048254)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
elastic fiber assembly (GO:0048251)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
iron import into the mitochondrion (GO:0048250)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-serine autophosphorylation (GO:0036289)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
SAGA complex assembly (GO:0036285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial translation (GO:0070131)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial translation (GO:0070130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of protein localization to telomere (GO:1904851)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-serine transport (GO:0042942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lymphocyte chemotaxis (GO:0048247)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
D-amino acid transport (GO:0042940)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
macrophage chemotaxis (GO:0048246)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
eosinophil chemotaxis (GO:0048245)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
norepinephrine secretion (GO:0048243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epinephrine secretion (GO:0048242)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epinephrine transport (GO:0048241)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine pyrophosphate transmembrane transport (GO:0030974)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sperm capacitation (GO:0048240)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
retrograde protein transport, ER to cytosol (GO:0030970)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial translation (GO:0070129)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to statin (GO:0036273)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational termination (GO:0070126)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational elongation (GO:0070125)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial translational initiation (GO:0070124)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tripeptide transport (GO:0042939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dipeptide transport (GO:0042938)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein targeting to vacuolar membrane (GO:1900483)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination at telomere (GO:0048239)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
swimming (GO:0036268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine hydroxylation (GO:0030961)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA (guanine-N7)-methylation (GO:0036265)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dorsal root ganglion morphogenesis (GO:1904835)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucocorticoid receptor signaling pathway (GO:0042921)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
plasma membrane to endosome transport (GO:0048227)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
multivesicular body assembly (GO:0036258)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
multivesicular body organization (GO:0036257)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
interleukin-27-mediated signaling pathway (GO:0070106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule plus-end (GO:1904825)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peroxisome transport along microtubule (GO:0036250)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
interleukin-6-mediated signaling pathway (GO:0070102)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate transport (GO:0042918)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle prefusion complex stabilization (GO:0048213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle docking (GO:0048211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle fusion to target membrane (GO:0048210)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to menadione (GO:0036245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to chromosome, telomeric region (GO:1904814)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dense core granule transport (GO:1904811)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-term synaptic depression (GO:1900454)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-term synaptic depression (GO:1900453)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of long-term synaptic depression (GO:1900452)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate receptor signaling pathway (GO:1900451)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
COPI coating of Golgi vesicle (GO:0048205)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi transport vesicle coating (GO:0048200)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of dense core granule transport (GO:1904809)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein oxidation (GO:1904808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein oxidation (GO:1904806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
granulocyte activation (GO:0036230)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate receptor signaling pathway (GO:1900449)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuron remodeling (GO:1904800)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to nuclear inner membrane (GO:0036228)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
midbrain-hindbrain boundary development (GO:0030917)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
otic vesicle formation (GO:0030916)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
paranodal junction assembly (GO:0030913)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
olfactory placode formation (GO:0030910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to stem cell factor stimulus (GO:0036216)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to stem cell factor (GO:0036215)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of defense response to bacterium (GO:1900426)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of defense response to bacterium (GO:1900425)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to bacterium (GO:1900424)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
spermine transport (GO:0000296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to oxidative stress (GO:1900408)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
M phase (GO:0000279)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
polysaccharide catabolic process (GO:0000272)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
polysaccharide biosynthetic process (GO:0000271)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
mitochondrial fission (GO:0000266)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane permeability (GO:0035795)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
allantoin metabolic process (GO:0000255)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of corticotropin-releasing hormone secretion (GO:0043397)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in kidney development (GO:0035787)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spliceosomal tri-snRNP complex assembly (GO:0000244)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of CAMKK-AMPK signaling cascade (GO:1905290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA binding (GO:0043388)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
mycotoxin catabolic process (GO:0043387)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mycotoxin metabolic process (GO:0043385)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative T cell selection (GO:0043383)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of memory T cell differentiation (GO:0043382)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of memory T cell differentiation (GO:0043380)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell apoptotic process (GO:1905288)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibrous ring of heart morphogenesis (GO:1905285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
leptotene (GO:0000237)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde transport, endosome to Golgi (GO:1905281)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
memory T cell differentiation (GO:0043379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde transport, endosome to Golgi (GO:1905279)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
beta selection (GO:0043366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell chemotaxis (GO:0035754)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleate erythrocyte differentiation (GO:0043363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lysosomal lumen pH elevation (GO:0035752)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal lumen pH (GO:0035751)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin organization (GO:1905269)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin organization (GO:1905268)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
meiotic spindle organization (GO:0000212)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
T-helper 2 cell cytokine production (GO:0035745)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
enucleate erythrocyte differentiation (GO:0043353)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CD4-positive, alpha-beta T cell proliferation (GO:0035739)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
hepatic stellate cell activation (GO:0035733)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type peptidase activity (GO:1905246)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to hepatocyte growth factor stimulus (GO:0035729)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
response to hepatocyte growth factor (GO:0035728)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
common myeloid progenitor cell proliferation (GO:0035726)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to dsRNA (GO:0043331)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
intraciliary retrograde transport (GO:0035721)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
response to exogenous dsRNA (GO:0043330)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
intraciliary anterograde transport (GO:0035720)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to L-glutamate (GO:1905232)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to insecticide (GO:0017085)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell degranulation (GO:0043323)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell degranulation (GO:0043321)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T-helper 1 cell activation (GO:0035711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell degranulation (GO:0043320)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet formation (GO:1905221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytotoxic T cell degranulation (GO:0043316)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neutrophil degranulation (GO:0043314)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neutrophil degranulation (GO:0043313)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neutrophil degranulation (GO:0043312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of eosinophil degranulation (GO:0043311)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration (GO:0035701)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell killing (GO:0031343)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of vesicle fusion (GO:0031340)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of platelet formation (GO:1905219)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA binding (GO:1905216)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA binding (GO:1905215)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of RNA binding (GO:1905214)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic chromosome condensation (GO:1905213)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of eosinophil degranulation (GO:0043309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
eosinophil degranulation (GO:0043308)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eosinophil activation (GO:0043307)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex III assembly (GO:0017062)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of mast cell degranulation (GO:0043306)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of mast cell degranulation (GO:0043305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RNA modification (GO:0009451)	107	0	2.81	-	 < 0.01	1.18E-01	1.00E00
regulation of mast cell degranulation (GO:0043304)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mast cell degranulation (GO:0043303)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of leukocyte degranulation (GO:0043302)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte degranulation (GO:0043301)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of leukocyte degranulation (GO:0043300)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
negative regulation of vesicle fusion (GO:0031339)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of vesicle fusion (GO:0031338)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of sulfur amino acid metabolic process (GO:0031337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of sulfur amino acid metabolic process (GO:0031335)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiocyte differentiation (GO:1905209)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiocyte differentiation (GO:1905208)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of cardiocyte differentiation (GO:1905207)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of connective tissue replacement (GO:1905205)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue replacement (GO:1905204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of connective tissue replacement (GO:1905203)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid biosynthetic process (GO:0009449)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyruvate oxidation (GO:0009444)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolate metabolic process (GO:0009441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
methylglyoxal metabolic process (GO:0009438)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
carnitine metabolic process (GO:0009437)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
NAD biosynthetic process (GO:0009435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine-mediated signaling pathway (GO:0070099)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein import (GO:0017038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucagon secretion (GO:0070094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucagon secretion (GO:0070093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucagon secretion (GO:0070092)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent endocytosis (GO:0070086)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to water (GO:0009415)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein initiator methionine removal (GO:0070084)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to water deprivation (GO:0009414)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi vesicle budding (GO:0048194)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to cold (GO:0009409)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
regulation of neuron remodeling (GO:1904799)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of core promoter binding (GO:1904798)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
toxin catabolic process (GO:0009407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of core promoter binding (GO:1904797)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tear secretion (GO:0070075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of core promoter binding (GO:1904796)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein nitrosylation (GO:0017014)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
toxin metabolic process (GO:0009404)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
clustering of voltage-gated calcium channels (GO:0070073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proton-transporting two-sector ATPase complex assembly (GO:0070071)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
proton-transporting V-type ATPase complex assembly (GO:0070070)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of shelterin complex assembly (GO:1904791)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of shelterin complex assembly (GO:1904790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cysteine transport (GO:0042883)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein-tetrapyrrole linkage (GO:0017006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytochrome complex assembly (GO:0017004)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
protein-heme linkage (GO:0017003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of NMDA glutamate receptor activity (GO:1904783)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of NMDA glutamate receptor activity (GO:1904782)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
'de novo' actin filament nucleation (GO:0070060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to centrosome (GO:1904781)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to centrosome (GO:1904780)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
arachidonic acid secretion (GO:0050482)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of short-term neuronal synaptic plasticity (GO:0048172)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to centrosome (GO:1904779)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cell cortex (GO:1904778)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell cortex (GO:1904776)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to tetrachloromethane (GO:1904772)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antisense RNA metabolic process (GO:0042868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyruvate biosynthetic process (GO:0042866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fused antrum stage (GO:0048165)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
primary follicle stage (GO:0048160)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of myofibroblast differentiation (GO:1904761)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of myofibroblast differentiation (GO:1904760)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-alanine metabolic process (GO:0042851)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell proliferation (GO:0030889)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to nucleolus (GO:1904751)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to nucleolus (GO:1904750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fibroblast proliferation (GO:0048147)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
D-glucuronate catabolic process (GO:0042840)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
astrocyte activation (GO:0048143)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
osteoclast maturation (GO:0036179)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to nucleolus (GO:1904749)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of apoptotic process involved in development (GO:1904748)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of apoptotic process involved in development (GO:1904747)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of apoptotic process involved in development (GO:1904746)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric DNA binding (GO:1904744)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric DNA binding (GO:1904742)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein arginylation (GO:0016598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-glucuronate metabolic process (GO:0042839)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
defense response to protozoan (GO:0042832)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
spermatocyte division (GO:0048137)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell asymmetric division (GO:0048133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
female germ-line stem cell asymmetric division (GO:0048132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of polarized epithelial cell differentiation (GO:0030862)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of polarized epithelial cell differentiation (GO:0030860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phenotypic switching (GO:0036166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle cell migration (GO:1904738)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of electron transfer activity (GO:1904734)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of electron transfer activity (GO:1904732)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal lipid absorption (GO:1904731)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
amyloid-beta metabolic process (GO:0050435)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral transcription (GO:0050434)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate biosynthetic process (GO:0042823)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catecholamine secretion (GO:0050432)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of purine nucleotide biosynthetic process (GO:1900371)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
pyridoxal phosphate metabolic process (GO:0042822)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin B6 catabolic process (GO:0042820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polarized epithelial cell differentiation (GO:0030859)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell differentiation (GO:0030858)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulocyte differentiation (GO:0030854)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulocyte differentiation (GO:0030853)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
inner dynein arm assembly (GO:0036159)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of granulocyte differentiation (GO:0030852)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
outer dynein arm assembly (GO:0036158)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
granulocyte differentiation (GO:0030851)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
acylglycerol acyl-chain remodeling (GO:0036155)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal lipid absorption (GO:1904729)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
triglyceride acyl-chain remodeling (GO:0036153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of post-transcriptional gene silencing by RNA (GO:1900369)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
histone deacetylation (GO:0016575)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA polyadenylation (GO:1900365)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vitamin B6 metabolic process (GO:0042816)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA polyadenylation (GO:1900364)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol acyl-chain remodeling (GO:0036149)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to mycotoxin (GO:0036146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendritic cell homeostasis (GO:0036145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of AMPA glutamate receptor clustering (GO:1904717)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated autophagy (GO:1904715)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated autophagy (GO:1904714)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, translocation (GO:0016561)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix, docking (GO:0016560)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of body hair planar orientation (GO:0048105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment of body hair or bristle planar orientation (GO:0048104)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic stem cell division (GO:0048103)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament depolymerization (GO:0030836)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
autophagic cell death (GO:0048102)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine hydroxylation (GO:0036138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Schwann cell migration (GO:0036135)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of granulosa cell apoptotic process (GO:1904709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of granulosa cell apoptotic process (GO:1904708)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
peroxisome fission (GO:0016559)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to adherens junction (GO:1904702)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein import into peroxisome matrix (GO:0016558)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
peroxisome membrane biogenesis (GO:0016557)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mRNA modification (GO:0016556)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
base conversion or substitution editing (GO:0016553)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
histone H3-K9 dimethylation (GO:0036123)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to platelet-derived growth factor stimulus (GO:0036120)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
protein autoprocessing (GO:0016540)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to platelet-derived growth factor (GO:0036119)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide biosynthetic process (GO:0030810)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
long-chain fatty-acyl-CoA catabolic process (GO:0036116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty-acyl-CoA catabolic process (GO:0036115)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty-acyl-CoA catabolic process (GO:0036113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiosis II cell cycle process (GO:0061983)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
meiosis I cell cycle process (GO:0061982)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
negative regulation of nucleotide biosynthetic process (GO:0030809)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of nucleotide biosynthetic process (GO:0030808)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
articular cartilage development (GO:0061975)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
perichondral bone morphogenesis (GO:0061974)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane bone morphogenesis (GO:0061973)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of left/right asymmetry (GO:0061966)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rDNA heterochromatin formation (GO:0000183)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
penetration of cumulus oophorus (GO:0061956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
midbody abscission (GO:0061952)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to plasma membrane (GO:0061951)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
regulation of protein K48-linked ubiquitination (GO:0061945)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein K48-linked ubiquitination (GO:0061944)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
monocyte extravasation (GO:0035696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein catabolic process (GO:0035694)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
rRNA modification (GO:0000154)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
leukocyte degranulation (GO:0043299)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
helper T cell diapedesis (GO:0035685)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
helper T cell extravasation (GO:0035684)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine propionylation (GO:0061921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
manchette assembly (GO:1905198)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
actin cortical patch assembly (GO:0000147)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
posterior lateral line neuromast hair cell development (GO:0035677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromast hair cell development (GO:0035675)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tricarboxylic acid transmembrane transport (GO:0035674)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligopeptide transmembrane transport (GO:0035672)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	65	0	1.71	-	 < 0.01	4.16E-01	1.00E00
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to morphine (GO:0043278)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic cell clearance (GO:0043277)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
anoikis (GO:0043276)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
autophagosome-lysosome fusion (GO:0061909)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor 4 signaling pathway (GO:0035660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glial cell activation (GO:0061900)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
interleukin-18-mediated signaling pathway (GO:0035655)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
clathrin-coated vesicle cargo loading, AP-3-mediated (GO:0035654)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
clathrin-coated vesicle cargo loading (GO:0035652)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
replication fork processing (GO:0031297)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
B cell costimulation (GO:0031296)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell costimulation (GO:0031295)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lymphocyte costimulation (GO:0031294)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
membrane protein intracellular domain proteolysis (GO:0031293)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
Ran protein signal transduction (GO:0031291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal ganglion cell axon guidance (GO:0031290)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to phagocytic vesicle (GO:1905169)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosomal protein catabolic process (GO:1905167)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of lysosomal protein catabolic process (GO:1905166)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal protein catabolic process (GO:1905165)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of phagosome maturation (GO:1905162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endosome to melanosome transport (GO:0035646)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sodium-independent organic anion transport (GO:0043252)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of guanylate cyclase activity (GO:0031284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanylate cyclase activity (GO:0031283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of guanylate cyclase activity (GO:0031282)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclase activity (GO:0031280)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane invagination (GO:1905155)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane invagination (GO:1905154)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of membrane invagination (GO:1905153)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
histidine biosynthetic process (GO:0000105)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated sodium channel activity (GO:1905152)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated sodium channel activity (GO:1905151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfate assimilation (GO:0000103)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated sodium channel activity (GO:1905150)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound catabolic process (GO:0009397)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid transport (GO:0000101)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
folic acid-containing compound biosynthetic process (GO:0009396)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
erythrocyte maturation (GO:0043249)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
proteasome assembly (GO:0043248)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide metabolic process (GO:0009394)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
telomere maintenance in response to DNA damage (GO:0043247)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein-containing complex disassembly (GO:0043243)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
bone mineralization involved in bone maturation (GO:0035630)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of pseudopodium assembly (GO:0031274)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of pseudopodium assembly (GO:0031272)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
lysosomal protein catabolic process (GO:1905146)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
translational attenuation (GO:0009386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor transactivation (GO:0035624)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intrahepatic bile duct development (GO:0035622)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ER to Golgi ceramide transport (GO:0035621)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pseudopodium assembly (GO:0031269)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
biotin import across plasma membrane (GO:1905135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic chromosome separation (GO:1905133)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic chromosome separation (GO:1905132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
stress granule disassembly (GO:0035617)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein branching point deglutamylation (GO:0035611)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein side chain deglutamylation (GO:0035610)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucosylceramidase activity (GO:1905123)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
C-terminal protein deglutamylation (GO:0035609)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein deglutamylation (GO:0035608)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein deacylation (GO:0035601)	65	0	1.71	-	 < 0.01	4.16E-01	1.00E00
tRNA methylthiolation (GO:0035600)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin rod assembly (GO:0031247)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to leucine (GO:0043201)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of pulmonary blood vessel remodeling (GO:1905109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligosaccharide catabolic process (GO:0009313)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
amine catabolic process (GO:0009310)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase III (GO:0042796)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
5S class rRNA transcription by RNA polymerase III (GO:0042791)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of acinar cell proliferation (GO:1904698)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of acinar cell proliferation (GO:1904697)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle contraction (GO:1904695)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
rRNA transcription (GO:0009303)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
midbrain morphogenesis (GO:1904693)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
snRNA transcription (GO:0009301)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of type B pancreatic cell proliferation (GO:1904691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic translational initiation (GO:1904690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of developmental pigmentation (GO:0048087)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-end processing (GO:0042780)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational initiation (GO:1904688)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of metalloendopeptidase activity (GO:1904685)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to 3-methylcholanthrene (GO:1904682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to 3-methylcholanthrene (GO:1904681)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage (GO:0042779)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proton motive force-driven mitochondrial ATP synthesis (GO:0042776)	56	0	1.47	-	 < 0.01	4.06E-01	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	53	0	1.39	-	 < 0.01	6.47E-01	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	55	0	1.45	-	 < 0.01	4.05E-01	1.00E00
DNA damage response, signal transduction resulting in transcription (GO:0042772)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of eye pigmentation (GO:0048073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of developmental pigmentation (GO:0048070)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of somatic stem cell division (GO:1904677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell division (GO:1904675)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of somatic stem cell population maintenance (GO:1904672)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eye pigmentation (GO:0048069)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of sulfur metabolic process (GO:0042762)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
very long-chain fatty acid biosynthetic process (GO:0042761)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
male germ-line stem cell population maintenance (GO:0036098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ubiquitin protein ligase activity (GO:1904668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
germ cell proliferation (GO:0036093)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of ubiquitin protein ligase activity (GO:1904667)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquitin protein ligase activity (GO:1904666)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cleavage furrow ingression (GO:0036090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid catabolic process (GO:0042758)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
drinking behavior (GO:0042756)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian rhythm (GO:0042754)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian rhythm (GO:0042753)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
post-embryonic eye morphogenesis (GO:0048050)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cleavage furrow formation (GO:0036089)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
glucose transmembrane transport (GO:1904659)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle (GO:0042749)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle, REM sleep (GO:0042747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle (GO:0042745)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide catabolic process (GO:0042744)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide metabolic process (GO:0042743)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
embryonic eye morphogenesis (GO:0048048)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
focal adhesion assembly (GO:0048041)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
intratendonous ossification (GO:0036077)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ligamentous ossification (GO:0036076)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
replacement ossification (GO:0036075)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of fat cell apoptotic process (GO:1904649)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
direct ossification (GO:0036072)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
N-glycan fucosylation (GO:0036071)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to curcumin (GO:1904643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic digit morphogenesis (GO:0042733)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
fibrinolysis (GO:0042730)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
heme O biosynthetic process (GO:0048034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heme O metabolic process (GO:0048033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein O-linked fucosylation (GO:0036066)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fucosylation (GO:0036065)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of podocyte apoptotic process (GO:1904635)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
slit diaphragm assembly (GO:0036060)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of podocyte apoptotic process (GO:1904633)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to glucoside (GO:1904632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to glucoside (GO:1904631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to diterpene (GO:1904630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptide hormone processing (GO:0016486)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound catabolic process (GO:0042728)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of proteinase activated receptor activity (GO:1900276)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound biosynthetic process (GO:0042727)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase C activity (GO:1900275)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
flavin-containing compound metabolic process (GO:0042726)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase C activity (GO:1900274)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase III (GO:0016480)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thiamine-containing compound biosynthetic process (GO:0042724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thiamine-containing compound metabolic process (GO:0042723)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of melanin biosynthetic process (GO:0048023)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
filtration diaphragm assembly (GO:0036058)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to diterpene (GO:1904629)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to phorbol 13-acetate 12-myristate (GO:1904627)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by RNA polymerase I (GO:0016479)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-directed DNA polymerase activity (GO:1900262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sperm ejaculation (GO:0042713)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Tie signaling pathway (GO:0048014)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hepatocyte growth factor receptor signaling pathway (GO:0048012)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neurotrophin TRK receptor signaling pathway (GO:0048011)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine desuccinylation (GO:0036049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein desuccinylation (GO:0036048)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine demalonylation (GO:0036047)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein demalonylation (GO:0036046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin binding (GO:1904618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin binding (GO:1904617)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin binding (GO:1904616)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
progesterone secretion (GO:0042701)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of peptide antigen (GO:0048002)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
CD8-positive, alpha-beta T cell activation (GO:0036037)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sequestering of triglyceride (GO:0030730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
osteoclast development (GO:0036035)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to monosodium L-glutamate (GO:1904609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to monosodium L-glutamate (GO:1904608)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural crest cell delamination (GO:0036032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic translational elongation (GO:1900248)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic translational elongation (GO:1900247)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle endocytosis (GO:1900243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phenotypic switching (GO:1900240)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic skeletal limb joint morphogenesis (GO:0036023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
limb joint morphogenesis (GO:0036022)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic recombination of immunoglobulin gene segments (GO:0016447)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of phenotypic switching (GO:1900239)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic hypermutation of immunoglobulin genes (GO:0016446)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic diversification of immunoglobulins (GO:0016445)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
somatic cell DNA recombination (GO:0016444)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of Kit signaling pathway (GO:1900235)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Kit signaling pathway (GO:1900234)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-transcriptional gene silencing (GO:0016441)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
P granule organization (GO:0030719)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell population maintenance (GO:0030718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to erythropoietin (GO:0036018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to erythropoietin (GO:0036017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interleukin-3 (GO:0036016)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to interleukin-3 (GO:0036015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of astrocyte activation (GO:0061889)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of astrocyte activation (GO:0061888)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mini excitatory postsynaptic potential (GO:0061884)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of amyloid-beta clearance (GO:1900223)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of amyloid-beta clearance (GO:1900222)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of amyloid-beta clearance (GO:1900221)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to macrophage colony-stimulating factor (GO:0036005)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell contraction (GO:0061875)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell contraction (GO:0061873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatic stellate cell migration (GO:0061871)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatic stellate cell migration (GO:0061870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiolipin metabolic process (GO:1900210)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid catabolic process (GO:0000098)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid biosynthetic process (GO:0000097)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
sulfur amino acid metabolic process (GO:0000096)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of hepatic stellate cell migration (GO:0061869)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardiolipin metabolic process (GO:1900208)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitotic metaphase (GO:0000089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic M phase (GO:0000087)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
mitotic G1 phase (GO:0000080)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuroblast migration (GO:0061855)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of neuroblast migration (GO:0061853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
DNA replication checkpoint signaling (GO:0000076)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to cholecystokinin (GO:0061847)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
Sertoli cell barrier remodeling (GO:0061843)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purinergic nucleotide receptor signaling pathway (GO:0035590)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to tricellular tight junction (GO:0061833)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit export from nucleus (GO:0000056)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ribosomal large subunit export from nucleus (GO:0000055)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
citrulline metabolic process (GO:0000052)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
urea cycle (GO:0000050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling using extracellular calcium source (GO:0035585)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcium-mediated signaling using intracellular calcium source (GO:0035584)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
sequestering of TGFbeta in extracellular matrix (GO:0035583)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sequestering of BMP in extracellular matrix (GO:0035582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of extracellular ligand from receptor (GO:0035581)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomeric D-loop disassembly (GO:0061820)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905091)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomeric DNA-containing double minutes formation (GO:0061819)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuolar sequestering (GO:0043181)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
electron transport coupled proton transport (GO:0015990)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoside salvage (GO:0043174)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of kidney size (GO:0035564)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide salvage (GO:0043173)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of chromatin binding (GO:0035563)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of chromatin binding (GO:0035562)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of chromatin binding (GO:0035561)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
proton motive force-driven ATP synthesis (GO:0015986)	60	0	1.58	-	 < 0.01	4.08E-01	1.00E00
ribosomal small subunit assembly (GO:0000028)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of tight junction disassembly (GO:1905075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribosomal large subunit assembly (GO:0000027)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of tight junction disassembly (GO:1905073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic spindle elongation (GO:0000022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
oxidative single-stranded DNA demethylation (GO:0035552)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein initiator methionine removal involved in protein maturation (GO:0035551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
allantois development (GO:1905069)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-proline biosynthetic process (GO:0055129)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic recombination (GO:0000019)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
single strand break repair (GO:0000012)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to cation stress (GO:0043157)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of SNARE complex assembly (GO:0035544)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SNARE complex assembly (GO:0035542)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate biosynthetic process (GO:0015966)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine tetraphosphate metabolic process (GO:0015965)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
diadenosine triphosphate catabolic process (GO:0015964)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diadenosine triphosphate metabolic process (GO:0015962)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate catabolic process (GO:0015961)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate biosynthetic process (GO:0015960)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle contraction (GO:0055118)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of base-excision repair (GO:1905053)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of base-excision repair (GO:1905051)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-mannose biosynthetic process (GO:0009298)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of metallopeptidase activity (GO:1905050)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA processing (GO:0043144)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
peptide modification (GO:0031179)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diadenosine polyphosphate metabolic process (GO:0015959)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
otolith mineralization completed early in development (GO:0031173)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi to transport vesicle transport (GO:0055108)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
Golgi to secretory granule transport (GO:0055107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell proliferation involved in axon regeneration (GO:1905045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell proliferation involved in axon regeneration (GO:1905044)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
otic placode development (GO:1905040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA replication, removal of RNA primer (GO:0043137)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retrograde transport, plasma membrane to Golgi (GO:0035526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hindgut contraction (GO:0043134)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
proline transmembrane transport (GO:0035524)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein K29-linked deubiquitination (GO:0035523)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
NAD transport (GO:0043132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated histone H2A deubiquitination (GO:0035522)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated histone deubiquitination (GO:0035521)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
monoubiquitinated protein deubiquitination (GO:0035520)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
rRNA methylation (GO:0031167)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
metallo-sulfur cluster assembly (GO:0031163)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
formate metabolic process (GO:0015942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane lipid metabolic process (GO:1905038)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of antifungal innate immune response (GO:1905035)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of antifungal innate immune response (GO:1905034)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein K29-linked ubiquitination (GO:0035519)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxidative RNA demethylation (GO:0035513)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
oxidative DNA demethylation (GO:0035511)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA dealkylation (GO:0035510)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
coenzyme A catabolic process (GO:0015938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
coenzyme A biosynthetic process (GO:0015937)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
coenzyme A metabolic process (GO:0015936)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of threonine-tRNA ligase activity (GO:1905023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of threonine-tRNA ligase activity (GO:1905021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to pH (GO:0009268)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of methionine-tRNA ligase activity (GO:1905020)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide catabolic process (GO:0009264)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide biosynthetic process (GO:0009263)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleotide metabolic process (GO:0009262)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
ribonucleotide catabolic process (GO:0009261)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of myosin light chain kinase activity (GO:0035505)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of myosin light chain kinase activity (GO:0035504)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephric part of ureteric bud development (GO:0035502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
replication fork arrest (GO:0043111)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipopolysaccharide transport (GO:0015920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of methionine-tRNA ligase activity (GO:1905018)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of isoleucine-tRNA ligase activity (GO:1905017)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of isoleucine-tRNA ligase activity (GO:1905015)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate catabolic process (GO:0009258)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
10-formyltetrahydrofolate metabolic process (GO:0009256)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glucan catabolic process (GO:0009251)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
glucan biosynthetic process (GO:0009250)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
hypoxanthine salvage (GO:0043103)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid salvage (GO:0043102)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine-containing compound salvage (GO:0043101)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
sister chromatid biorientation (GO:0031134)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of axon diameter (GO:0031133)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
long-chain fatty acid import across plasma membrane (GO:0015911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein lipoylation (GO:0009249)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolipid biosynthetic process (GO:0009247)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
isopentenyl diphosphate biosynthetic process (GO:0009240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
developmental induction (GO:0031128)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
sno(s)RNA 3'-end processing (GO:0031126)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
rRNA 3'-end processing (GO:0031125)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
snRNA pseudouridine synthesis (GO:0031120)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cobalamin metabolic process (GO:0009235)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA pseudouridine synthesis (GO:0031119)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
rRNA pseudouridine synthesis (GO:0031118)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule depolymerization (GO:0031117)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule polymerization (GO:0031116)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule polymerization (GO:0031115)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule depolymerization (GO:0031114)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule polymerization (GO:0031113)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	39	0	1.03	-	 < 0.01	6.27E-01	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	70	0	1.84	-	 < 0.01	2.66E-01	1.00E00
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar catabolic process (GO:0009227)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar biosynthetic process (GO:0009226)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide catabolic process (GO:0009222)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
septin ring organization (GO:0031106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axon regeneration (GO:0031103)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
animal organ regeneration (GO:0031100)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleotide metabolic process (GO:0009218)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cyclic nucleotide catabolic process (GO:0009214)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate catabolic process (GO:0009210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
follicle-stimulating hormone signaling pathway (GO:0042699)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
menarche (GO:0042696)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
thelarche (GO:0042695)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
muscle cell fate commitment (GO:0042693)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	72	0	1.89	-	 < 0.01	2.66E-01	1.00E00
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of termination of RNA polymerase II transcription (GO:1904594)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ribonucleoside triphosphate catabolic process (GO:0009203)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein refolding (GO:1904592)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	75	0	1.97	-	 < 0.01	2.68E-01	1.00E00
positive regulation of protein import (GO:1904591)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of protein import (GO:1904589)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to glycoprotein (GO:1904587)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to putrescine (GO:1904586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to putrescine (GO:1904585)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of intracellular mRNA localization (GO:1904582)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular mRNA localization (GO:1904580)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal cone cell differentiation (GO:0042670)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of selenocysteine insertion sequence binding (GO:1904574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of selenocysteine insertion sequence binding (GO:1904573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mRNA binding (GO:1904572)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of selenocysteine incorporation (GO:1904571)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of selenocysteine incorporation (GO:1904570)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mesodermal cell fate specification (GO:0042661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of selenocysteine incorporation (GO:1904569)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to wortmannin (GO:1904568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to wortmannin (GO:1904567)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostanoid catabolic process (GO:0062232)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate specification (GO:0042659)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
mitigation of host defenses by symbiont (GO:0030682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-alanine transmembrane transport (GO:1904557)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-tryptophan transmembrane transport (GO:1904556)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-proline transmembrane transport (GO:1904555)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to arachidonic acid (GO:1904550)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of oocyte maturation (GO:1900195)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oocyte maturation (GO:1900194)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of oocyte maturation (GO:1900193)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of DNA stability (GO:0097752)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endosome membrane tubulation (GO:0097750)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane tubulation (GO:0097749)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of clathrin-dependent endocytosis (GO:1900186)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
catagen (GO:0042637)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 5'-end processing (GO:0097745)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal urate salt excretion (GO:0097744)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of hair cycle (GO:0042634)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
de novo centriole assembly (GO:0097742)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cholesterol homeostasis (GO:0042632)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
negative regulation of protein localization to nucleus (GO:1900181)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of telomeric loop disassembly (GO:1904533)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of actin filament binding (GO:1904531)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament binding (GO:1904530)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mating plug formation (GO:0042628)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular exosome biogenesis (GO:0097734)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin metabolic process (GO:0030656)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament binding (GO:1904529)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microtubule binding (GO:1904528)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of microtubule binding (GO:1904527)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule binding (GO:1904526)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell-derived neurotrophic factor production (GO:1900168)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell-derived neurotrophic factor production (GO:1900166)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sperm motility (GO:0097722)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid scramblase activity (GO:1900161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aminoglycoside antibiotic metabolic process (GO:0030647)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular phosphate ion homeostasis (GO:0030643)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to basolateral plasma membrane (GO:1904510)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bone mineralization involved in bone maturation (GO:1900157)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ciliary basal body-plasma membrane docking (GO:0097711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
regulation of defense response to fungus (GO:1900150)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyketide metabolic process (GO:0030638)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to basolateral plasma membrane (GO:1904508)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance in response to DNA damage (GO:1904507)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance in response to DNA damage (GO:1904505)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipophagy (GO:1904504)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lipophagy (GO:1904502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
connective tissue replacement (GO:0097709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell migration (GO:1900149)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell migration (GO:1900148)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell migration (GO:1900147)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oligodendrocyte apoptotic process (GO:1900143)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of oligodendrocyte apoptotic process (GO:1900141)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of arachidonic acid secretion (GO:1900139)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of renin secretion into blood stream (GO:1900135)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcium-dependent cell-matrix adhesion (GO:0016340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of renin secretion into blood stream (GO:1900133)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipid binding (GO:1900131)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipid binding (GO:1900130)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dense core granule priming (GO:0061789)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hyaluronan biosynthetic process (GO:1900127)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of follicular epithelium (GO:0016333)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hyaluronan biosynthetic process (GO:1900126)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hyaluronan biosynthetic process (GO:1900125)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
vesicle fusion with vesicle (GO:0061782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor binding (GO:1900122)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of execution phase of apoptosis (GO:1900119)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
extracellular negative regulation of signal transduction (GO:1900116)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
neuron remodeling (GO:0016322)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
extracellular regulation of signal transduction (GO:1900115)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
female meiosis chromosome segregation (GO:0016321)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K9 trimethylation (GO:1900114)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to caloric restriction (GO:0061771)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 trimethylation (GO:1900113)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 trimethylation (GO:1900112)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K9 dimethylation (GO:1900110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrion transport along microtubule (GO:0047497)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
vesicle transport along microtubule (GO:0047496)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K9 dimethylation (GO:1900109)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lung blood pressure (GO:0061767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nodal signaling pathway (GO:1900108)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of nodal signaling pathway (GO:1900107)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
late endosome to lysosome transport via multivesicular body sorting pathway (GO:0061764)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multivesicular body-lysosome fusion (GO:0061763)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
CAMKK-AMPK signaling cascade (GO:0061762)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
antifungal innate immune response (GO:0061760)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasma cell differentiation (GO:1900100)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle mediated signaling (GO:0055096)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipoprotein particle mediated signaling (GO:0055095)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to lipoprotein particle (GO:0055094)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
response to hyperoxia (GO:0055093)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sterol homeostasis (GO:0055092)	46	0	1.21	-	 < 0.01	6.33E-01	1.00E00
phospholipid homeostasis (GO:0055091)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
acylglycerol homeostasis (GO:0055090)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
leukocyte adhesion to vascular endothelial cell (GO:0061756)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
substrate localization to autophagosome (GO:0061753)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fatty acid homeostasis (GO:0055089)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
motor behavior (GO:0061744)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cadmium ion homeostasis (GO:0055073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
manganese ion homeostasis (GO:0055071)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
copper ion homeostasis (GO:0055070)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
carnosine metabolic process (GO:0035498)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein lipidation involved in autophagosome assembly (GO:0061739)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
late endosomal microautophagy (GO:0061738)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
SNARE complex disassembly (GO:0035494)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
SNARE complex assembly (GO:0035493)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
engulfment of target by autophagosome (GO:0061736)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
zinc ion homeostasis (GO:0055069)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
phosphate ion homeostasis (GO:0055062)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleobase salvage (GO:0043096)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular metabolic compound salvage (GO:0043094)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
methylglyoxal catabolic process to lactate (GO:0061727)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cytosolic lipolysis (GO:0061725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipophagy (GO:0061724)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycophagy (GO:0061723)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
asymmetric neuroblast division (GO:0055059)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
neuroblast division (GO:0055057)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
penile erection (GO:0043084)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to pyruvate (GO:0061718)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of vascular wound healing (GO:0035470)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterior neural tube closure (GO:0061713)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
siderophore transport (GO:0015891)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
anastral spindle assembly (GO:0055048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
determination of pancreatic left/right asymmetry (GO:0035469)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
reticulophagy (GO:0061709)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cobalamin transport (GO:0015889)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thiamine transport (GO:0015888)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heme transport (GO:0015886)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
folic acid transport (GO:0015884)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
FAD transport (GO:0015883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
creatine transmembrane transport (GO:0015881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
coenzyme A transport (GO:0015880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to interferon-alpha (GO:0035457)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to interferon-alpha (GO:0035455)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
meiotic metaphase I plate congression (GO:0043060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carnitine transport (GO:0015879)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
biotin transport (GO:0015878)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
norepinephrine transport (GO:0015874)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dopamine transport (GO:0015872)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
choline transport (GO:0015871)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
acetylcholine transport (GO:0015870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle tissue development (GO:0055025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle tissue development (GO:0055024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tripeptide transmembrane transport (GO:0035443)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dipeptide transmembrane transport (GO:0035442)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ADP transport (GO:0015866)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell development (GO:0055015)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell development (GO:0055014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac muscle cell differentiation (GO:0055012)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell differentiation (GO:0055011)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in gamete generation (GO:0043046)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA methylation involved in embryo development (GO:0043045)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate catabolic process (GO:0009191)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
copper ion transmembrane transport (GO:0035434)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye development (GO:0031076)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
nucleoside transport (GO:0015858)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular cardiac myofibril assembly (GO:0055005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac myofibril assembly (GO:0055003)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
striated muscle cell development (GO:0055002)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate biosynthetic process (GO:0009188)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
tRNA aminoacylation (GO:0043039)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
amino acid activation (GO:0043038)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
ribonucleoside diphosphate metabolic process (GO:0009185)	38	0	1.00	-	 < 0.01	6.27E-01	1.00E00
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular matrix-cell signaling (GO:0035426)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
autocrine signaling (GO:0035425)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate catabolic process (GO:0009181)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage activation (GO:0043032)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
hair follicle morphogenesis (GO:0031069)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone deacetylation (GO:0031064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
monoamine transport (GO:0015844)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
urea transport (GO:0015840)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside diphosphate metabolic process (GO:0009179)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate catabolic process (GO:0009172)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
amino-acid betaine transport (GO:0015838)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chromatin remodeling at centromere (GO:0031055)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pre-miRNA processing (GO:0031054)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
peptidoglycan transport (GO:0015835)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
primary miRNA processing (GO:0031053)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
programmed DNA elimination by chromosome breakage (GO:0031052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate catabolic process (GO:0009169)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
nucleotide catabolic process (GO:0009166)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
nucleoside catabolic process (GO:0009164)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nucleoside biosynthetic process (GO:0009163)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
programmed DNA elimination (GO:0031049)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
small non-coding RNA-dependent heterochromatin formation (GO:0031048)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
valine transport (GO:0015829)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tryptophan transport (GO:0015827)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
threonine transport (GO:0015826)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-serine transport (GO:0015825)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proline transport (GO:0015824)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
phenylalanine transport (GO:0015823)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ornithine transport (GO:0015822)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leucine transport (GO:0015820)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate catabolic process (GO:0009158)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
ribonucleoside monophosphate biosynthetic process (GO:0009156)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide catabolic process (GO:0009155)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
maintenance of rDNA (GO:0043007)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide biosynthetic process (GO:0009153)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine deoxyribonucleotide metabolic process (GO:0009151)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
Golgi to plasma membrane CFTR protein transport (GO:0043000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lysine transport (GO:0015819)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isoleucine transport (GO:0015818)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histidine transport (GO:0015817)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine transport (GO:0015816)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
L-glutamate transmembrane transport (GO:0015813)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid transport (GO:0015812)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
L-cystine transport (GO:0015811)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aspartate transmembrane transport (GO:0015810)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
purine nucleoside triphosphate catabolic process (GO:0009146)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	73	0	1.92	-	 < 0.01	2.66E-01	1.00E00
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemoglobin biosynthetic process (GO:0046985)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of hemoglobin biosynthetic process (GO:0046984)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	82	0	2.16	-	 < 0.01	2.77E-01	1.00E00
pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-alanine transport (GO:0015808)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
L-amino acid transport (GO:0015807)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
microtubule organizing center organization (GO:0031023)	62	0	1.63	-	 < 0.01	4.11E-01	1.00E00
S-adenosyl-L-methionine transport (GO:0015805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutral amino acid transport (GO:0015804)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
nuclear migration along microfilament (GO:0031022)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid transport (GO:0015803)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
basic amino acid transport (GO:0015802)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid transport (GO:0015801)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
acidic amino acid transport (GO:0015800)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate catabolic process (GO:0009137)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of lysosome size (GO:0062196)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate biosynthetic process (GO:0009136)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
purine nucleoside diphosphate metabolic process (GO:0009135)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate biosynthetic process (GO:0009133)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
exocrine pancreas development (GO:0031017)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate catabolic process (GO:0009128)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate biosynthetic process (GO:0009127)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
purine nucleoside monophosphate metabolic process (GO:0009126)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate catabolic process (GO:0009125)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate biosynthetic process (GO:0009124)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
deoxyribonucleoside metabolic process (GO:0009120)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sensitization (GO:0046960)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to caffeine (GO:0031000)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
ribonucleoside metabolic process (GO:0009119)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
habituation (GO:0046959)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
radial spoke assembly (GO:0062177)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nonassociative learning (GO:0046958)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleoside metabolic process (GO:0009116)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
purine nucleobase biosynthetic process (GO:0009113)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nucleobase metabolic process (GO:0009112)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
vitamin catabolic process (GO:0009111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ketone body catabolic process (GO:0046952)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vitamin biosynthetic process (GO:0009110)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ketone body biosynthetic process (GO:0046951)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular ketone body metabolic process (GO:0046950)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
behavioral response to starvation (GO:0042595)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine deacetylation (GO:0034983)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial protein processing (GO:0034982)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
endothelin receptor signaling pathway involved in heart process (GO:0086101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endothelin receptor signaling pathway (GO:0086100)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipoate biosynthetic process (GO:0009107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipoate metabolic process (GO:0009106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of substance P secretion, neurotransmission (GO:1904496)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydroxylysine biosynthetic process (GO:0046947)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydroxylysine metabolic process (GO:0046946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of substance P secretion, neurotransmission (GO:1904494)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary transition zone (GO:1904491)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleoside monophosphate phosphorylation (GO:0046940)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor signaling pathway via STAT (GO:0097696)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
establishment of RNA localization to telomere (GO:0097694)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 monomethylation (GO:0097692)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
histone H3-R17 methylation (GO:0034971)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H3-R2 methylation (GO:0034970)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide phosphorylation (GO:0046939)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
glutamate receptor clustering (GO:0097688)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal absorption (GO:1904480)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone arginine methylation (GO:0034969)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
retinal metabolic process (GO:0042574)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
box H/ACA RNA processing (GO:0034964)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinoic acid metabolic process (GO:0042573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
double-strand break repair via classical nonhomologous end joining (GO:0097680)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
retinol metabolic process (GO:0042572)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
box C/D RNA processing (GO:0034963)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of transport across blood-brain barrier (GO:0150200)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of stimulus involved in sensory perception of pain (GO:0062149)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of intestinal absorption (GO:1904479)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal absorption (GO:1904478)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of endothelin production (GO:1904472)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endothelin production (GO:1904471)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endothelin production (GO:1904470)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 dimethylation (GO:0097676)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endothelin maturation (GO:0034959)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound catabolic process (GO:0042560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neutrophil chemotaxis (GO:0030593)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
DNA ADP-ribosylation (GO:0030592)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of matrix metallopeptidase secretion (GO:1904466)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of matrix metallopeptidase secretion (GO:1904465)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of matrix metallopeptidase secretion (GO:1904464)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of substance P secretion (GO:1904460)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound biosynthetic process (GO:0042559)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
pteridine-containing compound metabolic process (GO:0042558)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
superoxide anion generation (GO:0042554)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of substance P secretion (GO:1904458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuronal action potential (GO:1904457)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
fatty acid primary amide metabolic process (GO:0062126)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial gene expression (GO:0062125)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuronal action potential (GO:1904456)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of potassium:proton exchanging ATPase activity (GO:1904451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aspartate secretion (GO:1904450)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasma cell differentiation (GO:1900099)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma cell differentiation (GO:1900098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
protein N-linked glycosylation via arginine (GO:0042543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemoglobin biosynthetic process (GO:0042541)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
PML body organization (GO:0030578)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
Cajal body organization (GO:0030576)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
collagen catabolic process (GO:0030574)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aspartate secretion (GO:1904448)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fatty acid primary amide biosynthetic process (GO:0062112)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zinc ion import into organelle (GO:0062111)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of SMAD protein complex assembly (GO:0010991)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of SMAD protein complex assembly (GO:0010990)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
amylin receptor signaling pathway (GO:0097647)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hypotonic salinity response (GO:0042539)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
calcitonin family receptor signaling pathway (GO:0097646)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hyperosmotic salinity response (GO:0042538)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
benzene-containing compound metabolic process (GO:0042537)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of arginine catabolic process (GO:1900082)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of arginine catabolic process (GO:1900081)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion import across plasma membrane (GO:1904438)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transferrin receptor binding (GO:1904437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipoprotein particle clearance (GO:0010986)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein particle clearance (GO:0010985)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of transferrin receptor binding (GO:1904435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ferrous iron binding (GO:1904434)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ferrous iron binding (GO:1904432)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of high-density lipoprotein particle clearance (GO:0010982)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of programmed necrotic cell death (GO:0062100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of t-circle formation (GO:1904431)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of t-circle formation (GO:1904430)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of arginine biosynthetic process (GO:1900079)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-arginine import across plasma membrane (GO:0097638)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to insulin stimulus (GO:1900077)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
regulation of t-circle formation (GO:1904429)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of tubulin deacetylation (GO:1904428)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of GTP binding (GO:1904425)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of cellular hyperosmotic salinity response (GO:1900069)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
potassium ion export across plasma membrane (GO:0097623)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome organization (GO:1900063)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ceramide biosynthetic process (GO:1900060)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
female genitalia development (GO:0030540)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule nucleation (GO:0010968)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of xenophagy (GO:1904417)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of phosphate transport (GO:0010966)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of xenophagy (GO:1904415)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac ventricle development (GO:1904414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glucan biosynthetic process (GO:0010962)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac ventricle development (GO:1904412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular magnesium ion homeostasis (GO:0010961)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
magnesium ion homeostasis (GO:0010960)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound salvage (GO:0008655)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gap junction assembly (GO:0016264)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of retinoic acid biosynthetic process (GO:1900054)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenocysteine catabolic process (GO:0016261)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinoic acid biosynthetic process (GO:1900053)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenocysteine biosynthetic process (GO:0016260)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinoic acid biosynthetic process (GO:1900052)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
male genitalia development (GO:0030539)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
embryonic genitalia morphogenesis (GO:0030538)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid import across plasma membrane (GO:0010958)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of vitamin D biosynthetic process (GO:0010957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein processing (GO:0010955)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
selenocysteine metabolic process (GO:0016259)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
N-glycan processing to lysosome (GO:0016256)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
attachment of GPI anchor to protein (GO:0016255)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of hemostasis (GO:1900048)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
hexose transmembrane transport (GO:0008645)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of hemostasis (GO:1900047)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of hemostasis (GO:1900046)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
intracellular estrogen receptor signaling pathway (GO:0030520)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by competitive promoter binding (GO:0010944)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein deglutarylation (GO:0061698)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of necrotic cell death (GO:0010940)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to hypoxia (GO:1900039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of autophagosome size (GO:0016243)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular response to heat (GO:1900036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macroautophagy (GO:0016242)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to heat (GO:1900035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to heat (GO:1900034)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
regulation of necrotic cell death (GO:0010939)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage cytokine production (GO:0010936)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
macrophage cytokine production (GO:0010934)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
lysosomal microautophagy (GO:0016237)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
detoxification of inorganic compound (GO:0061687)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ruffle assembly (GO:1900029)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ruffle assembly (GO:1900028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ruffle assembly (GO:1900027)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
chaperone-mediated autophagy (GO:0061684)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomere capping (GO:0016233)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of D-erythro-sphingosine kinase activity (GO:1900022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
inorganic diphosphate transport (GO:0030505)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of bone mineralization (GO:0030502)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatase activity (GO:0010923)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
iron-sulfur cluster assembly (GO:0016226)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
evoked neurotransmitter secretion (GO:0061670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inositol phosphate biosynthetic process (GO:0010919)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial membrane potential (GO:0010918)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial membrane potential (GO:0010917)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of isomerase activity (GO:0010912)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial ribosome assembly (GO:0061668)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of isomerase activity (GO:0010911)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of eating behavior (GO:1903999)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of eating behavior (GO:1903998)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of glucose metabolic process (GO:0010907)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
muscle attachment (GO:0016203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of striated muscle tissue development (GO:0016202)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell activation (GO:1903980)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell activation (GO:1903979)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell activation (GO:1903978)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell migration (GO:1903977)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell migration (GO:1903976)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell migration (GO:1903975)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
chemorepulsion of axon (GO:0061643)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chemoattraction of axon (GO:0061642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of response to macrophage colony-stimulating factor (GO:1903969)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein complex stability (GO:0061635)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
monounsaturated fatty acid biosynthetic process (GO:1903966)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
monounsaturated fatty acid metabolic process (GO:1903964)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
arachidonate transport (GO:1903963)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion transmembrane transport (GO:1903961)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of anion transmembrane transport (GO:1903960)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
Roundabout signaling pathway (GO:0035385)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of anion transmembrane transport (GO:1903959)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
pharyngeal arch artery morphogenesis (GO:0061626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycolytic process from galactose (GO:0061623)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolytic process through glucose-1-phosphate (GO:0061622)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
canonical glycolysis (GO:0061621)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolytic process through glucose-6-phosphate (GO:0061620)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule (GO:0035372)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
glycolytic process through fructose-6-phosphate (GO:0061615)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of hepatocyte apoptotic process (GO:1903945)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
miRNA transcription (GO:0061614)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hepatocyte apoptotic process (GO:1903944)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of hepatocyte apoptotic process (GO:1903943)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of respiratory gaseous exchange (GO:1903942)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of respiratory gaseous exchange (GO:1903941)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of TORC2 signaling (GO:1903940)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-xylose transmembrane transport (GO:0015790)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to sodium arsenite (GO:1903936)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
response to sodium arsenite (GO:1903935)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA primase activity (GO:1903934)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA primase activity (GO:1903932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-glucose transmembrane transport (GO:0015786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate transmembrane transport (GO:0015782)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular triglyceride homeostasis (GO:0035356)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
primary palate development (GO:1903929)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
NAD transmembrane transport (GO:0035352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to bisphenol A (GO:1903926)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heme transmembrane transport (GO:0035351)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to bisphenol A (GO:1903925)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
FAD transmembrane transport (GO:0035350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein processing in phagocytic vesicle (GO:1903921)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
polysaccharide transport (GO:0015774)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligosaccharide transport (GO:0015772)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sucrose transport (GO:0015770)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
viral budding via host ESCRT complex (GO:0039702)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
coenzyme A transmembrane transport (GO:0035349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of actin filament severing (GO:1903919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of actin filament severing (GO:1903918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of the force of heart contraction by cardiac conduction (GO:0086092)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
disaccharide transport (GO:0015766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose-6-phosphate transport (GO:0015760)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
valine biosynthetic process (GO:0009099)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
leucine biosynthetic process (GO:0009098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cysteine catabolic process (GO:0009093)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
homoserine metabolic process (GO:0009092)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hippo signaling (GO:0035331)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of establishment of T cell polarity (GO:1903905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of T cell polarity (GO:1903903)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral life cycle (GO:1903902)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral life cycle (GO:1903901)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
galactose transmembrane transport (GO:0015757)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fructose transmembrane transport (GO:0015755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
methionine biosynthetic process (GO:0009086)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
hippo signaling (GO:0035329)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process (GO:0009085)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid catabolic process (GO:0009083)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
urate transport (GO:0015747)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
citrate transport (GO:0015746)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
succinate transport (GO:0015744)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
malate transport (GO:0015743)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
C4-dicarboxylate transport (GO:0015740)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
pyruvate family amino acid metabolic process (GO:0009078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
aromatic amino acid family metabolic process (GO:0009072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
serine family amino acid catabolic process (GO:0009071)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
serine family amino acid biosynthetic process (GO:0009070)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
wound healing, spreading of epidermal cells (GO:0035313)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
AV node cell to bundle of His cell communication (GO:0086067)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sialic acid transport (GO:0015739)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
taurine transport (GO:0015734)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
serine family amino acid metabolic process (GO:0009069)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid catabolic process (GO:0009068)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein dephosphorylation (GO:0035308)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
negative regulation of dephosphorylation (GO:0035305)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
aerobic respiration (GO:0009060)	116	0	3.05	-	 < 0.01	1.26E-01	1.00E00
oxaloacetate transport (GO:0015729)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lactate transport (GO:0015727)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
canalicular bile acid transport (GO:0015722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bile acid and bile salt transport (GO:0015721)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylcholine metabolic process (GO:0150174)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine metabolic process (GO:0150172)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to cycloheximide (GO:0046898)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pentose-phosphate shunt, oxidative branch (GO:0009051)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during bundle of His cell action potential (GO:0086048)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during SA node cell action potential (GO:0086046)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during AV node cell action potential (GO:0086045)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
bundle of His cell action potential (GO:0086043)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hexose phosphate transport (GO:0015712)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of hormone biosynthetic process (GO:0046886)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of follicle-stimulating hormone secretion (GO:0046880)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
thiosulfate transport (GO:0015709)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bicarbonate transport (GO:0015701)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of programmed necrotic cell death (GO:0062099)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of programmed necrotic cell death (GO:0062098)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of saliva secretion (GO:0046878)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of saliva secretion (GO:0046877)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
stomach development (GO:0062094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
quinolinate metabolic process (GO:0046874)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AV node cell to bundle of His cell signaling (GO:0086027)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carotenoid transport (GO:0046867)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tetraterpenoid transport (GO:0046866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terpenoid transport (GO:0046865)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isoprenoid transport (GO:0046864)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in cardiac conduction (GO:0086019)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte action potential (GO:0086017)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
AV node cell action potential (GO:0086016)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
SA node cell action potential (GO:0086015)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
atrial cardiac muscle cell action potential (GO:0086014)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
membrane depolarization during action potential (GO:0086010)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
inositol phosphate dephosphorylation (GO:0046855)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
phosphatidylinositol phosphate biosynthetic process (GO:0046854)	41	0	1.08	-	 < 0.01	6.27E-01	1.00E00
ventricular cardiac muscle cell action potential (GO:0086005)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell differentiation (GO:0042492)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuromuscular junction development (GO:1904398)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of odontogenesis (GO:0042483)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of odontogenesis (GO:0042482)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of odontogenesis (GO:0042481)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate junction organization (GO:0150118)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
cell-substrate junction organization (GO:0150115)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
regulation of transepithelial transport (GO:0150111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol esterification (GO:0150110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phospholipid dephosphorylation (GO:0046839)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
phosphorylated carbohydrate dephosphorylation (GO:0046838)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
response to L-phenylalanine derivative (GO:1904386)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolipid transport (GO:0046836)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
carbohydrate phosphorylation (GO:0046835)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
lipid phosphorylation (GO:0046834)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to sodium phosphate (GO:1904383)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA export from nucleus (GO:0046833)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of RNA export from nucleus (GO:0046831)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum mannose trimming (GO:1904380)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
middle ear morphogenesis (GO:0042474)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
outer ear morphogenesis (GO:0042473)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cell-cell junction (GO:0150106)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to cell-cell junction (GO:0150105)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
transport across blood-brain barrier (GO:0150104)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
reactive gliosis (GO:0150103)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule anchoring at centrosome (GO:0150101)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein export from nucleus (GO:0046827)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein export from nucleus (GO:0046826)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein export from nucleus (GO:0046825)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleocytoplasmic transport (GO:0046823)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sequestering of iron ion (GO:0097577)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vacuole fusion (GO:0097576)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
chemokinesis (GO:0042466)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kinesis (GO:0042465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation (GO:0030497)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
maturation of SSU-rRNA (GO:0030490)	41	0	1.08	-	 < 0.01	6.27E-01	1.00E00
sensory perception of hot stimulus (GO:0062036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokinesis (GO:1904367)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of cold stimulus (GO:0062035)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokinesis (GO:1904365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic sister chromatid segregation (GO:0062033)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcitonin secretion (GO:1904364)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcitonin secretion (GO:1904362)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
receptor-mediated virion attachment to host cell (GO:0046813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ribonucleoside biosynthetic process (GO:0042455)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ribonucleoside catabolic process (GO:0042454)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
deoxyguanosine metabolic process (GO:0042453)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
purine nucleoside biosynthetic process (GO:0042451)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
tRNA methylation (GO:0030488)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
positive regulation of stress granule assembly (GO:0062029)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of stress granule assembly (GO:0062028)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of telomere maintenance via telomere lengthening (GO:1904356)	50	0	1.32	-	 < 0.01	6.40E-01	1.00E00
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of telomere capping (GO:1904355)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of telomere capping (GO:1904354)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of telomere capping (GO:1904353)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein catabolic process in the vacuole (GO:1904352)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein catabolic process in the vacuole (GO:1904351)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein catabolic process in the vacuole (GO:1904350)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
progesterone metabolic process (GO:0042448)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
hormone catabolic process (GO:0042447)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
photoreceptor cell morphogenesis (GO:0008594)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hormone biosynthetic process (GO:0042446)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
hormone metabolic process (GO:0042445)	58	0	1.53	-	 < 0.01	4.07E-01	1.00E00
regulation of Toll signaling pathway (GO:0008592)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phenylethylamine metabolic process (GO:0042443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial double-strand break repair (GO:0097551)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear migration along microtubule (GO:0030473)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylcholine catabolic process (GO:0010899)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of small intestine smooth muscle contraction (GO:1904349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride catabolic process (GO:0010898)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of small intestine smooth muscle contraction (GO:1904348)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride catabolic process (GO:0010897)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of small intestine smooth muscle contraction (GO:1904347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride catabolic process (GO:0010896)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of small molecule metabolic process (GO:0062014)	46	0	1.21	-	 < 0.01	6.33E-01	1.00E00
axon midline choice point recognition (GO:0016199)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid biosynthetic process (GO:0010893)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of colon smooth muscle contraction (GO:1904343)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axon choice point recognition (GO:0016198)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of smoothened signaling pathway (GO:0008589)	56	0	1.47	-	 < 0.01	4.06E-01	1.00E00
regulation of colon smooth muscle contraction (GO:1904341)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of sequestering of triglyceride (GO:0010890)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopaminergic neuron differentiation (GO:1904340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ethanolamine-containing compound metabolic process (GO:0042439)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle uncoating (GO:0016191)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of synaptic assembly at neuromuscular junction (GO:0008582)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
indole-containing compound metabolic process (GO:0042430)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopaminergic neuron differentiation (GO:1904339)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dopaminergic neuron differentiation (GO:1904338)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholesterol storage (GO:0010887)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol storage (GO:0010886)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of ductus arteriosus closure (GO:1904336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol storage (GO:0010885)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of ductus arteriosus closure (GO:1904335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of lipid storage (GO:0010884)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle to endosome fusion (GO:0016189)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
serotonin metabolic process (GO:0042428)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle coating (GO:0016183)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration into thymus (GO:0097535)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle budding from endosome (GO:0016182)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lymphoid lineage cell migration (GO:0097534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
catecholamine catabolic process (GO:0042424)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
snRNA processing (GO:0016180)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
mast cell migration (GO:0097531)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
catecholamine biosynthetic process (GO:0042423)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
norepinephrine biosynthetic process (GO:0042421)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dopamine catabolic process (GO:0042420)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation, alternative pathway (GO:0030451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation, classical pathway (GO:0030450)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cholesterol storage (GO:0010878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid transport involved in lipid storage (GO:0010877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol efflux (GO:0010875)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol efflux (GO:0010874)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol esterification (GO:0010873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol esterification (GO:0010872)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
necroptotic signaling pathway (GO:0097527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dopamine metabolic process (GO:0042417)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
dopamine biosynthetic process (GO:0042416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
norepinephrine metabolic process (GO:0042415)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
epinephrine metabolic process (GO:0042414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
taurine biosynthetic process (GO:0042412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of complement activation (GO:0030449)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of triglyceride biosynthetic process (GO:0010868)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride biosynthetic process (GO:0010867)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of triglyceride biosynthetic process (GO:0010866)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase C activity (GO:0010863)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
cristae formation (GO:0042407)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
thyroid hormone metabolic process (GO:0042403)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular biogenic amine catabolic process (GO:0042402)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
sleep (GO:0030431)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of gastro-intestinal system smooth muscle contraction (GO:1904305)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcytosis (GO:1904300)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sialylation (GO:0097503)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mannosylation (GO:0097502)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
stress response to metal ion (GO:0097501)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
receptor localization to non-motile cilium (GO:0097500)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
siRNA processing (GO:0030422)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
defecation (GO:0030421)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of reciprocal meiotic recombination (GO:0010845)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retina layer formation (GO:0010842)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex IV assembly (GO:0008535)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
calcium activated galactosylceramide scrambling (GO:0061591)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
calcium activated phosphatidylcholine scrambling (GO:0061590)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of keratinocyte proliferation (GO:0010839)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of keratinocyte proliferation (GO:0010838)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of keratinocyte proliferation (GO:0010837)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein ADP-ribosylation (GO:0010836)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein ADP-ribosylation (GO:0010835)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
glycoside catabolic process (GO:0016139)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
calcium activated phosphatidylserine scrambling (GO:0061589)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of myotube differentiation (GO:0010832)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
calcium activated phospholipid scrambling (GO:0061588)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glycoside metabolic process (GO:0016137)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of myotube differentiation (GO:0010831)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of myotube differentiation (GO:0010830)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by transcription factor localization (GO:0061586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brassinosteroid biosynthetic process (GO:0016132)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell migration (GO:0061582)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
brassinosteroid metabolic process (GO:0016131)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
colon epithelial cell migration (GO:0061580)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA-templated viral transcription (GO:0039695)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose transmembrane transport (GO:0010829)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of centrosome duplication (GO:0010826)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
phytosteroid biosynthetic process (GO:0016129)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phytosteroid metabolic process (GO:0016128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sterol catabolic process (GO:0016127)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sterol biosynthetic process (GO:0016126)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sterol metabolic process (GO:0016125)	60	0	1.58	-	 < 0.01	4.08E-01	1.00E00
actin filament bundle retrograde transport (GO:0061573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative stranded viral RNA replication (GO:0039689)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
T cell chemotaxis (GO:0010818)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
calcitonin catabolic process (GO:0010816)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bradykinin catabolic process (GO:0010815)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
substance P catabolic process (GO:0010814)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuropeptide catabolic process (GO:0010813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell-substrate adhesion (GO:0010812)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
terpenoid catabolic process (GO:0016115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of PERK-mediated unfolded protein response (GO:1903897)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
terpenoid biosynthetic process (GO:0016114)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of IRE1-mediated unfolded protein response (GO:1903894)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triterpenoid biosynthetic process (GO:0016104)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diterpenoid biosynthetic process (GO:0016102)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diterpenoid metabolic process (GO:0016101)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
ganglion morphogenesis (GO:0061552)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of interleukin-17-mediated signaling pathway (GO:1903881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane fusion involved in viral entry into host cell (GO:0039663)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fusion of virus membrane with host endosome membrane (GO:0039654)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extraembryonic membrane development (GO:1903867)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
glutamate secretion, neurotransmission (GO:0061535)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of oxidative phosphorylation (GO:1903862)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendrite extension (GO:1903860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
posterior head segmentation (GO:0035289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
head segmentation (GO:0035287)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
brain segmentation (GO:0035284)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system segmentation (GO:0035283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindgut development (GO:0061525)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pre-miRNA export from nucleus (GO:0035281)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cristae formation (GO:1903852)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Langerhans cell differentiation (GO:0061520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cristae formation (GO:1903850)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
miRNA-mediated gene silencing by mRNA destabilization (GO:0035279)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
miRNA-mediated gene silencing by inhibition of translation (GO:0035278)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
macrophage homeostasis (GO:0061519)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
microglial cell proliferation (GO:0061518)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of aorta morphogenesis (GO:1903849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
macrophage proliferation (GO:0061517)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of aorta morphogenesis (GO:1903847)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myeloid cell development (GO:0061515)	41	0	1.08	-	 < 0.01	6.27E-01	1.00E00
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-34-mediated signaling pathway (GO:0061514)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cilium (GO:0061512)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
cellular response to arsenite ion (GO:1903843)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
centriole elongation (GO:0061511)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to arsenite ion (GO:1903842)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
quaternary ammonium group transport (GO:0015697)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular response to arsenite(3-) (GO:1903841)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to arsenite(3-) (GO:1903840)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
organic cation transport (GO:0015695)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
magnesium ion transport (GO:0015693)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
lead ion transport (GO:0015692)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cadmium ion transport (GO:0015691)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein O-linked mannosylation (GO:0035269)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
protein mannosylation (GO:0035268)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
gonad morphogenesis (GO:0035262)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
external genitalia morphogenesis (GO:0035261)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
early endosome to recycling endosome transport (GO:0061502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
magnesium ion transmembrane transport (GO:1903830)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-arginine transmembrane transport (GO:1903826)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
plasma membrane copper ion transport (GO:0015679)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
copper ion import (GO:0015677)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vanadium ion transport (GO:0015676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nickel cation transport (GO:0015675)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxygen transport (GO:0015671)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
carbon dioxide transport (GO:0015670)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity (GO:1903818)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of voltage-gated potassium channel activity (GO:1903817)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
gas transport (GO:0015669)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
L-serine import across plasma membrane (GO:1903812)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-histidine import across plasma membrane (GO:1903810)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ectopic germ cell programmed cell death (GO:0035234)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
L-leucine import across plasma membrane (GO:1903801)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA maturation (GO:1903800)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuron-glial cell signaling (GO:0150099)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
glial cell-neuron signaling (GO:0150098)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amyloid-beta clearance by cellular catabolic process (GO:0150094)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
multiple spine synapse organization, single dendrite (GO:0150090)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell competition in a multicellular organism (GO:0035212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multiple spine synapse organization (GO:0150089)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of neuroinflammatory response (GO:0150079)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuroinflammatory response (GO:0150078)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neuroinflammatory response (GO:0150076)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of arginase activity (GO:0150072)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of arginase activity (GO:0150070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
transport of virus (GO:0046794)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of deacetylase activity (GO:0150066)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microtubule polymerization (GO:0046785)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
viral mRNA export from host cell nucleus (GO:0046784)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of viral transcription (GO:0046782)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
viral budding from plasma membrane (GO:0046761)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to lysosome (GO:0150033)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to lysosome (GO:0150032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to lysosome (GO:0150031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
viral budding (GO:0046755)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
viral exocytosis (GO:0046754)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
non-lytic viral release (GO:0046753)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid biosynthetic process (GO:0042398)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
phosphagen biosynthetic process (GO:0042396)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcytosis (GO:1904298)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ERAD pathway (GO:1904294)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
viral capsid secondary envelopment (GO:0046745)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of ERAD pathway (GO:1904293)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of ERAD pathway (GO:1904292)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
protein localization to non-motile cilium (GO:0097499)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
endothelial tube lumen extension (GO:0097498)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic DNA damage checkpoint (GO:1904290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to histamine (GO:0034776)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
sympathetic neuron axon guidance (GO:0097492)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glutathione transmembrane transport (GO:0034775)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 dimethylation (GO:0034772)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H4-K20 monomethylation (GO:0034771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of neuron projection arborization (GO:0150012)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of neuron projection arborization (GO:0150011)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic DNA damage checkpoint (GO:1904289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin K catabolic process (GO:0042377)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dendrite extension (GO:0097484)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
phylloquinone catabolic process (GO:0042376)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phylloquinone metabolic process (GO:0042374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin K metabolic process (GO:0042373)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transmembrane transport (GO:0034760)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of spontaneous synaptic transmission (GO:0150003)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation by virus of viral protein levels in host cell (GO:0046726)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-alanine import across plasma membrane (GO:1904273)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-proline import across plasma membrane (GO:1904271)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyroptosome complex assembly (GO:1904270)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral motor column neuron migration (GO:0097477)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spinal cord motor neuron migration (GO:0097476)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transmembrane transport (GO:0034759)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of iron ion transport (GO:0034757)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retinal cone cell apoptotic process (GO:0097474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iron ion transport (GO:0034756)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin catabolic process (GO:0042365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal rod cell apoptotic process (GO:0097473)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
water-soluble vitamin biosynthetic process (GO:0042364)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
iron ion transmembrane transport (GO:0034755)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular hormone metabolic process (GO:0034754)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
fat-soluble vitamin catabolic process (GO:0042363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membrane disassembly (GO:0030397)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation by virus of viral protein levels in host cell (GO:0046719)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
viral entry into host cell (GO:0046718)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
acid secretion (GO:0046717)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
programmed cell death in response to reactive oxygen species (GO:0097468)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP biosynthetic process (GO:0046711)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vitamin D metabolic process (GO:0042359)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP metabolic process (GO:0046710)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
thiamine diphosphate metabolic process (GO:0042357)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose salvage (GO:0042352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose biosynthetic process (GO:0042350)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fructosamine metabolic process (GO:0030389)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fructose 1,6-bisphosphate metabolic process (GO:0030388)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sperm mitochondrion organization (GO:0030382)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
IDP catabolic process (GO:0046709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
zinc ion import into Golgi lumen (GO:1904257)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
IDP metabolic process (GO:0046707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CDP biosynthetic process (GO:0046705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of bile acid metabolic process (GO:1904253)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
CDP metabolic process (GO:0046704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bile acid metabolic process (GO:1904251)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
keratan sulfate catabolic process (GO:0042340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of multivesicular body size (GO:0010796)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of ubiquinone biosynthetic process (GO:0010795)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA export from nucleus (GO:0010793)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratan sulfate metabolic process (GO:0042339)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
histone H3-K79 methylation (GO:0034729)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyprenol biosynthetic process (GO:0016094)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
polyprenol metabolic process (GO:0016093)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
piecemeal microautophagy of the nucleus (GO:0034727)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
chromatin organization (GO:0034724)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 demethylation (GO:0034720)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pericyte cell differentiation (GO:1904238)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aconitate hydratase activity (GO:1904234)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of aconitate hydratase activity (GO:1904232)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of succinate dehydrogenase activity (GO:1904231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle targeting (GO:0016080)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of succinate dehydrogenase activity (GO:1904229)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of serine C-palmitoyltransferase activity (GO:1904221)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein maturation by iron-sulfur cluster transfer (GO:0097428)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of serine C-palmitoyltransferase activity (GO:1904220)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
liver regeneration (GO:0097421)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
vasoconstriction (GO:0042310)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of iodide transmembrane transport (GO:1904213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iodide transmembrane transport (GO:1904212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast migration (GO:0010761)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage chemotaxis (GO:0010760)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein import into nucleus (GO:0042308)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
immunoglobulin mediated immune response (GO:0016064)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
specification of segmental identity, mandibular segment (GO:0042305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of plasminogen activation (GO:0010757)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of plasminogen activation (GO:0010756)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of plasminogen activation (GO:0010755)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cGMP-mediated signaling (GO:0010754)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle hypertrophy (GO:1904204)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cGMP-mediated signaling (GO:0010753)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of cGMP-mediated signaling (GO:0010752)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of iodide transport (GO:1904202)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of iodide transport (GO:1904201)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carbohydrate catabolic process (GO:0016052)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
carbohydrate biosynthetic process (GO:0016051)	71	0	1.87	-	 < 0.01	2.66E-01	1.00E00
neuroblast migration (GO:0097402)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic vesicle lumen acidification (GO:0097401)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prenylcysteine metabolic process (GO:0030329)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prenylcysteine catabolic process (GO:0030328)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prenylated protein catabolic process (GO:0030327)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
embryonic limb morphogenesis (GO:0030326)	64	0	1.68	-	 < 0.01	4.14E-01	1.00E00
adrenal gland development (GO:0030325)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
stabilization of membrane potential (GO:0030322)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
transepithelial chloride transport (GO:0030321)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage derived foam cell differentiation (GO:0010743)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
detection of temperature stimulus (GO:0016048)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
macrophage derived foam cell differentiation (GO:0010742)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
detection of bacterium (GO:0016045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
flagellated sperm motility (GO:0030317)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein kinase A signaling (GO:0010737)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to phosphate starvation (GO:0016036)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell homeostasis (GO:0061484)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
tRNA import into mitochondrion (GO:0016031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to TNF agonist (GO:0061481)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
poly-N-acetyllactosamine metabolic process (GO:0030309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal cholesterol absorption (GO:0030300)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of primitive erythrocyte differentiation (GO:0010725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of definitive erythrocyte differentiation (GO:0010724)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ferrochelatase activity (GO:0010722)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CDP-diacylglycerol biosynthetic process (GO:0016024)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
T follicular helper cell differentiation (GO:0061470)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial to mesenchymal transition (GO:0010718)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of extracellular matrix disassembly (GO:0010716)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix disassembly (GO:0010715)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen metabolic process (GO:0010713)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA maturation (GO:1903799)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA maturation (GO:1903798)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of collagen catabolic process (GO:0010710)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of inorganic anion transmembrane transport (GO:1903797)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of inorganic anion transmembrane transport (GO:1903796)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of inorganic anion transmembrane transport (GO:1903795)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of anion transport (GO:1903793)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
guanine nucleotide transmembrane transport (GO:1903790)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
globoside biosynthetic process via lactosylceramide (GO:0010707)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ganglioside biosynthetic process via lactosylceramide (GO:0010706)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of amino acid transmembrane transport (GO:1903789)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of norepinephrine secretion (GO:0010701)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of norepinephrine secretion (GO:0010700)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glutathione biosynthetic process (GO:1903788)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of glutathione biosynthetic process (GO:1903786)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
charged-tRNA amino acid modification (GO:0019988)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac conduction (GO:1903779)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
translesion synthesis (GO:0019985)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
protein localization to vacuolar membrane (GO:1903778)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell fate commitment (GO:0061445)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA double-strand break processing (GO:1903775)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocardial cushion cell differentiation (GO:0061443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of viral budding via host ESCRT complex (GO:1903772)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
renal artery morphogenesis (GO:0061441)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of beta-galactosidase activity (GO:1903771)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
kidney vasculature development (GO:0061440)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
miRNA-mediated gene silencing (GO:0035195)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
kidney vasculature morphogenesis (GO:0061439)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
post-transcriptional gene silencing by RNA (GO:0035194)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
renal system vasculature morphogenesis (GO:0061438)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal system vasculature development (GO:0061437)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of skin barrier (GO:0061436)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of potassium ion export across plasma membrane (GO:1903766)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to caloric restriction (GO:0061433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hatching (GO:0035188)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of SUMO transferase activity (GO:1903755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of RIG-I signaling pathway (GO:0039536)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of MDA-5 signaling pathway (GO:0039534)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of anterograde synaptic vesicle transport (GO:1903742)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to cold (GO:0061411)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidate phosphatase activity (GO:1903741)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
RIG-I signaling pathway (GO:0039529)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
modulation by virus of host apoptotic process (GO:0039526)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic hemopoiesis (GO:0035166)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidate phosphatase activity (GO:1903730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane organization (GO:1903729)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
cGMP-mediated signaling (GO:0019934)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid metabolic process (GO:1903727)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid metabolic process (GO:1903726)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid metabolic process (GO:1903725)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole elongation (GO:1903724)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole elongation (GO:1903723)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of centriole elongation (GO:1903722)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of I-kappaB phosphorylation (GO:1903721)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of I-kappaB phosphorylation (GO:1903720)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of I-kappaB phosphorylation (GO:1903719)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of aerobic respiration (GO:1903715)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
cysteine transmembrane transport (GO:1903712)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermine transmembrane transport (GO:1903710)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hindlimb morphogenesis (GO:0035137)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
forelimb morphogenesis (GO:0035136)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
uterine gland development (GO:1903709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid storage (GO:0019915)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic limb morphogenesis (GO:0035127)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic appendage morphogenesis (GO:0035120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell-cell signaling involved in kidney development (GO:0060995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to fungicide (GO:0060992)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic hindlimb morphogenesis (GO:0035116)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
embryonic forelimb morphogenesis (GO:0035115)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
embryonic appendage morphogenesis (GO:0035113)	64	0	1.68	-	 < 0.01	4.14E-01	1.00E00
genitalia morphogenesis (GO:0035112)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
lipid tube assembly (GO:0060988)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
endocrine hormone secretion (GO:0060986)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac vascular smooth muscle cell differentiation (GO:0060983)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in coronary vasculogenesis (GO:0060980)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
limb morphogenesis (GO:0035108)	80	0	2.10	-	 < 0.01	2.73E-01	1.00E00
appendage morphogenesis (GO:0035107)	80	0	2.10	-	 < 0.01	2.73E-01	1.00E00
operant conditioning (GO:0035106)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in heart development (GO:0060973)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
left/right pattern formation (GO:0060972)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
embryonic heart tube left/right pattern formation (GO:0060971)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of gene silencing by RNA (GO:0060967)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA-mediated gene silencing (GO:0060965)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to mercury ion (GO:0046689)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to copper ion (GO:0046688)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to chromate (GO:0046687)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cadmium ion (GO:0046686)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
response to arsenic-containing substance (GO:0046685)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
response to pyrethroid (GO:0046684)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to organophosphorus (GO:0046683)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
endocardial cell fate commitment (GO:0060957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardial cell differentiation (GO:0060956)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to antibiotic (GO:0046677)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
negative regulation of retinal cell programmed cell death (GO:0046671)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of retinal cell programmed cell death (GO:0046668)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal cell programmed cell death (GO:0046666)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to luteinizing hormone (GO:0034699)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to gonadotropin (GO:0034698)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell development (GO:0060939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin E (GO:0034695)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to prostaglandin (GO:0034694)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell development (GO:0060936)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac fibroblast cell differentiation (GO:0060935)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate biosynthetic process (GO:0046654)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tetrahydrofolate metabolic process (GO:0046653)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell development (GO:0060928)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell development (GO:0060926)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell fate commitment (GO:0060923)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular node cell differentiation (GO:0060922)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac pacemaker cell differentiation (GO:0060920)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of granulosa cell proliferation (GO:1904197)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of granulosa cell proliferation (GO:1904195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of gamma-delta T cell activation (GO:0046645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholangiocyte apoptotic process (GO:1904193)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte apoptotic process (GO:1904192)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell proliferation (GO:0046642)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of alpha-beta T cell proliferation (GO:0046641)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell proliferation (GO:0046640)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation involved in lung development (GO:0060916)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell differentiation involved in lung development (GO:0060915)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chemotaxis to arachidonic acid (GO:0034670)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate specification (GO:0060912)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac cell fate commitment (GO:0060911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell differentiation (GO:0046639)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of alpha-beta T cell differentiation (GO:0046638)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell differentiation (GO:0046637)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of alpha-beta T cell activation (GO:0046636)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of alpha-beta T cell activation (GO:0046635)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of alpha-beta T cell activation (GO:0046634)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
alpha-beta T cell proliferation (GO:0046633)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of pyruvate dehydrogenase activity (GO:1904182)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane depolarization (GO:1904181)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane depolarization (GO:1904180)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine nucleoside metabolic process (GO:0042278)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
error-prone translesion synthesis (GO:0042276)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
error-free postreplication DNA repair (GO:0042275)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	61	0	1.60	-	 < 0.01	4.10E-01	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	58	0	1.53	-	 < 0.01	4.07E-01	1.00E00
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of meiosis I (GO:0060903)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
embryonic camera-type eye formation (GO:0060900)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of adipose tissue development (GO:1904179)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of adipose tissue development (GO:1904178)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
gamma-delta T cell activation (GO:0046629)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of adipose tissue development (GO:1904177)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin receptor signaling pathway (GO:0046627)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
negative regulation of bleb assembly (GO:1904171)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of bleb assembly (GO:1904170)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of cytolysis (GO:0042268)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
natural killer cell mediated cytotoxicity (GO:0042267)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
sensory neuron axon guidance (GO:0097374)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-aspartic acid hydroxylation (GO:0042264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA protection (GO:0042262)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cortisol biosynthetic process (GO:0034651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cortisol metabolic process (GO:0034650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
intestinal cholesterol absorption (GO:0030299)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lens placode formation involved in camera-type eye formation (GO:0046619)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xenobiotic export from cell (GO:0046618)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
DNA synthesis involved in UV-damage excision repair (GO:1904161)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mature ribosome assembly (GO:0042256)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ribosome assembly (GO:0042255)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
ribosome biogenesis (GO:0042254)	225	0	5.92	-	 < 0.01	4.65E-03	6.18E-01
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
mitochondrion migration along actin filament (GO:0034642)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonemal central apparatus assembly (GO:1904158)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DN4 thymocyte differentiation (GO:1904157)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of centrosome cycle (GO:0046606)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
DN2 thymocyte differentiation (GO:1904155)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic centrosome separation (GO:0046604)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic centrosome separation (GO:0046602)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of centriole replication (GO:0046601)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell mediated cytotoxicity (GO:1904150)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of centriole replication (GO:0046600)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity of embryonic epithelium (GO:0042249)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phosphatidylcholine catabolic process (GO:0034638)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular carbohydrate biosynthetic process (GO:0034637)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
RNA repair (GO:0042245)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutathione transport (GO:0034635)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil clearance (GO:0097350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maintenance of gastrointestinal epithelium (GO:0030277)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell mediated cytotoxicity (GO:1904149)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic cell cycle process involved in oocyte maturation (GO:1904145)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of alkaline phosphatase activity (GO:0010694)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of alkaline phosphatase activity (GO:0010693)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of alkaline phosphatase activity (GO:0010692)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of microglial cell migration (GO:1904141)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of microglial cell migration (GO:1904140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial outer membrane permeabilization (GO:0097345)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ripoptosome assembly (GO:0097343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
zymogen inhibition (GO:0097341)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
inhibition of cysteine-type endopeptidase activity (GO:0097340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic chromosome condensation (GO:0030263)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
apoptotic nuclear changes (GO:0030262)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
chromosome condensation (GO:0030261)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
regulation of microglial cell migration (GO:1904139)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to laminar fluid shear stress (GO:0034616)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to reactive oxygen species (GO:0034614)	66	0	1.74	-	 < 0.01	4.18E-01	1.00E00
response to tumor necrosis factor (GO:0034612)	74	0	1.95	-	 < 0.01	2.67E-01	1.00E00
lipid glycosylation (GO:0030259)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
growth hormone secretion (GO:0030252)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
positive regulation of otic vesicle morphogenesis (GO:1904120)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
amino acid import across plasma membrane (GO:0089718)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
cellular modified amino acid catabolic process (GO:0042219)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to antineoplastic agent (GO:0097327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte adhesion (GO:0097326)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte proliferation (GO:0097325)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
melanocyte migration (GO:0097324)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to heat (GO:0034605)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
plasma membrane tubulation (GO:0097320)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
autophagy of peroxisome (GO:0030242)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle thin filament assembly (GO:0030240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial structure maintenance (GO:0010669)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ectodermal cell differentiation (GO:0010668)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of otic vesicle morphogenesis (GO:1904118)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle filament sliding (GO:1904113)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
maternal determination of anterior/posterior axis, embryo (GO:0008358)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
L-histidine transmembrane transport (GO:0089709)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-histidine transmembrane export from vacuole (GO:0089708)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
olfactory learning (GO:0008355)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
germ cell migration (GO:0008354)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein kinase D signaling (GO:0089700)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myofibril assembly (GO:0030239)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
male sex determination (GO:0030238)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
female sex determination (GO:0030237)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle cell apoptotic process (GO:0010659)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholesterol import (GO:1904109)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
striated muscle cell apoptotic process (GO:0010658)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary inversin compartment (GO:1904108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle cell apoptotic process (GO:0010657)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell communication by chemical coupling (GO:0010652)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cap1 mRNA methylation (GO:0097309)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell communication by electrical coupling (GO:0010651)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein O-linked glycosylation (GO:1904100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell communication by electrical coupling (GO:0010650)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adult feeding behavior (GO:0008343)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
determination of adult lifespan (GO:0008340)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
programmed necrotic cell death (GO:0097300)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
extracellular matrix disassembly (GO:0022617)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
DNA strand elongation (GO:0022616)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
protein to membrane docking (GO:0022615)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
neutrophil differentiation (GO:0030223)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane to membrane docking (GO:0022614)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
platelet formation (GO:0030220)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by electrical coupling (GO:0010649)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cell communication by chemical coupling (GO:0010645)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell communication by electrical coupling (GO:0010644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell communication by chemical coupling (GO:0010643)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
endosome to lysosome transport (GO:0008333)	58	0	1.53	-	 < 0.01	4.07E-01	1.00E00
megakaryocyte differentiation (GO:0030219)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
hyaluronan catabolic process (GO:0030214)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
mammalian oogenesis stage (GO:0022605)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
hyaluronan biosynthetic process (GO:0030213)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
hyaluronan metabolic process (GO:0030212)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
heparin biosynthetic process (GO:0030210)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
menstrual cycle phase (GO:0022601)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
digestive system process (GO:0022600)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial fusion (GO:0010636)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
closure of optic fissure (GO:0061386)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate biosynthetic process (GO:0030208)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate catabolic process (GO:0030207)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate biosynthetic process (GO:0030206)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
dermatan sulfate metabolic process (GO:0030205)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chondroitin sulfate metabolic process (GO:0030204)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
heparin metabolic process (GO:0030202)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan metabolic process (GO:0030201)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
heparan sulfate proteoglycan catabolic process (GO:0030200)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of Schwann cell proliferation (GO:0010626)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Schwann cell proliferation (GO:0010624)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
programmed cell death involved in cell development (GO:0010623)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription by transcription factor localization (GO:0010621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammillary axonal complex development (GO:0061373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cardiac muscle adaptation (GO:0010616)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of cardiac muscle adaptation (GO:0010615)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cardiac muscle adaptation (GO:0010612)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
tarsal gland development (GO:1903699)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
behavioral response to formalin induced pain (GO:0061368)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mRNA stability involved in response to stress (GO:0010610)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of microvillus assembly (GO:1903697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
behavioral response to chemical pain (GO:0061366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of triglyceride lipase activity (GO:0061365)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
isoprenoid catabolic process (GO:0008300)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mRNA localization resulting in post-transcriptional regulation of gene expression (GO:0010609)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
axonal transport of mitochondrion (GO:0019896)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
regulation of wound healing, spreading of epidermal cells (GO:1903689)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of Wnt protein secretion (GO:0061357)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Wnt protein secretion (GO:0061355)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in heart morphogenesis (GO:0061346)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of cap-independent translational initiation (GO:1903677)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation of endogenous antigen (GO:0019883)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of cap-dependent translational initiation (GO:1903676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation (GO:0019882)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
cell adhesion involved in heart morphogenesis (GO:0061343)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cap-dependent translational initiation (GO:1903674)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic cleavage furrow formation (GO:1903673)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of sprouting angiogenesis (GO:1903671)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
lysine biosynthetic process via aminoadipic acid (GO:0019878)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment or maintenance of monopolar cell polarity (GO:0061339)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
behavioral response to nicotine (GO:0035095)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to nicotine (GO:0035094)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
sperm DNA condensation (GO:0035092)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of apical/basal cell polarity (GO:0035090)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement-dependent cytotoxicity (GO:1903660)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of apical/basal cell polarity (GO:0035089)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of complement-dependent cytotoxicity (GO:1903659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
axoneme assembly (GO:0035082)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903655)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903654)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
uracil metabolic process (GO:0019860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cytoplasmic transport (GO:1903651)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytoplasmic transport (GO:1903650)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
thymine metabolic process (GO:0019859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cytosine metabolic process (GO:0019858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
5-methylcytosine metabolic process (GO:0019857)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
renal filtration cell differentiation (GO:0061318)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
pyrimidine nucleobase biosynthetic process (GO:0019856)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cytoplasmic transport (GO:1903649)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in heart development (GO:0061316)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-ascorbic acid biosynthetic process (GO:0019853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of chaperone-mediated protein folding (GO:1903645)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chaperone-mediated protein folding (GO:1903644)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in heart development (GO:0061312)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cell surface receptor signaling pathway involved in heart development (GO:0061311)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development (GO:0061310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone acetylation (GO:0035067)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone acetylation (GO:0035066)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of histone acetylation (GO:0035065)	48	0	1.26	-	 < 0.01	6.36E-01	1.00E00
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell development involved in heart development (GO:0061308)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein insertion into mitochondrial outer membrane (GO:1903636)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal blood vessel morphogenesis (GO:0061304)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cornea development in camera-type eye (GO:0061303)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell-matrix adhesion (GO:0061302)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellum vasculature development (GO:0061300)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of aminoacyl-tRNA ligase activity (GO:1903630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cytolysis (GO:0019835)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of DNA catabolic process (GO:1903626)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA catabolic process (GO:1903625)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of DNA catabolic process (GO:1903624)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein tyrosine phosphatase activity (GO:1903615)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein tyrosine phosphatase activity (GO:1903614)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein tyrosine phosphatase activity (GO:1903613)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sperm-egg recognition (GO:0035036)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to cytoplasmic stress granule (GO:1903608)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
leading edge cell differentiation (GO:0035026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of Rho protein signal transduction (GO:0035025)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
quinolinate biosynthetic process (GO:0019805)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Rac protein signal transduction (GO:0035021)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
adaptation of signaling pathway (GO:0023058)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
neural plate regionalization (GO:0060897)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neural plate pattern specification (GO:0060896)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
limb epidermis development (GO:0060887)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal signal transduction (GO:0023041)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
semicircular canal fusion (GO:0060879)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CD40 signaling pathway (GO:0023035)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
semicircular canal formation (GO:0060876)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
semicircular canal development (GO:0060872)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of centriole replication (GO:0046599)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of viral entry into host cell (GO:0046598)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of viral entry into host cell (GO:0046597)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of viral entry into host cell (GO:0046596)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
termination of signal transduction (GO:0023021)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branching involved in lymph vessel morphogenesis (GO:0060854)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte development (GO:0003431)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
growth plate cartilage chondrocyte growth (GO:0003430)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lymphatic endothelial cell differentiation (GO:0060836)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
chondrocyte hypertrophy (GO:0003415)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hydroxyproline transport (GO:0034589)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
halogenated hydrocarbon metabolic process (GO:0042197)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
piRNA metabolic process (GO:0034587)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by heterochromatin formation (GO:0060820)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
optic cup formation involved in camera-type eye development (GO:0003408)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal pigment epithelium development (GO:0003406)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
planar cell polarity pathway involved in axis elongation (GO:0003402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
retinal cone cell development (GO:0046549)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein O-linked glycosylation (GO:1904098)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
retinal rod cell development (GO:0046548)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of COPII vesicle coating (GO:0003400)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of autophagic cell death (GO:1904094)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagic cell death (GO:1904093)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
development of secondary male sexual characteristics (GO:0046544)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
development of secondary female sexual characteristics (GO:0046543)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of autophagic cell death (GO:1904092)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
saliva secretion (GO:0046541)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of nucleus size (GO:0097298)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
'de novo' XMP biosynthetic process (GO:0097294)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
XMP biosynthetic process (GO:0097293)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
XMP metabolic process (GO:0097292)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
inactivation of X chromosome by genomic imprinting (GO:0060819)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ketone catabolic process (GO:0042182)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
ketone biosynthetic process (GO:0042181)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
random inactivation of X chromosome (GO:0060816)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular ketone metabolic process (GO:0042180)	36	0	.95	-	 < 0.01	1.00E00	1.00E00
negative regulation of photoreceptor cell differentiation (GO:0046533)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of photoreceptor cell differentiation (GO:0046532)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
xenobiotic catabolic process (GO:0042178)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
keratinocyte apoptotic process (GO:0097283)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of trophectodermal cell proliferation (GO:1904075)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of trophectodermal cell proliferation (GO:1904073)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
presynaptic active zone assembly (GO:1904071)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
complement-dependent cytotoxicity (GO:0097278)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingoid biosynthetic process (GO:0046520)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
heme metabolic process (GO:0042168)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
heme catabolic process (GO:0042167)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
urea homeostasis (GO:0097274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex II assembly (GO:0034553)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
respiratory chain complex II assembly (GO:0034552)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
collagen fibril organization (GO:0030199)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood coagulation (GO:0030195)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood coagulation (GO:0030194)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of blood coagulation (GO:0030193)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
sphingoid metabolic process (GO:0046519)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
ceramide catabolic process (GO:0046514)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
ceramide biosynthetic process (GO:0046513)	37	0	.97	-	 < 0.01	1.00E00	1.00E00
sphingosine biosynthetic process (GO:0046512)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
sphinganine biosynthetic process (GO:0046511)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lipoprotein catabolic process (GO:0042159)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
omega-hydroxylase P450 pathway (GO:0097267)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
self proteolysis (GO:0097264)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of locomotor rhythm (GO:1904059)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of sensory perception of pain (GO:1904058)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of sensory perception of pain (GO:1904057)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cholangiocyte proliferation (GO:1904056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cholangiocyte proliferation (GO:1904055)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cholangiocyte proliferation (GO:1904054)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
isoprenoid biosynthetic process (GO:0008299)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
intracellular mRNA localization (GO:0008298)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
uroporphyrinogen III metabolic process (GO:0046502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protoporphyrinogen IX metabolic process (GO:0046501)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
strand invasion (GO:0042148)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
spermidine biosynthetic process (GO:0008295)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal tubular secretion (GO:0097254)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
vacuole fusion, non-autophagic (GO:0042144)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oligodendrocyte apoptotic process (GO:0097252)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acetylcholine metabolic process (GO:0008291)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitochondrial respirasome assembly (GO:0097250)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
late meiotic recombination nodule assembly (GO:0042140)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of DNA-templated DNA replication initiation (GO:0030174)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of spontaneous neurotransmitter secretion (GO:1904048)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular endothelial growth factor production (GO:1904046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to aldosterone (GO:1904045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to aldosterone (GO:1904044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of lamellipodium assembly (GO:0010593)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sequestering of neurotransmitter (GO:0042137)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter biosynthetic process (GO:0042136)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
neurotransmitter catabolic process (GO:0042135)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
neurotransmitter metabolic process (GO:0042133)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
hematopoietic stem cell migration to bone marrow (GO:0097241)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chromosome attachment to the nuclear envelope (GO:0097240)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
platelet activation (GO:0030168)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
proteoglycan catabolic process (GO:0030167)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
proteoglycan biosynthetic process (GO:0030166)	40	0	1.05	-	 < 0.01	6.27E-01	1.00E00
miRNA catabolic process (GO:0010587)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell apoptotic process (GO:1904037)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
miRNA metabolic process (GO:0010586)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of t-SNARE clustering (GO:1904034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of t-SNARE clustering (GO:1904032)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cellular response to methylglyoxal (GO:0097238)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cellular response to toxic substance (GO:0097237)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
nitrate metabolic process (GO:0042126)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
sulfate transport (GO:0008272)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
mitochondrial unfolded protein response (GO:0034514)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pancreatic juice secretion (GO:0030157)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein import into mitochondrial matrix (GO:0030150)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
regulation of cyclin-dependent protein kinase activity (GO:1904029)	40	0	1.05	-	 < 0.01	6.27E-01	1.00E00
positive regulation of collagen fibril organization (GO:1904028)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of collagen fibril organization (GO:1904027)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of collagen fibril organization (GO:1904026)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vascular endothelial growth factor production (GO:0010573)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of platelet activation (GO:0010572)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of G protein-coupled receptor internalization (GO:1904022)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of G protein-coupled receptor internalization (GO:1904021)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of G protein-coupled receptor internalization (GO:1904020)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neutrophil activation (GO:0042119)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
endothelial cell activation (GO:0042118)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
centromere complex assembly (GO:0034508)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
monocyte activation (GO:0042117)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
macrophage activation (GO:0042116)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
tooth mineralization (GO:0034505)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to kinetochore (GO:0034501)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
sphingolipid catabolic process (GO:0030149)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of ketone biosynthetic process (GO:0010566)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to Thyroglobulin triiodothyronine (GO:1904016)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to serotonin (GO:1904015)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to serotonin (GO:1904014)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycoprotein biosynthetic process (GO:0010561)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of lysosomal membrane permeability (GO:0097214)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lysosomal membrane permeability (GO:0097213)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lysosomal membrane organization (GO:0097212)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of activated T cell proliferation (GO:0042104)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to gonadotropin-releasing hormone (GO:0097211)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to gonadotropin-releasing hormone (GO:0097210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
B cell proliferation (GO:0042100)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of lung blood pressure (GO:0014916)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell migration (GO:0014912)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
cellular response to monosodium glutamate (GO:1904009)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA threonylcarbamoyladenosine modification (GO:0002949)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to monosodium glutamate (GO:1904008)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase D activity (GO:1904006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA C5-cytosine methylation (GO:0002946)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase D activity (GO:1904005)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA dihydrouridine synthesis (GO:0002943)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of sebum secreting cell proliferation (GO:1904002)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of eating behavior (GO:1904000)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA N2-guanine methylation (GO:0002940)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
renal filtration (GO:0097205)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
activation of cysteine-type endopeptidase activity (GO:0097202)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell migration (GO:0014909)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
satellite cell activation involved in skeletal muscle regeneration (GO:0014901)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA N1-guanine methylation (GO:0002939)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of platelet activation (GO:0010544)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of platelet activation (GO:0010543)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
desmosome organization (GO:0002934)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
retina vasculature morphogenesis in camera-type eye (GO:0061299)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
retina vasculature development in camera-type eye (GO:0061298)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
tendon sheath development (GO:0002932)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in kidney development (GO:0061289)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of humoral immune response (GO:0002922)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of humoral immune response (GO:0002921)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of humoral immune response (GO:0002920)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
water homeostasis (GO:0030104)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
natural killer cell activation (GO:0030101)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition (GO:0010529)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of transposition (GO:0010528)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of transposition, RNA-mediated (GO:0010526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of transposition, RNA-mediated (GO:0010525)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion transport into cytosol (GO:0010524)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion transport into cytosol (GO:0010523)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcium ion transport into cytosol (GO:0010522)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of lymphocyte anergy (GO:0002913)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lymphocyte anergy (GO:0002911)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of reciprocal meiotic recombination (GO:0010520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermidine metabolic process (GO:0008216)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
spermine metabolic process (GO:0008215)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mineralocorticoid metabolic process (GO:0008212)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucocorticoid metabolic process (GO:0008211)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
estrogen metabolic process (GO:0008210)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipase activity (GO:0010519)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipase activity (GO:0010518)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipase activity (GO:0010517)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
negative regulation of mature B cell apoptotic process (GO:0002906)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mature B cell apoptotic process (GO:0002905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of B cell apoptotic process (GO:0002904)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
androgen metabolic process (GO:0008209)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell apoptotic process (GO:0002903)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of B cell apoptotic process (GO:0002902)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
C21-steroid hormone metabolic process (GO:0008207)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of gap junction assembly (GO:1903598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
bile acid metabolic process (GO:0008206)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of gap junction assembly (GO:1903596)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histamine secretion by mast cell (GO:1903595)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cholesterol metabolic process (GO:0008203)	57	0	1.50	-	 < 0.01	4.06E-01	1.00E00
steroid metabolic process (GO:0008202)	94	0	2.47	-	 < 0.01	1.80E-01	1.00E00
regulation of histamine secretion by mast cell (GO:1903593)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
RNA secondary structure unwinding (GO:0010501)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone deubiquitination (GO:1903586)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of histone deubiquitination (GO:1903584)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of ATP metabolic process (GO:1903580)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of ATP metabolic process (GO:1903579)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of ATP metabolic process (GO:1903578)	43	0	1.13	-	 < 0.01	6.29E-01	1.00E00
cellular response to L-arginine (GO:1903577)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to L-arginine (GO:1903576)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cornified envelope assembly (GO:1903575)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein localization to cilium (GO:1903566)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to cilium (GO:1903565)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to cilium (GO:1903564)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular exosome assembly (GO:1903553)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular exosome assembly (GO:1903551)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
one-carbon compound transport (GO:0019755)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to photoreceptor outer segment (GO:1903546)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of exosomal secretion (GO:1903543)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
negative regulation of exosomal secretion (GO:1903542)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of exosomal secretion (GO:1903541)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to postsynaptic membrane (GO:1903540)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of isoprenoid metabolic process (GO:0019747)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
paramesonephric duct development (GO:0061205)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nitrogen utilization (GO:0019740)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane tubulation (GO:1903527)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of membrane tubulation (GO:1903526)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
antifungal humoral response (GO:0019732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of membrane tubulation (GO:1903525)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
antibacterial humoral response (GO:0019731)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
antimicrobial humoral response (GO:0019730)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
positive regulation of single strand break repair (GO:1903518)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
B cell mediated immunity (GO:0019724)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
regulation of single strand break repair (GO:1903516)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum to cytosol transport (GO:1903513)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
Mo-molybdopterin cofactor metabolic process (GO:0019720)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phytanic acid metabolic process (GO:1903512)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mucopolysaccharide metabolic process (GO:1903510)	40	0	1.05	-	 < 0.01	6.27E-01	1.00E00
liposaccharide metabolic process (GO:1903509)	59	0	1.55	-	 < 0.01	4.07E-01	1.00E00
regulation of mitotic spindle checkpoint (GO:1903504)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in formation of primary germ layer (GO:0060795)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
sweat gland development (GO:0060792)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dynamin family protein polymerization involved in membrane fission (GO:0003373)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to camptothecin (GO:0072757)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cellular response to benomyl (GO:0072755)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to leptomycin B (GO:0072750)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hair follicle placode formation (GO:0060789)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to cytochalasin B (GO:0072749)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron development (GO:0003358)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
noradrenergic neuron differentiation (GO:0003357)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of cilium beat frequency (GO:0003356)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of cilium movement (GO:0003353)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cilium movement (GO:0003352)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
S-adenosylhomocysteine metabolic process (GO:0046498)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
cellular response to diamide (GO:0072738)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to diamide (GO:0072737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
isopentenyl diphosphate metabolic process (GO:0046490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in prostate gland development (GO:0060767)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mammary duct terminal end bud growth (GO:0060763)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epicardium-derived cardiac endothelial cell differentiation (GO:0003349)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac endothelial cell differentiation (GO:0003348)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epicardial cell to mesenchymal cell transition (GO:0003347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pericardium morphogenesis (GO:0003344)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cilium movement (GO:0003341)	68	0	1.79	-	 < 0.01	4.23E-01	1.00E00
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyoxylate metabolic process (GO:0046487)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to dithiothreitol (GO:0072721)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to dithiothreitol (GO:0072720)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in mammary gland duct branching (GO:0060751)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
metanephros morphogenesis (GO:0003338)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
corneocyte development (GO:0003335)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
keratinocyte development (GO:0003334)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
amino acid transmembrane transport (GO:0003333)	40	0	1.05	-	 < 0.01	6.27E-01	1.00E00
glycosphingolipid catabolic process (GO:0046479)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of extracellular matrix constituent secretion (GO:0003331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of extracellular matrix constituent secretion (GO:0003330)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lactosylceramide metabolic process (GO:0046478)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glycosylceramide catabolic process (GO:0046477)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycosylceramide biosynthetic process (GO:0046476)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to cisplatin (GO:0072719)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to cisplatin (GO:0072718)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to actinomycin D (GO:0072717)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidic acid metabolic process (GO:0046473)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
response to actinomycin D (GO:0072716)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
phosphatidylglycerol metabolic process (GO:0046471)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
cellular response to hydroxyurea (GO:0072711)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to hydroxyurea (GO:0072710)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in pregnancy (GO:0060745)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mammary gland branching involved in thelarche (GO:0060744)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation involved in prostate gland development (GO:0060743)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in prostate gland development (GO:0060742)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
prostate gland epithelium morphogenesis (GO:0060740)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell development (GO:0003323)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
platelet activating factor metabolic process (GO:0046469)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
membrane lipid catabolic process (GO:0046466)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
dolichyl diphosphate metabolic process (GO:0046465)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
acylglycerol catabolic process (GO:0046464)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
response to sorbitol (GO:0072708)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
monoacylglycerol metabolic process (GO:0046462)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
neutral lipid catabolic process (GO:0046461)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
cellular response to mercaptoethanol (GO:0072705)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to mercaptoethanol (GO:0072704)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
late endosome to Golgi transport (GO:0034499)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
early endosome to Golgi transport (GO:0034498)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to phagophore assembly site (GO:0034497)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
prostate gland morphogenetic growth (GO:0060737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of intestinal epithelial structure maintenance (GO:0060731)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of intestinal epithelial structure maintenance (GO:0060730)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid metabolic process (GO:0046459)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
hexadecanal metabolic process (GO:0046458)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pancreatic A cell differentiation (GO:0003310)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dihydrofolate metabolic process (GO:0046452)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
vacuolar transmembrane transport (GO:0034486)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper cell differentiation (GO:0042093)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
type 2 immune response (GO:0042092)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell differentiation (GO:0003309)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in heart development (GO:0003306)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
physiological cardiac muscle hypertrophy (GO:0003301)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
FAD metabolic process (GO:0046443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 trimethylation (GO:0097198)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pilomotor reflex (GO:0097195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
execution phase of apoptosis (GO:0097194)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
U6 snRNA 3'-end processing (GO:0034477)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
U5 snRNA 3'-end processing (GO:0034476)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
U4 snRNA 3'-end processing (GO:0034475)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
chorionic trophoblast cell differentiation (GO:0060718)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
U2 snRNA 3'-end processing (GO:0034474)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chorion development (GO:0060717)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
U1 snRNA 3'-end processing (GO:0034473)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA 3'-end processing (GO:0034472)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ncRNA 5'-end processing (GO:0034471)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
labyrinthine layer morphogenesis (GO:0060713)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast layer development (GO:0060712)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
chorio-allantoic fusion (GO:0060710)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to denervation involved in regulation of muscle adaptation (GO:0014894)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
striated muscle atrophy (GO:0014891)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-cysteine metabolic process (GO:0046439)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
D-amino acid biosynthetic process (GO:0046437)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dentinogenesis (GO:0097187)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
germ-line stem cell division (GO:0042078)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycogen cell differentiation involved in embryonic placenta development (GO:0060709)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to carbon monoxide (GO:0034465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spongiotrophoblast differentiation (GO:0060708)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intraciliary transport (GO:0042073)	44	0	1.16	-	 < 0.01	6.30E-01	1.00E00
trophoblast giant cell differentiation (GO:0060707)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
90S preribosome assembly (GO:0034463)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in embryonic placenta development (GO:0060706)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
small-subunit processome assembly (GO:0034462)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
muscle atrophy (GO:0014889)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoribonuclease activity (GO:0060702)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribonuclease activity (GO:0060701)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of ribonuclease activity (GO:0060700)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
transition between slow and fast fiber (GO:0014886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
ruffle assembly (GO:0097178)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of catecholamine metabolic process (GO:0042069)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring at centrosome (GO:0034454)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
microtubule anchoring (GO:0034453)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to injury involved in regulation of muscle adaptation (GO:0014876)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein repair (GO:0030091)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
response to muscle inactivity (GO:0014870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
D-amino acid metabolic process (GO:0046416)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
urate metabolic process (GO:0046415)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
circadian regulation of translation (GO:0097167)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
ammonium ion metabolic process (GO:0097164)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle clearance (GO:0034447)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of dopamine metabolic process (GO:0042053)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein oxidation (GO:0034443)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein oxidation (GO:0034442)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal myofibril assembly (GO:0014866)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurotransmitter secretion involved in regulation of skeletal muscle contraction (GO:0014860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of immunoglobulin mediated immune response (GO:0002890)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
olfactory behavior (GO:0042048)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
GABAergic neuron differentiation (GO:0097154)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
glycoprotein transport (GO:0034436)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cholesterol esterification (GO:0034435)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell apoptotic process (GO:0097152)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sterol esterification (GO:0034434)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuronal stem cell population maintenance (GO:0097150)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
steroid esterification (GO:0034433)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of skeletal muscle cell proliferation (GO:0014859)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle cell proliferation (GO:0014858)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle cell proliferation (GO:0014857)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
skeletal muscle cell proliferation (GO:0014856)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to inactivity (GO:0014854)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
insulin processing (GO:0030070)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to muscle activity (GO:0014850)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
intercellular transport (GO:0010496)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid leukocyte mediated immunity (GO:0002886)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
negative regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002881)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
post-translational protein acetylation (GO:0034421)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ureter smooth muscle contraction (GO:0014849)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
urinary tract smooth muscle contraction (GO:0014848)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
esophagus smooth muscle contraction (GO:0014846)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell proliferation (GO:0014841)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T cell anergy (GO:0002870)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
urate biosynthetic process (GO:0034418)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
DNA endoreduplication (GO:0042023)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vesicle transport along actin filament (GO:0030050)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
urinary bladder smooth muscle contraction (GO:0014832)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
gastro-intestinal system smooth muscle contraction (GO:0014831)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of gastrulation (GO:0010470)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nucleobase-containing small molecule biosynthetic process (GO:0034404)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
muscle filament sliding (GO:0030049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
vascular associated smooth muscle contraction (GO:0014829)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
actin modification (GO:0030047)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
parallel actin filament bundle assembly (GO:0030046)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
intestine smooth muscle contraction (GO:0014827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
actin filament fragmentation (GO:0030043)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
actin filament depolymerization (GO:0030042)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
artery smooth muscle contraction (GO:0014824)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to activity (GO:0014823)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
tonic smooth muscle contraction (GO:0014820)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mesenchymal cell proliferation (GO:0010463)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
positive regulation of heart rate (GO:0010460)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA replication (GO:0008156)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMPA glutamate receptor clustering (GO:0097113)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
carbon catabolite activation of transcription (GO:0045991)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
carbon catabolite regulation of transcription (GO:0045990)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
translocation of peptides or proteins into host (GO:0042000)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
microspike assembly (GO:0030035)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell differentiation (GO:0014816)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
microvillus assembly (GO:0030033)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
muscle cell migration (GO:0014812)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
negative regulation of heart rate (GO:0010459)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
exit from mitosis (GO:0010458)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
centriole-centriole cohesion (GO:0010457)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell fate commitment (GO:0010454)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell fate commitment (GO:0010453)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
histone H3-K36 methylation (GO:0010452)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell mediated immune response to tumor cell (GO:0002841)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell mediated immune response to tumor cell (GO:0002840)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle contraction (GO:0045988)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of nucleotide metabolic process (GO:0045981)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
negative regulation of nucleotide metabolic process (GO:0045980)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cellular manganese ion homeostasis (GO:0030026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circadian sleep/wake cycle process (GO:0022410)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of immune response to tumor cell (GO:0002839)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
response to acidic pH (GO:0010447)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of immune response to tumor cell (GO:0002838)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of immune response to tumor cell (GO:0002837)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
response to alkaline pH (GO:0010446)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to tumor cell (GO:0002836)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to tumor cell (GO:0002835)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of response to tumor cell (GO:0002834)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
fungiform papilla formation (GO:0061198)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fungiform papilla morphogenesis (GO:0061197)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of type 2 immune response (GO:0002830)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
fungiform papilla development (GO:0061196)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
taste bud development (GO:0061193)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translation, ncRNA-mediated (GO:0045975)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of translation, ncRNA-mediated (GO:0045974)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell cycle phase (GO:0022403)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
maintenance of cell polarity (GO:0030011)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
negative adaptation of signaling pathway (GO:0022401)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of type 2 immune response (GO:0002829)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of type 2 immune response (GO:0002828)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of T-helper 1 type immune response (GO:0002827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T-helper 1 type immune response (GO:0002825)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of ribosomal DNA heterochromatin formation (GO:0061188)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of rDNA heterochromatin formation (GO:0061187)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of dermatome development (GO:0061184)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of dermatome development (GO:0061183)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dopamine metabolic process (GO:0045964)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of chondrocyte development (GO:0061181)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of dopamine metabolic process (GO:0045963)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelium development (GO:0061180)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
DNA methylation on cytosine within a CG sequence (GO:0010424)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
hydrogen peroxide-mediated programmed cell death (GO:0010421)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, classical pathway (GO:0045959)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation, alternative pathway (GO:0045957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of establishment of bipolar cell polarity (GO:0061172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic recombination (GO:0045951)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic recombination (GO:0045950)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to 11-deoxycorticosterone (GO:1903496)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase III (GO:0045945)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
endoplasmic reticulum polarization (GO:0061163)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of monopolar cell polarity (GO:0061162)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of transcription by RNA polymerase I (GO:0045943)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cytokinesis (GO:1903490)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of steroid metabolic process (GO:0045940)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
box H/ACA RNA metabolic process (GO:0033979)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of lactation (GO:1903489)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
3'-UTR-mediated mRNA destabilization (GO:0061158)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
choline metabolic process (GO:0019695)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of lactation (GO:1903487)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate metabolic process (GO:0019694)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pulmonary artery morphogenesis (GO:0061156)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate metabolic process (GO:0019692)	21	0	.55	-	 < 0.01	1.00E00	1.00E00
trachea gland development (GO:0061153)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trachea submucosa development (GO:0061152)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
box C/D RNA metabolic process (GO:0033967)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
P-body assembly (GO:0033962)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
neural plate anterior/posterior regionalization (GO:0021999)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neural plate mediolateral regionalization (GO:0021998)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate axis specification (GO:0021997)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
neuropore closure (GO:0021995)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
initiation of neural tube closure (GO:0021993)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neural plate formation (GO:0021990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of female receptivity (GO:0045925)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of female receptivity (GO:0045924)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
lung ciliated cell differentiation (GO:0061141)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid metabolic process (GO:0045922)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
lung secretory cell differentiation (GO:0061140)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
olfactory cortex development (GO:0021989)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
habenula development (GO:0021986)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neurohypophysis development (GO:0021985)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adenohypophysis development (GO:0021984)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process, methylmalonyl pathway (GO:0019678)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NAD catabolic process (GO:0019677)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ammonia assimilation cycle (GO:0019676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytolysis (GO:0045918)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
NAD metabolic process (GO:0019674)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
GDP-mannose metabolic process (GO:0019673)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of complement activation (GO:0045917)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of complement activation (GO:0045916)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic cell cycle DNA replication (GO:1903465)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of catecholamine metabolic process (GO:0045915)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of catecholamine metabolic process (GO:0045914)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic cell cycle DNA replication (GO:1903463)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of carbohydrate metabolic process (GO:0045913)	49	0	1.29	-	 < 0.01	6.38E-01	1.00E00
negative regulation of carbohydrate metabolic process (GO:0045912)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
negative regulation of DNA recombination (GO:0045910)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
telencephalon regionalization (GO:0021978)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lactate catabolic process (GO:1903457)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to lactate via pyruvate (GO:0019661)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational termination (GO:0045905)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycolytic fermentation (GO:0019660)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational fidelity (GO:0045903)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of G1 to G0 transition (GO:1903451)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of translational elongation (GO:0045901)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of G1 to G0 transition (GO:1903450)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of translational elongation (GO:0045900)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
corticospinal neuron axon guidance (GO:0021966)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
spinal cord ventral commissure morphogenesis (GO:0021965)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glucose catabolic process to lactate (GO:0019659)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
anterior commissure morphogenesis (GO:0021960)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
lung proximal/distal axis specification (GO:0061115)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein transport from ciliary membrane to plasma membrane (GO:1903445)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of brown fat cell differentiation (GO:1903444)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to ciliary membrane (GO:1903441)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
dense core granule biogenesis (GO:0061110)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aerobic electron transport chain (GO:0019646)	47	0	1.24	-	 < 0.01	6.34E-01	1.00E00
seminal vesicle epithelium development (GO:0061108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
seminal vesicle development (GO:0061107)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of constitutive secretory pathway (GO:1903433)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroendocrine cell differentiation (GO:0061101)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell maturation (GO:1903431)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell maturation (GO:1903430)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formation of radial glial scaffolds (GO:0021943)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of Purkinje cell (GO:0021942)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
protein localization to microtubule cytoskeleton (GO:0072698)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to cell cortex (GO:0072697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell maturation (GO:1903429)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
regulation of DNA recombination at telomere (GO:0072695)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle recycling (GO:1903422)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor tangential migration (GO:0021935)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hindbrain tangential cell migration (GO:0021934)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
radial glia guided migration of cerebellar granule cell (GO:0021933)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
hindbrain radial glia guided cell migration (GO:0021932)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
urea metabolic process (GO:0019627)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebellar granule cell precursor proliferation (GO:0021930)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
short-chain fatty acid catabolic process (GO:0019626)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell extravasation (GO:0072683)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
response to glycoside (GO:1903416)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
physiological muscle hypertrophy (GO:0003298)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
atrial ventricular junction remodeling (GO:0003294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac septum cell differentiation (GO:0003292)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
atrial septum secundum morphogenesis (GO:0003290)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell proliferation in external granule layer (GO:0021924)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
thymocyte migration (GO:0072679)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T cell migration (GO:0072678)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
eosinophil migration (GO:0072677)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
reactive oxygen species biosynthetic process (GO:1903409)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
osteoclast fusion (GO:0072675)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903408)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903407)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
catechol-containing compound catabolic process (GO:0019614)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
multinuclear osteoclast differentiation (GO:0072674)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903406)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lamellipodium morphogenesis (GO:0072673)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
atrial septum primum morphogenesis (GO:0003289)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
septum secundum development (GO:0003285)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
septum primum development (GO:0003284)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrial septum development (GO:0003283)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to vacuole (GO:0072666)	45	0	1.18	-	 < 0.01	6.31E-01	1.00E00
2-oxobutyrate catabolic process (GO:0019606)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to peroxisome (GO:0072663)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
protein localization to peroxisome (GO:0072662)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in plasma membrane (GO:0072660)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of endoribonuclease activity (GO:0060699)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid catabolic process (GO:0060697)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid catabolic process (GO:0060696)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
chemosensory behavior (GO:0007635)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
epithelial cell maturation involved in salivary gland development (GO:0060691)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
jump response (GO:0007630)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
endocardial cushion fusion (GO:0003274)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell migration involved in endocardial cushion formation (GO:0003273)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dorsal/ventral neural tube patterning (GO:0021904)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
rostrocaudal neural tube patterning (GO:0021903)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in membrane (GO:0072658)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
maintenance of protein location in mitochondrion (GO:0072656)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	56	0	1.47	-	 < 0.01	4.06E-01	1.00E00
negative regulation of prostatic bud formation (GO:0060686)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of prostatic bud formation (GO:0060685)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
grooming behavior (GO:0007625)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
ultradian rhythm (GO:0007624)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
epithelial-mesenchymal cell signaling (GO:0060684)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
rhythmic behavior (GO:0007622)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
primary ureteric bud growth (GO:0060682)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of female receptivity (GO:0007621)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
copulation (GO:0007620)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of secondary heart field cardioblast proliferation (GO:0003266)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cardioblast proliferation (GO:0003264)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
courtship behavior (GO:0007619)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
ureteric bud elongation (GO:0060677)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mating behavior (GO:0007617)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
ureteric bud formation (GO:0060676)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell morphogenesis involved in placental branching (GO:0060672)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branching involved in labyrinthine layer morphogenesis (GO:0060670)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of membrane depolarization (GO:0003254)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
UDP-glucuronate metabolic process (GO:0046398)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
interleukin-33 production (GO:0072639)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
embryonic placenta morphogenesis (GO:0060669)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
sensory perception of smell (GO:0007608)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of phospholipid efflux (GO:1902999)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of neurofibrillary tangle assembly (GO:1902998)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sensory perception of chemical stimulus (GO:0007606)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
regulation of neurofibrillary tangle assembly (GO:1902996)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of phospholipid efflux (GO:1902995)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of phospholipid efflux (GO:1902994)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phototransduction, visible light (GO:0007603)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
phototransduction (GO:0007602)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
salivary gland cavitation (GO:0060662)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
submandibular salivary gland formation (GO:0060661)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
circumferential growth involved in left ventricle morphogenesis (GO:0003243)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
growth involved in heart morphogenesis (GO:0003241)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate catabolic process (GO:0046386)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
deoxyribose phosphate biosynthetic process (GO:0046385)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
CMP-N-acetylneuraminate metabolic process (GO:0046381)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nipple morphogenesis (GO:0060658)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
extracellular polysaccharide metabolic process (GO:0046379)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac atrium development (GO:0003230)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
fructose biosynthetic process (GO:0046370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland bud morphogenesis (GO:0060648)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication termination (GO:1902979)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication initiation (GO:1902975)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
mammary gland epithelial cell differentiation (GO:0060644)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
ventricular compact myocardium morphogenesis (GO:0003223)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
GDP-L-fucose metabolic process (GO:0046368)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
monosaccharide catabolic process (GO:0046365)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
monosaccharide biosynthetic process (GO:0046364)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
2-oxobutyrate metabolic process (GO:0046361)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
telomere tethering at nuclear periphery (GO:0034398)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
telomere localization (GO:0034397)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
mitotic DNA replication (GO:1902969)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
protein localization to cell surface (GO:0034394)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
mesenchymal-epithelial cell signaling (GO:0060638)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
regulation of smooth muscle cell apoptotic process (GO:0034391)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
smooth muscle cell apoptotic process (GO:0034390)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription initiation by RNA polymerase II (GO:0060633)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of microtubule-based movement (GO:0060632)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
regulation of meiosis I (GO:0060631)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac right ventricle formation (GO:0003219)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cardiac right ventricle morphogenesis (GO:0003215)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cardiac right atrium morphogenesis (GO:0003213)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cardiac ventricle formation (GO:0003211)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
acetyl-CoA catabolic process (GO:0046356)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
disaccharide biosynthetic process (GO:0046351)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lipid droplet organization (GO:0034389)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle clearance (GO:0034384)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle clearance (GO:0034383)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
chylomicron remnant clearance (GO:0034382)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle clearance (GO:0034381)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle assembly (GO:0034380)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of early endosome to recycling endosome transport (GO:1902954)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of chromosome condensation (GO:0060623)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic spine maintenance (GO:1902952)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of dendritic spine maintenance (GO:1902951)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
regulation of cholesterol import (GO:0060620)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cardiac atrium morphogenesis (GO:0003209)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
cardiac chamber formation (GO:0003207)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
amino sugar biosynthetic process (GO:0046349)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
amino sugar catabolic process (GO:0046348)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
CDP-diacylglycerol metabolic process (GO:0046341)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
diacylglycerol catabolic process (GO:0046340)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle assembly (GO:0034379)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
chylomicron assembly (GO:0034378)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
craniofacial suture morphogenesis (GO:0097094)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle assembly (GO:0034377)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
high-density lipoprotein particle remodeling (GO:0034375)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of tau-protein kinase activity (GO:1902949)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
nipple development (GO:0060618)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
low-density lipoprotein particle remodeling (GO:0034374)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of tau-protein kinase activity (GO:1902948)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tau-protein kinase activity (GO:1902947)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
very-low-density lipoprotein particle remodeling (GO:0034372)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to early endosome (GO:1902946)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
mammary gland bud formation (GO:0060615)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
chylomicron remodeling (GO:0034371)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
fat pad development (GO:0060613)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
diacylglycerol metabolic process (GO:0046339)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
phosphatidylethanolamine catabolic process (GO:0046338)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
methyl-branched fatty acid metabolic process (GO:0097089)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
lateral inhibition (GO:0046331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
plasma lipoprotein particle remodeling (GO:0034369)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein-lipid complex remodeling (GO:0034368)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
protein-containing complex remodeling (GO:0034367)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of intracellular calcium activated chloride channel activity (GO:1902938)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tube lumen cavitation (GO:0060605)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland duct morphogenesis (GO:0060603)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
positive regulation of alcohol biosynthetic process (GO:1902932)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
lateral sprouting from an epithelium (GO:0060601)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of alcohol biosynthetic process (GO:1902931)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of alcohol biosynthetic process (GO:1902930)	28	0	.74	-	 < 0.01	1.00E00	1.00E00
negative regulation of JNK cascade (GO:0046329)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
glycerol biosynthetic process from pyruvate (GO:0046327)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glucose import (GO:0046325)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
glucose import (GO:0046323)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of fatty acid oxidation (GO:0046322)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
ductus arteriosus closure (GO:0097070)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glial cell apoptotic process (GO:0034352)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of glial cell apoptotic process (GO:0034351)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of glial cell apoptotic process (GO:0034350)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
phosphocreatine biosynthetic process (GO:0046314)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
response to thyroxine (GO:0097068)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cellular response to thyroid hormone stimulus (GO:0097067)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
response to thyroid hormone (GO:0097066)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
glial cell apoptotic process (GO:0034349)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
anterior head development (GO:0097065)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
ncRNA export from nucleus (GO:0097064)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
dendritic spine maintenance (GO:0097062)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to type III interferon (GO:0034342)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein polyubiquitination (GO:1902916)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
response to type I interferon (GO:0034340)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
alkanesulfonate biosynthetic process (GO:0046305)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
L-kynurenine metabolic process (GO:0097052)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adherens junction maintenance (GO:0034334)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell apoptotic process (GO:0097050)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
adherens junction assembly (GO:0034333)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
negative regulation of autophagosome assembly (GO:1902902)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
dendritic cell apoptotic process (GO:0097048)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
phosphatidylserine exposure on blood platelet (GO:0097045)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K56 acetylation (GO:0097043)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle adaptation (GO:0014745)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle adaptation (GO:0014744)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
COP9 signalosome assembly (GO:0010387)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein linear polyubiquitination (GO:0097039)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
heme export (GO:0097037)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
diol biosynthetic process (GO:0034312)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
diol metabolic process (GO:0034311)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of muscle atrophy (GO:0014737)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of muscle atrophy (GO:0014736)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of muscle atrophy (GO:0014735)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
skeletal muscle hypertrophy (GO:0014734)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
skeletal muscle atrophy (GO:0014732)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
immune response-inhibiting signal transduction (GO:0002765)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid leukocyte differentiation (GO:0002763)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
primary alcohol biosynthetic process (GO:0034309)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
dendritic cell dendrite assembly (GO:0097026)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary alcohol metabolic process (GO:0034308)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
Toll signaling pathway (GO:0008063)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of antimicrobial humoral response (GO:0002759)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
innate immune response-activating signal transduction (GO:0002758)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
cell surface pattern recognition receptor signaling pathway (GO:0002752)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of anion channel activity (GO:0010360)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
eye pigment granule organization (GO:0008057)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
mitochondrial fusion (GO:0008053)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
female courtship behavior (GO:0008050)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
skeletal muscle satellite cell activation (GO:0014719)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of anion channel activity (GO:0010359)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
antigen processing and presentation following phagocytosis (GO:0002747)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
male courtship behavior (GO:0008049)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
energy homeostasis (GO:0097009)	22	0	.58	-	 < 0.01	1.00E00	1.00E00
regulation of plasma lipoprotein particle levels (GO:0097006)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic assembly at neuromuscular junction (GO:0045887)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic assembly at neuromuscular junction (GO:0045886)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of smoothened signaling pathway (GO:0045880)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein tyrosine kinase activity (GO:0061099)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of myeloid dendritic cell cytokine production (GO:0002733)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
synaptic target recognition (GO:0008039)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of dendritic cell cytokine production (GO:0002732)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of smoothened signaling pathway (GO:0045879)	23	0	.61	-	 < 0.01	1.00E00	1.00E00
regulation of dendritic cell cytokine production (GO:0002730)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of sister chromatid cohesion (GO:0045876)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of sister chromatid cohesion (GO:0045875)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tRNA processing (GO:0008033)	90	0	2.37	-	 < 0.01	1.77E-01	1.00E00
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein K6-linked ubiquitination (GO:0085020)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell cytokine production (GO:0002726)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of T cell cytokine production (GO:0002725)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of T cell cytokine production (GO:0002724)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
response to gamma radiation (GO:0010332)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
regulation of sequestering of zinc ion (GO:0061088)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of histone H3-K27 methylation (GO:0061087)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
negative regulation of histone H3-K27 methylation (GO:0061086)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of histone H3-K27 methylation (GO:0061085)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein refolding (GO:0061084)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of protein refolding (GO:0061083)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myeloid leukocyte cytokine production (GO:0061082)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of cytokine production involved in immune response (GO:0002719)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of natural killer cell mediated immunity (GO:0002717)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
negative regulation of natural killer cell mediated immunity (GO:0002716)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
membrane invagination (GO:0010324)	29	0	.76	-	 < 0.01	1.00E00	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of B cell mediated immunity (GO:0002713)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of T cell mediated immunity (GO:0002711)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
ciliary body morphogenesis (GO:0061073)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
iris morphogenesis (GO:0061072)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pH reduction (GO:0045851)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detoxification of zinc ion (GO:0010312)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide metabolic process (GO:0010310)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of production of molecular mediator of immune response (GO:0002701)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of adherens junction organization (GO:1903393)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of striated muscle tissue development (GO:0045844)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of striated muscle tissue development (GO:0045843)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
positive regulation of membrane potential (GO:0045838)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
positive regulation of homophilic cell adhesion (GO:1903387)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
myotome development (GO:0061055)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of homophilic cell adhesion (GO:1903385)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of meiotic nuclear division (GO:0045835)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
nucleoside bisphosphate catabolic process (GO:0033869)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of NAD(P)H oxidase activity (GO:0033864)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of NAD(P)H oxidase activity (GO:0033860)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte development (GO:0021897)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain astrocyte differentiation (GO:0021896)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cerebral cortex neuron differentiation (GO:0021895)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron development (GO:0021894)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
olfactory bulb interneuron development (GO:0021891)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
cell growth involved in cardiac muscle cell development (GO:0061049)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
regulation of mitotic chromosome condensation (GO:1903379)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of isotype switching (GO:0045829)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
glucuronate metabolic process (GO:0019585)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of branching involved in lung morphogenesis (GO:0061047)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of branching involved in lung morphogenesis (GO:0061046)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of isoprenoid metabolic process (GO:0045828)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of wound healing (GO:0061045)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
negative regulation of isoprenoid metabolic process (GO:0045827)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vascular wound healing (GO:0061044)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of vascular wound healing (GO:0061043)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
female gonad morphogenesis (GO:0061040)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycolytic process (GO:0045821)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycolytic process (GO:0045820)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
olfactory bulb interneuron differentiation (GO:0021889)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
uterus morphogenesis (GO:0061038)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cartilage development (GO:0061037)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
positive regulation of glycogen catabolic process (GO:0045819)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of fear response (GO:1903367)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
positive regulation of cartilage development (GO:0061036)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of glycogen catabolic process (GO:0045818)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of fear response (GO:1903366)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cartilage development (GO:0061035)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
regulation of fear response (GO:1903365)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
olfactory bulb mitral cell layer development (GO:0061034)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epigenetic maintenance of chromatin in transcription-competent conformation (GO:0045815)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
secretion by lung epithelial cell involved in lung growth (GO:0061033)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
visceral serous pericardium development (GO:0061032)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
endodermal digestive tract morphogenesis (GO:0061031)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
protein localization to basolateral plasma membrane (GO:1903361)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
forebrain neuron fate commitment (GO:0021877)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
forebrain neuroblast division (GO:0021873)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
forebrain regionalization (GO:0021871)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
eyelid development in camera-type eye (GO:0061029)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
Cajal-Retzius cell differentiation (GO:0021870)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of Golgi organization (GO:1903358)	15	0	.39	-	 < 0.01	1.00E00	1.00E00
glycerol catabolic process (GO:0019563)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of nucleus organization (GO:1903353)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
hemostasis (GO:0007599)	35	0	.92	-	 < 0.01	1.00E00	1.00E00
L-ornithine transmembrane transport (GO:1903352)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
blood coagulation, intrinsic pathway (GO:0007597)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
blood coagulation (GO:0007596)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
forebrain ventricular zone progenitor cell division (GO:0021869)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
forebrain radial glial cell differentiation (GO:0021861)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron development (GO:0021860)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
positive regulation of bicellular tight junction assembly (GO:1903348)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of bicellular tight junction assembly (GO:1903347)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
snRNA import into nucleus (GO:0061015)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
glutamate catabolic process to aspartate (GO:0019550)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
excretion (GO:0007588)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
gall bladder development (GO:0061010)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
digestion (GO:0007586)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
respiratory gaseous exchange by respiratory system (GO:0007585)	27	0	.71	-	 < 0.01	1.00E00	1.00E00
response to nutrient (GO:0007584)	26	0	.68	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron differentiation (GO:0021859)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
cerebral cortex GABAergic interneuron migration (GO:0021853)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
pyramidal neuron migration to cerebral cortex (GO:0021852)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
common bile duct development (GO:0061009)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of vacuolar transport (GO:1903337)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of cell proliferation involved in kidney morphogenesis (GO:0061006)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of vacuolar transport (GO:1903336)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell differentiation involved in kidney development (GO:0061005)	16	0	.42	-	 < 0.01	1.00E00	1.00E00
propionate catabolic process (GO:0019543)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vacuolar transport (GO:1903335)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
propionate biosynthetic process (GO:0019542)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
positive regulation of protein folding (GO:1903334)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
propionate metabolic process (GO:0019541)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein folding (GO:1903333)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of protein folding (GO:1903332)	9	0	.24	-	 < 0.01	1.00E00	1.00E00
positive regulation of iron-sulfur cluster assembly (GO:1903331)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuroblast division in subventricular zone (GO:0021849)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ventricular zone neuroblast division (GO:0021847)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cell proliferation in forebrain (GO:0021846)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
regulation of iron-sulfur cluster assembly (GO:1903329)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of tRNA metabolic process (GO:1903327)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of tRNA metabolic process (GO:1903326)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
oxygen metabolic process (GO:0072592)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
oxalate transport (GO:0019532)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
taurine metabolic process (GO:0019530)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
parturition (GO:0007567)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
motogenic signaling involved in postnatal olfactory bulb interneuron migration (GO:0021837)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein maturation (GO:1903318)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
caveolin-mediated endocytosis (GO:0072584)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
tricuspid valve formation (GO:0003195)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mitral valve formation (GO:0003192)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
postnatal olfactory bulb interneuron migration (GO:0021827)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve formation (GO:0003190)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
substrate-dependent cerebral cortex tangential migration (GO:0021825)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
glycine receptor clustering (GO:0072579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of regulated secretory pathway (GO:1903307)	34	0	.89	-	 < 0.01	1.00E00	1.00E00
hepatocyte proliferation (GO:0072574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
histone H3-K4 trimethylation (GO:0080182)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
negative regulation of hexokinase activity (GO:1903300)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
primary sex determination, germ-line (GO:0007542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
heart valve formation (GO:0003188)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
tricuspid valve morphogenesis (GO:0003186)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve morphogenesis (GO:0003185)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
layer formation in cerebral cortex (GO:0021819)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
pulmonary valve morphogenesis (GO:0003184)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitral valve morphogenesis (GO:0003183)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve morphogenesis (GO:0003181)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aortic valve morphogenesis (GO:0003180)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
L-methionine salvage from methylthioadenosine (GO:0019509)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
lytic vacuole organization (GO:0080171)	62	0	1.63	-	 < 0.01	4.11E-01	1.00E00
hydrogen peroxide transmembrane transport (GO:0080170)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
type B pancreatic cell maturation (GO:0072560)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
primary sex determination (GO:0007538)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
mammary gland specification (GO:0060594)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
sex determination (GO:0007530)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
heart valve morphogenesis (GO:0003179)	19	0	.50	-	 < 0.01	1.00E00	1.00E00
tricuspid valve development (GO:0003175)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
mitral valve development (GO:0003174)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
sinoatrial valve development (GO:0003172)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
atrioventricular valve development (GO:0003171)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cerebral cortex tangential migration (GO:0021800)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
regulation of protein serine/threonine phosphatase activity (GO:0080163)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
terminal button organization (GO:0072553)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
neuromuscular junction development (GO:0007528)	32	0	.84	-	 < 0.01	1.00E00	1.00E00
regulation of lipoprotein lipid oxidation (GO:0060587)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adult somatic muscle development (GO:0007527)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
multicellular organismal iron ion homeostasis (GO:0060586)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
somatic muscle development (GO:0007525)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
muscle cell fate determination (GO:0007521)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell fate commitment involved in pattern specification (GO:0060581)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
myoblast fusion (GO:0007520)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
bundle of His development (GO:0003166)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
Purkinje myocyte development (GO:0003165)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
His-Purkinje system development (GO:0003164)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
atrioventricular node development (GO:0003162)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cardiac conduction system development (GO:0003161)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
T-helper 17 cell lineage commitment (GO:0072540)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
ventral spinal cord interneuron fate commitment (GO:0060579)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
intestinal epithelial cell maturation (GO:0060574)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
cell fate specification involved in pattern specification (GO:0060573)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
adult heart development (GO:0007512)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial bud (GO:0060572)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
morphogenesis of an epithelial fold (GO:0060571)	10	0	.26	-	 < 0.01	1.00E00	1.00E00
regulation of animal organ formation (GO:0003156)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
muscular septum morphogenesis (GO:0003150)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
T-helper 17 cell differentiation (GO:0072539)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
glycolate biosynthetic process (GO:0046295)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
formaldehyde catabolic process (GO:0046294)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
T-helper 17 type immune response (GO:0072538)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
formaldehyde biosynthetic process (GO:0046293)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
fibroblast activation (GO:0072537)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
formaldehyde metabolic process (GO:0046292)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
purine-containing compound transmembrane transport (GO:0072530)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mesoderm migration involved in gastrulation (GO:0007509)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of termination of DNA-templated transcription (GO:0060567)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of postsynaptic density protein 95 clustering (GO:1902897)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
positive regulation of termination of DNA-templated transcription (GO:0060566)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
terminal web assembly (GO:1902896)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of miRNA transcription (GO:1902895)	25	0	.66	-	 < 0.01	1.00E00	1.00E00
negative regulation of miRNA transcription (GO:1902894)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
neuroepithelial cell differentiation (GO:0060563)	18	0	.47	-	 < 0.01	1.00E00	1.00E00
regulation of miRNA transcription (GO:1902893)	33	0	.87	-	 < 0.01	1.00E00	1.00E00
apoptotic process involved in morphogenesis (GO:0060561)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
mesodermal cell fate specification (GO:0007501)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
membranous septum morphogenesis (GO:0003149)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
outflow tract septum morphogenesis (GO:0003148)	12	0	.32	-	 < 0.01	1.00E00	1.00E00
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound catabolic process (GO:0072529)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound biosynthetic process (GO:0072528)	14	0	.37	-	 < 0.01	1.00E00	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	30	0	.79	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound catabolic process (GO:0072526)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound biosynthetic process (GO:0072525)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	31	0	.82	-	 < 0.01	1.00E00	1.00E00
purine-containing compound catabolic process (GO:0072523)	24	0	.63	-	 < 0.01	1.00E00	1.00E00
seminiferous tubule development (GO:0072520)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
protein localization to spindle microtubule (GO:1902889)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
protein localization to astral microtubule (GO:1902888)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vitamin D biosynthetic process (GO:0060556)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of response to oxidative stress (GO:1902884)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
negative regulation of response to oxidative stress (GO:1902883)	20	0	.53	-	 < 0.01	1.00E00	1.00E00
primary heart field specification (GO:0003138)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
AMP transport (GO:0080121)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
CAAX-box protein maturation (GO:0080120)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
negative regulation of necrotic cell death (GO:0060547)	17	0	.45	-	 < 0.01	1.00E00	1.00E00
negative regulation of necroptotic process (GO:0060546)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
positive regulation of necroptotic process (GO:0060545)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of necroptotic process (GO:0060544)	13	0	.34	-	 < 0.01	1.00E00	1.00E00
regulation of strand invasion (GO:0060542)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
detection of nodal flow (GO:0003127)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
trivalent inorganic anion homeostasis (GO:0072506)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
DNA demethylation (GO:0080111)	7	0	.18	-	 < 0.01	1.00E00	1.00E00
cellular trivalent inorganic anion homeostasis (GO:0072502)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
diaphragm development (GO:0060539)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
cartilage morphogenesis (GO:0060536)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
trachea cartilage morphogenesis (GO:0060535)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of retina development in camera-type eye (GO:1902866)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
trachea cartilage development (GO:0060534)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by circulating norepinephrine (GO:0003117)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of vasoconstriction by norepinephrine (GO:0003116)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
propionyl-CoA metabolic process (GO:1902858)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus morphogenesis (GO:0060526)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of non-motile cilium assembly (GO:1902856)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prostate glandular acinus development (GO:0060525)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
prostate epithelial cord elongation (GO:0060523)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of glomerular filtration (GO:0003105)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of glomerular filtration (GO:0003104)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of neuronal signal transduction (GO:1902847)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostatic bud formation (GO:0060513)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
prostate gland morphogenesis (GO:0060512)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
type II pneumocyte differentiation (GO:0060510)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
type I pneumocyte differentiation (GO:0060509)	6	0	.16	-	 < 0.01	1.00E00	1.00E00
smoothened signaling pathway involved in lung development (GO:0060506)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	4	0	.11	-	 < 0.01	1.00E00	1.00E00
aflatoxin catabolic process (GO:0046223)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
aflatoxin metabolic process (GO:0046222)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of late endosome to lysosome transport (GO:1902824)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of late endosome to lysosome transport (GO:1902823)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of late endosome to lysosome transport (GO:1902822)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nitric oxide catabolic process (GO:0046210)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of transcription elongation by RNA polymerase II (GO:0034244)	11	0	.29	-	 < 0.01	1.00E00	1.00E00
negative regulation of protein localization to microtubule (GO:1902817)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
regulation of protein localization to microtubule (GO:1902816)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
positive regulation of macrophage fusion (GO:0034241)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of macrophage fusion (GO:0034240)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
nitric oxide metabolic process (GO:0046209)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
spermine catabolic process (GO:0046208)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
nor-spermidine metabolic process (GO:0046204)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
spermidine catabolic process (GO:0046203)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of macrophage fusion (GO:0034239)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
macrophage fusion (GO:0034238)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
regulation of skeletal muscle fiber differentiation (GO:1902809)	5	0	.13	-	 < 0.01	1.00E00	1.00E00
islet amyloid polypeptide processing (GO:0034231)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
positive regulation of synaptic vesicle transport (GO:1902805)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
enkephalin processing (GO:0034230)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
negative regulation of synaptic vesicle transport (GO:1902804)	1	0	.03	-	 < 0.01	1.00E00	1.00E00
negative regulation of leukocyte chemotaxis (GO:0002689)	8	0	.21	-	 < 0.01	1.00E00	1.00E00
somatic recombination of T cell receptor gene segments (GO:0002681)	2	0	.05	-	 < 0.01	1.00E00	1.00E00
tRNA thio-modification (GO:0034227)	3	0	.08	-	 < 0.01	1.00E00	1.00E00
